Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	Func.ensGene	Gene.ensGene	GeneDetail.ensGene	ExonicFunc.ensGene	AAChange.ensGene	Func.knownGene	Gene.knownGene	GeneDetail.knownGene	ExonicFunc.knownGene	AAChange.knownGene	esp6500siv2_all	1000g2015aug_all	ExAC_ALL	ExAC_AFR	ExAC_AMR	ExAC_EAS	ExAC_FIN	ExAC_NFE	ExAC_OTH	ExAC_SAS	avsnp147	SIFT_score	SIFT_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_pred	LRT_score	LRT_pred	MutationTaster_score	MutationTaster_pred	MutationAssessor_score	MutationAssessor_pred	FATHMM_score	FATHMM_pred	PROVEAN_score	PROVEAN_pred	VEST3_score	CADD_raw	CADD_phred	DANN_score	fathmm-MKL_coding_score	fathmm-MKL_coding_pred	MetaSVM_score	MetaSVM_pred	MetaLR_score	MetaLR_pred	integrated_fitCons_score	integrated_confidence_value	GERP++_RS	phyloP7way_vertebrate	phyloP20way_mammalian	phastCons7way_vertebrate	phastCons20way_mammalian	SiPhy_29way_logOdds	dbscSNV_ADA_SCORE	dbscSNV_RF_SCORE	Interpro_domain	CLINSIG	CLNDBN	CLNACC	CLNDSDB	CLNDSDBID	cosmic70	ICGC_Id	ICGC_Occurrence	Otherinfo
10	104850745	104850745	T	G	exonic	NT5C2	.	nonsynonymous SNV	NT5C2:NM_001134373:exon16:c.A1220C:p.D407A,NT5C2:NM_012229:exon17:c.A1220C:p.D407A	exonic	ENSG00000076685	.	nonsynonymous SNV	ENSG00000076685:ENST00000421281:exon5:c.A320C:p.D107A,ENSG00000076685:ENST00000404739:exon15:c.A1220C:p.D407A,ENSG00000076685:ENST00000423468:exon15:c.A1133C:p.D378A,ENSG00000076685:ENST00000343289:exon16:c.A1220C:p.D407A	exonic	NT5C2	.	nonsynonymous SNV	NT5C2:uc010qqp.2:exon15:c.A1133C:p.D378A,NT5C2:uc001kwq.3:exon16:c.A1220C:p.D407A,NT5C2:uc001kwo.3:exon17:c.A1220C:p.D407A,NT5C2:uc001kwp.3:exon17:c.A761C:p.D254A	.	.	.	.	.	.	.	.	.	.	.	0.056	T	1.0	D	0.989	D	0.000	D	1	D	2.255	M	1.98	T	-7.66	D	0.797	6.730	32	0.997	0.997	D	-0.908	T	0.150	T	0.707	0	6.06	0.991	1.061	0.989	0.991	16.609	.	.	HAD-like domain	.	.	.	.	.	.	.	.	TCALL
10	104852955	104852955	C	T	exonic	NT5C2	.	nonsynonymous SNV	NT5C2:NM_001134373:exon14:c.G1100A:p.R367Q,NT5C2:NM_012229:exon15:c.G1100A:p.R367Q	exonic	ENSG00000076685	.	nonsynonymous SNV	ENSG00000076685:ENST00000421281:exon3:c.G200A:p.R67Q,ENSG00000076685:ENST00000404739:exon13:c.G1100A:p.R367Q,ENSG00000076685:ENST00000423468:exon13:c.G1013A:p.R338Q,ENSG00000076685:ENST00000343289:exon14:c.G1100A:p.R367Q	exonic	NT5C2	.	nonsynonymous SNV	NT5C2:uc010qqp.2:exon13:c.G1013A:p.R338Q,NT5C2:uc001kwq.3:exon14:c.G1100A:p.R367Q,NT5C2:uc001kwo.3:exon15:c.G1100A:p.R367Q,NT5C2:uc001kwp.3:exon15:c.G641A:p.R214Q	.	.	.	.	.	.	.	.	.	.	.	0.002	D	0.999	D	0.852	P	0.000	D	1	D	3.32	M	1.18	T	-3.54	D	0.928	6.832	33	1.000	0.989	D	-0.331	T	0.293	T	0.707	0	5.76	0.871	0.935	0.996	0.998	20.332	.	.	HAD-like domain	.	.	.	.	.	ID=COSM914303;OCCURENCE=1(large_intestine),1(endometrium)	MU71771	COCA-CN|1|187|0.00535,ALL-US|4|27|0.14815,STAD-US|1|289|0.00346,UCEC-US|1|246|0.00407,COAD-US|1|216|0.00463	TCALL
10	104852980	104852980	T	G	exonic;exonic	NT5C2	.	nonsynonymous SNV;nonsynonymous SNV	NT5C2:NM_001134373:exon14:c.A1075C:p.K359Q,NT5C2:NM_012229:exon15:c.A1075C:p.K359Q;NT5C2:NM_001134373:exon14:c.A1075C:p.K359Q,NT5C2:NM_012229:exon15:c.A1075C:p.K359Q	exonic;exonic	ENSG00000076685	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000076685:ENST00000421281:exon3:c.A175C:p.K59Q,ENSG00000076685:ENST00000404739:exon13:c.A1075C:p.K359Q,ENSG00000076685:ENST00000423468:exon13:c.A988C:p.K330Q,ENSG00000076685:ENST00000343289:exon14:c.A1075C:p.K359Q;ENSG00000076685:ENST00000421281:exon3:c.A175C:p.K59Q,ENSG00000076685:ENST00000404739:exon13:c.A1075C:p.K359Q,ENSG00000076685:ENST00000423468:exon13:c.A988C:p.K330Q,ENSG00000076685:ENST00000343289:exon14:c.A1075C:p.K359Q	exonic;exonic	NT5C2	.	nonsynonymous SNV;nonsynonymous SNV	NT5C2:uc010qqp.2:exon13:c.A988C:p.K330Q,NT5C2:uc001kwq.3:exon14:c.A1075C:p.K359Q,NT5C2:uc001kwo.3:exon15:c.A1075C:p.K359Q,NT5C2:uc001kwp.3:exon15:c.A616C:p.K206Q;NT5C2:uc010qqp.2:exon13:c.A988C:p.K330Q,NT5C2:uc001kwq.3:exon14:c.A1075C:p.K359Q,NT5C2:uc001kwo.3:exon15:c.A1075C:p.K359Q,NT5C2:uc001kwp.3:exon15:c.A616C:p.K206Q	.	.	.	.	.	.	.	.	.	.	.	0.005	D	1.0	D	0.998	D	0.000	D	1	D	2.52	M	1.85	T	-3.51	D	0.711	6.232	28.8	0.996	0.990	D	-0.738	T	0.189	T	0.707	0	5.76	0.991	1.061	0.996	1.000	16.369	.	.	HAD-like domain	.	.	.	.	.	.	.	.	ALL
10	104852980	104852980	T	G	exonic;exonic	NT5C2	.	nonsynonymous SNV;nonsynonymous SNV	NT5C2:NM_001134373:exon14:c.A1075C:p.K359Q,NT5C2:NM_012229:exon15:c.A1075C:p.K359Q;NT5C2:NM_001134373:exon14:c.A1075C:p.K359Q,NT5C2:NM_012229:exon15:c.A1075C:p.K359Q	exonic;exonic	ENSG00000076685	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000076685:ENST00000421281:exon3:c.A175C:p.K59Q,ENSG00000076685:ENST00000404739:exon13:c.A1075C:p.K359Q,ENSG00000076685:ENST00000423468:exon13:c.A988C:p.K330Q,ENSG00000076685:ENST00000343289:exon14:c.A1075C:p.K359Q;ENSG00000076685:ENST00000421281:exon3:c.A175C:p.K59Q,ENSG00000076685:ENST00000404739:exon13:c.A1075C:p.K359Q,ENSG00000076685:ENST00000423468:exon13:c.A988C:p.K330Q,ENSG00000076685:ENST00000343289:exon14:c.A1075C:p.K359Q	exonic;exonic	NT5C2	.	nonsynonymous SNV;nonsynonymous SNV	NT5C2:uc010qqp.2:exon13:c.A988C:p.K330Q,NT5C2:uc001kwq.3:exon14:c.A1075C:p.K359Q,NT5C2:uc001kwo.3:exon15:c.A1075C:p.K359Q,NT5C2:uc001kwp.3:exon15:c.A616C:p.K206Q;NT5C2:uc010qqp.2:exon13:c.A988C:p.K330Q,NT5C2:uc001kwq.3:exon14:c.A1075C:p.K359Q,NT5C2:uc001kwo.3:exon15:c.A1075C:p.K359Q,NT5C2:uc001kwp.3:exon15:c.A616C:p.K206Q	.	.	.	.	.	.	.	.	.	.	.	0.005	D	1.0	D	0.998	D	0.000	D	1	D	2.52	M	1.85	T	-3.51	D	0.711	6.232	28.8	0.996	0.990	D	-0.738	T	0.189	T	0.707	0	5.76	0.991	1.061	0.996	1.000	16.369	.	.	HAD-like domain	.	.	.	.	.	.	.	.	TCALL
10	123258034	123258034	A	T	exonic	FGFR2	.	nonsynonymous SNV	FGFR2:NM_001144914:exon9:c.T1311A:p.N437K,FGFR2:NM_001144916:exon9:c.T1302A:p.N434K,FGFR2:NM_001144917:exon10:c.T1299A:p.N433K,FGFR2:NM_001144918:exon10:c.T1296A:p.N432K,FGFR2:NM_023029:exon10:c.T1380A:p.N460K,FGFR2:NM_001144913:exon11:c.T1650A:p.N550K,FGFR2:NM_001144915:exon11:c.T1380A:p.N460K,FGFR2:NM_001144919:exon11:c.T1383A:p.N461K,FGFR2:NM_000141:exon12:c.T1647A:p.N549K,FGFR2:NM_022970:exon12:c.T1650A:p.N550K	exonic	ENSG00000066468	.	nonsynonymous SNV	ENSG00000066468:ENST00000429361:exon4:c.T423A:p.N141K,ENSG00000066468:ENST00000369061:exon9:c.T1311A:p.N437K,ENSG00000066468:ENST00000356226:exon10:c.T1296A:p.N432K,ENSG00000066468:ENST00000369059:exon10:c.T1305A:p.N435K,ENSG00000066468:ENST00000369060:exon10:c.T1299A:p.N433K,ENSG00000066468:ENST00000336553:exon11:c.T1374A:p.N458K,ENSG00000066468:ENST00000346997:exon11:c.T1641A:p.N547K,ENSG00000066468:ENST00000357555:exon11:c.T1380A:p.N460K,ENSG00000066468:ENST00000360144:exon11:c.T1383A:p.N461K,ENSG00000066468:ENST00000369056:exon11:c.T1650A:p.N550K,ENSG00000066468:ENST00000478859:exon11:c.T963A:p.N321K,ENSG00000066468:ENST00000351936:exon12:c.T1641A:p.N547K,ENSG00000066468:ENST00000358487:exon12:c.T1647A:p.N549K,ENSG00000066468:ENST00000369058:exon12:c.T1650A:p.N550K,ENSG00000066468:ENST00000457416:exon12:c.T1650A:p.N550K	exonic	FGFR2	.	nonsynonymous SNV	FGFR2:uc001lfg.4:exon5:c.T471A:p.N157K,FGFR2:uc021pzv.1:exon9:c.T1311A:p.N437K,FGFR2:uc021pzw.1:exon9:c.T1302A:p.N434K,FGFR2:uc010qtl.2:exon10:c.T1299A:p.N433K,FGFR2:uc010qtm.2:exon10:c.T1296A:p.N432K,FGFR2:uc031pxk.1:exon10:c.T1380A:p.N460K,FGFR2:uc001lfn.5:exon11:c.T477A:p.N159K,FGFR2:uc021pzx.1:exon11:c.T1380A:p.N460K,FGFR2:uc021qaa.1:exon11:c.T1650A:p.N550K,FGFR2:uc021qab.1:exon11:c.T1383A:p.N461K,FGFR2:uc021qac.1:exon11:c.T1434A:p.N478K,FGFR2:uc021pzy.1:exon12:c.T1650A:p.N550K,FGFR2:uc021pzz.1:exon12:c.T1647A:p.N549K	.	.	.	.	.	.	.	.	.	.	rs121913476	0.0	D	1.0	D	1.0	D	0.000	D	1	D	-0.145	N	-2.7	D	-4.8	D	0.507	5.591	26.5	0.998	0.824	D	0.135	D	0.616	D	0.635	0	2.67	0.090	0.196	0.998	0.999	7.515	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM427159,COSM427158,COSM36912,COSM1152148;OCCURENCE=1(lung),15(endometrium),4(breast)	MU12069	BRCA-EU|1|560|0.00179,BRCA-US|3|955|0.00314,UCEC-US|4|246|0.01626	EDA
10	131265545	131265545	C	T	exonic	MGMT	.	synonymous SNV	MGMT:NM_002412:exon1:c.C66T:p.R22R	exonic	ENSG00000170430	.	synonymous SNV	ENSG00000170430:ENST00000306010:exon1:c.C66T:p.R22R	exonic	MGMT	.	synonymous SNV	MGMT:uc001lkh.2:exon1:c.C66T:p.R22R	0.0437	0.0245607	0.0686	0.0165	0.0423	0	0.2047	0.1028	0.075	0.0491	rs16906252	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MU132887	COAD-US|1|216|0.00463	GBM
10	43609950	43609950	C	G	exonic	RET	.	nonsynonymous SNV	RET:NM_020630:exon11:c.C1902G:p.C634W,RET:NM_020975:exon11:c.C1902G:p.C634W	exonic	ENSG00000165731	.	nonsynonymous SNV	ENSG00000165731:ENST00000498820:exon5:c.C453G:p.C151W,ENSG00000165731:ENST00000340058:exon11:c.C1902G:p.C634W,ENSG00000165731:ENST00000355710:exon11:c.C1902G:p.C634W	exonic	RET	.	nonsynonymous SNV	RET:uc010qez.1:exon8:c.C1140G:p.C380W,RET:uc001jak.1:exon11:c.C1902G:p.C634W,RET:uc001jal.3:exon11:c.C1902G:p.C634W	.	.	.	.	.	.	.	.	.	.	rs77709286	0.003	D	1.0	D	0.999	D	0.000	D	1	A	2.47	M	-1.29	T	-7.66	D	0.992	6.012	27.9	0.995	0.867	D	1.119	D	0.975	D	0.696	0	3.62	0.871	0.935	0.831	0.825	12.576	.	.	.	Pathogenic|Pathogenic|Pathogenic	Multiple_endocrine_neoplasia,_type_2a|Pheochromocytoma|MEN2A_and_FMTC	RCV000014939.21|RCV000014940.25|RCV000021827.1	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM|.	C0025268:171400:ORPHA247698:61808009|C0031511:171300|.	ID=COSM975;OCCURENCE=5(thyroid)	.	.	THM
10	43617416	43617416	T	C	exonic	RET	.	nonsynonymous SNV	RET:NM_020630:exon16:c.T2753C:p.M918T,RET:NM_020975:exon16:c.T2753C:p.M918T	exonic	ENSG00000165731	.	nonsynonymous SNV	ENSG00000165731:ENST00000340058:exon16:c.T2753C:p.M918T,ENSG00000165731:ENST00000355710:exon16:c.T2753C:p.M918T	exonic	RET	.	nonsynonymous SNV	RET:uc010qez.1:exon13:c.T1991C:p.M664T,RET:uc001jak.1:exon16:c.T2753C:p.M918T,RET:uc001jal.3:exon16:c.T2753C:p.M918T	.	.	.	.	.	.	.	.	.	.	rs74799832	0.0	D	1.0	D	1.0	D	0.000	D	1	A	1.63	L	-2.68	D	-5.47	D	0.981	6.098	28.2	0.993	0.983	D	0.776	D	0.799	D	0.706	0	5.43	0.991	1.061	1.000	1.000	15.777	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Multiple_endocrine_neoplasia,_type_2b|Thyroid_carcinoma,_sporadic_medullary|Pheochromocytoma|not_provided|Multiple_endocrine_neoplasia,_type_2|Multiple_endocrine_neoplasia,_type_2a	RCV000014941.26|RCV000014942.22|RCV000014943.5|RCV000082054.6|RCV000161926.3|RCV000175096.1	MedGen:OMIM:Orphanet:SNOMED_CT:SNOMED_CT|MedGen|MedGen:OMIM|MedGen|MedGen:Orphanet:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT	C0025269:162300:ORPHA247709:6153000:61530001|C1833929|C0031511:171300|CN221809|CN073359:ORPHA653:61808009|C0025268:171400:ORPHA247698:61808009	ID=COSM965;OCCURENCE=1(breast),20(adrenal_gland),273(thyroid)	.	.	THM
10	89692904	89692904	C	T	exonic	PTEN	.	stopgain	PTEN:NM_000314:exon5:c.C388T:p.R130X,PTEN:NM_001304717:exon6:c.C907T:p.R303X	exonic	ENSG00000171862	.	stopgain	ENSG00000171862:ENST00000371953:exon5:c.C388T:p.R130X	exonic	PTEN	.	stopgain	PTEN:uc001kfb.3:exon5:c.C388T:p.R130X	.	.	8.237e-06	0	0	0	0	0	0	6.056e-05	rs121909224	.	.	.	.	.	.	0.000	D	1	A	.	.	.	.	.	.	.	12.360	39	0.998	0.946	D	.	.	.	.	0.722	0	5.22	0.871	0.852	1.000	1.000	18.778	.	.	Dual specificity phosphatase, catalytic domain;Protein-tyrosine phosphatase-like;Tensin phosphatase, lipid phosphatase domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Cowden_syndrome_1|Bannayan-Riley-Ruvalcaba_syndrome|Macrocephaly/autism_syndrome|not_provided|Hereditary_cancer-predisposing_syndrome|PTEN_hamartoma_tumor_syndrome	RCV000008263.4|RCV000008264.3|RCV000008265.3|RCV000078615.3|RCV000132187.4|RCV000199099.2	MedGen:OMIM|MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet|MedGen|MedGen:SNOMED_CT|MedGen:Orphanet	CN072330:158350|C0265326:153480:ORPHA109|C1854416:605309:ORPHA210548|CN221809|C0027672:699346009|C1959582:ORPHA306498	ID=COSM5152;OCCURENCE=1(lung),1(cervix),28(central_nervous_system),3(large_intestine),1(biliary_tract),5(prostate),2(ovary),1(soft_tissue),30(endometrium)	MU588799	GBM-US|3|268|0.01119,BRCA-EU|2|560|0.00357,SKCM-US|1|335|0.00299,PRAD-UK|1|108|0.00926,UCEC-US|7|246|0.02846	TH
10	89717672	89717672	C	T	exonic;exonic	PTEN	.	stopgain;stopgain	PTEN:NM_000314:exon7:c.C697T:p.R233X,PTEN:NM_001304718:exon7:c.C106T:p.R36X,PTEN:NM_001304717:exon8:c.C1216T:p.R406X;PTEN:NM_000314:exon7:c.C697T:p.R233X,PTEN:NM_001304718:exon7:c.C106T:p.R36X,PTEN:NM_001304717:exon8:c.C1216T:p.R406X	exonic;exonic	ENSG00000171862	.	stopgain;stopgain	ENSG00000171862:ENST00000371953:exon7:c.C697T:p.R233X;ENSG00000171862:ENST00000371953:exon7:c.C697T:p.R233X	exonic;exonic	PTEN	.	stopgain;stopgain	PTEN:uc001kfb.3:exon7:c.C697T:p.R233X;PTEN:uc001kfb.3:exon7:c.C697T:p.R233X	.	.	.	.	.	.	.	.	.	.	rs121909219	.	.	.	.	.	.	0.000	D	1	A	.	.	.	.	.	.	.	11.451	37	0.997	0.815	D	.	.	.	.	0.719	0	0.533	-0.058	0.807	0.993	0.999	14.484	.	.	C2 domain;Tensin phosphatase, C2 domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Cowden_syndrome_1|Bannayan-Riley-Ruvalcaba_syndrome|PTEN_hamartoma_tumor_syndrome|Hereditary_cancer-predisposing_syndrome|not_provided	RCV000008256.2|RCV000008257.2|RCV000128455.2|RCV000162649.3|RCV000212882.1	MedGen:OMIM|MedGen:OMIM:Orphanet|MedGen:Orphanet|MedGen:SNOMED_CT|MedGen	CN072330:158350|C0265326:153480:ORPHA109|C1959582:ORPHA306498|C0027672:699346009|CN221809	ID=COSM5154;OCCURENCE=1(ovary),1(soft_tissue),53(endometrium),11(large_intestine),1(prostate),17(central_nervous_system),4(lung),2(haematopoietic_and_lymphoid_tissue),2(cervix)	MU589331	COCA-CN|2|187|0.01070,PAEN-IT|1|37|0.02703,GBM-US|5|268|0.01866,STAD-US|3|289|0.01038,BRCA-EU|2|560|0.00357,CESC-US|1|194|0.00515,LUSC-KR|1|66|0.01515,UCEC-US|14|246|0.05691,MALY-DE|1|44|0.02273	BRACA
10	89717672	89717672	C	T	exonic;exonic	PTEN	.	stopgain;stopgain	PTEN:NM_000314:exon7:c.C697T:p.R233X,PTEN:NM_001304718:exon7:c.C106T:p.R36X,PTEN:NM_001304717:exon8:c.C1216T:p.R406X;PTEN:NM_000314:exon7:c.C697T:p.R233X,PTEN:NM_001304718:exon7:c.C106T:p.R36X,PTEN:NM_001304717:exon8:c.C1216T:p.R406X	exonic;exonic	ENSG00000171862	.	stopgain;stopgain	ENSG00000171862:ENST00000371953:exon7:c.C697T:p.R233X;ENSG00000171862:ENST00000371953:exon7:c.C697T:p.R233X	exonic;exonic	PTEN	.	stopgain;stopgain	PTEN:uc001kfb.3:exon7:c.C697T:p.R233X;PTEN:uc001kfb.3:exon7:c.C697T:p.R233X	.	.	.	.	.	.	.	.	.	.	rs121909219	.	.	.	.	.	.	0.000	D	1	A	.	.	.	.	.	.	.	11.451	37	0.997	0.815	D	.	.	.	.	0.719	0	0.533	-0.058	0.807	0.993	0.999	14.484	.	.	C2 domain;Tensin phosphatase, C2 domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Cowden_syndrome_1|Bannayan-Riley-Ruvalcaba_syndrome|PTEN_hamartoma_tumor_syndrome|Hereditary_cancer-predisposing_syndrome|not_provided	RCV000008256.2|RCV000008257.2|RCV000128455.2|RCV000162649.3|RCV000212882.1	MedGen:OMIM|MedGen:OMIM:Orphanet|MedGen:Orphanet|MedGen:SNOMED_CT|MedGen	CN072330:158350|C0265326:153480:ORPHA109|C1959582:ORPHA306498|C0027672:699346009|CN221809	ID=COSM5154;OCCURENCE=1(ovary),1(soft_tissue),53(endometrium),11(large_intestine),1(prostate),17(central_nervous_system),4(lung),2(haematopoietic_and_lymphoid_tissue),2(cervix)	MU589331	COCA-CN|2|187|0.01070,PAEN-IT|1|37|0.02703,GBM-US|5|268|0.01866,STAD-US|3|289|0.01038,BRCA-EU|2|560|0.00357,CESC-US|1|194|0.00515,LUSC-KR|1|66|0.01515,UCEC-US|14|246|0.05691,MALY-DE|1|44|0.02273	GBM
11	108218044	108218044	A	C	exonic	ATM	.	nonsynonymous SNV	ATM:NM_000051:exon59:c.A8623C:p.N2875H	exonic	ENSG00000149311	.	nonsynonymous SNV	ENSG00000149311:ENST00000278616:exon59:c.A8623C:p.N2875H,ENSG00000149311:ENST00000452508:exon60:c.A8623C:p.N2875H	exonic	ATM	.	nonsynonymous SNV	ATM:uc001pke.2:exon33:c.A4579C:p.N1527H,ATM:uc001pkb.1:exon59:c.A8623C:p.N2875H,ATM:uc009yxr.1:exon60:c.A8623C:p.N2875H	.	.	.	.	.	.	.	.	.	.	.	0.0	D	1.0	D	1.0	D	0.000	D	1	D	4.355	H	-3.27	D	-4.31	D	0.594	5.506	26.3	0.996	0.970	D	1.103	D	0.941	D	0.732	0	5.52	1.062	1.199	1.000	1.000	15.651	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Phosphatidylinositol 3/4-kinase, conserved site;Protein kinase-like domain	.	.	.	.	.	.	.	.	PRAD
1	11177096	11177096	C	A	exonic	MTOR	.	nonsynonymous SNV	MTOR:NM_004958:exon50:c.G6981T:p.M2327I	exonic	ENSG00000198793	.	nonsynonymous SNV	ENSG00000198793:ENST00000376838:exon12:c.G1596T:p.M532I,ENSG00000198793:ENST00000361445:exon50:c.G6981T:p.M2327I	exonic	MTOR	.	nonsynonymous SNV	MTOR:uc001asc.3:exon12:c.G1596T:p.M532I,MTOR:uc001asd.3:exon50:c.G6981T:p.M2327I	.	.	.	.	.	.	.	.	.	.	.	0.001	D	0.999	D	0.998	D	0.000	D	1	D	3.115	M	-0.94	T	-3.56	D	0.957	7.249	34	0.998	0.989	D	0.474	D	0.666	D	0.706	0	5.69	0.871	0.935	0.996	1.000	18.797	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Phosphatidylinositol 3/4-kinase, conserved site;Protein kinase-like domain	.	.	.	.	.	.	.	.	BRACA
1	11184573	11184573	G	T	exonic	MTOR	.	nonsynonymous SNV	MTOR:NM_004958:exon47:c.C6644A:p.S2215Y	exonic	ENSG00000198793	.	nonsynonymous SNV	ENSG00000198793:ENST00000376838:exon9:c.C1259A:p.S420Y,ENSG00000198793:ENST00000361445:exon47:c.C6644A:p.S2215Y	exonic	MTOR	.	nonsynonymous SNV	MTOR:uc001asc.3:exon9:c.C1259A:p.S420Y,MTOR:uc001asd.3:exon47:c.C6644A:p.S2215Y	.	.	.	.	.	.	.	.	.	.	.	0.004	D	0.984	D	0.876	P	0.000	D	1	D	2.83	M	-1.17	T	-2.92	D	0.931	6.788	32	0.996	0.996	D	0.424	D	0.655	D	0.707	0	5.8	0.917	1.044	0.995	1.000	18.296	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Protein kinase-like domain	.	.	.	.	.	ID=COSM20417;OCCURENCE=4(endometrium),3(large_intestine),1(kidney)	MU60722	KIRP-US|1|159|0.00629,CESC-US|1|194|0.00515,UCEC-US|3|246|0.01220,COAD-US|1|216|0.00463	EDA
1	11184580	11184580	G	A	exonic	MTOR	.	nonsynonymous SNV	MTOR:NM_004958:exon47:c.C6637T:p.P2213S	exonic	ENSG00000198793	.	nonsynonymous SNV	ENSG00000198793:ENST00000376838:exon9:c.C1252T:p.P418S,ENSG00000198793:ENST00000361445:exon47:c.C6637T:p.P2213S	exonic	MTOR	.	nonsynonymous SNV	MTOR:uc001asc.3:exon9:c.C1252T:p.P418S,MTOR:uc001asd.3:exon47:c.C6637T:p.P2213S	.	.	.	.	.	.	.	.	.	.	.	0.826	T	0.238	B	0.079	B	0.000	D	1	D	0.255	N	-1.07	T	-4.23	D	0.603	4.986	25.1	0.993	0.996	D	-0.734	T	0.234	T	0.707	0	5.8	0.917	1.044	1.000	1.000	18.296	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Protein kinase-like domain	.	.	.	.	.	.	.	.	M
1	11187094	11187094	G	T	exonic;exonic	MTOR	.	nonsynonymous SNV;nonsynonymous SNV	MTOR:NM_004958:exon45:c.C6324A:p.F2108L;MTOR:NM_004958:exon45:c.C6324A:p.F2108L	exonic;exonic	ENSG00000198793	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000198793:ENST00000376838:exon7:c.C939A:p.F313L,ENSG00000198793:ENST00000361445:exon45:c.C6324A:p.F2108L;ENSG00000198793:ENST00000376838:exon7:c.C939A:p.F313L,ENSG00000198793:ENST00000361445:exon45:c.C6324A:p.F2108L	exonic;exonic	MTOR	.	nonsynonymous SNV;nonsynonymous SNV	MTOR:uc001asc.3:exon7:c.C939A:p.F313L,MTOR:uc001asd.3:exon45:c.C6324A:p.F2108L;MTOR:uc001asc.3:exon7:c.C939A:p.F313L,MTOR:uc001asd.3:exon45:c.C6324A:p.F2108L	.	.	.	.	.	.	.	.	.	.	.	0.002	D	0.997	D	0.932	D	0.000	D	1	D	3.155	M	-1.35	T	-4.87	D	0.834	6.458	29.9	0.999	0.977	D	0.556	D	0.691	D	0.707	0	3.19	0.069	1.048	0.998	1.000	12.889	.	.	Protein kinase-like domain;Rapamycin-binding domain	.	.	.	.	.	.	.	.	BRACA
1	11187094	11187094	G	T	exonic;exonic	MTOR	.	nonsynonymous SNV;nonsynonymous SNV	MTOR:NM_004958:exon45:c.C6324A:p.F2108L;MTOR:NM_004958:exon45:c.C6324A:p.F2108L	exonic;exonic	ENSG00000198793	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000198793:ENST00000376838:exon7:c.C939A:p.F313L,ENSG00000198793:ENST00000361445:exon45:c.C6324A:p.F2108L;ENSG00000198793:ENST00000376838:exon7:c.C939A:p.F313L,ENSG00000198793:ENST00000361445:exon45:c.C6324A:p.F2108L	exonic;exonic	MTOR	.	nonsynonymous SNV;nonsynonymous SNV	MTOR:uc001asc.3:exon7:c.C939A:p.F313L,MTOR:uc001asd.3:exon45:c.C6324A:p.F2108L;MTOR:uc001asc.3:exon7:c.C939A:p.F313L,MTOR:uc001asd.3:exon45:c.C6324A:p.F2108L	.	.	.	.	.	.	.	.	.	.	.	0.002	D	0.997	D	0.932	D	0.000	D	1	D	3.155	M	-1.35	T	-4.87	D	0.834	6.458	29.9	0.999	0.977	D	0.556	D	0.691	D	0.707	0	3.19	0.069	1.048	0.998	1.000	12.889	.	.	Protein kinase-like domain;Rapamycin-binding domain	.	.	.	.	.	.	.	.	THCA
1	11187796	11187796	G	A	exonic	MTOR	.	nonsynonymous SNV	MTOR:NM_004958:exon44:c.C6101T:p.A2034V	exonic	ENSG00000198793	.	nonsynonymous SNV	ENSG00000198793:ENST00000376838:exon6:c.C716T:p.A239V,ENSG00000198793:ENST00000361445:exon44:c.C6101T:p.A2034V	exonic	MTOR	.	nonsynonymous SNV	MTOR:uc001asc.3:exon6:c.C716T:p.A239V,MTOR:uc001asd.3:exon44:c.C6101T:p.A2034V	.	.	.	.	.	.	.	.	.	.	.	0.001	D	1.0	D	0.999	D	0.000	D	1	D	3.6	H	2.87	T	-3.56	D	0.847	7.013	33	0.999	0.993	D	-0.618	T	0.175	T	0.707	0	5.8	0.917	1.048	0.982	0.845	20.063	.	.	Rapamycin-binding domain	.	.	.	.	.	.	.	.	BRACA
1	11188519	11188519	G	A	exonic	MTOR	.	nonsynonymous SNV	MTOR:NM_004958:exon42:c.C5902T:p.H1968Y	exonic	ENSG00000198793	.	nonsynonymous SNV	ENSG00000198793:ENST00000376838:exon4:c.C517T:p.H173Y,ENSG00000198793:ENST00000361445:exon42:c.C5902T:p.H1968Y	exonic	MTOR	.	nonsynonymous SNV	MTOR:uc001asc.3:exon4:c.C517T:p.H173Y,MTOR:uc001asd.3:exon42:c.C5902T:p.H1968Y	.	.	.	.	.	.	.	.	.	.	.	0.051	T	1.0	D	0.998	D	0.000	D	1	D	2.54	M	-1.77	D	-5.33	D	0.899	6.533	31	0.998	0.994	D	0.578	D	0.740	D	0.707	0	5.43	0.917	1.048	0.999	1.000	19.258	.	.	PIK-related kinase	.	.	.	.	.	.	.	.	M
1	11190804	11190804	C	T	exonic	MTOR	.	nonsynonymous SNV	MTOR:NM_004958:exon39:c.G5395A:p.E1799K	exonic	ENSG00000198793	.	nonsynonymous SNV	ENSG00000198793:ENST00000376838:exon1:c.G10A:p.E4K,ENSG00000198793:ENST00000361445:exon39:c.G5395A:p.E1799K	exonic	MTOR	.	nonsynonymous SNV	MTOR:uc001asc.3:exon1:c.G10A:p.E4K,MTOR:uc001asd.3:exon39:c.G5395A:p.E1799K	.	.	.	.	.	.	.	.	.	.	rs863225264	0.133	T	0.878	P	0.463	P	0.000	D	1	D	1.545	L	-0.61	T	-2.58	D	0.923	6.878	33	0.999	0.988	D	-0.456	T	0.332	T	0.707	0	5.54	0.871	0.881	0.998	0.995	19.502	.	.	PIK-related kinase;PIK-related kinase, FAT	Pathogenic|Pathogenic	Smith-Kingsmore_syndrome|not_provided	RCV000201885.1|RCV000255268.1	MedGen:OMIM|MedGen	CN233222:616638|CN221809	ID=COSM180789;OCCURENCE=1(central_nervous_system),1(large_intestine),1(prostate),5(endometrium)	MU99079	COCA-CN|1|187|0.00535,GBM-US|1|268|0.00373,CESC-US|1|194|0.00515,UCEC-US|2|246|0.00813	RCCC
1	11217230	11217230	C	T	exonic	MTOR	.	nonsynonymous SNV	MTOR:NM_004958:exon30:c.G4448A:p.C1483Y	exonic	ENSG00000198793	.	nonsynonymous SNV	ENSG00000198793:ENST00000361445:exon30:c.G4448A:p.C1483Y	exonic	MTOR	.	nonsynonymous SNV	MTOR:uc001asd.3:exon30:c.G4448A:p.C1483Y	.	.	.	.	.	.	.	.	.	.	.	0.0	D	0.995	D	0.829	P	0.000	D	1	D	3.255	M	-0.45	T	-9.57	D	0.986	6.627	32	0.998	0.984	D	0.269	D	0.535	D	0.722	0	5.32	0.871	0.935	1.000	0.998	19.001	.	.	Armadillo-type fold;PIK-related kinase;Tetratricopeptide-like helical domain	.	.	.	.	.	ID=COSM462615;OCCURENCE=1(kidney)	.	.	TCALL
1	115256529	115256529	T	A	exonic	NRAS	.	nonsynonymous SNV	NRAS:NM_002524:exon3:c.A182T:p.Q61L	exonic	ENSG00000213281	.	nonsynonymous SNV	ENSG00000213281:ENST00000369535:exon3:c.A182T:p.Q61L	exonic	NRAS	.	nonsynonymous SNV	NRAS:uc009wgu.3:exon3:c.A182T:p.Q61L	.	.	.	.	.	.	.	.	.	.	rs11554290	0.002	D	0.973	D	0.89	P	0.000	U	1	D	3.875	H	-1.79	D	-6.32	D	0.884	4.627	24.5	0.996	0.988	D	0.785	D	0.760	D	0.722	0	5.08	0.991	1.061	1.000	1.000	15.013	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Thyroid_cancer,_follicular|Epidermal_nevus|Non-small_cell_lung_cancer|Giant_pigmented_hairy_nevus|Neurocutaneous_melanosis|Epidermal_nevus_syndrome	RCV000014914.8|RCV000032847.8|RCV000037574.2|RCV000114744.7|RCV000114745.7|RCV000148032.4	MedGen:OMIM|MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet|MedGen:OMIM:SNOMED_CT	C0206682:188470|C0334082:162900:ORPHA35125:25201003|D002289:C0007131:254637007|C1842036:137550:ORPHA626|C0544862:249400:ORPHA2481|C0265318:163200:239112008	ID=COSM583;OCCURENCE=108(skin),7(urinary_tract),1(pancreas),6(liver),1(prostate),22(large_intestine),1(autonomic_ganglia),2(endometrium),11(thyroid),24(lung),1(meninges),41(haematopoietic_and_lymphoid_tissue),2(central_nervous_system),3(NS)	MU55967	GBM-US|1|268|0.00373,SKCA-BR|1|66|0.01515,BLCA-CN|1|103|0.00971,SKCM-US|10|335|0.02985,MELA-AU|3|183|0.01639	M
1	115256529	115256529	T	C	exonic	NRAS	.	nonsynonymous SNV	NRAS:NM_002524:exon3:c.A182G:p.Q61R	exonic	ENSG00000213281	.	nonsynonymous SNV	ENSG00000213281:ENST00000369535:exon3:c.A182G:p.Q61R	exonic	NRAS	.	nonsynonymous SNV	NRAS:uc009wgu.3:exon3:c.A182G:p.Q61R	.	.	.	.	.	.	.	.	.	.	rs11554290	0.029	D	0.214	B	0.304	B	0.000	U	1	D	3.325	M	-1.75	D	-3.38	D	0.915	3.571	23.1	0.997	0.986	D	0.292	D	0.595	D	0.722	0	5.08	0.991	1.061	1.000	1.000	15.013	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Thyroid_cancer,_follicular|Epidermal_nevus|Non-small_cell_lung_cancer|Giant_pigmented_hairy_nevus|Neurocutaneous_melanosis|Epidermal_nevus_syndrome	RCV000014914.8|RCV000032847.8|RCV000037574.2|RCV000114744.7|RCV000114745.7|RCV000148032.4	MedGen:OMIM|MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet|MedGen:OMIM:SNOMED_CT	C0206682:188470|C0334082:162900:ORPHA35125:25201003|D002289:C0007131:254637007|C1842036:137550:ORPHA626|C0544862:249400:ORPHA2481|C0265318:163200:239112008	ID=COSM584;OCCURENCE=4(soft_tissue),3(ovary),4(endometrium),474(skin),7(breast),1(small_intestine),7(urinary_tract),7(adrenal_gland),1(liver),4(eye),2(pancreas),4(biliary_tract),49(large_intestine),5(central_nervous_system),49(NS),289(thyroid),12(lung),9(meninges),3(testis),69(haematopoietic_and_lymphoid_tissue)	MU68272	AML-US|3|161|0.01863,BTCA-JP|4|239|0.01674,LAML-KR|1|107|0.00935,LICA-CN|1|163|0.00613,READ-US|1|80|0.01250,STAD-US|1|289|0.00346,SKCA-BR|1|66|0.01515,BLCA-CN|1|103|0.00971,UCEC-US|3|246|0.01220,THCA-US|27|400|0.06750,LIRI-JP|1|260|0.00385,BOCA-FR|1|98|0.01020,PACA-CA|1|227|0.00441,CLLE-ES|1|218|0.00459,BLCA-US|1|130|0.00769,SKCM-US|37|335|0.11045,MELA-AU|16|183|0.08743,COAD-US|1|216|0.00463	M
1	115256530	115256530	G	T	exonic;exonic	NRAS	.	nonsynonymous SNV;nonsynonymous SNV	NRAS:NM_002524:exon3:c.C181A:p.Q61K;NRAS:NM_002524:exon3:c.C181A:p.Q61K	exonic;exonic	ENSG00000213281	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000213281:ENST00000369535:exon3:c.C181A:p.Q61K;ENSG00000213281:ENST00000369535:exon3:c.C181A:p.Q61K	exonic;exonic	NRAS	.	nonsynonymous SNV;nonsynonymous SNV	NRAS:uc009wgu.3:exon3:c.C181A:p.Q61K;NRAS:uc009wgu.3:exon3:c.C181A:p.Q61K	.	.	.	.	.	.	.	.	.	.	rs121913254	0.009	D	0.948	P	0.76	P	0.000	U	1	D	3.73	H	-1.73	D	-3.38	D	0.884	4.363	24.1	0.995	0.994	D	0.702	D	0.742	D	0.722	0	5.08	0.917	1.048	1.000	1.000	18.663	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic	Giant_pigmented_hairy_nevus|Neurocutaneous_melanosis	RCV000114746.5|RCV000144964.3	MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet	C1842036:137550:ORPHA626|C0544862:249400:ORPHA2481	ID=COSM580;OCCURENCE=1(prostate),79(large_intestine),1(biliary_tract),2(urinary_tract),2(eye),1(kidney),2(liver),2(pancreas),2(breast),437(skin),2(endometrium),1(ovary),15(soft_tissue),5(autonomic_ganglia),2(cervix),71(haematopoietic_and_lymphoid_tissue),1(meninges),56(thyroid),18(lung),29(NS),4(bone),4(central_nervous_system),1(stomach)	MU55099	AML-US|8|161|0.04969,BTCA-JP|2|239|0.00837,LAML-KR|1|107|0.00935,READ-US|1|80|0.01250,LGG-US|1|283|0.00353,STAD-US|1|289|0.00346,NBL-US|1|108|0.00926,LUSC-KR|1|66|0.01515,UCEC-US|1|246|0.00407,THCA-US|7|400|0.01750,LIHC-US|1|188|0.00532,OV-AU|1|93|0.01075,SKCM-US|30|335|0.08955,MELA-AU|19|183|0.10383,COAD-US|3|216|0.01389	NB
1	115256530	115256530	G	T	exonic;exonic	NRAS	.	nonsynonymous SNV;nonsynonymous SNV	NRAS:NM_002524:exon3:c.C181A:p.Q61K;NRAS:NM_002524:exon3:c.C181A:p.Q61K	exonic;exonic	ENSG00000213281	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000213281:ENST00000369535:exon3:c.C181A:p.Q61K;ENSG00000213281:ENST00000369535:exon3:c.C181A:p.Q61K	exonic;exonic	NRAS	.	nonsynonymous SNV;nonsynonymous SNV	NRAS:uc009wgu.3:exon3:c.C181A:p.Q61K;NRAS:uc009wgu.3:exon3:c.C181A:p.Q61K	.	.	.	.	.	.	.	.	.	.	rs121913254	0.009	D	0.948	P	0.76	P	0.000	U	1	D	3.73	H	-1.73	D	-3.38	D	0.884	4.363	24.1	0.995	0.994	D	0.702	D	0.742	D	0.722	0	5.08	0.917	1.048	1.000	1.000	18.663	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic	Giant_pigmented_hairy_nevus|Neurocutaneous_melanosis	RCV000114746.5|RCV000144964.3	MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet	C1842036:137550:ORPHA626|C0544862:249400:ORPHA2481	ID=COSM580;OCCURENCE=1(prostate),79(large_intestine),1(biliary_tract),2(urinary_tract),2(eye),1(kidney),2(liver),2(pancreas),2(breast),437(skin),2(endometrium),1(ovary),15(soft_tissue),5(autonomic_ganglia),2(cervix),71(haematopoietic_and_lymphoid_tissue),1(meninges),56(thyroid),18(lung),29(NS),4(bone),4(central_nervous_system),1(stomach)	MU55099	AML-US|8|161|0.04969,BTCA-JP|2|239|0.00837,LAML-KR|1|107|0.00935,READ-US|1|80|0.01250,LGG-US|1|283|0.00353,STAD-US|1|289|0.00346,NBL-US|1|108|0.00926,LUSC-KR|1|66|0.01515,UCEC-US|1|246|0.00407,THCA-US|7|400|0.01750,LIHC-US|1|188|0.00532,OV-AU|1|93|0.01075,SKCM-US|30|335|0.08955,MELA-AU|19|183|0.10383,COAD-US|3|216|0.01389	Skin Melanoma
1	115258744	115258744	C	T	exonic	NRAS	.	nonsynonymous SNV	NRAS:NM_002524:exon2:c.G38A:p.G13D	exonic	ENSG00000213281	.	nonsynonymous SNV	ENSG00000213281:ENST00000369535:exon2:c.G38A:p.G13D	exonic	NRAS	.	nonsynonymous SNV	NRAS:uc009wgu.3:exon2:c.G38A:p.G13D	.	.	8.236e-06	0	0	0	0	1.498e-05	0	0	rs121434596	0.029	D	0.434	B	0.383	B	0.000	U	1	D	3.325	M	-0.7	T	-5.48	D	0.991	4.984	25.1	0.997	0.911	D	-0.083	T	0.448	T	0.628	0	5.58	0.871	0.935	0.999	1.000	19.377	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic	Juvenile_myelomonocytic_leukemia|Noonan_syndrome_6|RAS-associated_autoimmune_leukoproliferative_disorder|not_provided	RCV000014915.26|RCV000022690.25|RCV000144962.2|RCV000157672.1	MedGen:OMIM:Orphanet|MedGen:OMIM|MedGen:OMIM:Orphanet|MedGen	C0349639:607785:ORPHA86834|C2750732:613224|C2674723:614470:ORPHA268114|CN221809	ID=COSM573;OCCURENCE=6(large_intestine),24(skin),1(endometrium),181(haematopoietic_and_lymphoid_tissue),1(thyroid),2(upper_aerodigestive_tract),1(NS)	MU820588	AML-US|8|161|0.04969,COCA-CN|1|187|0.00535,LAML-KR|3|107|0.02804,ALL-US|3|27|0.11111,SKCM-US|1|335|0.00299,MELA-AU|2|183|0.01093	M
1	11856378	11856378	G	A	exonic;exonic;exonic	MTHFR	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	MTHFR:NM_005957:exon5:c.C665T:p.A222V;MTHFR:NM_005957:exon5:c.C665T:p.A222V;MTHFR:NM_005957:exon5:c.C665T:p.A222V	exonic;exonic;exonic	ENSG00000177000	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000177000:ENST00000376592:exon4:c.C665T:p.A222V,ENSG00000177000:ENST00000376583:exon5:c.C788T:p.A263V,ENSG00000177000:ENST00000376590:exon5:c.C665T:p.A222V,ENSG00000177000:ENST00000376585:exon6:c.C788T:p.A263V;ENSG00000177000:ENST00000376592:exon4:c.C665T:p.A222V,ENSG00000177000:ENST00000376583:exon5:c.C788T:p.A263V,ENSG00000177000:ENST00000376590:exon5:c.C665T:p.A222V,ENSG00000177000:ENST00000376585:exon6:c.C788T:p.A263V;ENSG00000177000:ENST00000376592:exon4:c.C665T:p.A222V,ENSG00000177000:ENST00000376583:exon5:c.C788T:p.A263V,ENSG00000177000:ENST00000376590:exon5:c.C665T:p.A222V,ENSG00000177000:ENST00000376585:exon6:c.C788T:p.A263V	exonic;exonic;exonic	MTHFR	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	MTHFR:uc001atb.1:exon4:c.C734T:p.A245V,MTHFR:uc001atc.2:exon5:c.C665T:p.A222V;MTHFR:uc001atb.1:exon4:c.C734T:p.A245V,MTHFR:uc001atc.2:exon5:c.C665T:p.A222V;MTHFR:uc001atb.1:exon4:c.C734T:p.A245V,MTHFR:uc001atc.2:exon5:c.C665T:p.A222V	0.2706	0.245407	0.3037	0.1124	0.5141	0.3052	0.2227	0.3450	0.3062	0.1409	rs1801133	0.027	D	0.999	D	0.987	D	0.000	D	0.000	P	2.425	M	-4.03	D	-3.76	D	0.955	4.914	25.0	0.999	0.980	D	-1.455	T	0.000	T	0.722	0	5.08	0.917	1.048	0.997	0.530	17.432	.	.	FAD-linked oxidoreductase-like	Benign|Uncertain significance|not provided|drug response|drug response	MTHFR_deficiency,_thermolabile_type|Gastrointestinal_stromal_tumor|not_provided|cyclophosphamide_response_-_Toxicity/ADR|carboplatin_response_-_Efficacy	RCV000003697.5|RCV000144921.1|RCV000153516.3|RCV000211133.1|RCV000211336.1	MedGen|MedGen:OMIM:Orphanet|MedGen|MedGen|MedGen	C1856059|C0238198:606764:ORPHA44890|CN221809|CN236519|CN236495	.	MU580088	LAML-KR|1|107|0.00935,LUSC-KR|1|66|0.01515	PA
1	11856378	11856378	G	A	exonic;exonic;exonic	MTHFR	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	MTHFR:NM_005957:exon5:c.C665T:p.A222V;MTHFR:NM_005957:exon5:c.C665T:p.A222V;MTHFR:NM_005957:exon5:c.C665T:p.A222V	exonic;exonic;exonic	ENSG00000177000	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000177000:ENST00000376592:exon4:c.C665T:p.A222V,ENSG00000177000:ENST00000376583:exon5:c.C788T:p.A263V,ENSG00000177000:ENST00000376590:exon5:c.C665T:p.A222V,ENSG00000177000:ENST00000376585:exon6:c.C788T:p.A263V;ENSG00000177000:ENST00000376592:exon4:c.C665T:p.A222V,ENSG00000177000:ENST00000376583:exon5:c.C788T:p.A263V,ENSG00000177000:ENST00000376590:exon5:c.C665T:p.A222V,ENSG00000177000:ENST00000376585:exon6:c.C788T:p.A263V;ENSG00000177000:ENST00000376592:exon4:c.C665T:p.A222V,ENSG00000177000:ENST00000376583:exon5:c.C788T:p.A263V,ENSG00000177000:ENST00000376590:exon5:c.C665T:p.A222V,ENSG00000177000:ENST00000376585:exon6:c.C788T:p.A263V	exonic;exonic;exonic	MTHFR	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	MTHFR:uc001atb.1:exon4:c.C734T:p.A245V,MTHFR:uc001atc.2:exon5:c.C665T:p.A222V;MTHFR:uc001atb.1:exon4:c.C734T:p.A245V,MTHFR:uc001atc.2:exon5:c.C665T:p.A222V;MTHFR:uc001atb.1:exon4:c.C734T:p.A245V,MTHFR:uc001atc.2:exon5:c.C665T:p.A222V	0.2706	0.245407	0.3037	0.1124	0.5141	0.3052	0.2227	0.3450	0.3062	0.1409	rs1801133	0.027	D	0.999	D	0.987	D	0.000	D	0.000	P	2.425	M	-4.03	D	-3.76	D	0.955	4.914	25.0	0.999	0.980	D	-1.455	T	0.000	T	0.722	0	5.08	0.917	1.048	0.997	0.530	17.432	.	.	FAD-linked oxidoreductase-like	Benign|Uncertain significance|not provided|drug response|drug response	MTHFR_deficiency,_thermolabile_type|Gastrointestinal_stromal_tumor|not_provided|cyclophosphamide_response_-_Toxicity/ADR|carboplatin_response_-_Efficacy	RCV000003697.5|RCV000144921.1|RCV000153516.3|RCV000211133.1|RCV000211336.1	MedGen|MedGen:OMIM:Orphanet|MedGen|MedGen|MedGen	C1856059|C0238198:606764:ORPHA44890|CN221809|CN236519|CN236495	.	MU580088	LAML-KR|1|107|0.00935,LUSC-KR|1|66|0.01515	REC
1	11856378	11856378	G	A	exonic;exonic;exonic	MTHFR	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	MTHFR:NM_005957:exon5:c.C665T:p.A222V;MTHFR:NM_005957:exon5:c.C665T:p.A222V;MTHFR:NM_005957:exon5:c.C665T:p.A222V	exonic;exonic;exonic	ENSG00000177000	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000177000:ENST00000376592:exon4:c.C665T:p.A222V,ENSG00000177000:ENST00000376583:exon5:c.C788T:p.A263V,ENSG00000177000:ENST00000376590:exon5:c.C665T:p.A222V,ENSG00000177000:ENST00000376585:exon6:c.C788T:p.A263V;ENSG00000177000:ENST00000376592:exon4:c.C665T:p.A222V,ENSG00000177000:ENST00000376583:exon5:c.C788T:p.A263V,ENSG00000177000:ENST00000376590:exon5:c.C665T:p.A222V,ENSG00000177000:ENST00000376585:exon6:c.C788T:p.A263V;ENSG00000177000:ENST00000376592:exon4:c.C665T:p.A222V,ENSG00000177000:ENST00000376583:exon5:c.C788T:p.A263V,ENSG00000177000:ENST00000376590:exon5:c.C665T:p.A222V,ENSG00000177000:ENST00000376585:exon6:c.C788T:p.A263V	exonic;exonic;exonic	MTHFR	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	MTHFR:uc001atb.1:exon4:c.C734T:p.A245V,MTHFR:uc001atc.2:exon5:c.C665T:p.A222V;MTHFR:uc001atb.1:exon4:c.C734T:p.A245V,MTHFR:uc001atc.2:exon5:c.C665T:p.A222V;MTHFR:uc001atb.1:exon4:c.C734T:p.A245V,MTHFR:uc001atc.2:exon5:c.C665T:p.A222V	0.2706	0.245407	0.3037	0.1124	0.5141	0.3052	0.2227	0.3450	0.3062	0.1409	rs1801133	0.027	D	0.999	D	0.987	D	0.000	D	0.000	P	2.425	M	-4.03	D	-3.76	D	0.955	4.914	25.0	0.999	0.980	D	-1.455	T	0.000	T	0.722	0	5.08	0.917	1.048	0.997	0.530	17.432	.	.	FAD-linked oxidoreductase-like	Benign|Uncertain significance|not provided|drug response|drug response	MTHFR_deficiency,_thermolabile_type|Gastrointestinal_stromal_tumor|not_provided|cyclophosphamide_response_-_Toxicity/ADR|carboplatin_response_-_Efficacy	RCV000003697.5|RCV000144921.1|RCV000153516.3|RCV000211133.1|RCV000211336.1	MedGen|MedGen:OMIM:Orphanet|MedGen|MedGen|MedGen	C1856059|C0238198:606764:ORPHA44890|CN221809|CN236519|CN236495	.	MU580088	LAML-KR|1|107|0.00935,LUSC-KR|1|66|0.01515	ST-PR
11	534285	534285	C	T	exonic	HRAS	.	nonsynonymous SNV	HRAS:NM_001130442:exon2:c.G38A:p.G13D,HRAS:NM_005343:exon2:c.G38A:p.G13D,HRAS:NM_176795:exon2:c.G38A:p.G13D	exonic	ENSG00000174775	.	nonsynonymous SNV	ENSG00000174775:ENST00000397594:exon1:c.G38A:p.G13D,ENSG00000174775:ENST00000311189:exon2:c.G38A:p.G13D,ENSG00000174775:ENST00000397596:exon2:c.G38A:p.G13D,ENSG00000174775:ENST00000417302:exon2:c.G38A:p.G13D,ENSG00000174775:ENST00000451590:exon2:c.G38A:p.G13D,ENSG00000174775:ENST00000493230:exon2:c.G38A:p.G13D	exonic	HRAS	.	nonsynonymous SNV	HRAS:uc001lpv.3:exon2:c.G38A:p.G13D,HRAS:uc010qvw.2:exon2:c.G38A:p.G13D,HRAS:uc010qvx.2:exon2:c.G38A:p.G13D	.	.	.	.	.	.	.	.	.	.	rs104894226	0.031	D	0.373	B	0.304	B	0.000	D	1	D	3.31	M	-0.7	T	-5.45	D	0.956	4.718	24.6	0.992	0.993	D	0.297	D	0.450	T	0.767	0	3.0	0.871	0.852	0.989	0.597	14.152	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic,Pathogenic|Pathogenic	not_provided,Costello_syndrome|not_provided	RCV000157914.1,RCV000013438.24|RCV000157913.1	MedGen,MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	CN221809,C0587248:218040:ORPHA3071:309776008|CN221809	ID=COSM490,COSM3448604;OCCURENCE=4(upper_aerodigestive_tract),1(haematopoietic_and_lymphoid_tissue),3(thyroid),1(urinary_tract),2(skin)	MU1665765	ORCA-IN|1|106|0.00943,SKCM-US|1|335|0.00299,MELA-AU|1|183|0.00546	COREAD
1	161479745	161479745	A	G	exonic	FCGR2A	.	nonsynonymous SNV	FCGR2A:NM_001136219:exon4:c.A500G:p.H167R,FCGR2A:NM_021642:exon4:c.A497G:p.H166R	exonic	ENSG00000143226	.	nonsynonymous SNV	ENSG00000143226:ENST00000467525:exon2:c.A395G:p.H132R,ENSG00000143226:ENST00000271450:exon4:c.A500G:p.H167R,ENSG00000143226:ENST00000367972:exon4:c.A497G:p.H166R	exonic	FCGR2A	.	nonsynonymous SNV	FCGR2A:uc001gam.3:exon4:c.A497G:p.H166R,FCGR2A:uc001gan.3:exon4:c.A500G:p.H167R,FCGR2A:uc021pcz.2:exon4:c.A83G:p.H28R,FCGR2A:uc021pda.2:exon4:c.A83G:p.H28R	0.5310	0.441693	0.4791	0.5458	0.5211	0.3274	0.5091	0.4942	0.4537	0.4153	rs1801274	0.173	T	0.0	B	0.002	B	0.000	N	1	P	1.355	L	2.78	T	-3.15	D	0.061	-1.872	0.002	0.228	0.009	N	-0.958	T	0.008	T	0.554	0	-4.15	-1.145	-4.176	0.000	0.000	4.498	.	.	Immunoglobulin subtype;Immunoglobulin-like domain;Immunoglobulin-like fold	other|other|other|drug response	Lupus_nephritis,_susceptibility_to|Pseudomonas_aeruginosa,_susceptibility_to_chronic_infection_by,_in_cystic_fibrosis|Malaria,_severe,_susceptibility_to|trastuzumab_response_-_Efficacy	RCV000015946.3|RCV000015947.3|RCV000054529.2|RCV000211160.1	.|.|MedGen|MedGen	.|.|C1970029|CN236585	.	.	.	BRACA
1	161514542	161514542	A	C	exonic	FCGR3A	.	nonsynonymous SNV	FCGR3A:NM_000569:exon4:c.T634G:p.F212V,FCGR3A:NM_001127592:exon4:c.T631G:p.F211V,FCGR3A:NM_001127593:exon5:c.T526G:p.F176V,FCGR3A:NM_001127595:exon5:c.T526G:p.F176V,FCGR3A:NM_001127596:exon5:c.T523G:p.F175V	exonic	ENSG00000203747	.	nonsynonymous SNV	ENSG00000203747:ENST00000367969:exon4:c.T634G:p.F212V,ENSG00000203747:ENST00000443193:exon4:c.T631G:p.F211V,ENSG00000203747:ENST00000540048:exon4:c.T526G:p.F176V,ENSG00000203747:ENST00000367967:exon5:c.T526G:p.F176V,ENSG00000203747:ENST00000436743:exon5:c.T526G:p.F176V	exonic	FCGR3A	.	nonsynonymous SNV	FCGR3A:uc001gar.3:exon4:c.T634G:p.F212V,FCGR3A:uc001gas.3:exon4:c.T631G:p.F211V,FCGR3A:uc001gat.4:exon5:c.T526G:p.F176V,FCGR3A:uc009wuh.3:exon5:c.T523G:p.F175V,FCGR3A:uc009wui.3:exon5:c.T526G:p.F176V	0.2739	.	0.3289	0.3321	0.2327	0.3273	0.2790	0.3468	0.3367	0.3428	rs396991	0.212	T	0.0	B	0.0	B	0.034	N	1	P	-0.22	N	2.76	T	2.46	N	0.309	-1.789	0.002	0.380	0.017	N	-0.916	T	0.003	T	0.447	0	-0.103	-0.404	-3.170	0.001	0.000	0.356	.	.	Immunoglobulin subtype;Immunoglobulin-like domain;Immunoglobulin-like fold	drug response|drug response|drug response	rituximab_response_-_Efficacy|cetuximab_response_-_Efficacy|trastuzumab_response_-_Efficacy	RCV000211135.1|RCV000211261.1|RCV000211344.1	MedGen|MedGen|MedGen	CN236577|CN236500|CN236585	.	MU4547350	LUSC-KR|1|66|0.01515,THCA-SA|1|15|0.06667	BRACA
1	161643798	161643798	T	C	exonic	FCGR2B	.	nonsynonymous SNV	FCGR2B:NM_001190828:exon4:c.T674C:p.I225T,FCGR2B:NM_001002273:exon5:c.T692C:p.I231T,FCGR2B:NM_001002274:exon5:c.T695C:p.I232T,FCGR2B:NM_001002275:exon5:c.T692C:p.I231T,FCGR2B:NM_004001:exon5:c.T695C:p.I232T	exonic	ENSG00000072694	.	nonsynonymous SNV	ENSG00000072694:ENST00000367960:exon4:c.T674C:p.I225T,ENSG00000072694:ENST00000367961:exon4:c.T674C:p.I225T,ENSG00000072694:ENST00000236937:exon5:c.T695C:p.I232T,ENSG00000072694:ENST00000358671:exon5:c.T695C:p.I232T,ENSG00000072694:ENST00000367962:exon5:c.T695C:p.I232T,ENSG00000072694:ENST00000403078:exon5:c.T695C:p.I232T	exonic	FCGR2B	.	nonsynonymous SNV	FCGR2B:uc009wun.2:exon4:c.T674C:p.I225T,FCGR2B:uc001gay.2:exon5:c.T692C:p.I231T,FCGR2B:uc001gaz.2:exon5:c.T695C:p.I232T,FCGR2B:uc001gba.2:exon5:c.T692C:p.I231T,FCGR2B:uc001gbb.2:exon5:c.T695C:p.I232T	.	0.185903	0.2369	0.3122	0.1404	0.3407	0.3947	0.1959	0.2222	0.2588	rs1050501	0.258	T	0.298	B	0.161	B	0.029	N	1	P	1.04	L	4.59	T	-1.56	N	0.265	0.457	7.094	0.885	0.043	N	-1.039	T	0.026	T	0.707	0	2.85	0.046	-0.216	0.002	0.298	6.260	.	.	.	other|other	Systemic_lupus_erythematosus,_susceptibility_to|Malaria,_resistance_to	RCV000005800.2|RCV000005801.2	.|MedGen	.|C2720293	.	MU4552844	LUSC-KR|1|66|0.01515,THCA-SA|1|15|0.06667	BRACA
1	162724415	162724415	C	G	exonic	DDR2	.	nonsynonymous SNV	DDR2:NM_006182:exon5:c.C187G:p.L63V,DDR2:NM_001014796:exon6:c.C187G:p.L63V	exonic	ENSG00000162733	.	nonsynonymous SNV	ENSG00000162733:ENST00000367921:exon5:c.C187G:p.L63V,ENSG00000162733:ENST00000415555:exon5:c.C187G:p.L63V,ENSG00000162733:ENST00000446985:exon5:c.C187G:p.L63V,ENSG00000162733:ENST00000367922:exon6:c.C187G:p.L63V	exonic	DDR2	.	nonsynonymous SNV	DDR2:uc001gcg.3:exon5:c.C187G:p.L63V,DDR2:uc001gcf.3:exon6:c.C187G:p.L63V	7.7e-05	0.000199681	6.594e-05	0	0	0	0	0.0001	0	0	rs144594252	0.146	T	1.0	D	1.0	D	0.000	D	1.000	D	2.89	M	-4.82	D	-1.65	N	0.917	3.306	22.9	0.997	0.961	D	1.091	D	0.952	D	0.722	0	3.51	0.871	-0.321	0.998	0.962	10.542	0.0110	0.144	Coagulation factor 5/8 C-terminal type domain;Galactose-binding domain-like	.	.	.	.	.	.	.	.	NSCLC
1	162729630	162729630	T	G	exonic	DDR2	.	nonsynonymous SNV	DDR2:NM_006182:exon8:c.T716G:p.L239R,DDR2:NM_001014796:exon9:c.T716G:p.L239R	exonic	ENSG00000162733	.	nonsynonymous SNV	ENSG00000162733:ENST00000367921:exon8:c.T716G:p.L239R,ENSG00000162733:ENST00000367922:exon9:c.T716G:p.L239R	exonic	DDR2	.	nonsynonymous SNV	DDR2:uc001gcg.3:exon8:c.T716G:p.L239R,DDR2:uc001gcf.3:exon9:c.T716G:p.L239R	.	.	.	.	.	.	.	.	.	.	.	0.241	T	0.996	D	0.921	D	0.000	D	1.000	D	2.425	M	1.74	T	-1.63	N	0.942	1.191	11.70	0.996	0.968	D	-1.002	T	0.076	T	0.707	0	4.6	0.991	1.051	1.000	0.993	10.656	.	.	.	.	.	.	.	.	.	.	.	NSCLC
1	162729671	162729671	G	T	exonic	DDR2	.	nonsynonymous SNV	DDR2:NM_006182:exon8:c.G757T:p.G253C,DDR2:NM_001014796:exon9:c.G757T:p.G253C	exonic	ENSG00000162733	.	nonsynonymous SNV	ENSG00000162733:ENST00000367921:exon8:c.G757T:p.G253C,ENSG00000162733:ENST00000367922:exon9:c.G757T:p.G253C	exonic	DDR2	.	nonsynonymous SNV	DDR2:uc001gcg.3:exon8:c.G757T:p.G253C,DDR2:uc001gcf.3:exon9:c.G757T:p.G253C	.	.	.	.	.	.	.	.	.	.	.	0.001	D	1.0	D	1.0	D	0.000	D	1	D	2.89	M	1.86	T	-6.48	D	0.675	6.382	29.5	0.998	0.990	D	-0.699	T	0.144	T	0.707	0	4.71	0.917	1.038	0.991	0.961	14.612	.	.	.	.	.	.	.	.	.	.	.	NSCLC
1	162741822	162741822	G	A	exonic	DDR2	.	nonsynonymous SNV	DDR2:NM_006182:exon13:c.G1513A:p.G505S,DDR2:NM_001014796:exon14:c.G1513A:p.G505S	exonic	ENSG00000162733	.	nonsynonymous SNV	ENSG00000162733:ENST00000367921:exon13:c.G1513A:p.G505S,ENSG00000162733:ENST00000367922:exon14:c.G1513A:p.G505S	exonic	DDR2	.	nonsynonymous SNV	DDR2:uc001gcg.3:exon13:c.G1513A:p.G505S,DDR2:uc001gcf.3:exon14:c.G1513A:p.G505S	0.0029	0.00279553	0.0015	0.0144	0.0004	0	0	8.605e-05	0	0	rs115169993	0.259	T	0.136	B	0.024	B	0.022	N	0.785	N	1.7	L	-1.71	D	-0.91	N	0.27	1.288	12.21	0.967	0.680	D	-1.031	T	0.052	T	0.707	0	1.98	0.917	1.048	0.999	0.658	2.398	.	.	.	.	.	.	.	.	.	.	.	NSCLC
1	162745497	162745497	A	T	exonic	DDR2	.	nonsynonymous SNV	DDR2:NM_006182:exon15:c.A1912T:p.I638F,DDR2:NM_001014796:exon16:c.A1912T:p.I638F	exonic	ENSG00000162733	.	nonsynonymous SNV	ENSG00000162733:ENST00000367921:exon15:c.A1912T:p.I638F,ENSG00000162733:ENST00000367922:exon16:c.A1912T:p.I638F	exonic	DDR2	.	nonsynonymous SNV	DDR2:uc001gcg.3:exon15:c.A1912T:p.I638F,DDR2:uc001gcf.3:exon16:c.A1912T:p.I638F	.	.	.	.	.	.	.	.	.	.	.	0.005	D	0.999	D	0.991	D	0.000	D	1	D	2.47	M	-2.67	D	-3.28	D	0.926	6.199	28.7	0.989	0.984	D	0.843	D	0.814	D	0.732	0	5.11	1.062	1.140	1.000	1.000	14.023	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	.	.	.	NSCLC
1	162748390	162748390	T	A	exonic	DDR2	.	nonsynonymous SNV	DDR2:NM_006182:exon17:c.T2304A:p.S768R,DDR2:NM_001014796:exon18:c.T2304A:p.S768R	exonic	ENSG00000162733	.	nonsynonymous SNV	ENSG00000162733:ENST00000367921:exon17:c.T2304A:p.S768R,ENSG00000162733:ENST00000367922:exon18:c.T2304A:p.S768R	exonic	DDR2	.	nonsynonymous SNV	DDR2:uc001gcg.3:exon17:c.T2304A:p.S768R,DDR2:uc001gcf.3:exon18:c.T2304A:p.S768R	.	.	.	.	.	.	.	.	.	.	.	0.001	D	1.0	D	0.993	D	0.000	D	1	D	4.06	H	-2.51	D	-4.69	D	0.993	5.359	25.9	0.998	0.835	D	0.671	D	0.822	D	0.732	0	1.93	0.046	-0.224	0.998	0.865	8.636	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	.	.	.	NSCLC
1	162748407	162748407	G	T	exonic	DDR2	.	nonsynonymous SNV	DDR2:NM_006182:exon17:c.G2321T:p.G774V,DDR2:NM_001014796:exon18:c.G2321T:p.G774V	exonic	ENSG00000162733	.	nonsynonymous SNV	ENSG00000162733:ENST00000367921:exon17:c.G2321T:p.G774V,ENSG00000162733:ENST00000367922:exon18:c.G2321T:p.G774V	exonic	DDR2	.	nonsynonymous SNV	DDR2:uc001gcg.3:exon17:c.G2321T:p.G774V,DDR2:uc001gcf.3:exon18:c.G2321T:p.G774V	.	.	.	.	.	.	.	.	.	.	.	0.002	D	0.997	D	0.992	D	0.000	D	1	D	4.68	H	-5.51	D	-7.06	D	0.98	6.160	28.5	0.998	0.973	D	0.998	D	0.988	D	0.707	0	5.49	0.917	1.048	1.000	1.000	13.660	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	.	.	.	NSCLC
11	64572092	64572092	C	-	exonic	MEN1	.	frameshift deletion	MEN1:NM_000244:exon10:c.1562delG:p.R521fs,MEN1:NM_130799:exon10:c.1547delG:p.R516fs,MEN1:NM_130800:exon10:c.1562delG:p.R521fs,MEN1:NM_130801:exon10:c.1562delG:p.R521fs,MEN1:NM_130802:exon10:c.1562delG:p.R521fs,MEN1:NM_130803:exon10:c.1562delG:p.R521fs,MEN1:NM_130804:exon11:c.1562delG:p.R521fs	exonic	ENSG00000133895	.	frameshift deletion	ENSG00000133895:ENST00000377316:exon8:c.1382delG:p.R461fs,ENSG00000133895:ENST00000377313:exon9:c.1562delG:p.R521fs,ENSG00000133895:ENST00000377326:exon9:c.1547delG:p.R516fs,ENSG00000133895:ENST00000312049:exon10:c.1547delG:p.R516fs,ENSG00000133895:ENST00000315422:exon10:c.1547delG:p.R516fs,ENSG00000133895:ENST00000337652:exon10:c.1562delG:p.R521fs,ENSG00000133895:ENST00000377321:exon10:c.1442delG:p.R481fs,ENSG00000133895:ENST00000394374:exon10:c.1562delG:p.R521fs,ENSG00000133895:ENST00000443283:exon10:c.1562delG:p.R521fs,ENSG00000133895:ENST00000394376:exon11:c.1562delG:p.R521fs	exonic	MEN1	.	frameshift deletion	MEN1:uc001obj.3:exon10:c.1562delG:p.R521fs,MEN1:uc001obk.3:exon10:c.1562delG:p.R521fs,MEN1:uc001obl.3:exon10:c.1442delG:p.R481fs,MEN1:uc001obm.3:exon10:c.1547delG:p.R516fs,MEN1:uc001obn.3:exon10:c.1562delG:p.R521fs,MEN1:uc001obo.3:exon10:c.1562delG:p.R521fs,MEN1:uc001obr.3:exon10:c.1562delG:p.R521fs,MEN1:uc001obq.3:exon11:c.1562delG:p.R521fs	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Thyroid Hurthle Cell Carcinoma
11	67352689	67352689	A	G	exonic	GSTP1	.	nonsynonymous SNV	GSTP1:NM_000852:exon5:c.A313G:p.I105V	exonic	ENSG00000084207	.	nonsynonymous SNV	ENSG00000084207:ENST00000398603:exon5:c.A313G:p.I105V,ENSG00000084207:ENST00000398606:exon5:c.A313G:p.I105V	exonic	GSTP1	.	nonsynonymous SNV	GSTP1:uc001omf.3:exon5:c.A313G:p.I105V	0.3608	0.352636	0.3335	0.4442	0.5351	0.1807	0.2749	0.3191	0.2962	0.2887	rs1695	1.0	T	0.0	B	0.0	B	0.320	N	.	.	-0.67	N	3.96	T	0.29	N	0.018	-2.678	0.001	0.324	0.009	N	-0.938	T	0.000	T	0.628	0	-1.16	-2.114	-0.811	0.055	0.009	6.983	.	.	Glutathione S-transferase, C-terminal;Glutathione S-transferase, C-terminal-like	drug response|drug response|drug response	fluorouracil_and_oxaliplatin_response_-_Efficacy|cyclophosphamide_and_epirubicin_response_-_Efficacy,_Toxicity/ADR|Platinum_compounds_response_-_Toxicity/ADR	RCV000211146.1|RCV000211269.1|RCV000211325.1	MedGen|MedGen|MedGen	CN236475|CN236473|CN236514	.	MU104662	COAD-US|1|216|0.00463	COREAD
12	111884608	111884608	T	C	exonic	SH2B3	.	nonsynonymous SNV	SH2B3:NM_001291424:exon2:c.T178C:p.W60R,SH2B3:NM_005475:exon3:c.T784C:p.W262R	exonic	ENSG00000111252	.	nonsynonymous SNV	ENSG00000111252:ENST00000538307:exon2:c.T178C:p.W60R,ENSG00000111252:ENST00000341259:exon3:c.T784C:p.W262R	exonic	SH2B3	.	nonsynonymous SNV	SH2B3:uc001tsf.3:exon2:c.T784C:p.W262R,SH2B3:uc010syf.2:exon2:c.T784C:p.W262R,SH2B3:uc010syg.2:exon2:c.T178C:p.W60R,SH2B3:uc001tse.3:exon3:c.T784C:p.W262R	0.6340	0.852636	0.6625	0.9271	0.8031	0.9991	0.6183	0.5145	0.6584	0.9069	rs3184504	1.0	T	0.0	B	0.0	B	0.000	N	1	P	-1.845	N	1.66	T	4.17	N	0.044	-1.068	0.012	0.245	0.077	N	-0.956	T	0.000	T	0.722	0	2.97	-0.616	0.069	0.841	0.074	8.173	.	.	Pleckstrin homology domain	.	.	.	.	.	.	.	.	COREAD
12	21329738	21329738	A	G	exonic	SLCO1B1	.	nonsynonymous SNV	SLCO1B1:NM_006446:exon5:c.A388G:p.N130D	exonic	ENSG00000134538	.	nonsynonymous SNV	ENSG00000134538:ENST00000256958:exon5:c.A388G:p.N130D	exonic	SLCO1B1	.	nonsynonymous SNV	SLCO1B1:uc001req.4:exon5:c.A388G:p.N130D	0.5263	0.622404	0.4795	0.7680	0.4303	0.7499	0.4494	0.4107	0.5022	0.4795	rs2306283	0.45	T	0.0	B	0.003	B	0.189	N	1	P	0.495	N	1.12	T	-1.78	N	0.005	-1.733	0.002	0.462	0.012	N	-0.983	T	0.000	T	0.487	0	-2.63	-1.926	-1.165	0.000	0.000	9.285	.	.	Major facilitator superfamily domain	Benign	not_specified	RCV000251891.1	MedGen	CN169374	.	MU4554337	THCA-SA|1|15|0.06667	CANCER
12	21331549	21331549	T	C	exonic	SLCO1B1	.	nonsynonymous SNV	SLCO1B1:NM_006446:exon6:c.T521C:p.V174A	exonic	ENSG00000134538	.	nonsynonymous SNV	ENSG00000134538:ENST00000256958:exon6:c.T521C:p.V174A	exonic	SLCO1B1	.	nonsynonymous SNV	SLCO1B1:uc001req.4:exon6:c.T521C:p.V174A	0.1149	0.0876597	0.1294	0.0284	0.1065	0.1263	0.2136	0.1603	0.1667	0.0503	rs4149056	0.001	D	1.0	D	0.996	D	0.001	N	1.000	P	3.35	M	0.95	T	-3.87	D	0.192	3.340	22.9	0.983	0.981	D	-0.941	T	0.001	T	0.487	0	3.62	0.991	0.915	0.202	0.046	12.676	.	.	Major facilitator superfamily domain	drug response|drug response|drug response|drug response|drug response	rosuvastatin_response_-_Other|pravastatin_response_-_Metabolism/PK|simvastatin_response_-_Toxicity/ADR|hmg_coa_reductase_inhibitors_response_-_Toxicity/ADR|cerivastatin_response_-_Toxicity/ADR	RCV000211187.1|RCV000211193.1|RCV000211245.1|RCV000211308.1|RCV000211366.1	MedGen|MedGen|MedGen|MedGen|MedGen	CN236613|CN236605|CN236621|CN236512|CN236499	.	.	.	CANCER
12	25360224	25360224	A	C	UTR3;UTR3	KRAS	NM_033360:c.*2626T>G,NM_004985:c.*2505T>G	.	.	UTR3;UTR3	ENSG00000133703	ENST00000311936:c.*2505T>G	.	.	UTR3;UTR3	KRAS	uc001rgp.1:c.*2626T>G,uc001rgq.1:c.*2505T>G	.	.	.	0.0347444	.	.	.	.	.	.	.	.	rs61764370	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Epithelial Ovarian Cancer
12	25360224	25360224	A	C	UTR3;UTR3	KRAS	NM_033360:c.*2626T>G,NM_004985:c.*2505T>G	.	.	UTR3;UTR3	ENSG00000133703	ENST00000311936:c.*2505T>G	.	.	UTR3;UTR3	KRAS	uc001rgp.1:c.*2626T>G,uc001rgq.1:c.*2505T>G	.	.	.	0.0347444	.	.	.	.	.	.	.	.	rs61764370	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	HNSC
12	25378561	25378561	G	A	exonic	KRAS	.	nonsynonymous SNV	KRAS:NM_004985:exon4:c.C437T:p.A146V,KRAS:NM_033360:exon4:c.C437T:p.A146V	exonic	ENSG00000133703	.	nonsynonymous SNV	ENSG00000133703:ENST00000256078:exon4:c.C437T:p.A146V,ENSG00000133703:ENST00000311936:exon4:c.C437T:p.A146V	exonic	KRAS	.	nonsynonymous SNV	KRAS:uc001rgp.1:exon4:c.C437T:p.A146V,KRAS:uc001rgq.1:exon4:c.C437T:p.A146V	.	.	.	.	.	.	.	.	.	.	.	0.0	D	0.999	D	0.909	D	0.000	D	1	D	3.13	M	-2.43	D	-3.63	D	0.988	6.934	33	0.999	0.997	D	0.877	D	0.846	D	0.732	0	5.52	0.897	1.027	1.000	1.000	18.785	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	.	.	.	.	.	ID=COSM19900,COSM1360827;OCCURENCE=2(thyroid),1(haematopoietic_and_lymphoid_tissue),18(large_intestine)	MU168750	COCA-CN|1|187|0.00535,COAD-US|1|216|0.00463	NSCLC
12	25398255	25398255	G	A	exonic	KRAS	.	stopgain	KRAS:NM_004985:exon2:c.C64T:p.Q22X,KRAS:NM_033360:exon2:c.C64T:p.Q22X	exonic	ENSG00000133703	.	stopgain	ENSG00000133703:ENST00000256078:exon2:c.C64T:p.Q22X,ENSG00000133703:ENST00000311936:exon2:c.C64T:p.Q22X,ENSG00000133703:ENST00000556131:exon2:c.C64T:p.Q22X,ENSG00000133703:ENST00000557334:exon2:c.C64T:p.Q22X	exonic	KRAS	.	stopgain	KRAS:uc001rgp.1:exon2:c.C64T:p.Q22X,KRAS:uc001rgq.1:exon2:c.C64T:p.Q22X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.000	D	1	A	.	.	.	.	.	.	.	11.904	38	0.998	0.989	D	.	.	.	.	0.732	0	5.68	0.917	1.029	1.000	1.000	18.372	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	.	.	.	.	.	ID=COSM3735050,COSM33721;OCCURENCE=1(large_intestine),1(endometrium)	.	.	Colon Mucinous Adenocarcinoma
12	25398281	25398281	C	T	exonic	KRAS	.	nonsynonymous SNV	KRAS:NM_004985:exon2:c.G38A:p.G13D,KRAS:NM_033360:exon2:c.G38A:p.G13D	exonic	ENSG00000133703	.	nonsynonymous SNV	ENSG00000133703:ENST00000256078:exon2:c.G38A:p.G13D,ENSG00000133703:ENST00000311936:exon2:c.G38A:p.G13D,ENSG00000133703:ENST00000556131:exon2:c.G38A:p.G13D,ENSG00000133703:ENST00000557334:exon2:c.G38A:p.G13D	exonic	KRAS	.	nonsynonymous SNV	KRAS:uc001rgp.1:exon2:c.G38A:p.G13D,KRAS:uc001rgq.1:exon2:c.G38A:p.G13D	.	.	.	.	.	.	.	.	.	.	rs112445441	0.032	D	0.803	P	0.506	P	0.000	D	1	D	3.375	M	-0.7	T	-5.4	D	0.993	6.222	28.8	0.998	0.979	D	0.569	D	0.690	D	0.732	0	5.68	0.871	0.919	1.000	1.000	18.372	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic	Non-small_cell_lung_cancer,Breast_adenocarcinoma|Non-small_cell_lung_cancer|Juvenile_myelomonocytic_leukemia|RAS-associated_autoimmune_leukoproliferative_disorder	RCV000038270.2,RCV000013409.6|RCV000038269.2|RCV000144967.4|RCV000144968.4	MeSH:MedGen:SNOMED_CT,MedGen|MeSH:MedGen:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet	D002289:C0007131:254637007,C0858252|D002289:C0007131:254637007|C0349639:607785:ORPHA86834|C2674723:614470:ORPHA268114	ID=COSM1140132,COSM532;OCCURENCE=103(haematopoietic_and_lymphoid_tissue),2(pleura),5(cervix),17(gastrointestinal_tract_(site_indeterminate)),2(peritoneum),118(lung),23(thyroid),1(bone),4(upper_aerodigestive_tract),3(oesophagus),1(central_nervous_system),43(stomach),29(pancreas),3(liver),5(urinary_tract),1(genital_tract),3337(large_intestine),21(biliary_tract),23(prostate),17(breast),3(skin),19(small_intestine),50(endometrium),35(ovary),36(soft_tissue)	MU70839	AML-US|2|161|0.01242,COCA-CN|11|187|0.05882,ESAD-UK|2|119|0.01681,LIHC-US|1|188|0.00532,BTCA-JP|2|239|0.00837,READ-US|6|80|0.07500,PACA-CA|1|227|0.00441,STAD-US|10|289|0.03460,PACA-AU|1|391|0.00256,CESC-US|2|194|0.01031,UCEC-US|7|246|0.02846,COAD-US|18|216|0.08333	COREAD
12	25398284	25398284	C	A	exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:NM_004985:exon2:c.G35T:p.G12V,KRAS:NM_033360:exon2:c.G35T:p.G12V;KRAS:NM_004985:exon2:c.G35T:p.G12V,KRAS:NM_033360:exon2:c.G35T:p.G12V;KRAS:NM_004985:exon2:c.G35T:p.G12V,KRAS:NM_033360:exon2:c.G35T:p.G12V	exonic;exonic;exonic	ENSG00000133703	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703:ENST00000256078:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000311936:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000556131:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000557334:exon2:c.G35T:p.G12V;ENSG00000133703:ENST00000256078:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000311936:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000556131:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000557334:exon2:c.G35T:p.G12V;ENSG00000133703:ENST00000256078:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000311936:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000556131:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000557334:exon2:c.G35T:p.G12V	exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:uc001rgp.1:exon2:c.G35T:p.G12V,KRAS:uc001rgq.1:exon2:c.G35T:p.G12V;KRAS:uc001rgp.1:exon2:c.G35T:p.G12V,KRAS:uc001rgq.1:exon2:c.G35T:p.G12V;KRAS:uc001rgp.1:exon2:c.G35T:p.G12V,KRAS:uc001rgq.1:exon2:c.G35T:p.G12V	.	.	.	.	.	.	.	.	.	.	rs121913529	0.01	D	0.999	D	0.978	D	0.000	D	1	D	3.135	M	-1.2	T	-6.95	D	0.956	6.463	29.9	0.998	0.984	D	0.543	D	0.699	D	0.732	0	5.68	0.871	0.919	1.000	1.000	18.372	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Carcinoma_of_pancreas|Nevus_sebaceous|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_cancer|not_provided,Non-small_cell_lung_cancer,Carcinoma_of_pancreas|Neoplasm_of_stomach|Epidermal_nevus|Nevus_sebaceous|Epidermal_nevus_syndrome|Juvenile_myelomonocytic_leukemia|RAS-associated_autoimmune_leukoproliferative_disorder|Non-small_cell_lung_cancer|Neoplasm_of_ovary	RCV000013413.4|RCV000029216.4|RCV000150895.1|RCV000154262.1|RCV000157944.2,RCV000038266.2,RCV000013411.5|RCV000013412.5|RCV000022799.5|RCV000029214.5|RCV000029215.5|RCV000144969.5|RCV000144970.3|RCV000150896.2|RCV000150897.2	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|MedGen,MeSH:MedGen:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|Gene:MedGen:OMIM:SNOMED_CT	C0235974:260350:ORPHA217074:372142002|C0853032|C0349639:607785:ORPHA86834|D002289:C0007131:254637007|CN221809,D002289:C0007131:254637007,C0235974:260350:ORPHA217074:372142002|D013274:C0038356:613659:126824007|C0334082:162900:ORPHA35125:25201003|C0853032|C0265318:163200:239112008|C0349639:607785:ORPHA86834|C2674723:614470:ORPHA268114|D002289:C0007131:254637007|6765:C0919267:167000:123843001	ID=COSM1140133,COSM520;OCCURENCE=24(skin),10(breast),24(small_intestine),17(urinary_tract),2(genital_tract),2(kidney),1(eye),5(liver),1402(pancreas),39(prostate),110(biliary_tract),4060(large_intestine),1(autonomic_ganglia),245(ovary),4(soft_tissue),102(endometrium),13(thyroid),13(peritoneum),878(lung),6(testis),8(cervix),36(haematopoietic_and_lymphoid_tissue),2(pleura),9(gastrointestinal_tract_(site_indeterminate)),1(central_nervous_system),32(stomach),2(thymus),3(upper_aerodigestive_tract),4(oesophagus)	MU12519	AML-US|2|161|0.01242,BTCA-JP|7|239|0.02929,LICA-CN|1|163|0.00613,READ-US|10|80|0.12500,OV-US|1|88|0.01136,STAD-US|1|289|0.00346,CESC-US|2|194|0.01031,BLCA-CN|1|103|0.00971,LUSC-CN|1|10|0.10000,BRCA-US|3|955|0.00314,UCEC-US|12|246|0.04878,THCA-US|1|400|0.00250,COCA-CN|8|187|0.04278,PACA-CA|66|227|0.29075,ALL-US|1|27|0.03704,BRCA-EU|1|560|0.00179,PACA-AU|111|391|0.28389,OV-AU|1|93|0.01075,COAD-US|16|216|0.07407	CANCER
12	25398284	25398284	C	A	exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:NM_004985:exon2:c.G35T:p.G12V,KRAS:NM_033360:exon2:c.G35T:p.G12V;KRAS:NM_004985:exon2:c.G35T:p.G12V,KRAS:NM_033360:exon2:c.G35T:p.G12V;KRAS:NM_004985:exon2:c.G35T:p.G12V,KRAS:NM_033360:exon2:c.G35T:p.G12V	exonic;exonic;exonic	ENSG00000133703	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703:ENST00000256078:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000311936:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000556131:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000557334:exon2:c.G35T:p.G12V;ENSG00000133703:ENST00000256078:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000311936:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000556131:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000557334:exon2:c.G35T:p.G12V;ENSG00000133703:ENST00000256078:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000311936:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000556131:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000557334:exon2:c.G35T:p.G12V	exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:uc001rgp.1:exon2:c.G35T:p.G12V,KRAS:uc001rgq.1:exon2:c.G35T:p.G12V;KRAS:uc001rgp.1:exon2:c.G35T:p.G12V,KRAS:uc001rgq.1:exon2:c.G35T:p.G12V;KRAS:uc001rgp.1:exon2:c.G35T:p.G12V,KRAS:uc001rgq.1:exon2:c.G35T:p.G12V	.	.	.	.	.	.	.	.	.	.	rs121913529	0.01	D	0.999	D	0.978	D	0.000	D	1	D	3.135	M	-1.2	T	-6.95	D	0.956	6.463	29.9	0.998	0.984	D	0.543	D	0.699	D	0.732	0	5.68	0.871	0.919	1.000	1.000	18.372	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Carcinoma_of_pancreas|Nevus_sebaceous|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_cancer|not_provided,Non-small_cell_lung_cancer,Carcinoma_of_pancreas|Neoplasm_of_stomach|Epidermal_nevus|Nevus_sebaceous|Epidermal_nevus_syndrome|Juvenile_myelomonocytic_leukemia|RAS-associated_autoimmune_leukoproliferative_disorder|Non-small_cell_lung_cancer|Neoplasm_of_ovary	RCV000013413.4|RCV000029216.4|RCV000150895.1|RCV000154262.1|RCV000157944.2,RCV000038266.2,RCV000013411.5|RCV000013412.5|RCV000022799.5|RCV000029214.5|RCV000029215.5|RCV000144969.5|RCV000144970.3|RCV000150896.2|RCV000150897.2	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|MedGen,MeSH:MedGen:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|Gene:MedGen:OMIM:SNOMED_CT	C0235974:260350:ORPHA217074:372142002|C0853032|C0349639:607785:ORPHA86834|D002289:C0007131:254637007|CN221809,D002289:C0007131:254637007,C0235974:260350:ORPHA217074:372142002|D013274:C0038356:613659:126824007|C0334082:162900:ORPHA35125:25201003|C0853032|C0265318:163200:239112008|C0349639:607785:ORPHA86834|C2674723:614470:ORPHA268114|D002289:C0007131:254637007|6765:C0919267:167000:123843001	ID=COSM1140133,COSM520;OCCURENCE=24(skin),10(breast),24(small_intestine),17(urinary_tract),2(genital_tract),2(kidney),1(eye),5(liver),1402(pancreas),39(prostate),110(biliary_tract),4060(large_intestine),1(autonomic_ganglia),245(ovary),4(soft_tissue),102(endometrium),13(thyroid),13(peritoneum),878(lung),6(testis),8(cervix),36(haematopoietic_and_lymphoid_tissue),2(pleura),9(gastrointestinal_tract_(site_indeterminate)),1(central_nervous_system),32(stomach),2(thymus),3(upper_aerodigestive_tract),4(oesophagus)	MU12519	AML-US|2|161|0.01242,BTCA-JP|7|239|0.02929,LICA-CN|1|163|0.00613,READ-US|10|80|0.12500,OV-US|1|88|0.01136,STAD-US|1|289|0.00346,CESC-US|2|194|0.01031,BLCA-CN|1|103|0.00971,LUSC-CN|1|10|0.10000,BRCA-US|3|955|0.00314,UCEC-US|12|246|0.04878,THCA-US|1|400|0.00250,COCA-CN|8|187|0.04278,PACA-CA|66|227|0.29075,ALL-US|1|27|0.03704,BRCA-EU|1|560|0.00179,PACA-AU|111|391|0.28389,OV-AU|1|93|0.01075,COAD-US|16|216|0.07407	COREAD
12	25398284	25398284	C	A	exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:NM_004985:exon2:c.G35T:p.G12V,KRAS:NM_033360:exon2:c.G35T:p.G12V;KRAS:NM_004985:exon2:c.G35T:p.G12V,KRAS:NM_033360:exon2:c.G35T:p.G12V;KRAS:NM_004985:exon2:c.G35T:p.G12V,KRAS:NM_033360:exon2:c.G35T:p.G12V	exonic;exonic;exonic	ENSG00000133703	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703:ENST00000256078:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000311936:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000556131:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000557334:exon2:c.G35T:p.G12V;ENSG00000133703:ENST00000256078:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000311936:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000556131:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000557334:exon2:c.G35T:p.G12V;ENSG00000133703:ENST00000256078:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000311936:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000556131:exon2:c.G35T:p.G12V,ENSG00000133703:ENST00000557334:exon2:c.G35T:p.G12V	exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:uc001rgp.1:exon2:c.G35T:p.G12V,KRAS:uc001rgq.1:exon2:c.G35T:p.G12V;KRAS:uc001rgp.1:exon2:c.G35T:p.G12V,KRAS:uc001rgq.1:exon2:c.G35T:p.G12V;KRAS:uc001rgp.1:exon2:c.G35T:p.G12V,KRAS:uc001rgq.1:exon2:c.G35T:p.G12V	.	.	.	.	.	.	.	.	.	.	rs121913529	0.01	D	0.999	D	0.978	D	0.000	D	1	D	3.135	M	-1.2	T	-6.95	D	0.956	6.463	29.9	0.998	0.984	D	0.543	D	0.699	D	0.732	0	5.68	0.871	0.919	1.000	1.000	18.372	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Carcinoma_of_pancreas|Nevus_sebaceous|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_cancer|not_provided,Non-small_cell_lung_cancer,Carcinoma_of_pancreas|Neoplasm_of_stomach|Epidermal_nevus|Nevus_sebaceous|Epidermal_nevus_syndrome|Juvenile_myelomonocytic_leukemia|RAS-associated_autoimmune_leukoproliferative_disorder|Non-small_cell_lung_cancer|Neoplasm_of_ovary	RCV000013413.4|RCV000029216.4|RCV000150895.1|RCV000154262.1|RCV000157944.2,RCV000038266.2,RCV000013411.5|RCV000013412.5|RCV000022799.5|RCV000029214.5|RCV000029215.5|RCV000144969.5|RCV000144970.3|RCV000150896.2|RCV000150897.2	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|MedGen,MeSH:MedGen:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|Gene:MedGen:OMIM:SNOMED_CT	C0235974:260350:ORPHA217074:372142002|C0853032|C0349639:607785:ORPHA86834|D002289:C0007131:254637007|CN221809,D002289:C0007131:254637007,C0235974:260350:ORPHA217074:372142002|D013274:C0038356:613659:126824007|C0334082:162900:ORPHA35125:25201003|C0853032|C0265318:163200:239112008|C0349639:607785:ORPHA86834|C2674723:614470:ORPHA268114|D002289:C0007131:254637007|6765:C0919267:167000:123843001	ID=COSM1140133,COSM520;OCCURENCE=24(skin),10(breast),24(small_intestine),17(urinary_tract),2(genital_tract),2(kidney),1(eye),5(liver),1402(pancreas),39(prostate),110(biliary_tract),4060(large_intestine),1(autonomic_ganglia),245(ovary),4(soft_tissue),102(endometrium),13(thyroid),13(peritoneum),878(lung),6(testis),8(cervix),36(haematopoietic_and_lymphoid_tissue),2(pleura),9(gastrointestinal_tract_(site_indeterminate)),1(central_nervous_system),32(stomach),2(thymus),3(upper_aerodigestive_tract),4(oesophagus)	MU12519	AML-US|2|161|0.01242,BTCA-JP|7|239|0.02929,LICA-CN|1|163|0.00613,READ-US|10|80|0.12500,OV-US|1|88|0.01136,STAD-US|1|289|0.00346,CESC-US|2|194|0.01031,BLCA-CN|1|103|0.00971,LUSC-CN|1|10|0.10000,BRCA-US|3|955|0.00314,UCEC-US|12|246|0.04878,THCA-US|1|400|0.00250,COCA-CN|8|187|0.04278,PACA-CA|66|227|0.29075,ALL-US|1|27|0.03704,BRCA-EU|1|560|0.00179,PACA-AU|111|391|0.28389,OV-AU|1|93|0.01075,COAD-US|16|216|0.07407	NSCLC
12	25398284	25398284	C	G	exonic	KRAS	.	nonsynonymous SNV	KRAS:NM_004985:exon2:c.G35C:p.G12A,KRAS:NM_033360:exon2:c.G35C:p.G12A	exonic	ENSG00000133703	.	nonsynonymous SNV	ENSG00000133703:ENST00000256078:exon2:c.G35C:p.G12A,ENSG00000133703:ENST00000311936:exon2:c.G35C:p.G12A,ENSG00000133703:ENST00000556131:exon2:c.G35C:p.G12A,ENSG00000133703:ENST00000557334:exon2:c.G35C:p.G12A	exonic	KRAS	.	nonsynonymous SNV	KRAS:uc001rgp.1:exon2:c.G35C:p.G12A,KRAS:uc001rgq.1:exon2:c.G35C:p.G12A	.	.	.	.	.	.	.	.	.	.	rs121913529	0.03	D	0.956	P	0.773	P	0.000	D	1	D	2.27	M	-1.14	T	-4.55	D	0.819	5.811	27.2	0.998	0.985	D	0.215	D	0.574	D	0.732	0	5.68	0.871	0.919	1.000	1.000	18.372	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Carcinoma_of_pancreas|Nevus_sebaceous|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_cancer|not_provided,Non-small_cell_lung_cancer,Carcinoma_of_pancreas|Neoplasm_of_stomach|Epidermal_nevus|Nevus_sebaceous|Epidermal_nevus_syndrome|Juvenile_myelomonocytic_leukemia|RAS-associated_autoimmune_leukoproliferative_disorder|Non-small_cell_lung_cancer|Neoplasm_of_ovary	RCV000013413.4|RCV000029216.4|RCV000150895.1|RCV000154262.1|RCV000157944.2,RCV000038266.2,RCV000013411.5|RCV000013412.5|RCV000022799.5|RCV000029214.5|RCV000029215.5|RCV000144969.5|RCV000144970.3|RCV000150896.2|RCV000150897.2	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|MedGen,MeSH:MedGen:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|Gene:MedGen:OMIM:SNOMED_CT	C0235974:260350:ORPHA217074:372142002|C0853032|C0349639:607785:ORPHA86834|D002289:C0007131:254637007|CN221809,D002289:C0007131:254637007,C0235974:260350:ORPHA217074:372142002|D013274:C0038356:613659:126824007|C0334082:162900:ORPHA35125:25201003|C0853032|C0265318:163200:239112008|C0349639:607785:ORPHA86834|C2674723:614470:ORPHA268114|D002289:C0007131:254637007|6765:C0919267:167000:123843001	ID=COSM1140134,COSM522;OCCURENCE=3(upper_aerodigestive_tract),1(bone),1(oesophagus),25(stomach),6(central_nervous_system),1(thymus),4(cervix),1(testis),33(haematopoietic_and_lymphoid_tissue),1(gastrointestinal_tract_(site_indeterminate)),6(thyroid),1(peritoneum),290(lung),55(endometrium),35(ovary),3(soft_tissue),7(urinary_tract),1(liver),75(pancreas),2(prostate),29(biliary_tract),1086(large_intestine),1(skin),1(breast),9(small_intestine)	MU89507	COCA-CN|1|187|0.00535,BRCA-UK|1|117|0.00855,BTCA-JP|2|239|0.00837,LAML-KR|1|107|0.00935,READ-US|3|80|0.03750,PACA-CA|1|227|0.00441,BLCA-CN|1|103|0.00971,PACA-AU|2|391|0.00512,UCEC-US|5|246|0.02033,COAD-US|5|216|0.02315	LUAD
12	25398284	25398284	C	T	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000133703	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D	.	.	1.976e-05	0.0001	0	0	0	1.873e-05	0	0	rs121913529	0.024	D	0.517	P	0.361	B	0.000	D	1	D	3.245	M	-1.19	T	-5.27	D	0.974	5.090	25.3	0.998	0.979	D	0.267	D	0.581	D	0.732	0	5.68	0.871	0.919	1.000	1.000	18.372	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Carcinoma_of_pancreas|Nevus_sebaceous|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_cancer|not_provided,Non-small_cell_lung_cancer,Carcinoma_of_pancreas|Neoplasm_of_stomach|Epidermal_nevus|Nevus_sebaceous|Epidermal_nevus_syndrome|Juvenile_myelomonocytic_leukemia|RAS-associated_autoimmune_leukoproliferative_disorder|Non-small_cell_lung_cancer|Neoplasm_of_ovary	RCV000013413.4|RCV000029216.4|RCV000150895.1|RCV000154262.1|RCV000157944.2,RCV000038266.2,RCV000013411.5|RCV000013412.5|RCV000022799.5|RCV000029214.5|RCV000029215.5|RCV000144969.5|RCV000144970.3|RCV000150896.2|RCV000150897.2	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|MedGen,MeSH:MedGen:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|Gene:MedGen:OMIM:SNOMED_CT	C0235974:260350:ORPHA217074:372142002|C0853032|C0349639:607785:ORPHA86834|D002289:C0007131:254637007|CN221809,D002289:C0007131:254637007,C0235974:260350:ORPHA217074:372142002|D013274:C0038356:613659:126824007|C0334082:162900:ORPHA35125:25201003|C0853032|C0265318:163200:239112008|C0349639:607785:ORPHA86834|C2674723:614470:ORPHA268114|D002289:C0007131:254637007|6765:C0919267:167000:123843001	ID=COSM521,COSM1135366;OCCURENCE=1(salivary_gland),171(endometrium),265(ovary),20(soft_tissue),19(urinary_tract),1(kidney),2323(pancreas),15(liver),3(eye),22(prostate),321(biliary_tract),6237(large_intestine),18(breast),24(skin),58(small_intestine),25(upper_aerodigestive_tract),10(oesophagus),4(central_nervous_system),93(stomach),2(testis),19(cervix),114(haematopoietic_and_lymphoid_tissue),15(gastrointestinal_tract_(site_indeterminate)),37(thyroid),737(lung),25(peritoneum)	MU37643	AML-US|4|161|0.02484,KIRP-US|2|159|0.01258,BTCA-JP|18|239|0.07531,READ-US|7|80|0.08750,STAD-US|7|289|0.02422,CESC-US|4|194|0.02062,BRCA-US|1|955|0.00105,UCEC-US|16|246|0.06504,LIRI-JP|1|260|0.00385,COCA-CN|22|187|0.11765,ESAD-UK|2|119|0.01681,LIHC-US|1|188|0.00532,ESCA-CN|2|228|0.00877,GBM-US|2|268|0.00746,LINC-JP|2|244|0.00820,PACA-CA|88|227|0.38767,ALL-US|1|27|0.03704,ORCA-IN|1|106|0.00943,PACA-AU|135|391|0.34527,CLLE-ES|1|218|0.00459,SKCM-US|1|335|0.00299,COAD-US|21|216|0.09722	COREAD
12	25398284	25398284	C	T	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000133703	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D	.	.	1.976e-05	0.0001	0	0	0	1.873e-05	0	0	rs121913529	0.024	D	0.517	P	0.361	B	0.000	D	1	D	3.245	M	-1.19	T	-5.27	D	0.974	5.090	25.3	0.998	0.979	D	0.267	D	0.581	D	0.732	0	5.68	0.871	0.919	1.000	1.000	18.372	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Carcinoma_of_pancreas|Nevus_sebaceous|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_cancer|not_provided,Non-small_cell_lung_cancer,Carcinoma_of_pancreas|Neoplasm_of_stomach|Epidermal_nevus|Nevus_sebaceous|Epidermal_nevus_syndrome|Juvenile_myelomonocytic_leukemia|RAS-associated_autoimmune_leukoproliferative_disorder|Non-small_cell_lung_cancer|Neoplasm_of_ovary	RCV000013413.4|RCV000029216.4|RCV000150895.1|RCV000154262.1|RCV000157944.2,RCV000038266.2,RCV000013411.5|RCV000013412.5|RCV000022799.5|RCV000029214.5|RCV000029215.5|RCV000144969.5|RCV000144970.3|RCV000150896.2|RCV000150897.2	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|MedGen,MeSH:MedGen:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|Gene:MedGen:OMIM:SNOMED_CT	C0235974:260350:ORPHA217074:372142002|C0853032|C0349639:607785:ORPHA86834|D002289:C0007131:254637007|CN221809,D002289:C0007131:254637007,C0235974:260350:ORPHA217074:372142002|D013274:C0038356:613659:126824007|C0334082:162900:ORPHA35125:25201003|C0853032|C0265318:163200:239112008|C0349639:607785:ORPHA86834|C2674723:614470:ORPHA268114|D002289:C0007131:254637007|6765:C0919267:167000:123843001	ID=COSM521,COSM1135366;OCCURENCE=1(salivary_gland),171(endometrium),265(ovary),20(soft_tissue),19(urinary_tract),1(kidney),2323(pancreas),15(liver),3(eye),22(prostate),321(biliary_tract),6237(large_intestine),18(breast),24(skin),58(small_intestine),25(upper_aerodigestive_tract),10(oesophagus),4(central_nervous_system),93(stomach),2(testis),19(cervix),114(haematopoietic_and_lymphoid_tissue),15(gastrointestinal_tract_(site_indeterminate)),37(thyroid),737(lung),25(peritoneum)	MU37643	AML-US|4|161|0.02484,KIRP-US|2|159|0.01258,BTCA-JP|18|239|0.07531,READ-US|7|80|0.08750,STAD-US|7|289|0.02422,CESC-US|4|194|0.02062,BRCA-US|1|955|0.00105,UCEC-US|16|246|0.06504,LIRI-JP|1|260|0.00385,COCA-CN|22|187|0.11765,ESAD-UK|2|119|0.01681,LIHC-US|1|188|0.00532,ESCA-CN|2|228|0.00877,GBM-US|2|268|0.00746,LINC-JP|2|244|0.00820,PACA-CA|88|227|0.38767,ALL-US|1|27|0.03704,ORCA-IN|1|106|0.00943,PACA-AU|135|391|0.34527,CLLE-ES|1|218|0.00459,SKCM-US|1|335|0.00299,COAD-US|21|216|0.09722	HCL
12	25398284	25398284	C	T	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000133703	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D	.	.	1.976e-05	0.0001	0	0	0	1.873e-05	0	0	rs121913529	0.024	D	0.517	P	0.361	B	0.000	D	1	D	3.245	M	-1.19	T	-5.27	D	0.974	5.090	25.3	0.998	0.979	D	0.267	D	0.581	D	0.732	0	5.68	0.871	0.919	1.000	1.000	18.372	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Carcinoma_of_pancreas|Nevus_sebaceous|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_cancer|not_provided,Non-small_cell_lung_cancer,Carcinoma_of_pancreas|Neoplasm_of_stomach|Epidermal_nevus|Nevus_sebaceous|Epidermal_nevus_syndrome|Juvenile_myelomonocytic_leukemia|RAS-associated_autoimmune_leukoproliferative_disorder|Non-small_cell_lung_cancer|Neoplasm_of_ovary	RCV000013413.4|RCV000029216.4|RCV000150895.1|RCV000154262.1|RCV000157944.2,RCV000038266.2,RCV000013411.5|RCV000013412.5|RCV000022799.5|RCV000029214.5|RCV000029215.5|RCV000144969.5|RCV000144970.3|RCV000150896.2|RCV000150897.2	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|MedGen,MeSH:MedGen:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|Gene:MedGen:OMIM:SNOMED_CT	C0235974:260350:ORPHA217074:372142002|C0853032|C0349639:607785:ORPHA86834|D002289:C0007131:254637007|CN221809,D002289:C0007131:254637007,C0235974:260350:ORPHA217074:372142002|D013274:C0038356:613659:126824007|C0334082:162900:ORPHA35125:25201003|C0853032|C0265318:163200:239112008|C0349639:607785:ORPHA86834|C2674723:614470:ORPHA268114|D002289:C0007131:254637007|6765:C0919267:167000:123843001	ID=COSM521,COSM1135366;OCCURENCE=1(salivary_gland),171(endometrium),265(ovary),20(soft_tissue),19(urinary_tract),1(kidney),2323(pancreas),15(liver),3(eye),22(prostate),321(biliary_tract),6237(large_intestine),18(breast),24(skin),58(small_intestine),25(upper_aerodigestive_tract),10(oesophagus),4(central_nervous_system),93(stomach),2(testis),19(cervix),114(haematopoietic_and_lymphoid_tissue),15(gastrointestinal_tract_(site_indeterminate)),37(thyroid),737(lung),25(peritoneum)	MU37643	AML-US|4|161|0.02484,KIRP-US|2|159|0.01258,BTCA-JP|18|239|0.07531,READ-US|7|80|0.08750,STAD-US|7|289|0.02422,CESC-US|4|194|0.02062,BRCA-US|1|955|0.00105,UCEC-US|16|246|0.06504,LIRI-JP|1|260|0.00385,COCA-CN|22|187|0.11765,ESAD-UK|2|119|0.01681,LIHC-US|1|188|0.00532,ESCA-CN|2|228|0.00877,GBM-US|2|268|0.00746,LINC-JP|2|244|0.00820,PACA-CA|88|227|0.38767,ALL-US|1|27|0.03704,ORCA-IN|1|106|0.00943,PACA-AU|135|391|0.34527,CLLE-ES|1|218|0.00459,SKCM-US|1|335|0.00299,COAD-US|21|216|0.09722	L
12	25398284	25398284	C	T	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000133703	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D	.	.	1.976e-05	0.0001	0	0	0	1.873e-05	0	0	rs121913529	0.024	D	0.517	P	0.361	B	0.000	D	1	D	3.245	M	-1.19	T	-5.27	D	0.974	5.090	25.3	0.998	0.979	D	0.267	D	0.581	D	0.732	0	5.68	0.871	0.919	1.000	1.000	18.372	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Carcinoma_of_pancreas|Nevus_sebaceous|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_cancer|not_provided,Non-small_cell_lung_cancer,Carcinoma_of_pancreas|Neoplasm_of_stomach|Epidermal_nevus|Nevus_sebaceous|Epidermal_nevus_syndrome|Juvenile_myelomonocytic_leukemia|RAS-associated_autoimmune_leukoproliferative_disorder|Non-small_cell_lung_cancer|Neoplasm_of_ovary	RCV000013413.4|RCV000029216.4|RCV000150895.1|RCV000154262.1|RCV000157944.2,RCV000038266.2,RCV000013411.5|RCV000013412.5|RCV000022799.5|RCV000029214.5|RCV000029215.5|RCV000144969.5|RCV000144970.3|RCV000150896.2|RCV000150897.2	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|MedGen,MeSH:MedGen:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|Gene:MedGen:OMIM:SNOMED_CT	C0235974:260350:ORPHA217074:372142002|C0853032|C0349639:607785:ORPHA86834|D002289:C0007131:254637007|CN221809,D002289:C0007131:254637007,C0235974:260350:ORPHA217074:372142002|D013274:C0038356:613659:126824007|C0334082:162900:ORPHA35125:25201003|C0853032|C0265318:163200:239112008|C0349639:607785:ORPHA86834|C2674723:614470:ORPHA268114|D002289:C0007131:254637007|6765:C0919267:167000:123843001	ID=COSM521,COSM1135366;OCCURENCE=1(salivary_gland),171(endometrium),265(ovary),20(soft_tissue),19(urinary_tract),1(kidney),2323(pancreas),15(liver),3(eye),22(prostate),321(biliary_tract),6237(large_intestine),18(breast),24(skin),58(small_intestine),25(upper_aerodigestive_tract),10(oesophagus),4(central_nervous_system),93(stomach),2(testis),19(cervix),114(haematopoietic_and_lymphoid_tissue),15(gastrointestinal_tract_(site_indeterminate)),37(thyroid),737(lung),25(peritoneum)	MU37643	AML-US|4|161|0.02484,KIRP-US|2|159|0.01258,BTCA-JP|18|239|0.07531,READ-US|7|80|0.08750,STAD-US|7|289|0.02422,CESC-US|4|194|0.02062,BRCA-US|1|955|0.00105,UCEC-US|16|246|0.06504,LIRI-JP|1|260|0.00385,COCA-CN|22|187|0.11765,ESAD-UK|2|119|0.01681,LIHC-US|1|188|0.00532,ESCA-CN|2|228|0.00877,GBM-US|2|268|0.00746,LINC-JP|2|244|0.00820,PACA-CA|88|227|0.38767,ALL-US|1|27|0.03704,ORCA-IN|1|106|0.00943,PACA-AU|135|391|0.34527,CLLE-ES|1|218|0.00459,SKCM-US|1|335|0.00299,COAD-US|21|216|0.09722	NSCLC
12	25398284	25398284	C	T	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000133703	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D	.	.	1.976e-05	0.0001	0	0	0	1.873e-05	0	0	rs121913529	0.024	D	0.517	P	0.361	B	0.000	D	1	D	3.245	M	-1.19	T	-5.27	D	0.974	5.090	25.3	0.998	0.979	D	0.267	D	0.581	D	0.732	0	5.68	0.871	0.919	1.000	1.000	18.372	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Carcinoma_of_pancreas|Nevus_sebaceous|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_cancer|not_provided,Non-small_cell_lung_cancer,Carcinoma_of_pancreas|Neoplasm_of_stomach|Epidermal_nevus|Nevus_sebaceous|Epidermal_nevus_syndrome|Juvenile_myelomonocytic_leukemia|RAS-associated_autoimmune_leukoproliferative_disorder|Non-small_cell_lung_cancer|Neoplasm_of_ovary	RCV000013413.4|RCV000029216.4|RCV000150895.1|RCV000154262.1|RCV000157944.2,RCV000038266.2,RCV000013411.5|RCV000013412.5|RCV000022799.5|RCV000029214.5|RCV000029215.5|RCV000144969.5|RCV000144970.3|RCV000150896.2|RCV000150897.2	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|MedGen,MeSH:MedGen:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|Gene:MedGen:OMIM:SNOMED_CT	C0235974:260350:ORPHA217074:372142002|C0853032|C0349639:607785:ORPHA86834|D002289:C0007131:254637007|CN221809,D002289:C0007131:254637007,C0235974:260350:ORPHA217074:372142002|D013274:C0038356:613659:126824007|C0334082:162900:ORPHA35125:25201003|C0853032|C0265318:163200:239112008|C0349639:607785:ORPHA86834|C2674723:614470:ORPHA268114|D002289:C0007131:254637007|6765:C0919267:167000:123843001	ID=COSM521,COSM1135366;OCCURENCE=1(salivary_gland),171(endometrium),265(ovary),20(soft_tissue),19(urinary_tract),1(kidney),2323(pancreas),15(liver),3(eye),22(prostate),321(biliary_tract),6237(large_intestine),18(breast),24(skin),58(small_intestine),25(upper_aerodigestive_tract),10(oesophagus),4(central_nervous_system),93(stomach),2(testis),19(cervix),114(haematopoietic_and_lymphoid_tissue),15(gastrointestinal_tract_(site_indeterminate)),37(thyroid),737(lung),25(peritoneum)	MU37643	AML-US|4|161|0.02484,KIRP-US|2|159|0.01258,BTCA-JP|18|239|0.07531,READ-US|7|80|0.08750,STAD-US|7|289|0.02422,CESC-US|4|194|0.02062,BRCA-US|1|955|0.00105,UCEC-US|16|246|0.06504,LIRI-JP|1|260|0.00385,COCA-CN|22|187|0.11765,ESAD-UK|2|119|0.01681,LIHC-US|1|188|0.00532,ESCA-CN|2|228|0.00877,GBM-US|2|268|0.00746,LINC-JP|2|244|0.00820,PACA-CA|88|227|0.38767,ALL-US|1|27|0.03704,ORCA-IN|1|106|0.00943,PACA-AU|135|391|0.34527,CLLE-ES|1|218|0.00459,SKCM-US|1|335|0.00299,COAD-US|21|216|0.09722	PA
12	25398284	25398284	C	T	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000133703	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D	.	.	1.976e-05	0.0001	0	0	0	1.873e-05	0	0	rs121913529	0.024	D	0.517	P	0.361	B	0.000	D	1	D	3.245	M	-1.19	T	-5.27	D	0.974	5.090	25.3	0.998	0.979	D	0.267	D	0.581	D	0.732	0	5.68	0.871	0.919	1.000	1.000	18.372	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Carcinoma_of_pancreas|Nevus_sebaceous|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_cancer|not_provided,Non-small_cell_lung_cancer,Carcinoma_of_pancreas|Neoplasm_of_stomach|Epidermal_nevus|Nevus_sebaceous|Epidermal_nevus_syndrome|Juvenile_myelomonocytic_leukemia|RAS-associated_autoimmune_leukoproliferative_disorder|Non-small_cell_lung_cancer|Neoplasm_of_ovary	RCV000013413.4|RCV000029216.4|RCV000150895.1|RCV000154262.1|RCV000157944.2,RCV000038266.2,RCV000013411.5|RCV000013412.5|RCV000022799.5|RCV000029214.5|RCV000029215.5|RCV000144969.5|RCV000144970.3|RCV000150896.2|RCV000150897.2	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|MedGen,MeSH:MedGen:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|Gene:MedGen:OMIM:SNOMED_CT	C0235974:260350:ORPHA217074:372142002|C0853032|C0349639:607785:ORPHA86834|D002289:C0007131:254637007|CN221809,D002289:C0007131:254637007,C0235974:260350:ORPHA217074:372142002|D013274:C0038356:613659:126824007|C0334082:162900:ORPHA35125:25201003|C0853032|C0265318:163200:239112008|C0349639:607785:ORPHA86834|C2674723:614470:ORPHA268114|D002289:C0007131:254637007|6765:C0919267:167000:123843001	ID=COSM521,COSM1135366;OCCURENCE=1(salivary_gland),171(endometrium),265(ovary),20(soft_tissue),19(urinary_tract),1(kidney),2323(pancreas),15(liver),3(eye),22(prostate),321(biliary_tract),6237(large_intestine),18(breast),24(skin),58(small_intestine),25(upper_aerodigestive_tract),10(oesophagus),4(central_nervous_system),93(stomach),2(testis),19(cervix),114(haematopoietic_and_lymphoid_tissue),15(gastrointestinal_tract_(site_indeterminate)),37(thyroid),737(lung),25(peritoneum)	MU37643	AML-US|4|161|0.02484,KIRP-US|2|159|0.01258,BTCA-JP|18|239|0.07531,READ-US|7|80|0.08750,STAD-US|7|289|0.02422,CESC-US|4|194|0.02062,BRCA-US|1|955|0.00105,UCEC-US|16|246|0.06504,LIRI-JP|1|260|0.00385,COCA-CN|22|187|0.11765,ESAD-UK|2|119|0.01681,LIHC-US|1|188|0.00532,ESCA-CN|2|228|0.00877,GBM-US|2|268|0.00746,LINC-JP|2|244|0.00820,PACA-CA|88|227|0.38767,ALL-US|1|27|0.03704,ORCA-IN|1|106|0.00943,PACA-AU|135|391|0.34527,CLLE-ES|1|218|0.00459,SKCM-US|1|335|0.00299,COAD-US|21|216|0.09722	PA
12	25398284	25398284	C	T	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000133703	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D	.	.	1.976e-05	0.0001	0	0	0	1.873e-05	0	0	rs121913529	0.024	D	0.517	P	0.361	B	0.000	D	1	D	3.245	M	-1.19	T	-5.27	D	0.974	5.090	25.3	0.998	0.979	D	0.267	D	0.581	D	0.732	0	5.68	0.871	0.919	1.000	1.000	18.372	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Carcinoma_of_pancreas|Nevus_sebaceous|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_cancer|not_provided,Non-small_cell_lung_cancer,Carcinoma_of_pancreas|Neoplasm_of_stomach|Epidermal_nevus|Nevus_sebaceous|Epidermal_nevus_syndrome|Juvenile_myelomonocytic_leukemia|RAS-associated_autoimmune_leukoproliferative_disorder|Non-small_cell_lung_cancer|Neoplasm_of_ovary	RCV000013413.4|RCV000029216.4|RCV000150895.1|RCV000154262.1|RCV000157944.2,RCV000038266.2,RCV000013411.5|RCV000013412.5|RCV000022799.5|RCV000029214.5|RCV000029215.5|RCV000144969.5|RCV000144970.3|RCV000150896.2|RCV000150897.2	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|MedGen,MeSH:MedGen:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|Gene:MedGen:OMIM:SNOMED_CT	C0235974:260350:ORPHA217074:372142002|C0853032|C0349639:607785:ORPHA86834|D002289:C0007131:254637007|CN221809,D002289:C0007131:254637007,C0235974:260350:ORPHA217074:372142002|D013274:C0038356:613659:126824007|C0334082:162900:ORPHA35125:25201003|C0853032|C0265318:163200:239112008|C0349639:607785:ORPHA86834|C2674723:614470:ORPHA268114|D002289:C0007131:254637007|6765:C0919267:167000:123843001	ID=COSM521,COSM1135366;OCCURENCE=1(salivary_gland),171(endometrium),265(ovary),20(soft_tissue),19(urinary_tract),1(kidney),2323(pancreas),15(liver),3(eye),22(prostate),321(biliary_tract),6237(large_intestine),18(breast),24(skin),58(small_intestine),25(upper_aerodigestive_tract),10(oesophagus),4(central_nervous_system),93(stomach),2(testis),19(cervix),114(haematopoietic_and_lymphoid_tissue),15(gastrointestinal_tract_(site_indeterminate)),37(thyroid),737(lung),25(peritoneum)	MU37643	AML-US|4|161|0.02484,KIRP-US|2|159|0.01258,BTCA-JP|18|239|0.07531,READ-US|7|80|0.08750,STAD-US|7|289|0.02422,CESC-US|4|194|0.02062,BRCA-US|1|955|0.00105,UCEC-US|16|246|0.06504,LIRI-JP|1|260|0.00385,COCA-CN|22|187|0.11765,ESAD-UK|2|119|0.01681,LIHC-US|1|188|0.00532,ESCA-CN|2|228|0.00877,GBM-US|2|268|0.00746,LINC-JP|2|244|0.00820,PACA-CA|88|227|0.38767,ALL-US|1|27|0.03704,ORCA-IN|1|106|0.00943,PACA-AU|135|391|0.34527,CLLE-ES|1|218|0.00459,SKCM-US|1|335|0.00299,COAD-US|21|216|0.09722	Pancreatic Ductal Carcinoma
12	25398284	25398284	C	T	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D;KRAS:NM_004985:exon2:c.G35A:p.G12D,KRAS:NM_033360:exon2:c.G35A:p.G12D	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000133703	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D;ENSG00000133703:ENST00000256078:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000311936:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000556131:exon2:c.G35A:p.G12D,ENSG00000133703:ENST00000557334:exon2:c.G35A:p.G12D	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D;KRAS:uc001rgp.1:exon2:c.G35A:p.G12D,KRAS:uc001rgq.1:exon2:c.G35A:p.G12D	.	.	1.976e-05	0.0001	0	0	0	1.873e-05	0	0	rs121913529	0.024	D	0.517	P	0.361	B	0.000	D	1	D	3.245	M	-1.19	T	-5.27	D	0.974	5.090	25.3	0.998	0.979	D	0.267	D	0.581	D	0.732	0	5.68	0.871	0.919	1.000	1.000	18.372	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Carcinoma_of_pancreas|Nevus_sebaceous|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_cancer|not_provided,Non-small_cell_lung_cancer,Carcinoma_of_pancreas|Neoplasm_of_stomach|Epidermal_nevus|Nevus_sebaceous|Epidermal_nevus_syndrome|Juvenile_myelomonocytic_leukemia|RAS-associated_autoimmune_leukoproliferative_disorder|Non-small_cell_lung_cancer|Neoplasm_of_ovary	RCV000013413.4|RCV000029216.4|RCV000150895.1|RCV000154262.1|RCV000157944.2,RCV000038266.2,RCV000013411.5|RCV000013412.5|RCV000022799.5|RCV000029214.5|RCV000029215.5|RCV000144969.5|RCV000144970.3|RCV000150896.2|RCV000150897.2	MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|MedGen,MeSH:MedGen:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet|MedGen:OMIM:Orphanet|MeSH:MedGen:SNOMED_CT|Gene:MedGen:OMIM:SNOMED_CT	C0235974:260350:ORPHA217074:372142002|C0853032|C0349639:607785:ORPHA86834|D002289:C0007131:254637007|CN221809,D002289:C0007131:254637007,C0235974:260350:ORPHA217074:372142002|D013274:C0038356:613659:126824007|C0334082:162900:ORPHA35125:25201003|C0853032|C0265318:163200:239112008|C0349639:607785:ORPHA86834|C2674723:614470:ORPHA268114|D002289:C0007131:254637007|6765:C0919267:167000:123843001	ID=COSM521,COSM1135366;OCCURENCE=1(salivary_gland),171(endometrium),265(ovary),20(soft_tissue),19(urinary_tract),1(kidney),2323(pancreas),15(liver),3(eye),22(prostate),321(biliary_tract),6237(large_intestine),18(breast),24(skin),58(small_intestine),25(upper_aerodigestive_tract),10(oesophagus),4(central_nervous_system),93(stomach),2(testis),19(cervix),114(haematopoietic_and_lymphoid_tissue),15(gastrointestinal_tract_(site_indeterminate)),37(thyroid),737(lung),25(peritoneum)	MU37643	AML-US|4|161|0.02484,KIRP-US|2|159|0.01258,BTCA-JP|18|239|0.07531,READ-US|7|80|0.08750,STAD-US|7|289|0.02422,CESC-US|4|194|0.02062,BRCA-US|1|955|0.00105,UCEC-US|16|246|0.06504,LIRI-JP|1|260|0.00385,COCA-CN|22|187|0.11765,ESAD-UK|2|119|0.01681,LIHC-US|1|188|0.00532,ESCA-CN|2|228|0.00877,GBM-US|2|268|0.00746,LINC-JP|2|244|0.00820,PACA-CA|88|227|0.38767,ALL-US|1|27|0.03704,ORCA-IN|1|106|0.00943,PACA-AU|135|391|0.34527,CLLE-ES|1|218|0.00459,SKCM-US|1|335|0.00299,COAD-US|21|216|0.09722	Tumor Of Exocrine Pancreas
12	25398285	25398285	C	A	exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C	exonic;exonic;exonic;exonic	ENSG00000133703	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C	exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C	.	.	1.976e-05	0	0	0.0001	0	1.873e-05	0	0	rs121913530	0.02	D	1.0	D	0.993	D	0.000	D	1	D	3.135	M	-1.24	T	-6.99	D	0.905	7.016	33	0.997	0.984	D	0.548	D	0.701	D	0.732	0	5.68	0.871	0.919	1.000	1.000	18.372	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic|not provided,Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|not provided|Pathogenic	Lung_cancer|Non-small_cell_lung_cancer|Endometrial_carcinoma,Squamous_cell_carcinoma_of_lung|Malignant_tumor_of_urinary_bladder|Non-small_cell_lung_cancer,Neoplasm_of_stomach|Non-small_cell_lung_cancer|Neoplasm_of_ovary|Juvenile_myelomonocytic_leukemia	RCV000013406.4|RCV000038265.2|RCV000119791.1,RCV000013407.4|RCV000013408.4|RCV000154401.2,RCV000013414.5|RCV000038264.2|RCV000119790.1|RCV000144971.3	MedGen:OMIM:SNOMED_CT|MeSH:MedGen:SNOMED_CT|MedGen:OMIM:SNOMED_CT,MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:SNOMED_CT,MeSH:MedGen:OMIM:SNOMED_CT|MeSH:MedGen:SNOMED_CT|Gene:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet	C0684249:211980:187875007|D002289:C0007131:254637007|C0476089:608089:254878006,C0149782|C0005684:109800:ORPHA157980:399326009|D002289:C0007131:254637007,D013274:C0038356:613659:126824007|D002289:C0007131:254637007|6765:C0919267:167000:123843001|C0349639:607785:ORPHA86834	ID=COSM1140136,COSM516;OCCURENCE=15(stomach),1(central_nervous_system),8(upper_aerodigestive_tract),2(oesophagus),3(peritoneum),1776(lung),18(thyroid),17(haematopoietic_and_lymphoid_tissue),2(testis),2(cervix),4(gastrointestinal_tract_(site_indeterminate)),13(soft_tissue),34(ovary),38(endometrium),5(skin),11(breast),8(small_intestine),1(kidney),130(pancreas),4(liver),15(urinary_tract),1(adrenal_gland),1476(large_intestine),51(biliary_tract),10(prostate)	MU22774	BTCA-JP|1|239|0.00418,LICA-CN|1|163|0.00613,READ-US|3|80|0.03750,STAD-US|1|289|0.00346,BLCA-CN|1|103|0.00971,CESC-US|1|194|0.00515,BRCA-US|1|955|0.00105,LUSC-KR|1|66|0.01515,UCEC-US|2|246|0.00813,COCA-CN|4|187|0.02139,ESAD-UK|1|119|0.00840,PACA-CA|1|227|0.00441,PACA-AU|6|391|0.01535,COAD-US|4|216|0.01852	CANCER
12	25398285	25398285	C	A	exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C	exonic;exonic;exonic;exonic	ENSG00000133703	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C	exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C	.	.	1.976e-05	0	0	0.0001	0	1.873e-05	0	0	rs121913530	0.02	D	1.0	D	0.993	D	0.000	D	1	D	3.135	M	-1.24	T	-6.99	D	0.905	7.016	33	0.997	0.984	D	0.548	D	0.701	D	0.732	0	5.68	0.871	0.919	1.000	1.000	18.372	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic|not provided,Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|not provided|Pathogenic	Lung_cancer|Non-small_cell_lung_cancer|Endometrial_carcinoma,Squamous_cell_carcinoma_of_lung|Malignant_tumor_of_urinary_bladder|Non-small_cell_lung_cancer,Neoplasm_of_stomach|Non-small_cell_lung_cancer|Neoplasm_of_ovary|Juvenile_myelomonocytic_leukemia	RCV000013406.4|RCV000038265.2|RCV000119791.1,RCV000013407.4|RCV000013408.4|RCV000154401.2,RCV000013414.5|RCV000038264.2|RCV000119790.1|RCV000144971.3	MedGen:OMIM:SNOMED_CT|MeSH:MedGen:SNOMED_CT|MedGen:OMIM:SNOMED_CT,MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:SNOMED_CT,MeSH:MedGen:OMIM:SNOMED_CT|MeSH:MedGen:SNOMED_CT|Gene:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet	C0684249:211980:187875007|D002289:C0007131:254637007|C0476089:608089:254878006,C0149782|C0005684:109800:ORPHA157980:399326009|D002289:C0007131:254637007,D013274:C0038356:613659:126824007|D002289:C0007131:254637007|6765:C0919267:167000:123843001|C0349639:607785:ORPHA86834	ID=COSM1140136,COSM516;OCCURENCE=15(stomach),1(central_nervous_system),8(upper_aerodigestive_tract),2(oesophagus),3(peritoneum),1776(lung),18(thyroid),17(haematopoietic_and_lymphoid_tissue),2(testis),2(cervix),4(gastrointestinal_tract_(site_indeterminate)),13(soft_tissue),34(ovary),38(endometrium),5(skin),11(breast),8(small_intestine),1(kidney),130(pancreas),4(liver),15(urinary_tract),1(adrenal_gland),1476(large_intestine),51(biliary_tract),10(prostate)	MU22774	BTCA-JP|1|239|0.00418,LICA-CN|1|163|0.00613,READ-US|3|80|0.03750,STAD-US|1|289|0.00346,BLCA-CN|1|103|0.00971,CESC-US|1|194|0.00515,BRCA-US|1|955|0.00105,LUSC-KR|1|66|0.01515,UCEC-US|2|246|0.00813,COCA-CN|4|187|0.02139,ESAD-UK|1|119|0.00840,PACA-CA|1|227|0.00441,PACA-AU|6|391|0.01535,COAD-US|4|216|0.01852	COREAD
12	25398285	25398285	C	A	exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C	exonic;exonic;exonic;exonic	ENSG00000133703	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C	exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C	.	.	1.976e-05	0	0	0.0001	0	1.873e-05	0	0	rs121913530	0.02	D	1.0	D	0.993	D	0.000	D	1	D	3.135	M	-1.24	T	-6.99	D	0.905	7.016	33	0.997	0.984	D	0.548	D	0.701	D	0.732	0	5.68	0.871	0.919	1.000	1.000	18.372	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic|not provided,Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|not provided|Pathogenic	Lung_cancer|Non-small_cell_lung_cancer|Endometrial_carcinoma,Squamous_cell_carcinoma_of_lung|Malignant_tumor_of_urinary_bladder|Non-small_cell_lung_cancer,Neoplasm_of_stomach|Non-small_cell_lung_cancer|Neoplasm_of_ovary|Juvenile_myelomonocytic_leukemia	RCV000013406.4|RCV000038265.2|RCV000119791.1,RCV000013407.4|RCV000013408.4|RCV000154401.2,RCV000013414.5|RCV000038264.2|RCV000119790.1|RCV000144971.3	MedGen:OMIM:SNOMED_CT|MeSH:MedGen:SNOMED_CT|MedGen:OMIM:SNOMED_CT,MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:SNOMED_CT,MeSH:MedGen:OMIM:SNOMED_CT|MeSH:MedGen:SNOMED_CT|Gene:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet	C0684249:211980:187875007|D002289:C0007131:254637007|C0476089:608089:254878006,C0149782|C0005684:109800:ORPHA157980:399326009|D002289:C0007131:254637007,D013274:C0038356:613659:126824007|D002289:C0007131:254637007|6765:C0919267:167000:123843001|C0349639:607785:ORPHA86834	ID=COSM1140136,COSM516;OCCURENCE=15(stomach),1(central_nervous_system),8(upper_aerodigestive_tract),2(oesophagus),3(peritoneum),1776(lung),18(thyroid),17(haematopoietic_and_lymphoid_tissue),2(testis),2(cervix),4(gastrointestinal_tract_(site_indeterminate)),13(soft_tissue),34(ovary),38(endometrium),5(skin),11(breast),8(small_intestine),1(kidney),130(pancreas),4(liver),15(urinary_tract),1(adrenal_gland),1476(large_intestine),51(biliary_tract),10(prostate)	MU22774	BTCA-JP|1|239|0.00418,LICA-CN|1|163|0.00613,READ-US|3|80|0.03750,STAD-US|1|289|0.00346,BLCA-CN|1|103|0.00971,CESC-US|1|194|0.00515,BRCA-US|1|955|0.00105,LUSC-KR|1|66|0.01515,UCEC-US|2|246|0.00813,COCA-CN|4|187|0.02139,ESAD-UK|1|119|0.00840,PACA-CA|1|227|0.00441,PACA-AU|6|391|0.01535,COAD-US|4|216|0.01852	L
12	25398285	25398285	C	A	exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C;KRAS:NM_004985:exon2:c.G34T:p.G12C,KRAS:NM_033360:exon2:c.G34T:p.G12C	exonic;exonic;exonic;exonic	ENSG00000133703	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C;ENSG00000133703:ENST00000256078:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000311936:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000556131:exon2:c.G34T:p.G12C,ENSG00000133703:ENST00000557334:exon2:c.G34T:p.G12C	exonic;exonic;exonic;exonic	KRAS	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C;KRAS:uc001rgp.1:exon2:c.G34T:p.G12C,KRAS:uc001rgq.1:exon2:c.G34T:p.G12C	.	.	1.976e-05	0	0	0.0001	0	1.873e-05	0	0	rs121913530	0.02	D	1.0	D	0.993	D	0.000	D	1	D	3.135	M	-1.24	T	-6.99	D	0.905	7.016	33	0.997	0.984	D	0.548	D	0.701	D	0.732	0	5.68	0.871	0.919	1.000	1.000	18.372	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic|not provided,Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|not provided|Pathogenic	Lung_cancer|Non-small_cell_lung_cancer|Endometrial_carcinoma,Squamous_cell_carcinoma_of_lung|Malignant_tumor_of_urinary_bladder|Non-small_cell_lung_cancer,Neoplasm_of_stomach|Non-small_cell_lung_cancer|Neoplasm_of_ovary|Juvenile_myelomonocytic_leukemia	RCV000013406.4|RCV000038265.2|RCV000119791.1,RCV000013407.4|RCV000013408.4|RCV000154401.2,RCV000013414.5|RCV000038264.2|RCV000119790.1|RCV000144971.3	MedGen:OMIM:SNOMED_CT|MeSH:MedGen:SNOMED_CT|MedGen:OMIM:SNOMED_CT,MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:SNOMED_CT,MeSH:MedGen:OMIM:SNOMED_CT|MeSH:MedGen:SNOMED_CT|Gene:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet	C0684249:211980:187875007|D002289:C0007131:254637007|C0476089:608089:254878006,C0149782|C0005684:109800:ORPHA157980:399326009|D002289:C0007131:254637007,D013274:C0038356:613659:126824007|D002289:C0007131:254637007|6765:C0919267:167000:123843001|C0349639:607785:ORPHA86834	ID=COSM1140136,COSM516;OCCURENCE=15(stomach),1(central_nervous_system),8(upper_aerodigestive_tract),2(oesophagus),3(peritoneum),1776(lung),18(thyroid),17(haematopoietic_and_lymphoid_tissue),2(testis),2(cervix),4(gastrointestinal_tract_(site_indeterminate)),13(soft_tissue),34(ovary),38(endometrium),5(skin),11(breast),8(small_intestine),1(kidney),130(pancreas),4(liver),15(urinary_tract),1(adrenal_gland),1476(large_intestine),51(biliary_tract),10(prostate)	MU22774	BTCA-JP|1|239|0.00418,LICA-CN|1|163|0.00613,READ-US|3|80|0.03750,STAD-US|1|289|0.00346,BLCA-CN|1|103|0.00971,CESC-US|1|194|0.00515,BRCA-US|1|955|0.00105,LUSC-KR|1|66|0.01515,UCEC-US|2|246|0.00813,COCA-CN|4|187|0.02139,ESAD-UK|1|119|0.00840,PACA-CA|1|227|0.00441,PACA-AU|6|391|0.01535,COAD-US|4|216|0.01852	NSCLC
12	25398285	25398285	C	G	exonic	KRAS	.	nonsynonymous SNV	KRAS:NM_004985:exon2:c.G34C:p.G12R,KRAS:NM_033360:exon2:c.G34C:p.G12R	exonic	ENSG00000133703	.	nonsynonymous SNV	ENSG00000133703:ENST00000256078:exon2:c.G34C:p.G12R,ENSG00000133703:ENST00000311936:exon2:c.G34C:p.G12R,ENSG00000133703:ENST00000556131:exon2:c.G34C:p.G12R,ENSG00000133703:ENST00000557334:exon2:c.G34C:p.G12R	exonic	KRAS	.	nonsynonymous SNV	KRAS:uc001rgp.1:exon2:c.G34C:p.G12R,KRAS:uc001rgq.1:exon2:c.G34C:p.G12R	.	.	.	.	.	.	.	.	.	.	rs121913530	0.02	D	0.802	P	0.562	P	0.000	D	1	D	2.675	M	-1.16	T	-6.05	D	0.906	4.956	25.0	0.999	0.985	D	0.190	D	0.557	D	0.732	0	5.68	0.871	0.919	1.000	1.000	18.372	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	Pathogenic|Pathogenic|not provided,Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|not provided|Pathogenic	Lung_cancer|Non-small_cell_lung_cancer|Endometrial_carcinoma,Squamous_cell_carcinoma_of_lung|Malignant_tumor_of_urinary_bladder|Non-small_cell_lung_cancer,Neoplasm_of_stomach|Non-small_cell_lung_cancer|Neoplasm_of_ovary|Juvenile_myelomonocytic_leukemia	RCV000013406.4|RCV000038265.2|RCV000119791.1,RCV000013407.4|RCV000013408.4|RCV000154401.2,RCV000013414.5|RCV000038264.2|RCV000119790.1|RCV000144971.3	MedGen:OMIM:SNOMED_CT|MeSH:MedGen:SNOMED_CT|MedGen:OMIM:SNOMED_CT,MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:SNOMED_CT,MeSH:MedGen:OMIM:SNOMED_CT|MeSH:MedGen:SNOMED_CT|Gene:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet	C0684249:211980:187875007|D002289:C0007131:254637007|C0476089:608089:254878006,C0149782|C0005684:109800:ORPHA157980:399326009|D002289:C0007131:254637007,D013274:C0038356:613659:126824007|D002289:C0007131:254637007|6765:C0919267:167000:123843001|C0349639:607785:ORPHA86834	ID=COSM518,COSM1157797;OCCURENCE=2(cervix),4(testis),13(haematopoietic_and_lymphoid_tissue),2(gastrointestinal_tract_(site_indeterminate)),10(thyroid),1(peritoneum),86(lung),2(upper_aerodigestive_tract),4(bone),1(oesophagus),2(central_nervous_system),1(stomach),5(urinary_tract),591(pancreas),1(prostate),24(biliary_tract),223(large_intestine),3(skin),5(breast),2(small_intestine),3(endometrium),23(ovary)	MU64708	BTCA-JP|1|239|0.00418,PACA-CA|35|227|0.15419,SKCA-BR|2|66|0.03030,BLCA-CN|1|103|0.00971,PACA-AU|64|391|0.16368,SKCM-US|1|335|0.00299,COAD-US|2|216|0.00926	PA
12	56478851	56478851	C	G	exonic	ERBB3	.	nonsynonymous SNV	ERBB3:NM_001005915:exon3:c.C307G:p.R103G,ERBB3:NM_001982:exon3:c.C307G:p.R103G	exonic	ENSG00000065361	.	nonsynonymous SNV	ENSG00000065361:ENST00000267101:exon3:c.C307G:p.R103G,ENSG00000065361:ENST00000411731:exon3:c.C307G:p.R103G,ENSG00000065361:ENST00000549672:exon3:c.C130G:p.R44G,ENSG00000065361:ENST00000551085:exon3:c.C307G:p.R103G,ENSG00000065361:ENST00000551242:exon3:c.C307G:p.R103G,ENSG00000065361:ENST00000415288:exon4:c.C130G:p.R44G,ENSG00000065361:ENST00000549061:exon4:c.C130G:p.R44G,ENSG00000065361:ENST00000549282:exon4:c.C307G:p.R103G	exonic	ERBB3	.	nonsynonymous SNV	ERBB3:uc001sjg.3:exon3:c.C307G:p.R103G,ERBB3:uc001sjh.3:exon3:c.C307G:p.R103G,ERBB3:uc010sqc.2:exon4:c.C130G:p.R44G	.	.	.	.	.	.	.	.	.	.	.	0.002	D	1.0	D	1.0	D	0.001	D	1	D	3.14	M	-1.46	T	-5.47	D	0.988	5.654	26.7	0.998	0.912	D	0.607	D	0.761	D	0.713	0	3.85	0.871	0.935	0.976	0.754	10.147	.	.	Receptor L-domain	.	.	.	.	.	.	.	.	UTH
12	56481922	56481922	G	A	exonic	ERBB3	.	nonsynonymous SNV	ERBB3:NM_001982:exon7:c.G850A:p.G284R	exonic	ENSG00000065361	.	nonsynonymous SNV	ENSG00000065361:ENST00000267101:exon7:c.G850A:p.G284R,ENSG00000065361:ENST00000551085:exon7:c.G850A:p.G284R,ENSG00000065361:ENST00000551242:exon7:c.G850A:p.G284R,ENSG00000065361:ENST00000415288:exon8:c.G673A:p.G225R	exonic	ERBB3	.	nonsynonymous SNV	ERBB3:uc001sjh.3:exon7:c.G850A:p.G284R,ERBB3:uc010sqc.2:exon8:c.G673A:p.G225R	.	.	.	.	.	.	.	.	.	.	.	0.001	D	0.323	B	0.081	B	0.001	D	1	D	-0.05	N	-0.22	T	-2.27	N	0.313	5.381	25.9	0.993	0.866	D	-0.936	T	0.125	T	0.672	0	3.07	0.917	1.048	0.999	1.000	10.168	.	.	Furin-like cysteine-rich domain;Insulin-like growth factor binding protein, N-terminal	.	.	.	.	.	ID=COSM941488,COSM48360;OCCURENCE=1(breast),1(large_intestine),1(endometrium),1(lung)	MU1838155	BTCA-JP|2|239|0.00837,BRCA-US|1|955|0.00105,UCEC-US|1|246|0.00407	UTH
12	56491672	56491672	T	C	exonic	ERBB3	.	nonsynonymous SNV	ERBB3:NM_001982:exon21:c.T2564C:p.V855A	exonic	ENSG00000065361	.	nonsynonymous SNV	ENSG00000065361:ENST00000553131:exon4:c.T287C:p.V96A,ENSG00000065361:ENST00000450146:exon8:c.T635C:p.V212A,ENSG00000065361:ENST00000267101:exon21:c.T2564C:p.V855A,ENSG00000065361:ENST00000551085:exon21:c.T2564C:p.V855A,ENSG00000065361:ENST00000415288:exon22:c.T2387C:p.V796A	exonic	ERBB3	.	nonsynonymous SNV	ERBB3:uc001sjk.3:exon4:c.T287C:p.V96A,ERBB3:uc010sqb.2:exon8:c.T635C:p.V212A,ERBB3:uc001sjh.3:exon21:c.T2564C:p.V855A,ERBB3:uc010sqc.2:exon22:c.T2387C:p.V796A	.	.	.	.	.	.	.	.	.	.	.	0.002	D	0.998	D	0.964	D	0.000	D	1	D	0.88	L	-1.7	D	-2.55	D	0.727	6.053	28.0	0.999	0.983	D	0.253	D	0.582	D	0.707	0	5.87	0.991	1.056	1.000	1.000	15.557	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	.	.	.	NSCLC
12	58145431	58145431	G	A	exonic	CDK4	.	nonsynonymous SNV	CDK4:NM_000075:exon2:c.C70T:p.R24C	exonic	ENSG00000135446	.	nonsynonymous SNV	ENSG00000135446:ENST00000552254:exon1:c.C70T:p.R24C,ENSG00000135446:ENST00000257904:exon2:c.C70T:p.R24C,ENSG00000135446:ENST00000312990:exon2:c.C70T:p.R24C,ENSG00000135446:ENST00000550419:exon2:c.C70T:p.R24C,ENSG00000135446:ENST00000552388:exon2:c.C70T:p.R24C,ENSG00000135446:ENST00000552862:exon2:c.C70T:p.R24C,ENSG00000135446:ENST00000553237:exon2:c.C70T:p.R24C	exonic	CDK4	.	nonsynonymous SNV	CDK4:uc001spv.3:exon2:c.C70T:p.R24C	.	.	8.239e-06	0	0	0.0001	0	0	0	0	rs11547328	0.021	D	0.737	P	0.161	B	0.000	D	1	D	2.27	M	1.95	T	-6.43	D	0.895	5.138	25.4	0.997	0.982	D	-0.794	T	0.135	T	0.733	0	4.28	-0.045	1.048	0.936	0.998	13.092	.	.	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine/threonine/dual specificity protein kinase, catalytic  domain	other|Pathogenic	Cutaneous_malignant_melanoma_3|Hereditary_cutaneous_melanoma	RCV000018436.2|RCV000168188.1	MedGen:OMIM|MedGen	C1836892:609048|C1512419	ID=COSM1677139;OCCURENCE=1(haematopoietic_and_lymphoid_tissue)	MU13624484	SKCA-BR|1|66|0.01515,SKCM-US|1|335|0.00299,MELA-AU|1|183|0.00546	Skin Melanoma
12	69202580	69202580	T	G	intronic	MDM2	.	.	.	intronic	ENSG00000135679	.	.	.	intronic	MDM2	.	.	.	.	0.366613	.	.	.	.	.	.	.	.	rs2279744	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	other	Accelerated_tumor_formation,_susceptibility_to	RCV000014918.4	MedGen:OMIM	C3280690:614401	.	.	.	HNC
12	69234988	69234988	A	-	UTR3	MDM2	NM_002392:c.*1359delA,NM_001145339:c.*1359delA,NM_001278462:c.*1359delA,NM_001145340:c.*1359delA,NM_001145337:c.*1359delA	.	.	UTR3	ENSG00000135679	ENST00000462284:c.*1359delA,ENST00000428863:c.*1359delA,ENST00000540827:c.*1359delA,ENST00000356290:c.*1359delA,ENST00000258149:c.*1359delA	.	.	UTR3	MDM2	uc001sui.4:c.*1359delA,uc021rad.2:c.*1359delA,uc009zqx.4:c.*1359delA,uc001sun.5:c.*1359delA,uc009zra.4:c.*1359delA,uc021raf.2:c.*1359delA,uc009zrc.4:c.*1359delA,uc009zrd.4:c.*1359delA,uc009zrf.4:c.*1359delA,uc001suo.4:c.*1359delA,uc009zre.4:c.*1359delA,uc009zrg.4:c.*1359delA,uc009zrh.4:c.*1359delA,uc021rah.2:c.*1359delA,uc021rai.2:c.*1359delA,uc021raj.2:c.*1359delA	.	.	.	0.384585	.	.	.	.	.	.	.	.	rs34886328	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	ESSC
13	103498198	103498199	A	G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Parietal Lobe Ependymoma
13	28592642	28592642	C	A	exonic;exonic	FLT3	.	nonsynonymous SNV;nonsynonymous SNV	FLT3:NM_004119:exon20:c.G2503T:p.D835Y;FLT3:NM_004119:exon20:c.G2503T:p.D835Y	exonic;exonic	ENSG00000122025	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000122025:ENST00000241453:exon20:c.G2503T:p.D835Y,ENSG00000122025:ENST00000380982:exon20:c.G2503T:p.D835Y;ENSG00000122025:ENST00000241453:exon20:c.G2503T:p.D835Y,ENSG00000122025:ENST00000380982:exon20:c.G2503T:p.D835Y	exonic;exonic	FLT3	.	nonsynonymous SNV;nonsynonymous SNV	FLT3:uc001urw.3:exon20:c.G2503T:p.D835Y;FLT3:uc001urw.3:exon20:c.G2503T:p.D835Y	.	.	.	.	.	.	.	.	.	.	rs121913488	0.001	D	1.0	D	0.999	D	0.000	D	1	D	1.04	L	-1.76	D	-8.17	D	0.949	7.508	34	0.995	0.994	D	0.312	D	0.631	D	0.554	0	5.84	0.871	0.935	0.993	0.996	20.221	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic|Pathogenic,Pathogenic,Pathogenic	Acute_myeloid_leukemia|Acute_lymphoid_leukemia,Acute_myeloid_leukemia,Acute_myeloid_leukemia	RCV000017665.4|RCV000017666.4,RCV000017662.5,RCV000017663.5	MedGen:OMIM:Orphanet:SNOMED_CT|Gene:MedGen:OMIM:Orphanet:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT	C0023467:601626:ORPHA519:17788007|100310785:C0023449:613065:ORPHA513:91857003,C0023467:601626:ORPHA519:17788007,C0023467:601626:ORPHA519:17788007	ID=COSM783;OCCURENCE=208(haematopoietic_and_lymphoid_tissue)	MU820458	AML-US|1|161|0.00621,LAML-KR|3|107|0.02804	AML
13	28592642	28592642	C	G	exonic;exonic	FLT3	.	nonsynonymous SNV;nonsynonymous SNV	FLT3:NM_004119:exon20:c.G2503C:p.D835H;FLT3:NM_004119:exon20:c.G2503C:p.D835H	exonic;exonic	ENSG00000122025	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000122025:ENST00000241453:exon20:c.G2503C:p.D835H,ENSG00000122025:ENST00000380982:exon20:c.G2503C:p.D835H;ENSG00000122025:ENST00000241453:exon20:c.G2503C:p.D835H,ENSG00000122025:ENST00000380982:exon20:c.G2503C:p.D835H	exonic;exonic	FLT3	.	nonsynonymous SNV;nonsynonymous SNV	FLT3:uc001urw.3:exon20:c.G2503C:p.D835H;FLT3:uc001urw.3:exon20:c.G2503C:p.D835H	.	.	.	.	.	.	.	.	.	.	rs121913488	0.015	D	1.0	D	0.998	D	0.000	D	1	D	1.485	L	-1.77	D	-6.34	D	0.915	6.967	33	0.996	0.994	D	0.374	D	0.670	D	0.554	0	5.84	0.871	0.935	0.993	0.996	20.221	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic|Pathogenic,Pathogenic,Pathogenic	Acute_myeloid_leukemia|Acute_lymphoid_leukemia,Acute_myeloid_leukemia,Acute_myeloid_leukemia	RCV000017665.4|RCV000017666.4,RCV000017662.5,RCV000017663.5	MedGen:OMIM:Orphanet:SNOMED_CT|Gene:MedGen:OMIM:Orphanet:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT	C0023467:601626:ORPHA519:17788007|100310785:C0023449:613065:ORPHA513:91857003,C0023467:601626:ORPHA519:17788007,C0023467:601626:ORPHA519:17788007	ID=COSM785;OCCURENCE=32(haematopoietic_and_lymphoid_tissue)	MU820775	AML-US|1|161|0.00621	AML
13	28592642	28592642	C	A	exonic;exonic	FLT3	.	nonsynonymous SNV;nonsynonymous SNV	FLT3:NM_004119:exon20:c.G2503T:p.D835Y;FLT3:NM_004119:exon20:c.G2503T:p.D835Y	exonic;exonic	ENSG00000122025	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000122025:ENST00000241453:exon20:c.G2503T:p.D835Y,ENSG00000122025:ENST00000380982:exon20:c.G2503T:p.D835Y;ENSG00000122025:ENST00000241453:exon20:c.G2503T:p.D835Y,ENSG00000122025:ENST00000380982:exon20:c.G2503T:p.D835Y	exonic;exonic	FLT3	.	nonsynonymous SNV;nonsynonymous SNV	FLT3:uc001urw.3:exon20:c.G2503T:p.D835Y;FLT3:uc001urw.3:exon20:c.G2503T:p.D835Y	.	.	.	.	.	.	.	.	.	.	rs121913488	0.001	D	1.0	D	0.999	D	0.000	D	1	D	1.04	L	-1.76	D	-8.17	D	0.949	7.508	34	0.995	0.994	D	0.312	D	0.631	D	0.554	0	5.84	0.871	0.935	0.993	0.996	20.221	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic|Pathogenic,Pathogenic,Pathogenic	Acute_myeloid_leukemia|Acute_lymphoid_leukemia,Acute_myeloid_leukemia,Acute_myeloid_leukemia	RCV000017665.4|RCV000017666.4,RCV000017662.5,RCV000017663.5	MedGen:OMIM:Orphanet:SNOMED_CT|Gene:MedGen:OMIM:Orphanet:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT	C0023467:601626:ORPHA519:17788007|100310785:C0023449:613065:ORPHA513:91857003,C0023467:601626:ORPHA519:17788007,C0023467:601626:ORPHA519:17788007	ID=COSM783;OCCURENCE=208(haematopoietic_and_lymphoid_tissue)	MU820458	AML-US|1|161|0.00621,LAML-KR|3|107|0.02804	AML
13	28592642	28592642	C	G	exonic;exonic	FLT3	.	nonsynonymous SNV;nonsynonymous SNV	FLT3:NM_004119:exon20:c.G2503C:p.D835H;FLT3:NM_004119:exon20:c.G2503C:p.D835H	exonic;exonic	ENSG00000122025	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000122025:ENST00000241453:exon20:c.G2503C:p.D835H,ENSG00000122025:ENST00000380982:exon20:c.G2503C:p.D835H;ENSG00000122025:ENST00000241453:exon20:c.G2503C:p.D835H,ENSG00000122025:ENST00000380982:exon20:c.G2503C:p.D835H	exonic;exonic	FLT3	.	nonsynonymous SNV;nonsynonymous SNV	FLT3:uc001urw.3:exon20:c.G2503C:p.D835H;FLT3:uc001urw.3:exon20:c.G2503C:p.D835H	.	.	.	.	.	.	.	.	.	.	rs121913488	0.015	D	1.0	D	0.998	D	0.000	D	1	D	1.485	L	-1.77	D	-6.34	D	0.915	6.967	33	0.996	0.994	D	0.374	D	0.670	D	0.554	0	5.84	0.871	0.935	0.993	0.996	20.221	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic|Pathogenic,Pathogenic,Pathogenic	Acute_myeloid_leukemia|Acute_lymphoid_leukemia,Acute_myeloid_leukemia,Acute_myeloid_leukemia	RCV000017665.4|RCV000017666.4,RCV000017662.5,RCV000017663.5	MedGen:OMIM:Orphanet:SNOMED_CT|Gene:MedGen:OMIM:Orphanet:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT	C0023467:601626:ORPHA519:17788007|100310785:C0023449:613065:ORPHA513:91857003,C0023467:601626:ORPHA519:17788007,C0023467:601626:ORPHA519:17788007	ID=COSM785;OCCURENCE=32(haematopoietic_and_lymphoid_tissue)	MU820775	AML-US|1|161|0.00621	AML
13	28624294	28624294	G	A	exonic	FLT3	.	nonsynonymous SNV	FLT3:NM_004119:exon6:c.C680T:p.T227M	exonic	ENSG00000122025	.	nonsynonymous SNV	ENSG00000122025:ENST00000241453:exon6:c.C680T:p.T227M,ENSG00000122025:ENST00000380982:exon6:c.C680T:p.T227M,ENSG00000122025:ENST00000380987:exon6:c.C680T:p.T227M,ENSG00000122025:ENST00000537084:exon6:c.C680T:p.T227M	exonic	FLT3	.	nonsynonymous SNV	FLT3:uc001urw.3:exon6:c.C680T:p.T227M,FLT3:uc010tdn.2:exon6:c.C680T:p.T227M	0.5229	0.558706	0.5988	0.3338	0.6219	0.7669	0.5893	0.6048	0.6090	0.6402	rs1933437	0.042	D	0.999	D	0.879	P	0.001	D	0.509	P	0.895	L	-1.23	T	-1.36	N	0.334	4.144	23.8	0.995	0.926	D	-0.903	T	0.000	T	0.539	0	3.85	0.917	0.108	0.992	0.613	11.157	.	.	.	not provided	not_specified	RCV000121129.1	MedGen	CN169374	.	MU24013025	COCA-CN|1|187|0.00535	R
13	32968854	32968854	C	A	exonic	BRCA2	.	nonsynonymous SNV	BRCA2:NM_000059:exon25:c.C9285A:p.D3095E	exonic	ENSG00000139618	.	nonsynonymous SNV	ENSG00000139618:ENST00000380152:exon25:c.C9285A:p.D3095E,ENSG00000139618:ENST00000544455:exon25:c.C9285A:p.D3095E	exonic	BRCA2	.	nonsynonymous SNV	BRCA2:uc001uub.1:exon25:c.C9285A:p.D3095E	.	.	.	.	.	.	.	.	.	.	.	0.0	D	1.0	D	1.0	D	0.000	D	0.987	D	2.65	M	-2.76	D	-1.16	N	0.896	5.158	25.4	0.992	0.773	D	0.663	D	0.821	D	0.651	0	3.53	-0.275	-0.735	0.971	0.973	8.063	.	.	BRCA2, oligonucleotide/oligosaccharide-binding 3;Nucleic acid-binding, OB-fold	.	.	.	.	.	ID=COSM24506;OCCURENCE=1(breast)	.	.	BRACA
13	49033946	49033947	-	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Estrogen-receptor Positive Breast Cancer
14	105243048	105243048	G	T	exonic	AKT1	.	nonsynonymous SNV	AKT1:NM_001014431:exon4:c.C235A:p.Q79K,AKT1:NM_005163:exon4:c.C235A:p.Q79K,AKT1:NM_001014432:exon5:c.C235A:p.Q79K	exonic	ENSG00000142208	.	nonsynonymous SNV	ENSG00000142208:ENST00000544168:exon2:c.C49A:p.Q17K,ENSG00000142208:ENST00000554581:exon3:c.C235A:p.Q79K,ENSG00000142208:ENST00000555380:exon3:c.C49A:p.Q17K,ENSG00000142208:ENST00000402615:exon4:c.C235A:p.Q79K,ENSG00000142208:ENST00000407796:exon4:c.C235A:p.Q79K,ENSG00000142208:ENST00000554848:exon4:c.C235A:p.Q79K,ENSG00000142208:ENST00000555528:exon4:c.C235A:p.Q79K,ENSG00000142208:ENST00000349310:exon5:c.C235A:p.Q79K,ENSG00000142208:ENST00000555926:exon5:c.C235A:p.Q79K	exonic	AKT1	.	nonsynonymous SNV	AKT1:uc010tyk.2:exon2:c.C49A:p.Q17K,AKT1:uc001ypl.3:exon3:c.C235A:p.Q79K,AKT1:uc001ypk.3:exon4:c.C235A:p.Q79K,AKT1:uc001ypn.3:exon4:c.C235A:p.Q79K,AKT1:uc010axa.3:exon4:c.C235A:p.Q79K,AKT1:uc001ypm.3:exon5:c.C235A:p.Q79K	.	.	.	.	.	.	.	.	.	.	.	0.023	D	0.996	D	0.967	D	0.000	D	1	D	1.825	L	0.89	T	-3.56	D	0.815	4.997	25.1	0.995	0.972	D	0.177	D	0.573	D	0.672	0	4.55	0.917	0.949	1.000	1.000	17.484	.	.	Pleckstrin homology domain;Pleckstrin homology-like domain	.	.	.	.	.	ID=COSM159008;OCCURENCE=1(breast),1(endometrium)	MU1840609	BRCA-UK|1|117|0.00855,BRCA-EU|2|560|0.00357,UCEC-US|1|246|0.00407	M
14	105246551	105246551	C	T	exonic;exonic	AKT1	.	nonsynonymous SNV;nonsynonymous SNV	AKT1:NM_001014431:exon3:c.G49A:p.E17K,AKT1:NM_005163:exon3:c.G49A:p.E17K,AKT1:NM_001014432:exon4:c.G49A:p.E17K;AKT1:NM_001014431:exon3:c.G49A:p.E17K,AKT1:NM_005163:exon3:c.G49A:p.E17K,AKT1:NM_001014432:exon4:c.G49A:p.E17K	exonic;exonic	ENSG00000142208	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000142208:ENST00000554581:exon2:c.G49A:p.E17K,ENSG00000142208:ENST00000402615:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000407796:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000554848:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000555528:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000349310:exon4:c.G49A:p.E17K,ENSG00000142208:ENST00000555926:exon4:c.G49A:p.E17K;ENSG00000142208:ENST00000554581:exon2:c.G49A:p.E17K,ENSG00000142208:ENST00000402615:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000407796:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000554848:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000555528:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000349310:exon4:c.G49A:p.E17K,ENSG00000142208:ENST00000555926:exon4:c.G49A:p.E17K	exonic;exonic	AKT1	.	nonsynonymous SNV;nonsynonymous SNV	AKT1:uc001ypl.3:exon2:c.G49A:p.E17K,AKT1:uc001ypk.3:exon3:c.G49A:p.E17K,AKT1:uc001ypn.3:exon3:c.G49A:p.E17K,AKT1:uc010axa.3:exon3:c.G49A:p.E17K,AKT1:uc001ypm.3:exon4:c.G49A:p.E17K;AKT1:uc001ypl.3:exon2:c.G49A:p.E17K,AKT1:uc001ypk.3:exon3:c.G49A:p.E17K,AKT1:uc001ypn.3:exon3:c.G49A:p.E17K,AKT1:uc010axa.3:exon3:c.G49A:p.E17K,AKT1:uc001ypm.3:exon4:c.G49A:p.E17K	.	.	8.427e-06	0	0	0	0	1.535e-05	0	0	rs121434592	0.01	D	1.0	D	1.0	D	0.000	D	1	D	2.175	M	1.17	T	-3.59	D	0.884	6.534	31	0.999	0.995	D	-0.641	T	0.222	T	0.707	0	4.61	0.871	0.852	0.858	0.955	16.176	.	.	Pleckstrin homology domain;Pleckstrin homology-like domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic	Breast_adenocarcinoma|Carcinoma_of_colon|Neoplasm_of_ovary|Proteus_syndrome	RCV000015017.4|RCV000015018.4|RCV000015019.4|RCV000031926.5	MedGen|MedGen:OMIM:SNOMED_CT|Gene:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT	C0858252|C0699790:114500:269533000|6765:C0919267:167000:123843001|C0085261:176920:ORPHA744:23150001	ID=COSM33765;OCCURENCE=1(haematopoietic_and_lymphoid_tissue),10(thyroid),15(lung),46(meninges),2(NS),1(upper_aerodigestive_tract),12(bone),1(central_nervous_system),1(thymus),16(urinary_tract),4(prostate),13(large_intestine),75(breast),53(skin),15(endometrium),2(ovary),7(soft_tissue)	MU10466	BRCA-UK|3|117|0.02564,BTCA-JP|1|239|0.00418,LUSC-US|1|178|0.00562,STAD-US|1|289|0.00346,BLCA-CN|1|103|0.00971,CESC-US|2|194|0.01031,THCA-US|2|400|0.00500,COCA-CN|1|187|0.00535,PRAD-US|1|256|0.00391,BRCA-EU|12|560|0.02143,PACA-AU|1|391|0.00256,SKCM-US|1|335|0.00299,COAD-US|3|216|0.01389	BRACA
14	105246551	105246551	C	T	exonic;exonic	AKT1	.	nonsynonymous SNV;nonsynonymous SNV	AKT1:NM_001014431:exon3:c.G49A:p.E17K,AKT1:NM_005163:exon3:c.G49A:p.E17K,AKT1:NM_001014432:exon4:c.G49A:p.E17K;AKT1:NM_001014431:exon3:c.G49A:p.E17K,AKT1:NM_005163:exon3:c.G49A:p.E17K,AKT1:NM_001014432:exon4:c.G49A:p.E17K	exonic;exonic	ENSG00000142208	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000142208:ENST00000554581:exon2:c.G49A:p.E17K,ENSG00000142208:ENST00000402615:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000407796:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000554848:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000555528:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000349310:exon4:c.G49A:p.E17K,ENSG00000142208:ENST00000555926:exon4:c.G49A:p.E17K;ENSG00000142208:ENST00000554581:exon2:c.G49A:p.E17K,ENSG00000142208:ENST00000402615:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000407796:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000554848:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000555528:exon3:c.G49A:p.E17K,ENSG00000142208:ENST00000349310:exon4:c.G49A:p.E17K,ENSG00000142208:ENST00000555926:exon4:c.G49A:p.E17K	exonic;exonic	AKT1	.	nonsynonymous SNV;nonsynonymous SNV	AKT1:uc001ypl.3:exon2:c.G49A:p.E17K,AKT1:uc001ypk.3:exon3:c.G49A:p.E17K,AKT1:uc001ypn.3:exon3:c.G49A:p.E17K,AKT1:uc010axa.3:exon3:c.G49A:p.E17K,AKT1:uc001ypm.3:exon4:c.G49A:p.E17K;AKT1:uc001ypl.3:exon2:c.G49A:p.E17K,AKT1:uc001ypk.3:exon3:c.G49A:p.E17K,AKT1:uc001ypn.3:exon3:c.G49A:p.E17K,AKT1:uc010axa.3:exon3:c.G49A:p.E17K,AKT1:uc001ypm.3:exon4:c.G49A:p.E17K	.	.	8.427e-06	0	0	0	0	1.535e-05	0	0	rs121434592	0.01	D	1.0	D	1.0	D	0.000	D	1	D	2.175	M	1.17	T	-3.59	D	0.884	6.534	31	0.999	0.995	D	-0.641	T	0.222	T	0.707	0	4.61	0.871	0.852	0.858	0.955	16.176	.	.	Pleckstrin homology domain;Pleckstrin homology-like domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic	Breast_adenocarcinoma|Carcinoma_of_colon|Neoplasm_of_ovary|Proteus_syndrome	RCV000015017.4|RCV000015018.4|RCV000015019.4|RCV000031926.5	MedGen|MedGen:OMIM:SNOMED_CT|Gene:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT	C0858252|C0699790:114500:269533000|6765:C0919267:167000:123843001|C0085261:176920:ORPHA744:23150001	ID=COSM33765;OCCURENCE=1(haematopoietic_and_lymphoid_tissue),10(thyroid),15(lung),46(meninges),2(NS),1(upper_aerodigestive_tract),12(bone),1(central_nervous_system),1(thymus),16(urinary_tract),4(prostate),13(large_intestine),75(breast),53(skin),15(endometrium),2(ovary),7(soft_tissue)	MU10466	BRCA-UK|3|117|0.02564,BTCA-JP|1|239|0.00418,LUSC-US|1|178|0.00562,STAD-US|1|289|0.00346,BLCA-CN|1|103|0.00971,CESC-US|2|194|0.01031,THCA-US|2|400|0.00500,COCA-CN|1|187|0.00535,PRAD-US|1|256|0.00391,BRCA-EU|12|560|0.02143,PACA-AU|1|391|0.00256,SKCM-US|1|335|0.00299,COAD-US|3|216|0.01389	M
14	62213848	62213848	T	C	ncRNA_exonic	HIF1A-AS2	.	.	.	ncRNA_intronic	ENSG00000258667,ENSG00000258964	.	.	.	ncRNA_exonic	HIF1A-AS2	.	.	.	0.7862	0.757588	0.8289	0.6626	0.8968	0.8056	0.9310	0.8546	0.8184	0.7377	rs2057482	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PA
14	65453063	65453063	G	C	intronic	CHURC1-FNTB	.	.	.	intronic	ENSG00000125954,ENSG00000257365	.	.	.	intronic	CHURC1-FNTB	.	.	.	.	0.376597	.	.	.	.	.	.	.	.	rs11623866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	OV-PR
15	66727451	66727451	A	C	exonic	MAP2K1	.	nonsynonymous SNV	MAP2K1:NM_002755:exon2:c.A167C:p.Q56P	exonic	ENSG00000169032	.	nonsynonymous SNV	ENSG00000169032:ENST00000307102:exon2:c.A167C:p.Q56P	exonic	MAP2K1	.	nonsynonymous SNV	MAP2K1:uc010bhq.3:exon2:c.A167C:p.Q56P,MAP2K1:uc010ujp.2:exon2:c.A101C:p.Q34P	.	.	.	.	.	.	.	.	.	.	.	0.013	D	0.964	D	0.65	P	0.000	D	1	D	2.22	M	-4.51	D	-4.05	D	0.876	5.184	25.5	0.993	0.987	D	0.940	D	0.913	D	0.737	0	5.07	1.062	1.028	1.000	0.996	14.047	.	.	.	.	.	.	.	.	ID=COSM1235481;OCCURENCE=1(stomach),1(lung)	.	.	M
15	66729154	66729154	G	C	exonic	MAP2K1	.	nonsynonymous SNV	MAP2K1:NM_002755:exon3:c.G362C:p.C121S	exonic	ENSG00000169032	.	nonsynonymous SNV	ENSG00000169032:ENST00000307102:exon3:c.G362C:p.C121S	exonic	MAP2K1	.	nonsynonymous SNV	MAP2K1:uc010bhq.3:exon3:c.G362C:p.C121S,MAP2K1:uc010ujp.2:exon3:c.G296C:p.C99S	.	.	.	.	.	.	.	.	.	.	.	0.001	D	0.999	D	0.993	D	0.000	D	1	D	1.235	L	-0.08	T	-8.76	D	0.868	6.080	28.2	0.996	0.994	D	-0.531	T	0.343	T	0.707	0	5.15	0.917	0.953	1.000	1.000	18.656	.	.	Protein kinase domain;Protein kinase-like domain;Serine/threonine/dual specificity protein kinase, catalytic  domain	.	.	.	.	.	ID=COSM1315829;OCCURENCE=1(NS)	MU5220713	STAD-US|1|289|0.00346	M
15	66729162	66729162	C	T	exonic	MAP2K1	.	nonsynonymous SNV	MAP2K1:NM_002755:exon3:c.C370T:p.P124S	exonic	ENSG00000169032	.	nonsynonymous SNV	ENSG00000169032:ENST00000307102:exon3:c.C370T:p.P124S	exonic	MAP2K1	.	nonsynonymous SNV	MAP2K1:uc010bhq.3:exon3:c.C370T:p.P124S,MAP2K1:uc010ujp.2:exon3:c.C304T:p.P102S	.	.	.	.	.	.	.	.	.	.	.	0.029	D	0.999	D	0.986	D	0.000	D	1	D	2.62	M	-3.57	D	-5.88	D	0.739	6.548	31	0.999	0.986	D	0.076	D	0.502	D	0.707	0	5.15	0.871	0.852	0.997	0.988	18.656	.	.	Protein kinase domain;Protein kinase-like domain;Serine/threonine/dual specificity protein kinase, catalytic  domain	.	.	.	.	.	ID=COSM235614;OCCURENCE=2(urinary_tract),1(large_intestine),13(skin)	MU167057	BLCA-CN|1|103|0.00971,SKCM-US|7|335|0.02090,MELA-AU|3|183|0.01639,COAD-US|1|216|0.00463	M
15	74315213	74315213	C	T	exonic	PML	.	nonsynonymous SNV	PML:NM_002675:exon3:c.C647T:p.A216V,PML:NM_033238:exon3:c.C647T:p.A216V,PML:NM_033239:exon3:c.C647T:p.A216V,PML:NM_033240:exon3:c.C647T:p.A216V,PML:NM_033244:exon3:c.C647T:p.A216V,PML:NM_033246:exon3:c.C647T:p.A216V,PML:NM_033247:exon3:c.C647T:p.A216V,PML:NM_033249:exon3:c.C647T:p.A216V,PML:NM_033250:exon3:c.C647T:p.A216V	exonic	ENSG00000140464	.	nonsynonymous SNV	ENSG00000140464:ENST00000268058:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000268059:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000354026:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000359928:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000395132:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000395135:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000435786:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000436891:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000563500:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000564428:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000565898:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000567543:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000569477:exon3:c.C647T:p.A216V,ENSG00000140464:ENST00000569965:exon3:c.C647T:p.A216V	exonic	PML	.	nonsynonymous SNV	PML:uc002aww.1:exon2:c.C392T:p.A131V,PML:uc002awj.1:exon3:c.C647T:p.A216V,PML:uc002awk.3:exon3:c.C647T:p.A216V,PML:uc002awl.3:exon3:c.C647T:p.A216V,PML:uc002awm.3:exon3:c.C647T:p.A216V,PML:uc002awn.3:exon3:c.C647T:p.A216V,PML:uc002awo.3:exon3:c.C647T:p.A216V,PML:uc002awp.3:exon3:c.C647T:p.A216V,PML:uc002awq.3:exon3:c.C647T:p.A216V,PML:uc002awr.3:exon3:c.C647T:p.A216V,PML:uc002aws.3:exon3:c.C647T:p.A216V,PML:uc002awt.3:exon3:c.C647T:p.A216V,PML:uc002awu.3:exon3:c.C647T:p.A216V,PML:uc002awv.3:exon3:c.C647T:p.A216V	.	.	.	.	.	.	.	.	.	.	.	0.62	T	1.0	D	0.997	D	0.000	D	0.966	D	1.04	L	1.0	T	-2.69	D	0.545	5.140	25.4	0.991	0.932	D	-0.746	T	0.230	T	0.706	0	4.82	0.871	0.892	0.803	0.954	14.629	.	.	Zinc finger, B-box	.	.	.	.	.	.	.	.	APML
15	74315219	74315219	T	C	exonic	PML	.	nonsynonymous SNV	PML:NM_002675:exon3:c.T653C:p.L218P,PML:NM_033238:exon3:c.T653C:p.L218P,PML:NM_033239:exon3:c.T653C:p.L218P,PML:NM_033240:exon3:c.T653C:p.L218P,PML:NM_033244:exon3:c.T653C:p.L218P,PML:NM_033246:exon3:c.T653C:p.L218P,PML:NM_033247:exon3:c.T653C:p.L218P,PML:NM_033249:exon3:c.T653C:p.L218P,PML:NM_033250:exon3:c.T653C:p.L218P	exonic	ENSG00000140464	.	nonsynonymous SNV	ENSG00000140464:ENST00000268058:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000268059:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000354026:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000359928:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000395132:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000395135:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000435786:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000436891:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000563500:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000564428:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000565898:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000567543:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000569477:exon3:c.T653C:p.L218P,ENSG00000140464:ENST00000569965:exon3:c.T653C:p.L218P	exonic	PML	.	nonsynonymous SNV	PML:uc002aww.1:exon2:c.T398C:p.L133P,PML:uc002awj.1:exon3:c.T653C:p.L218P,PML:uc002awk.3:exon3:c.T653C:p.L218P,PML:uc002awl.3:exon3:c.T653C:p.L218P,PML:uc002awm.3:exon3:c.T653C:p.L218P,PML:uc002awn.3:exon3:c.T653C:p.L218P,PML:uc002awo.3:exon3:c.T653C:p.L218P,PML:uc002awp.3:exon3:c.T653C:p.L218P,PML:uc002awq.3:exon3:c.T653C:p.L218P,PML:uc002awr.3:exon3:c.T653C:p.L218P,PML:uc002aws.3:exon3:c.T653C:p.L218P,PML:uc002awt.3:exon3:c.T653C:p.L218P,PML:uc002awu.3:exon3:c.T653C:p.L218P,PML:uc002awv.3:exon3:c.T653C:p.L218P	.	.	.	.	.	.	.	.	.	.	.	0.007	D	1.0	D	0.998	D	0.001	D	1.000	D	1.04	L	0.6	T	-4.99	D	0.787	5.146	25.4	0.999	0.930	D	-0.647	T	0.230	T	0.706	0	4.82	0.991	1.011	0.920	0.899	11.766	.	.	Zinc finger, B-box	.	.	.	.	.	.	.	.	APML
15	88476265	88476265	C	T	exonic	NTRK3	.	nonsynonymous SNV	NTRK3:NM_001243101:exon15:c.G1843A:p.G615R,NTRK3:NM_001012338:exon16:c.G1867A:p.G623R,NTRK3:NM_002530:exon16:c.G1867A:p.G623R	exonic	ENSG00000140538	.	nonsynonymous SNV	ENSG00000140538:ENST00000557856:exon13:c.G1843A:p.G615R,ENSG00000140538:ENST00000558676:exon13:c.G1843A:p.G615R,ENSG00000140538:ENST00000357724:exon14:c.G1843A:p.G615R,ENSG00000140538:ENST00000542733:exon14:c.G1573A:p.G525R,ENSG00000140538:ENST00000355254:exon15:c.G1867A:p.G623R,ENSG00000140538:ENST00000360948:exon15:c.G1867A:p.G623R,ENSG00000140538:ENST00000394480:exon16:c.G1867A:p.G623R	exonic	NTRK3	.	nonsynonymous SNV	NTRK3:uc002bmh.2:exon13:c.G1843A:p.G615R,NTRK3:uc010bnh.1:exon13:c.G1843A:p.G615R,NTRK3:uc010upl.1:exon14:c.G1573A:p.G525R,NTRK3:uc021sua.1:exon15:c.G1843A:p.G615R,NTRK3:uc002bme.2:exon16:c.G1867A:p.G623R,NTRK3:uc002bmf.2:exon16:c.G1867A:p.G623R	.	.	.	.	.	.	.	.	.	.	.	0.0	D	1.0	D	1.0	D	0.000	D	1	D	3.315	M	-2.59	D	-6.42	D	0.916	6.811	32	0.999	0.995	D	0.954	D	0.869	D	0.554	0	5.49	0.871	0.935	1.000	0.999	18.358	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	.	.	.	BRACA
15	90631838	90631838	C	T	exonic;exonic	IDH2	.	nonsynonymous SNV;nonsynonymous SNV	IDH2:NM_001290114:exon2:c.G125A:p.R42K,IDH2:NM_001289910:exon4:c.G359A:p.R120K,IDH2:NM_002168:exon4:c.G515A:p.R172K;IDH2:NM_001290114:exon2:c.G125A:p.R42K,IDH2:NM_001289910:exon4:c.G359A:p.R120K,IDH2:NM_002168:exon4:c.G515A:p.R172K	exonic;exonic	ENSG00000182054	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000182054:ENST00000539790:exon2:c.G125A:p.R42K,ENSG00000182054:ENST00000330062:exon4:c.G515A:p.R172K,ENSG00000182054:ENST00000540499:exon4:c.G359A:p.R120K;ENSG00000182054:ENST00000539790:exon2:c.G125A:p.R42K,ENSG00000182054:ENST00000330062:exon4:c.G515A:p.R172K,ENSG00000182054:ENST00000540499:exon4:c.G359A:p.R120K	exonic;exonic	IDH2	.	nonsynonymous SNV;nonsynonymous SNV	IDH2:uc010uqc.2:exon2:c.G125A:p.R42K,IDH2:uc002box.3:exon4:c.G515A:p.R172K,IDH2:uc010uqb.2:exon4:c.G359A:p.R120K;IDH2:uc010uqc.2:exon2:c.G125A:p.R42K,IDH2:uc002box.3:exon4:c.G515A:p.R172K,IDH2:uc010uqb.2:exon4:c.G359A:p.R120K	.	.	.	.	.	.	.	.	.	.	rs121913503	0.001	D	1.0	D	0.999	D	0.000	D	1	D	3.9	H	-2.12	D	-2.81	D	0.948	4.687	24.6	0.988	0.994	D	0.823	D	0.845	D	0.745	0	4.07	0.871	0.935	0.998	0.979	10.781	.	.	Isopropylmalate dehydrogenase-like domain	.	.	.	.	.	ID=COSM33733;OCCURENCE=52(central_nervous_system),3(bone),97(haematopoietic_and_lymphoid_tissue),1(breast),12(biliary_tract)	MU265	BOCA-UK|1|66|0.01515,LIHC-US|1|188|0.00532,BTCA-JP|3|239|0.01255,LAML-KR|2|107|0.01869,LGG-US|7|283|0.02473	AML
15	90631838	90631838	C	T	exonic;exonic	IDH2	.	nonsynonymous SNV;nonsynonymous SNV	IDH2:NM_001290114:exon2:c.G125A:p.R42K,IDH2:NM_001289910:exon4:c.G359A:p.R120K,IDH2:NM_002168:exon4:c.G515A:p.R172K;IDH2:NM_001290114:exon2:c.G125A:p.R42K,IDH2:NM_001289910:exon4:c.G359A:p.R120K,IDH2:NM_002168:exon4:c.G515A:p.R172K	exonic;exonic	ENSG00000182054	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000182054:ENST00000539790:exon2:c.G125A:p.R42K,ENSG00000182054:ENST00000330062:exon4:c.G515A:p.R172K,ENSG00000182054:ENST00000540499:exon4:c.G359A:p.R120K;ENSG00000182054:ENST00000539790:exon2:c.G125A:p.R42K,ENSG00000182054:ENST00000330062:exon4:c.G515A:p.R172K,ENSG00000182054:ENST00000540499:exon4:c.G359A:p.R120K	exonic;exonic	IDH2	.	nonsynonymous SNV;nonsynonymous SNV	IDH2:uc010uqc.2:exon2:c.G125A:p.R42K,IDH2:uc002box.3:exon4:c.G515A:p.R172K,IDH2:uc010uqb.2:exon4:c.G359A:p.R120K;IDH2:uc010uqc.2:exon2:c.G125A:p.R42K,IDH2:uc002box.3:exon4:c.G515A:p.R172K,IDH2:uc010uqb.2:exon4:c.G359A:p.R120K	.	.	.	.	.	.	.	.	.	.	rs121913503	0.001	D	1.0	D	0.999	D	0.000	D	1	D	3.9	H	-2.12	D	-2.81	D	0.948	4.687	24.6	0.988	0.994	D	0.823	D	0.845	D	0.745	0	4.07	0.871	0.935	0.998	0.979	10.781	.	.	Isopropylmalate dehydrogenase-like domain	.	.	.	.	.	ID=COSM33733;OCCURENCE=52(central_nervous_system),3(bone),97(haematopoietic_and_lymphoid_tissue),1(breast),12(biliary_tract)	MU265	BOCA-UK|1|66|0.01515,LIHC-US|1|188|0.00532,BTCA-JP|3|239|0.01255,LAML-KR|2|107|0.01869,LGG-US|7|283|0.02473	MDS
15	90631934	90631934	C	-	exonic;exonic	IDH2	.	frameshift deletion;frameshift deletion	IDH2:NM_001290114:exon2:c.29delG:p.R10fs,IDH2:NM_001289910:exon4:c.263delG:p.R88fs,IDH2:NM_002168:exon4:c.419delG:p.R140fs;IDH2:NM_001290114:exon2:c.29delG:p.R10fs,IDH2:NM_001289910:exon4:c.263delG:p.R88fs,IDH2:NM_002168:exon4:c.419delG:p.R140fs	exonic;exonic	ENSG00000182054	.	frameshift deletion;frameshift deletion	ENSG00000182054:ENST00000539790:exon2:c.29delG:p.R10fs,ENSG00000182054:ENST00000330062:exon4:c.419delG:p.R140fs,ENSG00000182054:ENST00000540499:exon4:c.263delG:p.R88fs;ENSG00000182054:ENST00000539790:exon2:c.29delG:p.R10fs,ENSG00000182054:ENST00000330062:exon4:c.419delG:p.R140fs,ENSG00000182054:ENST00000540499:exon4:c.263delG:p.R88fs	exonic;exonic	IDH2	.	frameshift deletion;frameshift deletion	IDH2:uc010uqc.2:exon2:c.29delG:p.R10fs,IDH2:uc002box.3:exon4:c.419delG:p.R140fs,IDH2:uc010uqb.2:exon4:c.263delG:p.R88fs;IDH2:uc010uqc.2:exon2:c.29delG:p.R10fs,IDH2:uc002box.3:exon4:c.419delG:p.R140fs,IDH2:uc010uqb.2:exon4:c.263delG:p.R88fs	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AML
15	90631934	90631934	C	-	exonic;exonic	IDH2	.	frameshift deletion;frameshift deletion	IDH2:NM_001290114:exon2:c.29delG:p.R10fs,IDH2:NM_001289910:exon4:c.263delG:p.R88fs,IDH2:NM_002168:exon4:c.419delG:p.R140fs;IDH2:NM_001290114:exon2:c.29delG:p.R10fs,IDH2:NM_001289910:exon4:c.263delG:p.R88fs,IDH2:NM_002168:exon4:c.419delG:p.R140fs	exonic;exonic	ENSG00000182054	.	frameshift deletion;frameshift deletion	ENSG00000182054:ENST00000539790:exon2:c.29delG:p.R10fs,ENSG00000182054:ENST00000330062:exon4:c.419delG:p.R140fs,ENSG00000182054:ENST00000540499:exon4:c.263delG:p.R88fs;ENSG00000182054:ENST00000539790:exon2:c.29delG:p.R10fs,ENSG00000182054:ENST00000330062:exon4:c.419delG:p.R140fs,ENSG00000182054:ENST00000540499:exon4:c.263delG:p.R88fs	exonic;exonic	IDH2	.	frameshift deletion;frameshift deletion	IDH2:uc010uqc.2:exon2:c.29delG:p.R10fs,IDH2:uc002box.3:exon4:c.419delG:p.R140fs,IDH2:uc010uqb.2:exon4:c.263delG:p.R88fs;IDH2:uc010uqc.2:exon2:c.29delG:p.R10fs,IDH2:uc002box.3:exon4:c.419delG:p.R140fs,IDH2:uc010uqb.2:exon4:c.263delG:p.R88fs	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MDS
16	2130300	2130300	C	T	exonic	TSC2	.	stopgain	TSC2:NM_001077183:exon29:c.C3400T:p.Q1134X,TSC2:NM_000548:exon30:c.C3532T:p.Q1178X,TSC2:NM_001114382:exon30:c.C3532T:p.Q1178X	exonic	ENSG00000103197	.	stopgain	ENSG00000103197:ENST00000382538:exon28:c.C3256T:p.Q1086X,ENSG00000103197:ENST00000439673:exon28:c.C3292T:p.Q1098X,ENSG00000103197:ENST00000353929:exon29:c.C3403T:p.Q1135X,ENSG00000103197:ENST00000401874:exon29:c.C3400T:p.Q1134X,ENSG00000103197:ENST00000568454:exon29:c.C3433T:p.Q1145X,ENSG00000103197:ENST00000219476:exon30:c.C3532T:p.Q1178X,ENSG00000103197:ENST00000350773:exon30:c.C3532T:p.Q1178X	exonic	TSC2	.	stopgain	TSC2:uc002cop.3:exon26:c.C2800T:p.Q934X,TSC2:uc010uvv.2:exon28:c.C3292T:p.Q1098X,TSC2:uc010uvw.2:exon28:c.C3256T:p.Q1086X,TSC2:uc002coo.3:exon29:c.C3400T:p.Q1134X,TSC2:uc002con.3:exon30:c.C3532T:p.Q1178X,TSC2:uc010bsd.3:exon30:c.C3532T:p.Q1178X	.	.	.	.	.	.	.	.	.	.	rs45517297	.	.	.	.	.	.	0.986	N	1	A	.	.	.	.	.	.	.	8.977	35	0.988	0.358	N	.	.	.	.	0.707	0	1.33	-0.039	-0.397	0.079	0.000	4.175	.	.	.	Uncertain significance,not provided	not_specified,Tuberous_sclerosis_syndrome	RCV000190020.1,RCV000042522.2	MedGen,MedGen:Orphanet:SNOMED_CT	CN169374,C0041341:ORPHA805:7199000	.	.	.	THCA
16	23646276	23646276	A	-	exonic	PALB2	.	frameshift deletion	PALB2:NM_024675:exon4:c.1591delT:p.L531fs	exonic	ENSG00000083093	.	frameshift deletion	ENSG00000083093:ENST00000261584:exon4:c.1591delT:p.L531fs	exonic	PALB2	.	frameshift deletion	PALB2:uc002dlx.1:exon4:c.1591delT:p.L531fs	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BRACA
1	65321333	65321333	G	A	exonic	JAK1	.	stopgain	JAK1:NM_002227:exon11:c.C1507T:p.Q503X	exonic	ENSG00000162434	.	stopgain	ENSG00000162434:ENST00000342505:exon11:c.C1507T:p.Q503X	exonic	JAK1	.	stopgain	JAK1:uc001dbu.1:exon11:c.C1507T:p.Q503X,JAK1:uc009wam.1:exon12:c.C1507T:p.Q503X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	A	.	.	.	.	.	.	.	11.881	38	0.998	0.767	D	.	.	.	.	0.706	0	3.54	0.630	1.048	0.990	0.996	10.244	.	.	SH2 domain	.	.	.	.	.	.	.	.	Skin Melanoma
16	69745145	69745145	G	A	exonic	NQO1	.	nonsynonymous SNV	NQO1:NM_001286137:exon4:c.C343T:p.P115S,NQO1:NM_001025433:exon5:c.C457T:p.P153S,NQO1:NM_001025434:exon5:c.C445T:p.P149S,NQO1:NM_000903:exon6:c.C559T:p.P187S	exonic	ENSG00000181019	.	nonsynonymous SNV	ENSG00000181019:ENST00000439109:exon4:c.C343T:p.P115S,ENSG00000181019:ENST00000379046:exon5:c.C445T:p.P149S,ENSG00000181019:ENST00000379047:exon5:c.C457T:p.P153S,ENSG00000181019:ENST00000561500:exon5:c.C445T:p.P149S,ENSG00000181019:ENST00000320623:exon6:c.C559T:p.P187S,ENSG00000181019:ENST00000564043:exon6:c.C496T:p.P166S	exonic	NQO1	.	nonsynonymous SNV	NQO1:uc010vll.2:exon4:c.C343T:p.P115S,NQO1:uc002exq.3:exon5:c.C457T:p.P153S,NQO1:uc002exr.3:exon5:c.C445T:p.P149S,NQO1:uc002exp.3:exon6:c.C559T:p.P187S	0.1974	0.288938	0.2452	0.1919	0.4056	0.4502	0.1834	0.1880	0.2124	0.3163	rs1800566	0.176	T	1.0	D	0.999	D	0.000	D	0.000	P	2.085	M	3.11	T	-5.8	D	0.871	6.611	32	0.997	0.969	D	-0.903	T	0.000	T	0.706	0	5.41	0.917	1.048	1.000	1.000	18.331	.	.	Flavodoxin-like fold;Flavoprotein-like	other|other|Pathogenic|drug response	Benzene_toxicity,_susceptibility_to|Leukemia,_post-chemotherapy,_susceptibility_to|Breast_cancer,_post-chemotherapy_poor_survival_in|Alkylating_Agents,_anthracyclines_and_related_substances,_fluorouracil,_and_Platinum_compounds_response_-_Efficacy	RCV000018300.2|RCV000018301.2|RCV000018302.23|RCV000211294.1	MedGen|MedGen|MedGen|MedGen	C2675718|C2675719|C2675722|CN236460	.	MU583912	BTCA-JP|1|239|0.00418,LUSC-KR|1|66|0.01515	L
17	33433425	33433425	G	A	exonic	RAD51D	.	stopgain	RAD51D:NM_133629:exon3:c.C220T:p.R74X,RAD51D:NM_001142571:exon6:c.C616T:p.R206X,RAD51D:NM_002878:exon6:c.C556T:p.R186X	exonic	ENSG00000185379,ENSG00000267618	.	stopgain	ENSG00000185379:ENST00000590631:exon2:c.C25T:p.R9X,ENSG00000267618:ENST00000593039:exon2:c.C79T:p.R27X,ENSG00000185379:ENST00000335858:exon3:c.C220T:p.R74X,ENSG00000267618:ENST00000591723:exon3:c.C25T:p.R9X,ENSG00000185379:ENST00000587405:exon4:c.C199T:p.R67X,ENSG00000185379:ENST00000588372:exon4:c.C199T:p.R67X,ENSG00000185379:ENST00000360276:exon5:c.C421T:p.R141X,ENSG00000185379:ENST00000460118:exon5:c.C199T:p.R67X,ENSG00000267618:ENST00000592181:exon5:c.C199T:p.R67X,ENSG00000185379:ENST00000345365:exon6:c.C556T:p.R186X,ENSG00000185379:ENST00000590016:exon6:c.C616T:p.R206X,ENSG00000185379:ENST00000592577:exon6:c.C562T:p.R188X,ENSG00000185379:ENST00000394589:exon7:c.C556T:p.R186X	exonic	RAD51D,RAD51L3-RFFL	.	stopgain	RAD51L3-RFFL:uc002hiq.2:exon2:c.C79T:p.R27X,RAD51D:uc002his.2:exon3:c.C220T:p.R74X,RAD51D:uc002hiu.2:exon4:c.C25T:p.R9X,RAD51D:uc002hit.2:exon5:c.C199T:p.R67X,RAD51D:uc010ctk.2:exon5:c.C199T:p.R67X,RAD51D:uc002hir.2:exon6:c.C556T:p.R186X,RAD51D:uc010wcd.1:exon6:c.C616T:p.R206X,RAD51D:uc010wce.1:exon6:c.C199T:p.R67X	.	.	5.276e-05	0	0	0	0	9.562e-05	0	0	rs387906843	.	.	.	.	.	.	0.000	D	1	A	.	.	.	.	.	.	.	12.383	39	0.998	0.894	D	.	.	.	.	0.732	0	3.98	-0.022	0.902	0.227	0.937	12.022	.	.	AAA+ ATPase domain;DNA recombination and repair protein Rad51, C-terminal;DNA recombination and repair protein RecA-like, ATP-binding domain;P-loop containing nucleoside triphosphate hydrolase	other|Pathogenic	Breast-ovarian_cancer,_familial_4|Hereditary_cancer-predisposing_syndrome	RCV000023220.3|RCV000129358.3	MedGen:OMIM|MedGen:SNOMED_CT	C3280345:614291|C0027672:699346009	.	.	.	BRACA
17	37868205	37868205	G	C	exonic	ERBB2	.	nonsynonymous SNV	ERBB2:NM_001289937:exon8:c.G926C:p.G309A,ERBB2:NM_004448:exon8:c.G926C:p.G309A,ERBB2:NM_001005862:exon11:c.G836C:p.G279A,ERBB2:NM_001289938:exon11:c.G836C:p.G279A,ERBB2:NM_001289936:exon12:c.G881C:p.G294A	exonic	ENSG00000141736	.	nonsynonymous SNV	ENSG00000141736:ENST00000445658:exon2:c.G98C:p.G33A,ENSG00000141736:ENST00000582648:exon3:c.G250C:p.D84H,ENSG00000141736:ENST00000269571:exon8:c.G926C:p.G309A,ENSG00000141736:ENST00000540042:exon8:c.G836C:p.G279A,ENSG00000141736:ENST00000540147:exon8:c.G836C:p.G279A,ENSG00000141736:ENST00000541774:exon8:c.G881C:p.G294A,ENSG00000141736:ENST00000584450:exon8:c.G926C:p.G309A,ENSG00000141736:ENST00000406381:exon10:c.G836C:p.G279A,ENSG00000141736:ENST00000578199:exon11:c.G836C:p.G279A,ENSG00000141736:ENST00000584601:exon12:c.G836C:p.G279A	exonic	ERBB2	.	nonsynonymous SNV	ERBB2:uc010wek.2:exon2:c.G98C:p.G33A,ERBB2:uc002hsn.1:exon8:c.G926C:p.G309A,ERBB2:uc002hso.3:exon8:c.G926C:p.G309A,ERBB2:uc002hsp.3:exon8:c.G335C:p.G112A,ERBB2:uc010cwb.3:exon8:c.G926C:p.G309A,ERBB2:uc002hsl.3:exon11:c.G836C:p.G279A,ERBB2:uc002hsm.3:exon11:c.G836C:p.G279A,ERBB2:uc010cwa.3:exon12:c.G881C:p.G294A	.	.	.	.	.	.	.	.	.	.	.	0.03	D	1.0	D	0.997	D	.	.	1.000	D	1.85	L	-0.36	T	-2.07	N	0.264	3.375	22.9	0.946	0.962	D	-0.120	T	0.464	T	0.722	0	5.83	0.917	0.994	0.998	0.992	18.885	.	.	Furin-like cysteine-rich domain;Insulin-like growth factor binding protein, N-terminal	.	.	.	.	.	ID=COSM436496;OCCURENCE=1(breast)	MU12009	BRCA-US|1|955|0.00105	BRACA
17	37868208	37868208	C	T	exonic	ERBB2	.	nonsynonymous SNV	ERBB2:NM_001289937:exon8:c.C929T:p.S310F,ERBB2:NM_004448:exon8:c.C929T:p.S310F,ERBB2:NM_001005862:exon11:c.C839T:p.S280F,ERBB2:NM_001289938:exon11:c.C839T:p.S280F,ERBB2:NM_001289936:exon12:c.C884T:p.S295F	exonic	ENSG00000141736	.	nonsynonymous SNV	ENSG00000141736:ENST00000445658:exon2:c.C101T:p.S34F,ENSG00000141736:ENST00000582648:exon3:c.C253T:p.P85S,ENSG00000141736:ENST00000269571:exon8:c.C929T:p.S310F,ENSG00000141736:ENST00000540042:exon8:c.C839T:p.S280F,ENSG00000141736:ENST00000540147:exon8:c.C839T:p.S280F,ENSG00000141736:ENST00000541774:exon8:c.C884T:p.S295F,ENSG00000141736:ENST00000584450:exon8:c.C929T:p.S310F,ENSG00000141736:ENST00000406381:exon10:c.C839T:p.S280F,ENSG00000141736:ENST00000578199:exon11:c.C839T:p.S280F,ENSG00000141736:ENST00000584601:exon12:c.C839T:p.S280F	exonic	ERBB2	.	nonsynonymous SNV	ERBB2:uc010wek.2:exon2:c.C101T:p.S34F,ERBB2:uc002hsn.1:exon8:c.C929T:p.S310F,ERBB2:uc002hso.3:exon8:c.C929T:p.S310F,ERBB2:uc002hsp.3:exon8:c.C338T:p.S113F,ERBB2:uc010cwb.3:exon8:c.C929T:p.S310F,ERBB2:uc002hsl.3:exon11:c.C839T:p.S280F,ERBB2:uc002hsm.3:exon11:c.C839T:p.S280F,ERBB2:uc010cwa.3:exon12:c.C884T:p.S295F	.	.	.	.	.	.	.	.	.	.	.	0.026	D	1.0	D	0.992	D	.	.	1	D	2.15	M	-0.11	T	-4.21	D	0.834	6.634	32	0.953	0.966	D	-0.180	T	0.444	T	0.722	0	5.83	0.871	0.888	1.000	0.993	18.885	.	.	Furin-like cysteine-rich domain;Insulin-like growth factor binding protein, N-terminal	.	.	.	.	.	ID=COSM48358;OCCURENCE=9(urinary_tract),3(large_intestine),3(breast),1(ovary),3(lung),1(stomach)	MU85975	STAD-US|4|289|0.01384,BLCA-CN|4|103|0.03883,CESC-US|4|194|0.02062,BRCA-US|1|955|0.00105,COAD-US|1|216|0.00463,MELA-AU|1|183|0.00546	COC-PR
17	37879658	37879658	G	A	exonic	ERBB2	.	nonsynonymous SNV	ERBB2:NM_001289937:exon17:c.G2033A:p.R678Q,ERBB2:NM_004448:exon17:c.G2033A:p.R678Q,ERBB2:NM_001005862:exon20:c.G1943A:p.R648Q,ERBB2:NM_001289936:exon21:c.G1988A:p.R663Q	exonic	ENSG00000141736	.	nonsynonymous SNV	ENSG00000141736:ENST00000445658:exon11:c.G1205A:p.R402Q,ENSG00000141736:ENST00000269571:exon17:c.G2033A:p.R678Q,ENSG00000141736:ENST00000540147:exon17:c.G1943A:p.R648Q,ENSG00000141736:ENST00000541774:exon17:c.G1988A:p.R663Q,ENSG00000141736:ENST00000584450:exon17:c.G2033A:p.R678Q,ENSG00000141736:ENST00000406381:exon19:c.G1943A:p.R648Q,ENSG00000141736:ENST00000584601:exon21:c.G1943A:p.R648Q	exonic	ERBB2	.	nonsynonymous SNV	ERBB2:uc010wek.2:exon11:c.G1205A:p.R402Q,ERBB2:uc002hso.3:exon17:c.G2033A:p.R678Q,ERBB2:uc002hsp.3:exon17:c.G1442A:p.R481Q,ERBB2:uc010cwb.3:exon17:c.G2033A:p.R678Q,ERBB2:uc002hsm.3:exon20:c.G1943A:p.R648Q,ERBB2:uc010cwa.3:exon21:c.G1988A:p.R663Q	.	.	.	.	.	.	.	.	.	.	.	0.103	T	0.654	P	0.103	B	.	.	1	D	1.295	L	-1.2	T	-1.59	N	0.612	4.666	24.5	0.994	0.941	D	-0.403	T	0.303	T	0.742	0	4.97	0.917	0.953	0.707	0.991	17.861	.	.	.	.	.	.	.	.	ID=COSM436498;OCCURENCE=2(stomach),1(large_intestine),1(prostate),2(urinary_tract),1(breast),1(endometrium)	MU8291	COCA-CN|1|187|0.00535,BTCA-JP|1|239|0.00418,PRAD-US|1|256|0.00391,STAD-US|2|289|0.00692,BLCA-CN|1|103|0.00971,PACA-AU|1|391|0.00256,BRCA-US|1|955|0.00105,UCEC-US|1|246|0.00407	BRACA
17	37880220	37880220	T	C	exonic;exonic	ERBB2	.	nonsynonymous SNV;nonsynonymous SNV	ERBB2:NM_001289937:exon19:c.T2264C:p.L755S,ERBB2:NM_004448:exon19:c.T2264C:p.L755S,ERBB2:NM_001005862:exon22:c.T2174C:p.L725S,ERBB2:NM_001289936:exon23:c.T2219C:p.L740S;ERBB2:NM_001289937:exon19:c.T2264C:p.L755S,ERBB2:NM_004448:exon19:c.T2264C:p.L755S,ERBB2:NM_001005862:exon22:c.T2174C:p.L725S,ERBB2:NM_001289936:exon23:c.T2219C:p.L740S	exonic;exonic	ENSG00000141736	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000141736:ENST00000445658:exon13:c.T1436C:p.L479S,ENSG00000141736:ENST00000269571:exon19:c.T2264C:p.L755S,ENSG00000141736:ENST00000540147:exon19:c.T2174C:p.L725S,ENSG00000141736:ENST00000541774:exon19:c.T2219C:p.L740S,ENSG00000141736:ENST00000584450:exon19:c.T2264C:p.L755S,ENSG00000141736:ENST00000406381:exon21:c.T2174C:p.L725S,ENSG00000141736:ENST00000584601:exon23:c.T2174C:p.L725S;ENSG00000141736:ENST00000445658:exon13:c.T1436C:p.L479S,ENSG00000141736:ENST00000269571:exon19:c.T2264C:p.L755S,ENSG00000141736:ENST00000540147:exon19:c.T2174C:p.L725S,ENSG00000141736:ENST00000541774:exon19:c.T2219C:p.L740S,ENSG00000141736:ENST00000584450:exon19:c.T2264C:p.L755S,ENSG00000141736:ENST00000406381:exon21:c.T2174C:p.L725S,ENSG00000141736:ENST00000584601:exon23:c.T2174C:p.L725S	exonic;exonic	ERBB2	.	nonsynonymous SNV;nonsynonymous SNV	ERBB2:uc010wek.2:exon13:c.T1436C:p.L479S,ERBB2:uc002hso.3:exon19:c.T2264C:p.L755S,ERBB2:uc002hsp.3:exon19:c.T1673C:p.L558S,ERBB2:uc010cwb.3:exon19:c.T2264C:p.L755S,ERBB2:uc002hsm.3:exon22:c.T2174C:p.L725S,ERBB2:uc010cwa.3:exon23:c.T2219C:p.L740S;ERBB2:uc010wek.2:exon13:c.T1436C:p.L479S,ERBB2:uc002hso.3:exon19:c.T2264C:p.L755S,ERBB2:uc002hsp.3:exon19:c.T1673C:p.L558S,ERBB2:uc010cwb.3:exon19:c.T2264C:p.L755S,ERBB2:uc002hsm.3:exon22:c.T2174C:p.L725S,ERBB2:uc010cwa.3:exon23:c.T2219C:p.L740S	.	.	.	.	.	.	.	.	.	.	rs121913470	0.0	D	1.0	D	1.0	D	.	.	1	D	2.835	M	-0.29	T	-5.03	D	0.957	6.490	30	0.998	0.973	D	0.206	D	0.530	D	0.644	0	5.18	0.991	0.964	1.000	1.000	14.724	.	.	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM14060;OCCURENCE=4(stomach),1(lung),1(endometrium),2(large_intestine),6(small_intestine),14(breast)	MU16931	KIRP-US|1|159|0.00629,BRCA-EU|1|560|0.00179,BRCA-US|5|955|0.00524,UCEC-US|1|246|0.00407	BRACA
17	37880220	37880220	T	C	exonic;exonic	ERBB2	.	nonsynonymous SNV;nonsynonymous SNV	ERBB2:NM_001289937:exon19:c.T2264C:p.L755S,ERBB2:NM_004448:exon19:c.T2264C:p.L755S,ERBB2:NM_001005862:exon22:c.T2174C:p.L725S,ERBB2:NM_001289936:exon23:c.T2219C:p.L740S;ERBB2:NM_001289937:exon19:c.T2264C:p.L755S,ERBB2:NM_004448:exon19:c.T2264C:p.L755S,ERBB2:NM_001005862:exon22:c.T2174C:p.L725S,ERBB2:NM_001289936:exon23:c.T2219C:p.L740S	exonic;exonic	ENSG00000141736	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000141736:ENST00000445658:exon13:c.T1436C:p.L479S,ENSG00000141736:ENST00000269571:exon19:c.T2264C:p.L755S,ENSG00000141736:ENST00000540147:exon19:c.T2174C:p.L725S,ENSG00000141736:ENST00000541774:exon19:c.T2219C:p.L740S,ENSG00000141736:ENST00000584450:exon19:c.T2264C:p.L755S,ENSG00000141736:ENST00000406381:exon21:c.T2174C:p.L725S,ENSG00000141736:ENST00000584601:exon23:c.T2174C:p.L725S;ENSG00000141736:ENST00000445658:exon13:c.T1436C:p.L479S,ENSG00000141736:ENST00000269571:exon19:c.T2264C:p.L755S,ENSG00000141736:ENST00000540147:exon19:c.T2174C:p.L725S,ENSG00000141736:ENST00000541774:exon19:c.T2219C:p.L740S,ENSG00000141736:ENST00000584450:exon19:c.T2264C:p.L755S,ENSG00000141736:ENST00000406381:exon21:c.T2174C:p.L725S,ENSG00000141736:ENST00000584601:exon23:c.T2174C:p.L725S	exonic;exonic	ERBB2	.	nonsynonymous SNV;nonsynonymous SNV	ERBB2:uc010wek.2:exon13:c.T1436C:p.L479S,ERBB2:uc002hso.3:exon19:c.T2264C:p.L755S,ERBB2:uc002hsp.3:exon19:c.T1673C:p.L558S,ERBB2:uc010cwb.3:exon19:c.T2264C:p.L755S,ERBB2:uc002hsm.3:exon22:c.T2174C:p.L725S,ERBB2:uc010cwa.3:exon23:c.T2219C:p.L740S;ERBB2:uc010wek.2:exon13:c.T1436C:p.L479S,ERBB2:uc002hso.3:exon19:c.T2264C:p.L755S,ERBB2:uc002hsp.3:exon19:c.T1673C:p.L558S,ERBB2:uc010cwb.3:exon19:c.T2264C:p.L755S,ERBB2:uc002hsm.3:exon22:c.T2174C:p.L725S,ERBB2:uc010cwa.3:exon23:c.T2219C:p.L740S	.	.	.	.	.	.	.	.	.	.	rs121913470	0.0	D	1.0	D	1.0	D	.	.	1	D	2.835	M	-0.29	T	-5.03	D	0.957	6.490	30	0.998	0.973	D	0.206	D	0.530	D	0.644	0	5.18	0.991	0.964	1.000	1.000	14.724	.	.	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM14060;OCCURENCE=4(stomach),1(lung),1(endometrium),2(large_intestine),6(small_intestine),14(breast)	MU16931	KIRP-US|1|159|0.00629,BRCA-EU|1|560|0.00179,BRCA-US|5|955|0.00524,UCEC-US|1|246|0.00407	COC-PR
17	37880220	37880220	T	G	exonic	ERBB2	.	nonsynonymous SNV	ERBB2:NM_001289937:exon19:c.T2264G:p.L755W,ERBB2:NM_004448:exon19:c.T2264G:p.L755W,ERBB2:NM_001005862:exon22:c.T2174G:p.L725W,ERBB2:NM_001289936:exon23:c.T2219G:p.L740W	exonic	ENSG00000141736	.	nonsynonymous SNV	ENSG00000141736:ENST00000445658:exon13:c.T1436G:p.L479W,ENSG00000141736:ENST00000269571:exon19:c.T2264G:p.L755W,ENSG00000141736:ENST00000540147:exon19:c.T2174G:p.L725W,ENSG00000141736:ENST00000541774:exon19:c.T2219G:p.L740W,ENSG00000141736:ENST00000584450:exon19:c.T2264G:p.L755W,ENSG00000141736:ENST00000406381:exon21:c.T2174G:p.L725W,ENSG00000141736:ENST00000584601:exon23:c.T2174G:p.L725W	exonic	ERBB2	.	nonsynonymous SNV	ERBB2:uc010wek.2:exon13:c.T1436G:p.L479W,ERBB2:uc002hso.3:exon19:c.T2264G:p.L755W,ERBB2:uc002hsp.3:exon19:c.T1673G:p.L558W,ERBB2:uc010cwb.3:exon19:c.T2264G:p.L755W,ERBB2:uc002hsm.3:exon22:c.T2174G:p.L725W,ERBB2:uc010cwa.3:exon23:c.T2219G:p.L740W	.	.	.	.	.	.	.	.	.	.	.	0.0	D	1.0	D	1.0	D	.	.	1	D	3.64	H	-0.33	T	-5.14	D	0.902	6.489	30	0.961	0.976	D	0.469	D	0.602	D	0.644	0	5.18	0.991	0.964	1.000	1.000	14.724	.	.	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM436499;OCCURENCE=1(breast)	MU5093096	BRCA-US|1|955|0.00105	BRACA
17	37880261	37880261	G	C	exonic	ERBB2	.	nonsynonymous SNV	ERBB2:NM_001289937:exon19:c.G2305C:p.D769H,ERBB2:NM_004448:exon19:c.G2305C:p.D769H,ERBB2:NM_001005862:exon22:c.G2215C:p.D739H,ERBB2:NM_001289936:exon23:c.G2260C:p.D754H	exonic	ENSG00000141736	.	nonsynonymous SNV	ENSG00000141736:ENST00000445658:exon13:c.G1477C:p.D493H,ENSG00000141736:ENST00000269571:exon19:c.G2305C:p.D769H,ENSG00000141736:ENST00000540147:exon19:c.G2215C:p.D739H,ENSG00000141736:ENST00000541774:exon19:c.G2260C:p.D754H,ENSG00000141736:ENST00000584450:exon19:c.G2305C:p.D769H,ENSG00000141736:ENST00000406381:exon21:c.G2215C:p.D739H,ENSG00000141736:ENST00000584601:exon23:c.G2215C:p.D739H	exonic	ERBB2	.	nonsynonymous SNV	ERBB2:uc010wek.2:exon13:c.G1477C:p.D493H,ERBB2:uc002hso.3:exon19:c.G2305C:p.D769H,ERBB2:uc002hsp.3:exon19:c.G1714C:p.D572H,ERBB2:uc010cwb.3:exon19:c.G2305C:p.D769H,ERBB2:uc002hsm.3:exon22:c.G2215C:p.D739H,ERBB2:uc010cwa.3:exon23:c.G2260C:p.D754H	.	.	.	.	.	.	.	.	.	.	rs121913468	0.001	D	1.0	D	1.0	D	.	.	1	D	-0.05	N	-1.64	D	-6.13	D	0.868	6.838	33	0.996	0.993	D	0.262	D	0.520	D	0.644	0	5.02	0.917	1.048	0.989	0.994	17.957	0.7428	0.688	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM13170;OCCURENCE=1(breast),1(stomach),1(lung)	MU33638	CESC-US|1|194|0.00515,BRCA-US|1|955|0.00105	BRACA
17	37880261	37880261	G	T	exonic	ERBB2	.	nonsynonymous SNV	ERBB2:NM_001289937:exon19:c.G2305T:p.D769Y,ERBB2:NM_004448:exon19:c.G2305T:p.D769Y,ERBB2:NM_001005862:exon22:c.G2215T:p.D739Y,ERBB2:NM_001289936:exon23:c.G2260T:p.D754Y	exonic	ENSG00000141736	.	nonsynonymous SNV	ENSG00000141736:ENST00000445658:exon13:c.G1477T:p.D493Y,ENSG00000141736:ENST00000269571:exon19:c.G2305T:p.D769Y,ENSG00000141736:ENST00000540147:exon19:c.G2215T:p.D739Y,ENSG00000141736:ENST00000541774:exon19:c.G2260T:p.D754Y,ENSG00000141736:ENST00000584450:exon19:c.G2305T:p.D769Y,ENSG00000141736:ENST00000406381:exon21:c.G2215T:p.D739Y,ENSG00000141736:ENST00000584601:exon23:c.G2215T:p.D739Y	exonic	ERBB2	.	nonsynonymous SNV	ERBB2:uc010wek.2:exon13:c.G1477T:p.D493Y,ERBB2:uc002hso.3:exon19:c.G2305T:p.D769Y,ERBB2:uc002hsp.3:exon19:c.G1714T:p.D572Y,ERBB2:uc010cwb.3:exon19:c.G2305T:p.D769Y,ERBB2:uc002hsm.3:exon22:c.G2215T:p.D739Y,ERBB2:uc010cwa.3:exon23:c.G2260T:p.D754Y	.	.	.	.	.	.	.	.	.	.	.	0.0	D	1.0	D	1.0	D	.	.	1	D	1.305	L	-1.66	D	-7.88	D	0.896	7.136	34	0.995	0.993	D	0.375	D	0.633	D	0.644	0	5.02	0.917	1.048	0.989	0.994	17.957	0.9633	0.71	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM1251412;OCCURENCE=2(breast),2(oesophagus)	MU29552	BRCA-EU|2|560|0.00357,STAD-US|1|289|0.00346,BRCA-US|2|955|0.00209	BRACA
17	37881000	37881000	G	T	exonic;exonic	ERBB2	.	nonsynonymous SNV;nonsynonymous SNV	ERBB2:NM_001289937:exon20:c.G2329T:p.V777L,ERBB2:NM_004448:exon20:c.G2329T:p.V777L,ERBB2:NM_001005862:exon23:c.G2239T:p.V747L,ERBB2:NM_001289936:exon24:c.G2284T:p.V762L;ERBB2:NM_001289937:exon20:c.G2329T:p.V777L,ERBB2:NM_004448:exon20:c.G2329T:p.V777L,ERBB2:NM_001005862:exon23:c.G2239T:p.V747L,ERBB2:NM_001289936:exon24:c.G2284T:p.V762L	exonic;exonic	ENSG00000141736	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000141736:ENST00000445658:exon14:c.G1501T:p.V501L,ENSG00000141736:ENST00000269571:exon20:c.G2329T:p.V777L,ENSG00000141736:ENST00000540147:exon20:c.G2239T:p.V747L,ENSG00000141736:ENST00000541774:exon20:c.G2284T:p.V762L,ENSG00000141736:ENST00000584450:exon20:c.G2329T:p.V777L,ENSG00000141736:ENST00000406381:exon22:c.G2239T:p.V747L,ENSG00000141736:ENST00000584601:exon24:c.G2239T:p.V747L;ENSG00000141736:ENST00000445658:exon14:c.G1501T:p.V501L,ENSG00000141736:ENST00000269571:exon20:c.G2329T:p.V777L,ENSG00000141736:ENST00000540147:exon20:c.G2239T:p.V747L,ENSG00000141736:ENST00000541774:exon20:c.G2284T:p.V762L,ENSG00000141736:ENST00000584450:exon20:c.G2329T:p.V777L,ENSG00000141736:ENST00000406381:exon22:c.G2239T:p.V747L,ENSG00000141736:ENST00000584601:exon24:c.G2239T:p.V747L	exonic;exonic	ERBB2	.	nonsynonymous SNV;nonsynonymous SNV	ERBB2:uc010wek.2:exon14:c.G1501T:p.V501L,ERBB2:uc002hso.3:exon20:c.G2329T:p.V777L,ERBB2:uc002hsp.3:exon20:c.G1738T:p.V580L,ERBB2:uc010cwb.3:exon20:c.G2329T:p.V777L,ERBB2:uc002hsm.3:exon23:c.G2239T:p.V747L,ERBB2:uc010cwa.3:exon24:c.G2284T:p.V762L;ERBB2:uc010wek.2:exon14:c.G1501T:p.V501L,ERBB2:uc002hso.3:exon20:c.G2329T:p.V777L,ERBB2:uc002hsp.3:exon20:c.G1738T:p.V580L,ERBB2:uc010cwb.3:exon20:c.G2329T:p.V777L,ERBB2:uc002hsm.3:exon23:c.G2239T:p.V747L,ERBB2:uc010cwa.3:exon24:c.G2284T:p.V762L	.	.	.	.	.	.	.	.	.	.	rs121913471	0.482	T	0.008	B	0.013	B	.	.	1	D	-1.945	N	0.45	T	-0.97	N	0.833	3.438	23.0	0.975	0.986	D	-0.998	T	0.047	T	0.722	0	5.3	0.917	1.045	0.999	0.999	18.569	.	.	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Uncertain significance	not_specified	RCV000038130.2	MedGen	CN169374	ID=COSM14062;OCCURENCE=2(stomach),1(lung),4(large_intestine),2(breast)	MU119026	LICA-CN|1|163|0.00613,BRCA-EU|1|560|0.00179,BRCA-US|1|955|0.00105	BRACA
17	37881000	37881000	G	T	exonic;exonic	ERBB2	.	nonsynonymous SNV;nonsynonymous SNV	ERBB2:NM_001289937:exon20:c.G2329T:p.V777L,ERBB2:NM_004448:exon20:c.G2329T:p.V777L,ERBB2:NM_001005862:exon23:c.G2239T:p.V747L,ERBB2:NM_001289936:exon24:c.G2284T:p.V762L;ERBB2:NM_001289937:exon20:c.G2329T:p.V777L,ERBB2:NM_004448:exon20:c.G2329T:p.V777L,ERBB2:NM_001005862:exon23:c.G2239T:p.V747L,ERBB2:NM_001289936:exon24:c.G2284T:p.V762L	exonic;exonic	ENSG00000141736	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000141736:ENST00000445658:exon14:c.G1501T:p.V501L,ENSG00000141736:ENST00000269571:exon20:c.G2329T:p.V777L,ENSG00000141736:ENST00000540147:exon20:c.G2239T:p.V747L,ENSG00000141736:ENST00000541774:exon20:c.G2284T:p.V762L,ENSG00000141736:ENST00000584450:exon20:c.G2329T:p.V777L,ENSG00000141736:ENST00000406381:exon22:c.G2239T:p.V747L,ENSG00000141736:ENST00000584601:exon24:c.G2239T:p.V747L;ENSG00000141736:ENST00000445658:exon14:c.G1501T:p.V501L,ENSG00000141736:ENST00000269571:exon20:c.G2329T:p.V777L,ENSG00000141736:ENST00000540147:exon20:c.G2239T:p.V747L,ENSG00000141736:ENST00000541774:exon20:c.G2284T:p.V762L,ENSG00000141736:ENST00000584450:exon20:c.G2329T:p.V777L,ENSG00000141736:ENST00000406381:exon22:c.G2239T:p.V747L,ENSG00000141736:ENST00000584601:exon24:c.G2239T:p.V747L	exonic;exonic	ERBB2	.	nonsynonymous SNV;nonsynonymous SNV	ERBB2:uc010wek.2:exon14:c.G1501T:p.V501L,ERBB2:uc002hso.3:exon20:c.G2329T:p.V777L,ERBB2:uc002hsp.3:exon20:c.G1738T:p.V580L,ERBB2:uc010cwb.3:exon20:c.G2329T:p.V777L,ERBB2:uc002hsm.3:exon23:c.G2239T:p.V747L,ERBB2:uc010cwa.3:exon24:c.G2284T:p.V762L;ERBB2:uc010wek.2:exon14:c.G1501T:p.V501L,ERBB2:uc002hso.3:exon20:c.G2329T:p.V777L,ERBB2:uc002hsp.3:exon20:c.G1738T:p.V580L,ERBB2:uc010cwb.3:exon20:c.G2329T:p.V777L,ERBB2:uc002hsm.3:exon23:c.G2239T:p.V747L,ERBB2:uc010cwa.3:exon24:c.G2284T:p.V762L	.	.	.	.	.	.	.	.	.	.	rs121913471	0.482	T	0.008	B	0.013	B	.	.	1	D	-1.945	N	0.45	T	-0.97	N	0.833	3.438	23.0	0.975	0.986	D	-0.998	T	0.047	T	0.722	0	5.3	0.917	1.045	0.999	0.999	18.569	.	.	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Uncertain significance	not_specified	RCV000038130.2	MedGen	CN169374	ID=COSM14062;OCCURENCE=2(stomach),1(lung),4(large_intestine),2(breast)	MU119026	LICA-CN|1|163|0.00613,BRCA-EU|1|560|0.00179,BRCA-US|1|955|0.00105	COC-PR
17	37881332	37881332	G	A	exonic;exonic	ERBB2	.	nonsynonymous SNV;nonsynonymous SNV	ERBB2:NM_001289937:exon21:c.G2524A:p.V842I,ERBB2:NM_004448:exon21:c.G2524A:p.V842I,ERBB2:NM_001005862:exon24:c.G2434A:p.V812I,ERBB2:NM_001289936:exon25:c.G2479A:p.V827I;ERBB2:NM_001289937:exon21:c.G2524A:p.V842I,ERBB2:NM_004448:exon21:c.G2524A:p.V842I,ERBB2:NM_001005862:exon24:c.G2434A:p.V812I,ERBB2:NM_001289936:exon25:c.G2479A:p.V827I	exonic;exonic	ENSG00000141736	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000141736:ENST00000445658:exon15:c.G1696A:p.V566I,ENSG00000141736:ENST00000269571:exon21:c.G2524A:p.V842I,ENSG00000141736:ENST00000540147:exon21:c.G2434A:p.V812I,ENSG00000141736:ENST00000541774:exon21:c.G2479A:p.V827I,ENSG00000141736:ENST00000584450:exon21:c.G2524A:p.V842I,ENSG00000141736:ENST00000406381:exon23:c.G2434A:p.V812I,ENSG00000141736:ENST00000584601:exon25:c.G2434A:p.V812I;ENSG00000141736:ENST00000445658:exon15:c.G1696A:p.V566I,ENSG00000141736:ENST00000269571:exon21:c.G2524A:p.V842I,ENSG00000141736:ENST00000540147:exon21:c.G2434A:p.V812I,ENSG00000141736:ENST00000541774:exon21:c.G2479A:p.V827I,ENSG00000141736:ENST00000584450:exon21:c.G2524A:p.V842I,ENSG00000141736:ENST00000406381:exon23:c.G2434A:p.V812I,ENSG00000141736:ENST00000584601:exon25:c.G2434A:p.V812I	exonic;exonic	ERBB2	.	nonsynonymous SNV;nonsynonymous SNV	ERBB2:uc010wek.2:exon15:c.G1696A:p.V566I,ERBB2:uc002hso.3:exon21:c.G2524A:p.V842I,ERBB2:uc002hsp.3:exon21:c.G1933A:p.V645I,ERBB2:uc010cwb.3:exon21:c.G2524A:p.V842I,ERBB2:uc002hsm.3:exon24:c.G2434A:p.V812I,ERBB2:uc010cwa.3:exon25:c.G2479A:p.V827I;ERBB2:uc010wek.2:exon15:c.G1696A:p.V566I,ERBB2:uc002hso.3:exon21:c.G2524A:p.V842I,ERBB2:uc002hsp.3:exon21:c.G1933A:p.V645I,ERBB2:uc010cwb.3:exon21:c.G2524A:p.V842I,ERBB2:uc002hsm.3:exon24:c.G2434A:p.V812I,ERBB2:uc010cwa.3:exon25:c.G2479A:p.V827I	.	.	.	.	.	.	.	.	.	.	.	0.002	D	0.999	D	0.926	D	.	.	1	D	0.635	N	-1.69	D	-0.88	N	0.558	6.819	32	0.988	0.969	D	0.233	D	0.562	D	0.722	0	5.09	0.917	1.048	0.957	0.962	18.285	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM14065;OCCURENCE=5(large_intestine),1(small_intestine),2(breast),2(endometrium),1(stomach)	MU14665	COCA-CN|1|187|0.00535,ESAD-UK|3|119|0.02521,BTCA-JP|1|239|0.00418,STAD-US|1|289|0.00346,BRCA-US|1|955|0.00105,UCEC-US|2|246|0.00813	BRACA
17	37881332	37881332	G	A	exonic;exonic	ERBB2	.	nonsynonymous SNV;nonsynonymous SNV	ERBB2:NM_001289937:exon21:c.G2524A:p.V842I,ERBB2:NM_004448:exon21:c.G2524A:p.V842I,ERBB2:NM_001005862:exon24:c.G2434A:p.V812I,ERBB2:NM_001289936:exon25:c.G2479A:p.V827I;ERBB2:NM_001289937:exon21:c.G2524A:p.V842I,ERBB2:NM_004448:exon21:c.G2524A:p.V842I,ERBB2:NM_001005862:exon24:c.G2434A:p.V812I,ERBB2:NM_001289936:exon25:c.G2479A:p.V827I	exonic;exonic	ENSG00000141736	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000141736:ENST00000445658:exon15:c.G1696A:p.V566I,ENSG00000141736:ENST00000269571:exon21:c.G2524A:p.V842I,ENSG00000141736:ENST00000540147:exon21:c.G2434A:p.V812I,ENSG00000141736:ENST00000541774:exon21:c.G2479A:p.V827I,ENSG00000141736:ENST00000584450:exon21:c.G2524A:p.V842I,ENSG00000141736:ENST00000406381:exon23:c.G2434A:p.V812I,ENSG00000141736:ENST00000584601:exon25:c.G2434A:p.V812I;ENSG00000141736:ENST00000445658:exon15:c.G1696A:p.V566I,ENSG00000141736:ENST00000269571:exon21:c.G2524A:p.V842I,ENSG00000141736:ENST00000540147:exon21:c.G2434A:p.V812I,ENSG00000141736:ENST00000541774:exon21:c.G2479A:p.V827I,ENSG00000141736:ENST00000584450:exon21:c.G2524A:p.V842I,ENSG00000141736:ENST00000406381:exon23:c.G2434A:p.V812I,ENSG00000141736:ENST00000584601:exon25:c.G2434A:p.V812I	exonic;exonic	ERBB2	.	nonsynonymous SNV;nonsynonymous SNV	ERBB2:uc010wek.2:exon15:c.G1696A:p.V566I,ERBB2:uc002hso.3:exon21:c.G2524A:p.V842I,ERBB2:uc002hsp.3:exon21:c.G1933A:p.V645I,ERBB2:uc010cwb.3:exon21:c.G2524A:p.V842I,ERBB2:uc002hsm.3:exon24:c.G2434A:p.V812I,ERBB2:uc010cwa.3:exon25:c.G2479A:p.V827I;ERBB2:uc010wek.2:exon15:c.G1696A:p.V566I,ERBB2:uc002hso.3:exon21:c.G2524A:p.V842I,ERBB2:uc002hsp.3:exon21:c.G1933A:p.V645I,ERBB2:uc010cwb.3:exon21:c.G2524A:p.V842I,ERBB2:uc002hsm.3:exon24:c.G2434A:p.V812I,ERBB2:uc010cwa.3:exon25:c.G2479A:p.V827I	.	.	.	.	.	.	.	.	.	.	.	0.002	D	0.999	D	0.926	D	.	.	1	D	0.635	N	-1.69	D	-0.88	N	0.558	6.819	32	0.988	0.969	D	0.233	D	0.562	D	0.722	0	5.09	0.917	1.048	0.957	0.962	18.285	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM14065;OCCURENCE=5(large_intestine),1(small_intestine),2(breast),2(endometrium),1(stomach)	MU14665	COCA-CN|1|187|0.00535,ESAD-UK|3|119|0.02521,BTCA-JP|1|239|0.00418,STAD-US|1|289|0.00346,BRCA-US|1|955|0.00105,UCEC-US|2|246|0.00813	COC-PR
17	37881404	37881404	C	A	exonic	ERBB2	.	nonsynonymous SNV	ERBB2:NM_001289937:exon21:c.C2596A:p.L866M,ERBB2:NM_004448:exon21:c.C2596A:p.L866M,ERBB2:NM_001005862:exon24:c.C2506A:p.L836M,ERBB2:NM_001289936:exon25:c.C2551A:p.L851M	exonic	ENSG00000141736	.	nonsynonymous SNV	ENSG00000141736:ENST00000445658:exon15:c.C1768A:p.L590M,ENSG00000141736:ENST00000269571:exon21:c.C2596A:p.L866M,ENSG00000141736:ENST00000540147:exon21:c.C2506A:p.L836M,ENSG00000141736:ENST00000541774:exon21:c.C2551A:p.L851M,ENSG00000141736:ENST00000584450:exon21:c.C2596A:p.L866M,ENSG00000141736:ENST00000406381:exon23:c.C2506A:p.L836M,ENSG00000141736:ENST00000584601:exon25:c.C2506A:p.L836M	exonic	ERBB2	.	nonsynonymous SNV	ERBB2:uc010wek.2:exon15:c.C1768A:p.L590M,ERBB2:uc002hso.3:exon21:c.C2596A:p.L866M,ERBB2:uc002hsp.3:exon21:c.C2005A:p.L669M,ERBB2:uc010cwb.3:exon21:c.C2596A:p.L866M,ERBB2:uc002hsm.3:exon24:c.C2506A:p.L836M,ERBB2:uc010cwa.3:exon25:c.C2551A:p.L851M	.	.	.	.	.	.	.	.	.	.	.	0.002	D	1.0	D	1.0	D	.	.	1.000	D	2.1	M	-2.68	D	-1.56	N	0.765	6.070	28.1	0.938	0.948	D	0.706	D	0.800	D	0.722	0	4.13	0.871	0.935	0.993	1.000	10.558	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	.	.	.	COC-PR
17	37881616	37881616	C	T	exonic	ERBB2	.	nonsynonymous SNV	ERBB2:NM_001289937:exon22:c.C2686T:p.R896C,ERBB2:NM_004448:exon22:c.C2686T:p.R896C,ERBB2:NM_001005862:exon25:c.C2596T:p.R866C,ERBB2:NM_001289936:exon26:c.C2641T:p.R881C	exonic	ENSG00000141736	.	nonsynonymous SNV	ENSG00000141736:ENST00000445658:exon16:c.C1858T:p.R620C,ENSG00000141736:ENST00000269571:exon22:c.C2686T:p.R896C,ENSG00000141736:ENST00000540147:exon22:c.C2596T:p.R866C,ENSG00000141736:ENST00000541774:exon22:c.C2641T:p.R881C,ENSG00000141736:ENST00000584450:exon22:c.C2686T:p.R896C,ENSG00000141736:ENST00000406381:exon24:c.C2596T:p.R866C,ENSG00000141736:ENST00000584601:exon26:c.C2596T:p.R866C	exonic	ERBB2	.	nonsynonymous SNV	ERBB2:uc010wek.2:exon16:c.C1858T:p.R620C,ERBB2:uc002hso.3:exon22:c.C2686T:p.R896C,ERBB2:uc002hsp.3:exon22:c.C2095T:p.R699C,ERBB2:uc010cwb.3:exon22:c.C2686T:p.R896C,ERBB2:uc002hsm.3:exon25:c.C2596T:p.R866C,ERBB2:uc010cwa.3:exon26:c.C2641T:p.R881C	.	.	8.242e-06	9.634e-05	0	0	0	0	0	0	rs758222990	0.055	T	0.004	B	0.004	B	.	.	1.000	D	0.805	L	-0.02	T	-2.01	N	0.313	4.728	24.6	0.984	0.820	D	-0.921	T	0.146	T	0.722	0	3.22	-0.473	0.020	0.896	0.973	10.966	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM14066;OCCURENCE=1(large_intestine),1(breast),1(central_nervous_system)	MU41128427	ESCA-CN|1|228|0.00439	BRACA
17	46805705	46805705	C	T	exonic	HOXB13	.	nonsynonymous SNV	HOXB13:NM_006361:exon1:c.G251A:p.G84E	exonic	ENSG00000159184	.	nonsynonymous SNV	ENSG00000159184:ENST00000290295:exon1:c.G251A:p.G84E	exonic	HOXB13	.	nonsynonymous SNV	HOXB13:uc002ioa.3:exon1:c.G251A:p.G84E	0.0015	0.000199681	0.0022	0.0004	0	0	0.0077	0.0031	0.0011	0	rs138213197	0.006	D	1.0	D	1.0	D	0.000	D	1	D	2.505	M	0.54	T	-6.49	D	0.921	6.404	29.6	0.998	0.991	D	-0.278	T	0.363	T	0.598	0	4.73	0.871	0.935	0.999	1.000	16.452	.	.	Homeobox protein Hox1A3 N-terminal	Uncertain significance|Pathogenic|other	not_specified|Prostate_cancer_susceptibility|not_provided	RCV000115969.2|RCV000210093.1|RCV000229815.1	MedGen|MedGen|MedGen	CN169374|C3469524|CN221809	.	MU4541602	SKCM-US|1|335|0.00299	PRAD
17	7577120	7577120	C	T	exonic	TP53	.	nonsynonymous SNV	TP53:NM_001126115:exon4:c.G422A:p.R141H,TP53:NM_001126116:exon4:c.G422A:p.R141H,TP53:NM_001126117:exon4:c.G422A:p.R141H,TP53:NM_001276697:exon4:c.G341A:p.R114H,TP53:NM_001276698:exon4:c.G341A:p.R114H,TP53:NM_001276699:exon4:c.G341A:p.R114H,TP53:NM_001126118:exon7:c.G701A:p.R234H,TP53:NM_000546:exon8:c.G818A:p.R273H,TP53:NM_001126112:exon8:c.G818A:p.R273H,TP53:NM_001126113:exon8:c.G818A:p.R273H,TP53:NM_001126114:exon8:c.G818A:p.R273H,TP53:NM_001276695:exon8:c.G701A:p.R234H,TP53:NM_001276696:exon8:c.G701A:p.R234H,TP53:NM_001276760:exon8:c.G701A:p.R234H,TP53:NM_001276761:exon8:c.G701A:p.R234H	exonic	ENSG00000141510	.	nonsynonymous SNV	ENSG00000141510:ENST00000509690:exon5:c.G422A:p.R141H,ENSG00000141510:ENST00000359597:exon7:c.G818A:p.R273H,ENSG00000141510:ENST00000269305:exon8:c.G818A:p.R273H,ENSG00000141510:ENST00000420246:exon8:c.G818A:p.R273H,ENSG00000141510:ENST00000445888:exon8:c.G818A:p.R273H,ENSG00000141510:ENST00000455263:exon8:c.G818A:p.R273H	exonic	TP53	.	nonsynonymous SNV	TP53:uc002gii.2:exon4:c.G341A:p.R114H,TP53:uc010cnf.2:exon4:c.G341A:p.R114H,TP53:uc010cng.2:exon4:c.G341A:p.R114H,TP53:uc002gih.3:exon7:c.G818A:p.R273H,TP53:uc031qyq.1:exon7:c.G701A:p.R234H,TP53:uc002gij.3:exon8:c.G701A:p.R234H,TP53:uc002gim.3:exon8:c.G818A:p.R273H,TP53:uc010cnh.2:exon8:c.G818A:p.R273H,TP53:uc010cni.2:exon8:c.G818A:p.R273H	.	0.000199681	2.628e-05	0	0	0	0	4.746e-05	0	0	rs28934576	0.011	D	1.0	D	0.989	D	0.000	D	1	A	2.455	M	-7.32	D	-4.31	D	0.97	5.846	27.3	0.998	0.995	D	0.939	D	0.992	D	0.722	0	4.92	0.871	0.932	0.975	0.792	15.662	.	.	p53, DNA-binding domain;p53-like transcription factor, DNA-binding;p53/RUNT-type transcription factor, DNA-binding domain	Likely pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic	Hereditary_cancer-predisposing_syndrome,Li-Fraumeni_syndrome_1|Thyroid_cancer,_anaplastic|Hereditary_cancer-predisposing_syndrome|not_provided	RCV000222860.1,RCV000013163.21|RCV000013164.5|RCV000115738.5|RCV000254693.1	MedGen:SNOMED_CT,MedGen:OMIM|MedGen:Orphanet|MedGen:SNOMED_CT|MedGen	C0027672:699346009,C1835398:151623|C0238461:ORPHA142|C0027672:699346009|CN221809	ID=COSM99729,COSM1645335,COSM3356963,COSM10660;OCCURENCE=1(vulva),32(oesophagus),44(upper_aerodigestive_tract),4(bone),1(thymus),45(central_nervous_system),22(stomach),1(cervix),27(haematopoietic_and_lymphoid_tissue),42(lung),4(penis),8(endometrium),57(ovary),1(soft_tissue),1(fallopian_tube),5(biliary_tract),144(large_intestine),19(urinary_tract),2(genital_tract),4(liver),25(pancreas),70(breast),8(skin)	MU24637	LUSC-US|1|178|0.00562,OV-US|3|88|0.03409,READ-US|4|80|0.05000,LGG-US|9|283|0.03180,STAD-US|7|289|0.02422,BRCA-US|9|955|0.00942,UCEC-US|4|246|0.01626,MALY-DE|3|44|0.06818,COCA-CN|5|187|0.02674,ESAD-UK|4|119|0.03361,LIHC-US|1|188|0.00532,ESCA-CN|4|228|0.01754,GBM-US|4|268|0.01493,PRAD-CA|1|124|0.00806,PACA-CA|9|227|0.03965,BRCA-EU|5|560|0.00893,ORCA-IN|1|106|0.00943,PACA-AU|9|391|0.02302,OV-AU|6|93|0.06452,COAD-US|7|216|0.03241	BRACA
17	7577121	7577121	G	A	exonic	TP53	.	nonsynonymous SNV	TP53:NM_001126115:exon4:c.C421T:p.R141C,TP53:NM_001126116:exon4:c.C421T:p.R141C,TP53:NM_001126117:exon4:c.C421T:p.R141C,TP53:NM_001276697:exon4:c.C340T:p.R114C,TP53:NM_001276698:exon4:c.C340T:p.R114C,TP53:NM_001276699:exon4:c.C340T:p.R114C,TP53:NM_001126118:exon7:c.C700T:p.R234C,TP53:NM_000546:exon8:c.C817T:p.R273C,TP53:NM_001126112:exon8:c.C817T:p.R273C,TP53:NM_001126113:exon8:c.C817T:p.R273C,TP53:NM_001126114:exon8:c.C817T:p.R273C,TP53:NM_001276695:exon8:c.C700T:p.R234C,TP53:NM_001276696:exon8:c.C700T:p.R234C,TP53:NM_001276760:exon8:c.C700T:p.R234C,TP53:NM_001276761:exon8:c.C700T:p.R234C	exonic	ENSG00000141510	.	nonsynonymous SNV	ENSG00000141510:ENST00000509690:exon5:c.C421T:p.R141C,ENSG00000141510:ENST00000359597:exon7:c.C817T:p.R273C,ENSG00000141510:ENST00000269305:exon8:c.C817T:p.R273C,ENSG00000141510:ENST00000420246:exon8:c.C817T:p.R273C,ENSG00000141510:ENST00000445888:exon8:c.C817T:p.R273C,ENSG00000141510:ENST00000455263:exon8:c.C817T:p.R273C	exonic	TP53	.	nonsynonymous SNV	TP53:uc002gii.2:exon4:c.C340T:p.R114C,TP53:uc010cnf.2:exon4:c.C340T:p.R114C,TP53:uc010cng.2:exon4:c.C340T:p.R114C,TP53:uc002gih.3:exon7:c.C817T:p.R273C,TP53:uc031qyq.1:exon7:c.C700T:p.R234C,TP53:uc002gij.3:exon8:c.C700T:p.R234C,TP53:uc002gim.3:exon8:c.C817T:p.R273C,TP53:uc010cnh.2:exon8:c.C817T:p.R273C,TP53:uc010cni.2:exon8:c.C817T:p.R273C	.	.	8.886e-06	0	0	0	0	1.605e-05	0	0	rs121913343	0.003	D	1.0	D	0.999	D	0.000	D	1	D	3.145	M	-7.34	D	-6.91	D	0.988	6.741	32	0.999	0.982	D	0.964	D	0.993	D	0.722	0	3.95	0.917	1.045	0.975	0.825	11.223	.	.	p53, DNA-binding domain;p53-like transcription factor, DNA-binding;p53/RUNT-type transcription factor, DNA-binding domain	Pathogenic|Pathogenic|Uncertain significance|other|Pathogenic	Hereditary_cancer-predisposing_syndrome|Li-Fraumeni_syndrome_1|Malignant_tumor_of_prostate|Li-Fraumeni_syndrome|not_provided	RCV000131966.4|RCV000144665.4|RCV000149051.1|RCV000205625.1|RCV000254692.1	MedGen:SNOMED_CT|MedGen:OMIM|MedGen:OMIM:SNOMED_CT|MedGen:Orphanet:SNOMED_CT|MedGen	C0027672:699346009|C1835398:151623|C0376358:176807:399068003|C0085390:ORPHA524:428850001|CN221809	ID=COSM3355991,COSM10659,COSM1645518,COSM99933;OCCURENCE=34(ovary),14(endometrium),3(small_intestine),22(breast),11(skin),5(prostate),111(large_intestine),3(biliary_tract),1(genital_tract),1(adrenal_gland),14(urinary_tract),2(kidney),16(pancreas),20(liver),131(central_nervous_system),23(stomach),2(vulva),25(oesophagus),26(upper_aerodigestive_tract),9(bone),4(thyroid),1(penis),17(lung),5(cervix),25(haematopoietic_and_lymphoid_tissue)	MU5286	BRCA-UK|1|117|0.00855,BTCA-JP|2|239|0.00837,LUSC-US|1|178|0.00562,READ-US|4|80|0.05000,OV-US|2|88|0.02273,LGG-US|31|283|0.10954,STAD-US|6|289|0.02076,BRCA-US|4|955|0.00419,UCEC-US|4|246|0.01626,LIRI-JP|3|260|0.01154,COCA-CN|3|187|0.01604,ESAD-UK|2|119|0.01681,ESCA-CN|3|228|0.01316,LINC-JP|1|244|0.00410,GBM-US|1|268|0.00373,BOCA-FR|2|98|0.02041,PACA-CA|5|227|0.02203,BRCA-EU|3|560|0.00536,ORCA-IN|3|106|0.02830,PACA-AU|5|391|0.01279,COAD-US|2|216|0.00926	BRACA
17	7577535	7577535	C	G	exonic	TP53	.	nonsynonymous SNV	TP53:NM_001126115:exon3:c.G350C:p.R117T,TP53:NM_001126116:exon3:c.G350C:p.R117T,TP53:NM_001126117:exon3:c.G350C:p.R117T,TP53:NM_001276697:exon3:c.G269C:p.R90T,TP53:NM_001276698:exon3:c.G269C:p.R90T,TP53:NM_001276699:exon3:c.G269C:p.R90T,TP53:NM_001126118:exon6:c.G629C:p.R210T,TP53:NM_000546:exon7:c.G746C:p.R249T,TP53:NM_001126112:exon7:c.G746C:p.R249T,TP53:NM_001126113:exon7:c.G746C:p.R249T,TP53:NM_001126114:exon7:c.G746C:p.R249T,TP53:NM_001276695:exon7:c.G629C:p.R210T,TP53:NM_001276696:exon7:c.G629C:p.R210T,TP53:NM_001276760:exon7:c.G629C:p.R210T,TP53:NM_001276761:exon7:c.G629C:p.R210T	exonic	ENSG00000141510	.	nonsynonymous SNV	ENSG00000141510:ENST00000509690:exon4:c.G350C:p.R117T,ENSG00000141510:ENST00000359597:exon6:c.G746C:p.R249T,ENSG00000141510:ENST00000413465:exon6:c.G746C:p.R249T,ENSG00000141510:ENST00000269305:exon7:c.G746C:p.R249T,ENSG00000141510:ENST00000420246:exon7:c.G746C:p.R249T,ENSG00000141510:ENST00000445888:exon7:c.G746C:p.R249T,ENSG00000141510:ENST00000455263:exon7:c.G746C:p.R249T	exonic	TP53	.	nonsynonymous SNV	TP53:uc002gii.2:exon3:c.G269C:p.R90T,TP53:uc010cnf.2:exon3:c.G269C:p.R90T,TP53:uc010cng.2:exon3:c.G269C:p.R90T,TP53:uc002gio.3:exon4:c.G350C:p.R117T,TP53:uc002gig.1:exon6:c.G746C:p.R249T,TP53:uc002gih.3:exon6:c.G746C:p.R249T,TP53:uc002gin.3:exon6:c.G467C:p.R156T,TP53:uc031qyq.1:exon6:c.G629C:p.R210T,TP53:uc002gij.3:exon7:c.G629C:p.R210T,TP53:uc002gim.3:exon7:c.G746C:p.R249T,TP53:uc010cnh.2:exon7:c.G746C:p.R249T,TP53:uc010cni.2:exon7:c.G746C:p.R249T	.	.	.	.	.	.	.	.	.	.	.	0.0	D	1.0	D	0.995	D	0.000	D	1.000	D	2.755	M	-7.3	D	-5.32	D	0.921	5.974	27.7	0.984	0.986	D	0.954	D	0.992	D	0.722	0	3.64	0.871	0.848	0.892	0.891	12.864	.	.	p53, DNA-binding domain;p53-like transcription factor, DNA-binding;p53/RUNT-type transcription factor, DNA-binding domain	.	.	.	.	.	ID=COSM1728798,COSM375643,COSM43665,COSM3403260,COSM375642;OCCURENCE=1(lung),1(upper_aerodigestive_tract),2(oesophagus),2(central_nervous_system),1(pancreas),2(liver),1(prostate),5(breast),3(skin),2(ovary)	MU603634	COCA-CN|1|187|0.00535,GBM-US|1|268|0.00373	BRACA
17	7577538	7577538	C	T	exonic	TP53	.	nonsynonymous SNV	TP53:NM_001126115:exon3:c.G347A:p.R116Q,TP53:NM_001126116:exon3:c.G347A:p.R116Q,TP53:NM_001126117:exon3:c.G347A:p.R116Q,TP53:NM_001276697:exon3:c.G266A:p.R89Q,TP53:NM_001276698:exon3:c.G266A:p.R89Q,TP53:NM_001276699:exon3:c.G266A:p.R89Q,TP53:NM_001126118:exon6:c.G626A:p.R209Q,TP53:NM_000546:exon7:c.G743A:p.R248Q,TP53:NM_001126112:exon7:c.G743A:p.R248Q,TP53:NM_001126113:exon7:c.G743A:p.R248Q,TP53:NM_001126114:exon7:c.G743A:p.R248Q,TP53:NM_001276695:exon7:c.G626A:p.R209Q,TP53:NM_001276696:exon7:c.G626A:p.R209Q,TP53:NM_001276760:exon7:c.G626A:p.R209Q,TP53:NM_001276761:exon7:c.G626A:p.R209Q	exonic	ENSG00000141510	.	nonsynonymous SNV	ENSG00000141510:ENST00000509690:exon4:c.G347A:p.R116Q,ENSG00000141510:ENST00000359597:exon6:c.G743A:p.R248Q,ENSG00000141510:ENST00000413465:exon6:c.G743A:p.R248Q,ENSG00000141510:ENST00000514944:exon6:c.G464A:p.R155Q,ENSG00000141510:ENST00000269305:exon7:c.G743A:p.R248Q,ENSG00000141510:ENST00000420246:exon7:c.G743A:p.R248Q,ENSG00000141510:ENST00000445888:exon7:c.G743A:p.R248Q,ENSG00000141510:ENST00000455263:exon7:c.G743A:p.R248Q	exonic	TP53	.	nonsynonymous SNV	TP53:uc002gii.2:exon3:c.G266A:p.R89Q,TP53:uc010cnf.2:exon3:c.G266A:p.R89Q,TP53:uc010cng.2:exon3:c.G266A:p.R89Q,TP53:uc002gio.3:exon4:c.G347A:p.R116Q,TP53:uc002gig.1:exon6:c.G743A:p.R248Q,TP53:uc002gih.3:exon6:c.G743A:p.R248Q,TP53:uc002gin.3:exon6:c.G464A:p.R155Q,TP53:uc031qyq.1:exon6:c.G626A:p.R209Q,TP53:uc002gij.3:exon7:c.G626A:p.R209Q,TP53:uc002gim.3:exon7:c.G743A:p.R248Q,TP53:uc010cnh.2:exon7:c.G743A:p.R248Q,TP53:uc010cni.2:exon7:c.G743A:p.R248Q	7.7e-05	.	5.768e-05	0	0	0.0002	0	7.493e-05	0	0	rs11540652	0.008	D	1.0	D	0.999	D	0.000	D	1.000	A	2.97	M	-7.28	D	-3.44	D	0.872	7.525	34	0.999	0.980	D	0.960	D	0.993	D	0.722	0	3.65	0.033	0.848	0.928	0.944	10.669	.	.	p53, DNA-binding domain;p53-like transcription factor, DNA-binding;p53/RUNT-type transcription factor, DNA-binding domain	Likely pathogenic,Uncertain significance,Pathogenic|other|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Hereditary_cancer-predisposing_syndrome,Li-Fraumeni_syndrome,Li-Fraumeni_syndrome_1|Hereditary_cancer-predisposing_syndrome|Sarcoma|Li-Fraumeni_syndrome_2|Li-Fraumeni_syndrome|not_provided	RCV000219834.1,RCV000229442.1,RCV000013150.22|RCV000115736.7|RCV000148913.1|RCV000179773.1|RCV000197114.2|RCV000235221.1	MedGen:SNOMED_CT,MedGen:Orphanet:SNOMED_CT,MedGen:OMIM|MedGen:SNOMED_CT|MedGen|MedGen:OMIM|MedGen:Orphanet:SNOMED_CT|MedGen	C0027672:699346009,C0085390:ORPHA524:428850001,C1835398:151623|C0027672:699346009|C1261473|C1836482:609265|C0085390:ORPHA524:428850001|CN221809	ID=COSM99021,COSM99020,COSM10662,COSM99602,COSM3356964,COSM1640830;OCCURENCE=37(urinary_tract),1(adrenal_gland),2(kidney),17(pancreas),8(liver),5(prostate),154(large_intestine),4(biliary_tract),72(breast),13(skin),7(small_intestine),12(endometrium),1(pituitary),32(ovary),3(cervix),58(haematopoietic_and_lymphoid_tissue),1(pleura),5(thyroid),1(peritoneum),18(lung),37(upper_aerodigestive_tract),2(NS),4(bone),3(vulva),37(oesophagus),45(central_nervous_system),37(stomach)	MU30748	BRCA-UK|1|117|0.00855,BTCA-JP|3|239|0.01255,LUSC-US|1|178|0.00562,OV-US|1|88|0.01136,READ-US|3|80|0.03750,PAEN-AU|1|52|0.01923,COCA-CN|4|187|0.02139,LIHC-US|1|188|0.00532,GBM-US|6|268|0.02239,LINC-JP|1|244|0.00410,PRAD-US|2|256|0.00781,ALL-US|1|27|0.03704,PACA-AU|7|391|0.01790,OV-AU|2|93|0.02151,COAD-US|12|216|0.05556,LGG-US|7|283|0.02473,STAD-US|5|289|0.01730,BLCA-CN|1|103|0.00971,UCEC-US|4|246|0.01626,MALY-DE|1|44|0.02273,PAEN-IT|1|37|0.02703,ESAD-UK|5|119|0.04202,ESCA-CN|1|228|0.00439,PACA-CA|3|227|0.01322,BRCA-EU|3|560|0.00536,ORCA-IN|5|106|0.04717	BRACA
17	7577539	7577539	G	A	exonic	TP53	.	nonsynonymous SNV	TP53:NM_001126115:exon3:c.C346T:p.R116W,TP53:NM_001126116:exon3:c.C346T:p.R116W,TP53:NM_001126117:exon3:c.C346T:p.R116W,TP53:NM_001276697:exon3:c.C265T:p.R89W,TP53:NM_001276698:exon3:c.C265T:p.R89W,TP53:NM_001276699:exon3:c.C265T:p.R89W,TP53:NM_001126118:exon6:c.C625T:p.R209W,TP53:NM_000546:exon7:c.C742T:p.R248W,TP53:NM_001126112:exon7:c.C742T:p.R248W,TP53:NM_001126113:exon7:c.C742T:p.R248W,TP53:NM_001126114:exon7:c.C742T:p.R248W,TP53:NM_001276695:exon7:c.C625T:p.R209W,TP53:NM_001276696:exon7:c.C625T:p.R209W,TP53:NM_001276760:exon7:c.C625T:p.R209W,TP53:NM_001276761:exon7:c.C625T:p.R209W	exonic	ENSG00000141510	.	nonsynonymous SNV	ENSG00000141510:ENST00000509690:exon4:c.C346T:p.R116W,ENSG00000141510:ENST00000359597:exon6:c.C742T:p.R248W,ENSG00000141510:ENST00000413465:exon6:c.C742T:p.R248W,ENSG00000141510:ENST00000514944:exon6:c.C463T:p.R155W,ENSG00000141510:ENST00000269305:exon7:c.C742T:p.R248W,ENSG00000141510:ENST00000420246:exon7:c.C742T:p.R248W,ENSG00000141510:ENST00000445888:exon7:c.C742T:p.R248W,ENSG00000141510:ENST00000455263:exon7:c.C742T:p.R248W	exonic	TP53	.	nonsynonymous SNV	TP53:uc002gii.2:exon3:c.C265T:p.R89W,TP53:uc010cnf.2:exon3:c.C265T:p.R89W,TP53:uc010cng.2:exon3:c.C265T:p.R89W,TP53:uc002gio.3:exon4:c.C346T:p.R116W,TP53:uc002gig.1:exon6:c.C742T:p.R248W,TP53:uc002gih.3:exon6:c.C742T:p.R248W,TP53:uc002gin.3:exon6:c.C463T:p.R155W,TP53:uc031qyq.1:exon6:c.C625T:p.R209W,TP53:uc002gij.3:exon7:c.C625T:p.R209W,TP53:uc002gim.3:exon7:c.C742T:p.R248W,TP53:uc010cnh.2:exon7:c.C742T:p.R248W,TP53:uc010cni.2:exon7:c.C742T:p.R248W	.	.	8.24e-06	0	0	0	0	1.498e-05	0	0	rs121912651	0.003	D	1.0	D	1.0	D	0.000	D	1.000	A	3.315	M	-7.34	D	-7.01	D	0.951	7.204	34	0.999	0.940	D	0.987	D	0.993	D	0.722	0	2.56	0.917	0.949	0.969	0.967	7.568	.	.	p53, DNA-binding domain;p53-like transcription factor, DNA-binding;p53/RUNT-type transcription factor, DNA-binding domain	Pathogenic|Pathogenic|other|Pathogenic	Li-Fraumeni_syndrome_1|Hereditary_cancer-predisposing_syndrome|Li-Fraumeni_syndrome|not_provided	RCV000013140.23|RCV000115735.5|RCV000168242.4|RCV000213057.2	MedGen:OMIM|MedGen:SNOMED_CT|MedGen:Orphanet:SNOMED_CT|MedGen	C1835398:151623|C0027672:699346009|C0085390:ORPHA524:428850001|CN221809	ID=COSM3388183,COSM120007,COSM120006,COSM10656,COSM120005,COSM1640831;OCCURENCE=61(breast),26(skin),9(biliary_tract),144(large_intestine),4(prostate),4(liver),2(kidney),11(pancreas),21(urinary_tract),31(ovary),4(soft_tissue),20(endometrium),20(lung),1(penis),4(thyroid),27(haematopoietic_and_lymphoid_tissue),1(pleura),1(cervix),28(stomach),33(central_nervous_system),45(oesophagus),1(vulva),1(bone),21(upper_aerodigestive_tract),1(NS)	MU17943	AML-US|2|161|0.01242,BRCA-UK|1|117|0.00855,BTCA-JP|1|239|0.00418,LUSC-US|1|178|0.00562,READ-US|3|80|0.03750,OV-US|2|88|0.02273,LGG-US|2|283|0.00707,STAD-US|1|289|0.00346,BRCA-US|6|955|0.00628,LUSC-KR|1|66|0.01515,UCEC-US|5|246|0.02033,COCA-CN|4|187|0.02139,ESAD-UK|2|119|0.01681,LIHC-US|1|188|0.00532,ESCA-CN|1|228|0.00439,GBM-US|3|268|0.01119,PRAD-CA|1|124|0.00806,PACA-CA|5|227|0.02203,BRCA-EU|3|560|0.00536,ORCA-IN|6|106|0.05660,PACA-AU|4|391|0.01023,SKCM-US|1|335|0.00299,MELA-AU|2|183|0.01093,COAD-US|5|216|0.02315	BRACA
17	7578406	7578406	C	T	exonic	TP53	.	nonsynonymous SNV	TP53:NM_001126115:exon1:c.G128A:p.R43H,TP53:NM_001126116:exon1:c.G128A:p.R43H,TP53:NM_001126117:exon1:c.G128A:p.R43H,TP53:NM_001276697:exon1:c.G47A:p.R16H,TP53:NM_001276698:exon1:c.G47A:p.R16H,TP53:NM_001276699:exon1:c.G47A:p.R16H,TP53:NM_001126118:exon4:c.G407A:p.R136H,TP53:NM_000546:exon5:c.G524A:p.R175H,TP53:NM_001126112:exon5:c.G524A:p.R175H,TP53:NM_001126113:exon5:c.G524A:p.R175H,TP53:NM_001126114:exon5:c.G524A:p.R175H,TP53:NM_001276695:exon5:c.G407A:p.R136H,TP53:NM_001276696:exon5:c.G407A:p.R136H,TP53:NM_001276760:exon5:c.G407A:p.R136H,TP53:NM_001276761:exon5:c.G407A:p.R136H	exonic	ENSG00000141510	.	nonsynonymous SNV	ENSG00000141510:ENST00000509690:exon2:c.G128A:p.R43H,ENSG00000141510:ENST00000359597:exon4:c.G524A:p.R175H,ENSG00000141510:ENST00000413465:exon4:c.G524A:p.R175H,ENSG00000141510:ENST00000514944:exon4:c.G245A:p.R82H,ENSG00000141510:ENST00000269305:exon5:c.G524A:p.R175H,ENSG00000141510:ENST00000420246:exon5:c.G524A:p.R175H,ENSG00000141510:ENST00000445888:exon5:c.G524A:p.R175H,ENSG00000141510:ENST00000455263:exon5:c.G524A:p.R175H	exonic	TP53	.	nonsynonymous SNV	TP53:uc002gii.2:exon1:c.G47A:p.R16H,TP53:uc010cnf.2:exon1:c.G47A:p.R16H,TP53:uc010cng.2:exon1:c.G47A:p.R16H,TP53:uc002gio.3:exon2:c.G128A:p.R43H,TP53:uc002gig.1:exon4:c.G524A:p.R175H,TP53:uc002gih.3:exon4:c.G524A:p.R175H,TP53:uc002gin.3:exon4:c.G245A:p.R82H,TP53:uc010vug.3:exon4:c.G407A:p.R136H,TP53:uc031qyq.1:exon4:c.G407A:p.R136H,TP53:uc002gij.3:exon5:c.G407A:p.R136H,TP53:uc002gim.3:exon5:c.G524A:p.R175H,TP53:uc010cnh.2:exon5:c.G524A:p.R175H,TP53:uc010cni.2:exon5:c.G524A:p.R175H	.	.	8.243e-06	0	0	0	0	1.499e-05	0	0	rs28934578	0.0	D	1.0	D	0.999	D	0.000	D	1	A	3.345	M	-7.55	D	-4.6	D	0.975	4.992	25.1	0.999	0.989	D	0.920	D	0.996	D	0.722	0	5.41	0.033	0.852	0.977	0.868	17.077	.	.	p53, DNA-binding domain;p53-like transcription factor, DNA-binding;p53/RUNT-type transcription factor, DNA-binding domain	other,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Hereditary_cancer-predisposing_syndrome,Li-Fraumeni_syndrome_1|Hereditary_cancer-predisposing_syndrome|Li-Fraumeni_syndrome|not_provided|Malignant_tumor_of_esophagus	RCV000161065.1,RCV000013173.21|RCV000131301.5|RCV000204931.2|RCV000213054.2|RCV000239398.1	MedGen:SNOMED_CT,MedGen:OMIM|MedGen:SNOMED_CT|MedGen:Orphanet:SNOMED_CT|MedGen|MedGen:OMIM:SNOMED_CT	C0027672:699346009,C1835398:151623|C0027672:699346009|C0085390:ORPHA524:428850001|CN221809|C0546837:133239:363402007	ID=COSM3355994,COSM1640851,COSM99024,COSM99023,COSM10648,COSM99914,COSM99022;OCCURENCE=4(skin),97(breast),9(biliary_tract),321(large_intestine),4(prostate),4(kidney),9(liver),22(pancreas),28(urinary_tract),1(adrenal_gland),65(ovary),1(soft_tissue),9(endometrium),2(salivary_gland),1(penis),18(lung),2(thyroid),35(haematopoietic_and_lymphoid_tissue),4(cervix),62(stomach),70(central_nervous_system),80(oesophagus),2(vulva),3(bone),51(upper_aerodigestive_tract)	MU7870	AML-US|1|161|0.00621,BTCA-JP|1|239|0.00418,READ-US|6|80|0.07500,LGG-US|3|283|0.01060,STAD-US|6|289|0.02076,BLCA-CN|2|103|0.01942,BRCA-US|18|955|0.01885,UCEC-US|2|246|0.00813,COCA-CN|8|187|0.04278,ESAD-UK|5|119|0.04202,ESCA-CN|5|228|0.02193,GBM-US|4|268|0.01493,PRAD-US|2|256|0.00781,PACA-CA|8|227|0.03524,BRCA-EU|11|560|0.01964,ORCA-IN|7|106|0.06604,PACA-AU|15|391|0.03836,OV-AU|3|93|0.03226,SKCM-US|1|335|0.00299,PBCA-DE|1|246|0.00407,COAD-US|15|216|0.06944,MELA-AU|1|183|0.00546	BRACA
17	7579472	7579472	G	C	exonic;exonic;exonic	TP53	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R;TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R;TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R	exonic;exonic;exonic	ENSG00000141510	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R;ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R;ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R	exonic;exonic;exonic	TP53	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R;TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R;TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R	0.6300	0.542931	0.6600	0.3842	0.7115	0.5892	0.7304	0.7345	0.6648	0.4988	rs1042522	0.642	T	0.745	P	0.372	B	0.371	U	1	P	0	N	-2.05	D	-0.19	N	0.267	-0.415	0.355	0.570	0.361	N	-0.929	T	0.000	T	0.722	0	1.87	0.518	1.045	0.001	0.001	9.773	.	.	.	Benign,Benign|Benign|Benign|Benign|Uncertain significance|drug response|drug response|drug response|drug response|drug response,Uncertain significance|Uncertain significance	not_specified,CODON_72_POLYMORPHISM,_(rs1042522)|not_provided|not_specified|Hereditary_cancer-predisposing_syndrome|Li-Fraumeni_syndrome_1|paclitaxel_response_-_Efficacy,_Toxicity/ADR|cyclophosphamide_response_-_Efficacy,_Toxicity/ADR|antineoplastic_agents_response_-_Efficacy,_Toxicity/ADR|fluorouracil_response_-_Efficacy,_Toxicity/ADR|cisplatin_response_-_Efficacy,_Toxicity/ADR,Hereditary_cancer-predisposing_syndrome|Li-Fraumeni_syndrome	RCV000152112.1,RCV000013144.3|RCV000034639.1|RCV000079202.6|RCV000132165.3|RCV000144668.1|RCV000211157.1|RCV000211212.1|RCV000211311.1|RCV000211338.1|RCV000211395.1,RCV000164487.1|RCV000227427.1	MedGen,.|MedGen|MedGen|MedGen:SNOMED_CT|MedGen:OMIM|MedGen|MedGen|MedGen|MedGen|MedGen,MedGen:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	CN169374,.|CN221809|CN169374|C0027672:699346009|C1835398:151623|CN236572|CN236518|CN236462|CN236554|CN236501,C0027672:699346009|C0085390:ORPHA524:428850001	ID=COSM250061;OCCURENCE=1(central_nervous_system),2(upper_aerodigestive_tract),1(urinary_tract),1(liver)	MU3888541	COCA-CN|1|187|0.00535,STAD-US|1|289|0.00346,BLCA-US|1|130|0.00769	BRACA
17	7579472	7579472	G	C	exonic;exonic;exonic	TP53	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R;TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R;TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R	exonic;exonic;exonic	ENSG00000141510	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R;ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R;ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R	exonic;exonic;exonic	TP53	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R;TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R;TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R	0.6300	0.542931	0.6600	0.3842	0.7115	0.5892	0.7304	0.7345	0.6648	0.4988	rs1042522	0.642	T	0.745	P	0.372	B	0.371	U	1	P	0	N	-2.05	D	-0.19	N	0.267	-0.415	0.355	0.570	0.361	N	-0.929	T	0.000	T	0.722	0	1.87	0.518	1.045	0.001	0.001	9.773	.	.	.	Benign,Benign|Benign|Benign|Benign|Uncertain significance|drug response|drug response|drug response|drug response|drug response,Uncertain significance|Uncertain significance	not_specified,CODON_72_POLYMORPHISM,_(rs1042522)|not_provided|not_specified|Hereditary_cancer-predisposing_syndrome|Li-Fraumeni_syndrome_1|paclitaxel_response_-_Efficacy,_Toxicity/ADR|cyclophosphamide_response_-_Efficacy,_Toxicity/ADR|antineoplastic_agents_response_-_Efficacy,_Toxicity/ADR|fluorouracil_response_-_Efficacy,_Toxicity/ADR|cisplatin_response_-_Efficacy,_Toxicity/ADR,Hereditary_cancer-predisposing_syndrome|Li-Fraumeni_syndrome	RCV000152112.1,RCV000013144.3|RCV000034639.1|RCV000079202.6|RCV000132165.3|RCV000144668.1|RCV000211157.1|RCV000211212.1|RCV000211311.1|RCV000211338.1|RCV000211395.1,RCV000164487.1|RCV000227427.1	MedGen,.|MedGen|MedGen|MedGen:SNOMED_CT|MedGen:OMIM|MedGen|MedGen|MedGen|MedGen|MedGen,MedGen:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	CN169374,.|CN221809|CN169374|C0027672:699346009|C1835398:151623|CN236572|CN236518|CN236462|CN236554|CN236501,C0027672:699346009|C0085390:ORPHA524:428850001	ID=COSM250061;OCCURENCE=1(central_nervous_system),2(upper_aerodigestive_tract),1(urinary_tract),1(liver)	MU3888541	COCA-CN|1|187|0.00535,STAD-US|1|289|0.00346,BLCA-US|1|130|0.00769	CER
17	7579472	7579472	G	C	exonic;exonic;exonic	TP53	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R;TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R;TP53:NM_001126118:exon3:c.C98G:p.P33R,TP53:NM_000546:exon4:c.C215G:p.P72R,TP53:NM_001126112:exon4:c.C215G:p.P72R,TP53:NM_001126113:exon4:c.C215G:p.P72R,TP53:NM_001126114:exon4:c.C215G:p.P72R,TP53:NM_001276695:exon4:c.C98G:p.P33R,TP53:NM_001276696:exon4:c.C98G:p.P33R,TP53:NM_001276760:exon4:c.C98G:p.P33R,TP53:NM_001276761:exon4:c.C98G:p.P33R	exonic;exonic;exonic	ENSG00000141510	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R;ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R;ENSG00000141510:ENST00000359597:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000413465:exon3:c.C215G:p.P72R,ENSG00000141510:ENST00000269305:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000420246:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000445888:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000455263:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000508793:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000604348:exon4:c.C215G:p.P72R,ENSG00000141510:ENST00000503591:exon5:c.C215G:p.P72R	exonic;exonic;exonic	TP53	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R;TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R;TP53:uc002gig.1:exon3:c.C215G:p.P72R,TP53:uc002gih.3:exon3:c.C215G:p.P72R,TP53:uc010vug.3:exon3:c.C98G:p.P33R,TP53:uc031qyq.1:exon3:c.C98G:p.P33R,TP53:uc002gij.3:exon4:c.C98G:p.P33R,TP53:uc002gim.3:exon4:c.C215G:p.P72R,TP53:uc010cnh.2:exon4:c.C215G:p.P72R,TP53:uc010cni.2:exon4:c.C215G:p.P72R,TP53:uc010cnk.2:exon5:c.C260G:p.P87R	0.6300	0.542931	0.6600	0.3842	0.7115	0.5892	0.7304	0.7345	0.6648	0.4988	rs1042522	0.642	T	0.745	P	0.372	B	0.371	U	1	P	0	N	-2.05	D	-0.19	N	0.267	-0.415	0.355	0.570	0.361	N	-0.929	T	0.000	T	0.722	0	1.87	0.518	1.045	0.001	0.001	9.773	.	.	.	Benign,Benign|Benign|Benign|Benign|Uncertain significance|drug response|drug response|drug response|drug response|drug response,Uncertain significance|Uncertain significance	not_specified,CODON_72_POLYMORPHISM,_(rs1042522)|not_provided|not_specified|Hereditary_cancer-predisposing_syndrome|Li-Fraumeni_syndrome_1|paclitaxel_response_-_Efficacy,_Toxicity/ADR|cyclophosphamide_response_-_Efficacy,_Toxicity/ADR|antineoplastic_agents_response_-_Efficacy,_Toxicity/ADR|fluorouracil_response_-_Efficacy,_Toxicity/ADR|cisplatin_response_-_Efficacy,_Toxicity/ADR,Hereditary_cancer-predisposing_syndrome|Li-Fraumeni_syndrome	RCV000152112.1,RCV000013144.3|RCV000034639.1|RCV000079202.6|RCV000132165.3|RCV000144668.1|RCV000211157.1|RCV000211212.1|RCV000211311.1|RCV000211338.1|RCV000211395.1,RCV000164487.1|RCV000227427.1	MedGen,.|MedGen|MedGen|MedGen:SNOMED_CT|MedGen:OMIM|MedGen|MedGen|MedGen|MedGen|MedGen,MedGen:SNOMED_CT|MedGen:Orphanet:SNOMED_CT	CN169374,.|CN221809|CN169374|C0027672:699346009|C1835398:151623|CN236572|CN236518|CN236462|CN236554|CN236501,C0027672:699346009|C0085390:ORPHA524:428850001	ID=COSM250061;OCCURENCE=1(central_nervous_system),2(upper_aerodigestive_tract),1(urinary_tract),1(liver)	MU3888541	COCA-CN|1|187|0.00535,STAD-US|1|289|0.00346,BLCA-US|1|130|0.00769	L
17	7579548	7579548	G	A	exonic	TP53	.	nonsynonymous SNV	TP53:NM_001126118:exon3:c.C22T:p.P8S,TP53:NM_000546:exon4:c.C139T:p.P47S,TP53:NM_001126112:exon4:c.C139T:p.P47S,TP53:NM_001126113:exon4:c.C139T:p.P47S,TP53:NM_001126114:exon4:c.C139T:p.P47S,TP53:NM_001276695:exon4:c.C22T:p.P8S,TP53:NM_001276696:exon4:c.C22T:p.P8S,TP53:NM_001276760:exon4:c.C22T:p.P8S,TP53:NM_001276761:exon4:c.C22T:p.P8S	exonic	ENSG00000141510	.	nonsynonymous SNV	ENSG00000141510:ENST00000359597:exon3:c.C139T:p.P47S,ENSG00000141510:ENST00000413465:exon3:c.C139T:p.P47S,ENSG00000141510:ENST00000269305:exon4:c.C139T:p.P47S,ENSG00000141510:ENST00000420246:exon4:c.C139T:p.P47S,ENSG00000141510:ENST00000445888:exon4:c.C139T:p.P47S,ENSG00000141510:ENST00000455263:exon4:c.C139T:p.P47S,ENSG00000141510:ENST00000508793:exon4:c.C139T:p.P47S,ENSG00000141510:ENST00000604348:exon4:c.C139T:p.P47S,ENSG00000141510:ENST00000503591:exon5:c.C139T:p.P47S	exonic	TP53	.	nonsynonymous SNV	TP53:uc002gig.1:exon3:c.C139T:p.P47S,TP53:uc002gih.3:exon3:c.C139T:p.P47S,TP53:uc010vug.3:exon3:c.C22T:p.P8S,TP53:uc031qyq.1:exon3:c.C22T:p.P8S,TP53:uc002gij.3:exon4:c.C22T:p.P8S,TP53:uc002gim.3:exon4:c.C139T:p.P47S,TP53:uc010cnh.2:exon4:c.C139T:p.P47S,TP53:uc010cni.2:exon4:c.C139T:p.P47S,TP53:uc010cnk.2:exon5:c.C184T:p.P62S	0.0052	0.00559105	0.0017	0.0184	0.0014	0	0	3.001e-05	0	6.063e-05	rs1800371	0.232	T	0.017	B	0.01	B	0.000	N	1	N	0.805	L	-2.3	D	0.44	N	0.231	-1.738	0.002	0.429	0.020	N	0.794	D	0.730	D	0.722	0	-7.9	-0.283	-1.085	0.000	0.000	1.861	.	.	p53 transactivation domain	other|Benign|Benign|Benign	not_specified|Hereditary_cancer-predisposing_syndrome|Li-Fraumeni_syndrome_1|Li-Fraumeni_syndrome	RCV000036530.4|RCV000131567.4|RCV000172826.1|RCV000203736.2	MedGen|MedGen:SNOMED_CT|MedGen:OMIM|MedGen:Orphanet:SNOMED_CT	CN169374|C0027672:699346009|C1835398:151623|C0085390:ORPHA524:428850001	.	.	.	CANCER
1	8073509	8073509	C	A	exonic	ERRFI1	.	stopgain	ERRFI1:NM_018948:exon4:c.G1150T:p.E384X	exonic	ENSG00000116285	.	stopgain	ENSG00000116285:ENST00000377482:exon4:c.G1150T:p.E384X	exonic	ERRFI1	.	stopgain	ERRFI1:uc001apa.1:exon2:c.G925T:p.E309X,ERRFI1:uc001aoz.3:exon4:c.G1150T:p.E384X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.000	D	1	D	.	.	.	.	.	.	.	13.509	42	0.997	0.930	D	.	.	.	.	0.707	0	5.9	0.871	0.935	1.000	1.000	19.267	.	.	.	.	.	.	.	.	ID=COSM912447;OCCURENCE=1(endometrium)	MU1957973	UCEC-US|1|246|0.00407	CH
18	42531913	42531913	G	A	exonic	SETBP1	.	nonsynonymous SNV	SETBP1:NM_015559:exon4:c.G2608A:p.G870S	exonic	ENSG00000152217	.	nonsynonymous SNV	ENSG00000152217:ENST00000282030:exon4:c.G2608A:p.G870S	exonic	SETBP1	.	nonsynonymous SNV	SETBP1:uc010dni.3:exon4:c.G2608A:p.G870S	.	.	1.657e-05	0	0	0	0	3.02e-05	0	0	rs267607040	0.0	D	1.0	D	1.0	D	0.000	D	1.000	D	1.04	L	-2.68	D	-5.7	D	0.992	6.014	27.9	0.998	0.993	D	0.675	D	0.789	D	0.563	0	6.17	0.917	1.048	1.000	0.942	20.879	.	.	.	Pathogenic	Schinzel-Giedion_syndrome	RCV000001090.3	MedGen:OMIM:SNOMED_CT	C1849294:269150:18899000	ID=COSM1234973;OCCURENCE=29(haematopoietic_and_lymphoid_tissue)	.	.	CML
19	1220489	1220489	C	A	exonic	STK11	.	nonsynonymous SNV	STK11:NM_000455:exon4:c.C582A:p.D194E	exonic	ENSG00000118046	.	nonsynonymous SNV	ENSG00000118046:ENST00000585851:exon2:c.C408A:p.D136E,ENSG00000118046:ENST00000326873:exon4:c.C582A:p.D194E	exonic	STK11	.	nonsynonymous SNV	STK11:uc002lrl.1:exon4:c.C582A:p.D194E	.	.	.	.	.	.	.	.	.	.	rs786202134	0.0	D	1.0	D	1.0	D	0.000	D	1	D	4.165	H	-3.13	D	-4.0	D	0.977	5.739	26.9	0.997	0.899	D	0.997	D	0.911	D	0.713	0	4.52	0.033	0.935	0.922	0.988	10.877	.	.	Protein kinase domain;Protein kinase-like domain;Serine/threonine/dual specificity protein kinase, catalytic  domain	Likely pathogenic	Hereditary_cancer-predisposing_syndrome	RCV000164794.1	MedGen:SNOMED_CT	C0027672:699346009	.	.	.	PA
19	44055726	44055726	T	C	exonic;exonic	XRCC1	.	nonsynonymous SNV;nonsynonymous SNV	XRCC1:NM_006297:exon10:c.A1196G:p.Q399R;XRCC1:NM_006297:exon10:c.A1196G:p.Q399R	exonic;exonic	ENSG00000073050	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000073050:ENST00000543982:exon9:c.A1103G:p.Q368R,ENSG00000073050:ENST00000262887:exon10:c.A1196G:p.Q399R;ENSG00000073050:ENST00000543982:exon9:c.A1103G:p.Q368R,ENSG00000073050:ENST00000262887:exon10:c.A1196G:p.Q399R	exonic;exonic	XRCC1	.	nonsynonymous SNV;nonsynonymous SNV	XRCC1:uc010xwp.1:exon9:c.A1103G:p.Q368R,XRCC1:uc002owt.2:exon10:c.A1196G:p.Q399R;XRCC1:uc010xwp.1:exon9:c.A1103G:p.Q368R,XRCC1:uc002owt.2:exon10:c.A1196G:p.Q399R	0.7092	0.739617	0.6834	0.8565	0.7491	0.7421	0.6836	0.6458	0.6748	0.6500	rs25487	1.0	T	0.0	B	0.0	B	0.000	N	1.000	P	.	.	2.85	T	2.1	N	0.033	0.745	9.117	0.127	0.408	N	-0.976	T	0.000	T	0.707	0	4.13	-0.203	0.069	0.892	0.976	7.732	.	.	BRCT domain	drug response|drug response|drug response|drug response|drug response	carboplatin_response_-_Efficacy,_Toxicity/ADR|platinum_response_-_Efficacy,_Toxicity/ADR|Platinum_compounds_response_-_Efficacy,_Toxicity/ADR|cisplatin_response_-_Efficacy,_Toxicity/ADR|oxaliplatin_response_-_Efficacy,_Toxicity/ADR	RCV000211186.1|RCV000211213.1|RCV000211303.1|RCV000211309.1|RCV000211393.1	MedGen|MedGen|MedGen|MedGen|MedGen	CN236496|CN236574|CN236513|CN236501|CN236570	.	MU71535	COAD-US|1|216|0.00463	CER
19	44055726	44055726	T	C	exonic;exonic	XRCC1	.	nonsynonymous SNV;nonsynonymous SNV	XRCC1:NM_006297:exon10:c.A1196G:p.Q399R;XRCC1:NM_006297:exon10:c.A1196G:p.Q399R	exonic;exonic	ENSG00000073050	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000073050:ENST00000543982:exon9:c.A1103G:p.Q368R,ENSG00000073050:ENST00000262887:exon10:c.A1196G:p.Q399R;ENSG00000073050:ENST00000543982:exon9:c.A1103G:p.Q368R,ENSG00000073050:ENST00000262887:exon10:c.A1196G:p.Q399R	exonic;exonic	XRCC1	.	nonsynonymous SNV;nonsynonymous SNV	XRCC1:uc010xwp.1:exon9:c.A1103G:p.Q368R,XRCC1:uc002owt.2:exon10:c.A1196G:p.Q399R;XRCC1:uc010xwp.1:exon9:c.A1103G:p.Q368R,XRCC1:uc002owt.2:exon10:c.A1196G:p.Q399R	0.7092	0.739617	0.6834	0.8565	0.7491	0.7421	0.6836	0.6458	0.6748	0.6500	rs25487	1.0	T	0.0	B	0.0	B	0.000	N	1.000	P	.	.	2.85	T	2.1	N	0.033	0.745	9.117	0.127	0.408	N	-0.976	T	0.000	T	0.707	0	4.13	-0.203	0.069	0.892	0.976	7.732	.	.	BRCT domain	drug response|drug response|drug response|drug response|drug response	carboplatin_response_-_Efficacy,_Toxicity/ADR|platinum_response_-_Efficacy,_Toxicity/ADR|Platinum_compounds_response_-_Efficacy,_Toxicity/ADR|cisplatin_response_-_Efficacy,_Toxicity/ADR|oxaliplatin_response_-_Efficacy,_Toxicity/ADR	RCV000211186.1|RCV000211213.1|RCV000211303.1|RCV000211309.1|RCV000211393.1	MedGen|MedGen|MedGen|MedGen|MedGen	CN236496|CN236574|CN236513|CN236501|CN236570	.	MU71535	COAD-US|1|216|0.00463	NSCLC
19	44057574	44057574	G	A	exonic	XRCC1	.	nonsynonymous SNV	XRCC1:NM_006297:exon6:c.C580T:p.R194W	exonic	ENSG00000073050	.	nonsynonymous SNV	ENSG00000073050:ENST00000543982:exon5:c.C487T:p.R163W,ENSG00000073050:ENST00000594107:exon5:c.C469T:p.R157W,ENSG00000073050:ENST00000262887:exon6:c.C580T:p.R194W,ENSG00000073050:ENST00000598165:exon6:c.C601T:p.R201W	exonic	XRCC1	.	nonsynonymous SNV	XRCC1:uc010xwp.1:exon5:c.C487T:p.R163W,XRCC1:uc002owt.2:exon6:c.C580T:p.R194W	0.0617	0.123802	0.0928	0.0613	0.1656	0.3074	0.0343	0.0631	0.0828	0.0932	rs1799782	0.001	D	1.0	D	0.899	P	0.000	D	0.000	P	2.215	M	3.83	T	-3.68	D	0.451	6.753	32	0.999	0.793	D	-0.959	T	0.000	T	0.707	0	1.03	0.630	1.048	0.905	0.997	6.643	.	.	.	.	.	.	.	.	.	MU147607	LAML-KR|1|107|0.00935,COAD-US|1|216|0.00463	NSCLC
19	45854919	45854919	T	G	exonic;exonic	ERCC2	.	nonsynonymous SNV;nonsynonymous SNV	ERCC2:NM_000400:exon23:c.A2251C:p.K751Q;ERCC2:NM_000400:exon23:c.A2251C:p.K751Q	exonic;exonic	ENSG00000104884	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000104884:ENST00000391944:exon21:c.A2017C:p.K673Q,ENSG00000104884:ENST00000391945:exon23:c.A2251C:p.K751Q;ENSG00000104884:ENST00000391944:exon21:c.A2017C:p.K673Q,ENSG00000104884:ENST00000391945:exon23:c.A2251C:p.K751Q	exonic;exonic	ERCC2	.	nonsynonymous SNV;nonsynonymous SNV	ERCC2:uc002pbh.2:exon10:c.A940C:p.K314Q,ERCC2:uc002pbi.2:exon12:c.A1330C:p.K444Q,ERCC2:uc010ejz.2:exon21:c.A2017C:p.K673Q,ERCC2:uc002pbj.2:exon23:c.A2251C:p.K751Q;ERCC2:uc002pbh.2:exon10:c.A940C:p.K314Q,ERCC2:uc002pbi.2:exon12:c.A1330C:p.K444Q,ERCC2:uc010ejz.2:exon21:c.A2017C:p.K673Q,ERCC2:uc002pbj.2:exon23:c.A2251C:p.K751Q	0.3260	0.236621	0.3308	0.2262	0.1870	0.0757	0.4133	0.3865	0.3	0.3738	rs13181	0.59	T	0.0	B	0.001	B	0.200	N	1	P	0.62	N	-1.42	T	-0.62	N	0.075	0.982	10.56	0.632	0.024	N	-1.087	T	0.000	T	0.707	0	4.29	0.028	0.127	0.199	0.068	11.392	.	.	.	Benign	not_specified	RCV000120777.2	MedGen	CN169374	.	MU4549012	THCA-SA|1|15|0.06667	NSCLC
19	45854919	45854919	T	G	exonic;exonic	ERCC2	.	nonsynonymous SNV;nonsynonymous SNV	ERCC2:NM_000400:exon23:c.A2251C:p.K751Q;ERCC2:NM_000400:exon23:c.A2251C:p.K751Q	exonic;exonic	ENSG00000104884	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000104884:ENST00000391944:exon21:c.A2017C:p.K673Q,ENSG00000104884:ENST00000391945:exon23:c.A2251C:p.K751Q;ENSG00000104884:ENST00000391944:exon21:c.A2017C:p.K673Q,ENSG00000104884:ENST00000391945:exon23:c.A2251C:p.K751Q	exonic;exonic	ERCC2	.	nonsynonymous SNV;nonsynonymous SNV	ERCC2:uc002pbh.2:exon10:c.A940C:p.K314Q,ERCC2:uc002pbi.2:exon12:c.A1330C:p.K444Q,ERCC2:uc010ejz.2:exon21:c.A2017C:p.K673Q,ERCC2:uc002pbj.2:exon23:c.A2251C:p.K751Q;ERCC2:uc002pbh.2:exon10:c.A940C:p.K314Q,ERCC2:uc002pbi.2:exon12:c.A1330C:p.K444Q,ERCC2:uc010ejz.2:exon21:c.A2017C:p.K673Q,ERCC2:uc002pbj.2:exon23:c.A2251C:p.K751Q	0.3260	0.236621	0.3308	0.2262	0.1870	0.0757	0.4133	0.3865	0.3	0.3738	rs13181	0.59	T	0.0	B	0.001	B	0.200	N	1	P	0.62	N	-1.42	T	-0.62	N	0.075	0.982	10.56	0.632	0.024	N	-1.087	T	0.000	T	0.707	0	4.29	0.028	0.127	0.199	0.068	11.392	.	.	.	Benign	not_specified	RCV000120777.2	MedGen	CN169374	.	MU4549012	THCA-SA|1|15|0.06667	OS
19	49377242	49377242	G	C	exonic	PPP1R15A	.	nonsynonymous SNV	PPP1R15A:NM_014330:exon2:c.G752C:p.R251P	exonic	ENSG00000087074	.	nonsynonymous SNV	ENSG00000087074:ENST00000200453:exon2:c.G752C:p.R251P	exonic	PPP1R15A	.	nonsynonymous SNV	PPP1R15A:uc002pky.4:exon2:c.G752C:p.R251P	0.3103	0.347843	0.2108	0.6720	0.2050	0.0995	0.1594	0.1457	0.1927	0.2669	rs557806	0.467	T	0.0	B	0.0	B	0.014	N	1	P	-1.59	N	3.49	T	0.48	N	0.005	0.443	6.982	0.431	0.004	N	-0.939	T	0.000	T	0.722	0	1.24	-1.852	-0.829	0.009	0.000	11.307	.	.	.	.	.	.	.	.	.	MU147514	SKCA-BR|1|66|0.01515,COAD-US|1|216|0.00463,THCA-SA|1|15|0.06667	COREAD
1	97915614	97915614	C	T	splicing	DPYD	NM_000110:exon14:c.1905+1G>A	.	.	splicing	ENSG00000188641	ENST00000370192:exon14:c.1905+1G>A	.	.	splicing	DPYD	uc001drv.3:exon14:c.1905+1G>A	.	.	0.0042	0.00299521	0.0052	0.0007	0.0007	0	0.0221	0.0058	0.0066	0.0047	rs3918290	.	.	.	.	.	.	.	.	1	D	.	.	.	.	.	.	.	4.038	23.7	0.991	0.976	D	.	.	.	.	0.165	0	5.31	0.871	0.892	0.997	0.979	18.986	0.9999	0.946	.	Pathogenic|Pathogenic|not provided|Uncertain significance|drug response|drug response|drug response|drug response	Dihydropyrimidine_dehydrogenase_deficiency|Fluorouracil_response|not_provided|Hirschsprung_disease_1|Pyrimidine_analogues_response_-_Toxicity/ADR|capecitabine_response_-_Toxicity/ADR|tegafur_response_-_Toxicity/ADR|fluorouracil_response_-_Toxicity/ADR	RCV000000460.2|RCV000030868.2|RCV000086468.1|RCV000201291.1|RCV000211222.1|RCV000211317.1|RCV000211354.1|RCV000211404.1	MedGen:OMIM|MedGen|MedGen|MedGen:OMIM|MedGen|MedGen|MedGen|MedGen	C2720286:274270|CN077983|CN221809|C2931876:142623|CN236468|CN236492|CN236622|CN236593	.	.	.	CANCER
19	7975157	7975157	G	A	exonic	MAP2K7	.	nonsynonymous SNV	MAP2K7:NM_001297556:exon4:c.G346A:p.E116K,MAP2K7:NM_145185:exon4:c.G346A:p.E116K,MAP2K7:NM_001297555:exon5:c.G394A:p.E132K	exonic	ENSG00000076984	.	nonsynonymous SNV	ENSG00000076984:ENST00000397979:exon4:c.G346A:p.E116K,ENSG00000076984:ENST00000397981:exon4:c.G346A:p.E116K,ENSG00000076984:ENST00000545011:exon4:c.G472A:p.E158K,ENSG00000076984:ENST00000397983:exon5:c.G394A:p.E132K	exonic	MAP2K7	.	nonsynonymous SNV	MAP2K7:uc002mit.3:exon4:c.G346A:p.E116K,MAP2K7:uc002miv.2:exon4:c.G346A:p.E116K,MAP2K7:uc010xkb.2:exon4:c.G346A:p.E116K	.	.	.	.	.	.	.	.	.	.	rs28395770	0.509	T	0.005	B	0.012	B	0.000	D	1	D	0.895	L	2.6	T	-2.45	N	0.629	2.891	21.8	0.998	0.976	D	-1.048	T	0.028	T	0.707	0	5.31	0.917	1.048	1.000	1.000	16.461	.	.	Protein kinase domain;Protein kinase-like domain;Serine/threonine/dual specificity protein kinase, catalytic  domain	.	.	.	.	.	.	.	.	L
1	97981343	97981343	A	C	exonic	DPYD	.	nonsynonymous SNV	DPYD:NM_000110:exon13:c.T1679G:p.I560S	exonic	ENSG00000188641	.	nonsynonymous SNV	ENSG00000188641:ENST00000370192:exon13:c.T1679G:p.I560S	exonic	DPYD	.	nonsynonymous SNV	DPYD:uc001drv.3:exon13:c.T1679G:p.I560S	0.0004	0.000199681	0.0003	0	0	0	0	0.0006	0.0011	0	rs55886062	0.0	D	0.999	D	0.99	D	0.000	D	1	D	1.77	L	-0.89	T	-5.13	D	0.968	6.560	31	0.996	0.992	D	-0.024	T	0.452	T	0.638	0	5.2	1.062	1.140	1.000	1.000	15.355	.	.	Aldolase-type TIM barrel;Dihydroorotate dehydrogenase domain	Pathogenic|drug response|drug response|drug response|drug response	not_provided|fluorouracil_response_-_Toxicity/ADR|Pyrimidine_analogues_response_-_Toxicity/ADR|capecitabine_response_-_Toxicity/ADR|tegafur_response_-_Toxicity/ADR	RCV000086474.2|RCV000211143.1|RCV000211265.1|RCV000211360.1|RCV000211391.1	MedGen|MedGen|MedGen|MedGen|MedGen	CN221809|CN236593|CN236468|CN236492|CN236622	.	.	.	CANCER
21	40191638	40191638	A	G	exonic	ETS2	.	synonymous SNV	ETS2:NM_005239:exon8:c.A1023G:p.P341P,ETS2:NM_001256295:exon9:c.A1443G:p.P481P	exonic	ENSG00000157557	.	synonymous SNV	ENSG00000157557:ENST00000360938:exon8:c.A1023G:p.P341P,ENSG00000157557:ENST00000360214:exon9:c.A1023G:p.P341P	exonic	ETS2	.	synonymous SNV	ETS2:uc002yxg.4:exon8:c.A1023G:p.P341P,ETS2:uc002yxf.3:exon9:c.A1443G:p.P481P	0.7706	0.580671	0.7228	0.6045	0.5486	0.4590	0.7553	0.8510	0.7466	0.5216	rs461155	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	NSCLC
21	44514777	44514777	T	G	exonic;exonic	U2AF1	.	nonsynonymous SNV;nonsynonymous SNV	U2AF1:NM_001025203:exon6:c.A470C:p.Q157P,U2AF1:NM_006758:exon6:c.A470C:p.Q157P,U2AF1:NM_001025204:exon7:c.A251C:p.Q84P;U2AF1:NM_001025203:exon6:c.A470C:p.Q157P,U2AF1:NM_006758:exon6:c.A470C:p.Q157P,U2AF1:NM_001025204:exon7:c.A251C:p.Q84P	exonic;exonic	ENSG00000160201	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000160201:ENST00000459639:exon5:c.A251C:p.Q84P,ENSG00000160201:ENST00000291552:exon6:c.A470C:p.Q157P,ENSG00000160201:ENST00000380276:exon6:c.A470C:p.Q157P,ENSG00000160201:ENST00000398137:exon7:c.A251C:p.Q84P;ENSG00000160201:ENST00000459639:exon5:c.A251C:p.Q84P,ENSG00000160201:ENST00000291552:exon6:c.A470C:p.Q157P,ENSG00000160201:ENST00000380276:exon6:c.A470C:p.Q157P,ENSG00000160201:ENST00000398137:exon7:c.A251C:p.Q84P	exonic;exonic	U2AF1	.	nonsynonymous SNV;nonsynonymous SNV	U2AF1:uc002zcy.1:exon5:c.A251C:p.Q84P,U2AF1:uc002zda.1:exon6:c.A470C:p.Q157P,U2AF1:uc002zdb.1:exon6:c.A470C:p.Q157P,U2AF1:uc010gpi.1:exon6:c.A470C:p.Q157P,U2AF1:uc002zcz.1:exon7:c.A251C:p.Q84P;U2AF1:uc002zcy.1:exon5:c.A251C:p.Q84P,U2AF1:uc002zda.1:exon6:c.A470C:p.Q157P,U2AF1:uc002zdb.1:exon6:c.A470C:p.Q157P,U2AF1:uc010gpi.1:exon6:c.A470C:p.Q157P,U2AF1:uc002zcz.1:exon7:c.A251C:p.Q84P	.	.	3.306e-05	0	0	0.0001	0	4.515e-05	0	0	rs371246226	0.002	D	0.701	P	0.737	P	0.000	D	1	D	3.495	M	0.95	T	-5.47	D	0.944	6.233	28.8	0.994	0.982	D	-0.258	T	0.311	T	0.672	0	5.01	0.991	1.056	0.999	0.992	15.010	.	.	Nucleotide-binding alpha-beta plait domain;RNA recognition motif domain;Zinc finger, CCCH-type	.	.	.	.	.	ID=COSM1318797,COSM211534;OCCURENCE=15(haematopoietic_and_lymphoid_tissue)	.	.	AML
21	44514777	44514777	T	G	exonic;exonic	U2AF1	.	nonsynonymous SNV;nonsynonymous SNV	U2AF1:NM_001025203:exon6:c.A470C:p.Q157P,U2AF1:NM_006758:exon6:c.A470C:p.Q157P,U2AF1:NM_001025204:exon7:c.A251C:p.Q84P;U2AF1:NM_001025203:exon6:c.A470C:p.Q157P,U2AF1:NM_006758:exon6:c.A470C:p.Q157P,U2AF1:NM_001025204:exon7:c.A251C:p.Q84P	exonic;exonic	ENSG00000160201	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000160201:ENST00000459639:exon5:c.A251C:p.Q84P,ENSG00000160201:ENST00000291552:exon6:c.A470C:p.Q157P,ENSG00000160201:ENST00000380276:exon6:c.A470C:p.Q157P,ENSG00000160201:ENST00000398137:exon7:c.A251C:p.Q84P;ENSG00000160201:ENST00000459639:exon5:c.A251C:p.Q84P,ENSG00000160201:ENST00000291552:exon6:c.A470C:p.Q157P,ENSG00000160201:ENST00000380276:exon6:c.A470C:p.Q157P,ENSG00000160201:ENST00000398137:exon7:c.A251C:p.Q84P	exonic;exonic	U2AF1	.	nonsynonymous SNV;nonsynonymous SNV	U2AF1:uc002zcy.1:exon5:c.A251C:p.Q84P,U2AF1:uc002zda.1:exon6:c.A470C:p.Q157P,U2AF1:uc002zdb.1:exon6:c.A470C:p.Q157P,U2AF1:uc010gpi.1:exon6:c.A470C:p.Q157P,U2AF1:uc002zcz.1:exon7:c.A251C:p.Q84P;U2AF1:uc002zcy.1:exon5:c.A251C:p.Q84P,U2AF1:uc002zda.1:exon6:c.A470C:p.Q157P,U2AF1:uc002zdb.1:exon6:c.A470C:p.Q157P,U2AF1:uc010gpi.1:exon6:c.A470C:p.Q157P,U2AF1:uc002zcz.1:exon7:c.A251C:p.Q84P	.	.	3.306e-05	0	0	0.0001	0	4.515e-05	0	0	rs371246226	0.002	D	0.701	P	0.737	P	0.000	D	1	D	3.495	M	0.95	T	-5.47	D	0.944	6.233	28.8	0.994	0.982	D	-0.258	T	0.311	T	0.672	0	5.01	0.991	1.056	0.999	0.992	15.010	.	.	Nucleotide-binding alpha-beta plait domain;RNA recognition motif domain;Zinc finger, CCCH-type	.	.	.	.	.	ID=COSM1318797,COSM211534;OCCURENCE=15(haematopoietic_and_lymphoid_tissue)	.	.	MDS
21	44524456	44524456	G	A	exonic;exonic	U2AF1	.	nonsynonymous SNV;nonsynonymous SNV	U2AF1:NM_001025203:exon2:c.C101T:p.S34F,U2AF1:NM_006758:exon2:c.C101T:p.S34F;U2AF1:NM_001025203:exon2:c.C101T:p.S34F,U2AF1:NM_006758:exon2:c.C101T:p.S34F	exonic;exonic	ENSG00000160201	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000160201:ENST00000291552:exon2:c.C101T:p.S34F,ENSG00000160201:ENST00000380276:exon2:c.C101T:p.S34F,ENSG00000160201:ENST00000464750:exon2:c.C101T:p.S34F;ENSG00000160201:ENST00000291552:exon2:c.C101T:p.S34F,ENSG00000160201:ENST00000380276:exon2:c.C101T:p.S34F,ENSG00000160201:ENST00000464750:exon2:c.C101T:p.S34F	exonic;exonic	U2AF1	.	nonsynonymous SNV;nonsynonymous SNV	U2AF1:uc002zda.1:exon2:c.C101T:p.S34F,U2AF1:uc002zdb.1:exon2:c.C101T:p.S34F,U2AF1:uc002zdc.1:exon2:c.C101T:p.S34F,U2AF1:uc010gpi.1:exon2:c.C101T:p.S34F;U2AF1:uc002zda.1:exon2:c.C101T:p.S34F,U2AF1:uc002zdb.1:exon2:c.C101T:p.S34F,U2AF1:uc002zdc.1:exon2:c.C101T:p.S34F,U2AF1:uc010gpi.1:exon2:c.C101T:p.S34F	7.7e-05	.	4.213e-05	0	8.675e-05	0.0001	0	3.091e-05	0	6.169e-05	rs371769427	0.0	D	1.0	D	1.0	D	0.000	D	1	D	3.82	H	0.88	T	-5.64	D	0.87	6.826	32	0.999	0.981	D	0.082	D	0.410	T	0.722	0	5.47	0.917	1.044	1.000	1.000	19.317	.	.	Zinc finger, CCCH-type	.	.	.	.	.	ID=COSM166866,COSM1142948;OCCURENCE=3(urinary_tract),3(liver),4(pancreas),3(endometrium),14(lung),36(haematopoietic_and_lymphoid_tissue),1(stomach)	MU820754	BTCA-JP|1|239|0.00418,LINC-JP|1|244|0.00410,LAML-KR|1|107|0.00935,PACA-CA|2|227|0.00881,CESC-US|2|194|0.01031,PACA-AU|4|391|0.01023,BLCA-CN|1|103|0.00971,BLCA-US|1|130|0.00769,UCEC-US|2|246|0.00813,LIRI-JP|1|260|0.00385	AML
21	44524456	44524456	G	A	exonic;exonic	U2AF1	.	nonsynonymous SNV;nonsynonymous SNV	U2AF1:NM_001025203:exon2:c.C101T:p.S34F,U2AF1:NM_006758:exon2:c.C101T:p.S34F;U2AF1:NM_001025203:exon2:c.C101T:p.S34F,U2AF1:NM_006758:exon2:c.C101T:p.S34F	exonic;exonic	ENSG00000160201	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000160201:ENST00000291552:exon2:c.C101T:p.S34F,ENSG00000160201:ENST00000380276:exon2:c.C101T:p.S34F,ENSG00000160201:ENST00000464750:exon2:c.C101T:p.S34F;ENSG00000160201:ENST00000291552:exon2:c.C101T:p.S34F,ENSG00000160201:ENST00000380276:exon2:c.C101T:p.S34F,ENSG00000160201:ENST00000464750:exon2:c.C101T:p.S34F	exonic;exonic	U2AF1	.	nonsynonymous SNV;nonsynonymous SNV	U2AF1:uc002zda.1:exon2:c.C101T:p.S34F,U2AF1:uc002zdb.1:exon2:c.C101T:p.S34F,U2AF1:uc002zdc.1:exon2:c.C101T:p.S34F,U2AF1:uc010gpi.1:exon2:c.C101T:p.S34F;U2AF1:uc002zda.1:exon2:c.C101T:p.S34F,U2AF1:uc002zdb.1:exon2:c.C101T:p.S34F,U2AF1:uc002zdc.1:exon2:c.C101T:p.S34F,U2AF1:uc010gpi.1:exon2:c.C101T:p.S34F	7.7e-05	.	4.213e-05	0	8.675e-05	0.0001	0	3.091e-05	0	6.169e-05	rs371769427	0.0	D	1.0	D	1.0	D	0.000	D	1	D	3.82	H	0.88	T	-5.64	D	0.87	6.826	32	0.999	0.981	D	0.082	D	0.410	T	0.722	0	5.47	0.917	1.044	1.000	1.000	19.317	.	.	Zinc finger, CCCH-type	.	.	.	.	.	ID=COSM166866,COSM1142948;OCCURENCE=3(urinary_tract),3(liver),4(pancreas),3(endometrium),14(lung),36(haematopoietic_and_lymphoid_tissue),1(stomach)	MU820754	BTCA-JP|1|239|0.00418,LINC-JP|1|244|0.00410,LAML-KR|1|107|0.00935,PACA-CA|2|227|0.00881,CESC-US|2|194|0.01031,PACA-AU|4|391|0.01023,BLCA-CN|1|103|0.00971,BLCA-US|1|130|0.00769,UCEC-US|2|246|0.00813,LIRI-JP|1|260|0.00385	MDS
2	198266834	198266834	T	C	exonic	SF3B1	.	nonsynonymous SNV	SF3B1:NM_012433:exon15:c.A2098G:p.K700E	exonic	ENSG00000115524	.	nonsynonymous SNV	ENSG00000115524:ENST00000335508:exon15:c.A2098G:p.K700E	exonic	SF3B1	.	nonsynonymous SNV	SF3B1:uc002uue.3:exon15:c.A2098G:p.K700E	.	0.000199681	0.0002	0.0003	8.687e-05	0.0003	0	0.0003	0	0	rs559063155	0.004	D	1.0	D	0.999	D	0.000	D	1	D	3.68	H	-0.05	T	-3.91	D	0.874	6.029	28.0	0.999	0.988	D	0.399	D	0.574	D	0.672	0	6.02	0.991	1.061	1.000	1.000	16.542	.	.	Armadillo-like helical;Armadillo-type fold	.	.	.	.	.	ID=COSM84677;OCCURENCE=11(pancreas),1(eye),12(breast),235(haematopoietic_and_lymphoid_tissue),20(NS),1(central_nervous_system)	MU9178	ESAD-UK|1|119|0.00840,CMDI-UK|68|129|0.52713,BRCA-UK|4|117|0.03419,BTCA-JP|1|239|0.00418,PRAD-CA|1|124|0.00806,PACA-CA|4|227|0.01762,BRCA-EU|12|560|0.02143,CLLE-ES|7|218|0.03211,PACA-AU|4|391|0.01023,BRCA-US|8|955|0.00838,PRAD-UK|2|108|0.01852	BRACA
2	198267359	198267359	C	A	exonic	SF3B1	.	nonsynonymous SNV	SF3B1:NM_012433:exon14:c.G1998T:p.K666N	exonic	ENSG00000115524	.	nonsynonymous SNV	ENSG00000115524:ENST00000335508:exon14:c.G1998T:p.K666N	exonic	SF3B1	.	nonsynonymous SNV	SF3B1:uc002uue.3:exon14:c.G1998T:p.K666N	.	.	2.473e-05	0	0	0	0	4.497e-05	0	0	rs377023736	0.0	D	1.0	D	0.992	D	0.000	D	1	D	3.7	H	-0.17	T	-4.88	D	0.555	6.554	31	0.999	0.971	D	0.219	D	0.528	D	0.672	0	4.81	0.871	0.934	1.000	1.000	11.020	.	.	Armadillo-like helical;Armadillo-type fold	Pathogenic	Myelodysplastic_syndrome_progressed_to_acute_myeloid_leukemia	RCV000203465.1	MedGen	CN234857	ID=COSM131557;OCCURENCE=1(endometrium),13(haematopoietic_and_lymphoid_tissue),3(NS)	MU54890	CMDI-UK|5|129|0.03876,LAML-KR|1|107|0.00935,CLLE-ES|1|218|0.00459	BRACA
2	202149589	202149589	G	C	exonic	CASP8	.	nonsynonymous SNV	CASP8:NM_033356:exon7:c.G808C:p.D270H,CASP8:NM_001080124:exon8:c.G808C:p.D270H,CASP8:NM_001080125:exon8:c.G1030C:p.D344H,CASP8:NM_001228:exon9:c.G904C:p.D302H,CASP8:NM_033355:exon9:c.G853C:p.D285H	exonic	ENSG00000064012	.	nonsynonymous SNV	ENSG00000064012:ENST00000444430:exon2:c.G190C:p.D64H,ENSG00000064012:ENST00000264274:exon6:c.G601C:p.D201H,ENSG00000064012:ENST00000323492:exon7:c.G808C:p.D270H,ENSG00000064012:ENST00000358485:exon8:c.G1030C:p.D344H,ENSG00000064012:ENST00000392263:exon8:c.G808C:p.D270H,ENSG00000064012:ENST00000264275:exon9:c.G904C:p.D302H,ENSG00000064012:ENST00000432109:exon9:c.G853C:p.D285H	exonic	CASP8	.	nonsynonymous SNV	CASP8:uc010ftf.2:exon4:c.G601C:p.D201H,CASP8:uc002uxw.1:exon7:c.G808C:p.D270H,CASP8:uc002uxq.1:exon8:c.G808C:p.D270H,CASP8:uc002uxt.1:exon8:c.G1030C:p.D344H,CASP8:uc002uxp.1:exon9:c.G904C:p.D302H,CASP8:uc002uxr.1:exon9:c.G853C:p.D285H	0.1097	0.0527157	0.0907	0.0636	0.0505	0.0003	0.1018	0.1242	0.0991	0.0429	rs1045485	0.166	T	0.397	B	0.129	B	0.825	N	1	P	0.8	N	1.68	T	-0.88	N	0.131	-0.432	0.323	0.414	0.097	N	-1.006	T	0.000	T	0.661	0	-3.42	-1.711	-0.704	0.000	0.000	8.764	.	.	Caspase-like domain;Death-like domain;Peptidase C14, ICE, catalytic subunit p20;Peptidase C14, caspase domain;Peptidase C14A, caspase precursor p45, core	other	Breast_cancer,_protection_against	RCV000008203.3	MedGen	C4016759	.	MU154954	COAD-US|1|216|0.00463	NB
2	209113112	209113112	C	T	exonic	IDH1	.	nonsynonymous SNV	IDH1:NM_001282386:exon4:c.G395A:p.R132H,IDH1:NM_001282387:exon4:c.G395A:p.R132H,IDH1:NM_005896:exon4:c.G395A:p.R132H	exonic	ENSG00000138413	.	nonsynonymous SNV	ENSG00000138413:ENST00000415282:exon3:c.G395A:p.R132H,ENSG00000138413:ENST00000345146:exon4:c.G395A:p.R132H,ENSG00000138413:ENST00000415913:exon4:c.G395A:p.R132H,ENSG00000138413:ENST00000446179:exon4:c.G395A:p.R132H	exonic	IDH1	.	nonsynonymous SNV	IDH1:uc002vcs.3:exon4:c.G395A:p.R132H,IDH1:uc002vct.3:exon4:c.G395A:p.R132H,IDH1:uc002vcu.3:exon4:c.G395A:p.R132H	.	.	1.648e-05	0	0	0	0	2.997e-05	0	0	rs121913500	0.025	D	0.127	B	0.06	B	0.000	D	1	D	4.54	H	-2.19	D	-4.44	D	0.815	7.592	34	0.999	0.941	D	0.587	D	0.782	D	0.707	0	4.69	0.871	0.852	0.997	0.997	14.378	.	.	Isopropylmalate dehydrogenase-like domain	Pathogenic	Glioblastoma_multiforme,_somatic	RCV000144504.3	MedGen	C4016231	ID=COSM28746;OCCURENCE=1(salivary_gland),5(prostate),1(large_intestine),1(urinary_tract),1(skin),1(NS),39(bone),3497(central_nervous_system),214(haematopoietic_and_lymphoid_tissue),1(lung)	MU866	BOCA-UK|3|66|0.04545,GBM-US|12|268|0.04478,LAML-KR|7|107|0.06542,PRAD-US|2|256|0.00781,LGG-US|193|283|0.68198,BLCA-US|1|130|0.00769,MALY-DE|1|44|0.02273	Anaplastic Oligodendroglioma
2	209113113	209113113	G	A	exonic	IDH1	.	nonsynonymous SNV	IDH1:NM_001282386:exon4:c.C394T:p.R132C,IDH1:NM_001282387:exon4:c.C394T:p.R132C,IDH1:NM_005896:exon4:c.C394T:p.R132C	exonic	ENSG00000138413	.	nonsynonymous SNV	ENSG00000138413:ENST00000415282:exon3:c.C394T:p.R132C,ENSG00000138413:ENST00000345146:exon4:c.C394T:p.R132C,ENSG00000138413:ENST00000415913:exon4:c.C394T:p.R132C,ENSG00000138413:ENST00000446179:exon4:c.C394T:p.R132C	exonic	IDH1	.	nonsynonymous SNV	IDH1:uc002vcs.3:exon4:c.C394T:p.R132C,IDH1:uc002vct.3:exon4:c.C394T:p.R132C,IDH1:uc002vcu.3:exon4:c.C394T:p.R132C	.	.	.	.	.	.	.	.	.	.	rs121913499	0.025	D	0.259	B	0.126	B	0.000	D	1	D	4.54	H	-2.2	D	-6.68	D	0.979	7.432	34	0.999	0.965	D	0.732	D	0.809	D	0.707	0	5.57	0.917	0.953	0.996	0.998	19.534	.	.	Isopropylmalate dehydrogenase-like domain	.	.	.	.	.	ID=COSM28747;OCCURENCE=212(haematopoietic_and_lymphoid_tissue),3(NS),184(bone),106(central_nervous_system),1(prostate),3(large_intestine),33(biliary_tract),3(liver),6(skin),1(breast),11(soft_tissue),1(autonomic_ganglia)	MU197	BOCA-UK|19|66|0.28788,BTCA-JP|5|239|0.02092,LAML-KR|5|107|0.04673,LGG-US|11|283|0.03887,BRCA-US|1|955|0.00105,LIRI-JP|1|260|0.00385,LIHC-US|2|188|0.01064,LINC-JP|1|244|0.00410,PRAD-US|1|256|0.00391,SKCM-US|12|335|0.03582,PBCA-DE|1|246|0.00407,MELA-AU|3|183|0.01639,COAD-US|1|216|0.00463	AML
2	22127164	22127164	C	T	intergenic	LOC645949,LOC102723362	dist=193640;dist=632187	.	.	ncRNA_intronic	ENSG00000233005	.	.	.	intergenic	LOC645949,Mir_548	dist=193640;dist=1413767	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	HNSC
22	30051593	30051594	-	T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Peritoneal Mesothelioma
2	29432664	29432664	C	T	exonic	ALK	.	nonsynonymous SNV	ALK:NM_004304:exon25:c.G3824A:p.R1275Q	exonic	ENSG00000171094	.	nonsynonymous SNV	ENSG00000171094:ENST00000389048:exon25:c.G3824A:p.R1275Q	exonic	ALK	.	nonsynonymous SNV	ALK:uc010ymo.3:exon6:c.G620A:p.R207Q,ALK:uc031rnw.1:exon7:c.G620A:p.R207Q,ALK:uc002rmy.3:exon25:c.G3824A:p.R1275Q	.	.	.	.	.	.	.	.	.	.	rs113994087	0.002	D	1.0	D	0.999	D	0.001	N	1	D	2.555	M	-1.91	D	-3.94	D	0.951	8.353	35	1.000	0.977	D	0.612	D	0.767	D	0.554	0	5.47	0.871	0.931	0.998	1.000	18.104	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	other	Neuroblastoma_3	RCV000019709.5	MedGen:OMIM	C2751681:613014	ID=COSM28056;OCCURENCE=1(breast),1(large_intestine),72(autonomic_ganglia)	MU3872800	NBL-US|7|108|0.06481	NB
2	29432682	29432682	C	G	exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV	ALK:NM_004304:exon25:c.G3806C:p.G1269A;ALK:NM_004304:exon25:c.G3806C:p.G1269A	exonic;exonic	ENSG00000171094	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094:ENST00000389048:exon25:c.G3806C:p.G1269A;ENSG00000171094:ENST00000389048:exon25:c.G3806C:p.G1269A	exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV	ALK:uc010ymo.3:exon6:c.G602C:p.G201A,ALK:uc031rnw.1:exon7:c.G602C:p.G201A,ALK:uc002rmy.3:exon25:c.G3806C:p.G1269A;ALK:uc010ymo.3:exon6:c.G602C:p.G201A,ALK:uc031rnw.1:exon7:c.G602C:p.G201A,ALK:uc002rmy.3:exon25:c.G3806C:p.G1269A	.	.	.	.	.	.	.	.	.	.	.	0.575	T	0.996	D	0.945	D	0.000	D	1	D	-0.435	N	-1.49	T	-5.92	D	0.769	4.642	24.5	0.997	0.983	D	-0.229	T	0.394	T	0.554	0	5.47	0.871	0.931	1.000	0.999	18.104	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM1169707;OCCURENCE=3(lung)	.	.	CANCER
2	29432682	29432682	C	G	exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV	ALK:NM_004304:exon25:c.G3806C:p.G1269A;ALK:NM_004304:exon25:c.G3806C:p.G1269A	exonic;exonic	ENSG00000171094	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094:ENST00000389048:exon25:c.G3806C:p.G1269A;ENSG00000171094:ENST00000389048:exon25:c.G3806C:p.G1269A	exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV	ALK:uc010ymo.3:exon6:c.G602C:p.G201A,ALK:uc031rnw.1:exon7:c.G602C:p.G201A,ALK:uc002rmy.3:exon25:c.G3806C:p.G1269A;ALK:uc010ymo.3:exon6:c.G602C:p.G201A,ALK:uc031rnw.1:exon7:c.G602C:p.G201A,ALK:uc002rmy.3:exon25:c.G3806C:p.G1269A	.	.	.	.	.	.	.	.	.	.	.	0.575	T	0.996	D	0.945	D	0.000	D	1	D	-0.435	N	-1.49	T	-5.92	D	0.769	4.642	24.5	0.997	0.983	D	-0.229	T	0.394	T	0.554	0	5.47	0.871	0.931	1.000	0.999	18.104	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM1169707;OCCURENCE=3(lung)	.	.	NSCLC
2	29436859	29436859	A	C	exonic;exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ALK:NM_004304:exon24:c.T3734G:p.F1245C;ALK:NM_004304:exon24:c.T3734G:p.F1245C;ALK:NM_004304:exon24:c.T3734G:p.F1245C	exonic;exonic;exonic	ENSG00000171094	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094:ENST00000389048:exon24:c.T3734G:p.F1245C;ENSG00000171094:ENST00000389048:exon24:c.T3734G:p.F1245C;ENSG00000171094:ENST00000389048:exon24:c.T3734G:p.F1245C	exonic;exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ALK:uc010ymo.3:exon5:c.T530G:p.F177C,ALK:uc031rnw.1:exon6:c.T530G:p.F177C,ALK:uc002rmy.3:exon24:c.T3734G:p.F1245C;ALK:uc010ymo.3:exon5:c.T530G:p.F177C,ALK:uc031rnw.1:exon6:c.T530G:p.F177C,ALK:uc002rmy.3:exon24:c.T3734G:p.F1245C;ALK:uc010ymo.3:exon5:c.T530G:p.F177C,ALK:uc031rnw.1:exon6:c.T530G:p.F177C,ALK:uc002rmy.3:exon24:c.T3734G:p.F1245C	.	.	.	.	.	.	.	.	.	.	rs863225283	0.0	D	1.0	D	1.0	D	0.000	D	1	D	1.8	L	-2.51	D	-7.88	D	0.972	6.652	32	0.994	0.991	D	0.604	D	0.777	D	0.616	0	5.63	1.062	1.199	1.000	1.000	15.838	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic	Neuroblastoma_3	RCV000201887.1	MedGen:OMIM	C2751681:613014	ID=COSM28500;OCCURENCE=3(autonomic_ganglia)	.	.	CANCER
2	29436859	29436859	A	C	exonic;exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ALK:NM_004304:exon24:c.T3734G:p.F1245C;ALK:NM_004304:exon24:c.T3734G:p.F1245C;ALK:NM_004304:exon24:c.T3734G:p.F1245C	exonic;exonic;exonic	ENSG00000171094	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094:ENST00000389048:exon24:c.T3734G:p.F1245C;ENSG00000171094:ENST00000389048:exon24:c.T3734G:p.F1245C;ENSG00000171094:ENST00000389048:exon24:c.T3734G:p.F1245C	exonic;exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ALK:uc010ymo.3:exon5:c.T530G:p.F177C,ALK:uc031rnw.1:exon6:c.T530G:p.F177C,ALK:uc002rmy.3:exon24:c.T3734G:p.F1245C;ALK:uc010ymo.3:exon5:c.T530G:p.F177C,ALK:uc031rnw.1:exon6:c.T530G:p.F177C,ALK:uc002rmy.3:exon24:c.T3734G:p.F1245C;ALK:uc010ymo.3:exon5:c.T530G:p.F177C,ALK:uc031rnw.1:exon6:c.T530G:p.F177C,ALK:uc002rmy.3:exon24:c.T3734G:p.F1245C	.	.	.	.	.	.	.	.	.	.	rs863225283	0.0	D	1.0	D	1.0	D	0.000	D	1	D	1.8	L	-2.51	D	-7.88	D	0.972	6.652	32	0.994	0.991	D	0.604	D	0.777	D	0.616	0	5.63	1.062	1.199	1.000	1.000	15.838	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic	Neuroblastoma_3	RCV000201887.1	MedGen:OMIM	C2751681:613014	ID=COSM28500;OCCURENCE=3(autonomic_ganglia)	.	.	NB
2	29436859	29436859	A	C	exonic;exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ALK:NM_004304:exon24:c.T3734G:p.F1245C;ALK:NM_004304:exon24:c.T3734G:p.F1245C;ALK:NM_004304:exon24:c.T3734G:p.F1245C	exonic;exonic;exonic	ENSG00000171094	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094:ENST00000389048:exon24:c.T3734G:p.F1245C;ENSG00000171094:ENST00000389048:exon24:c.T3734G:p.F1245C;ENSG00000171094:ENST00000389048:exon24:c.T3734G:p.F1245C	exonic;exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ALK:uc010ymo.3:exon5:c.T530G:p.F177C,ALK:uc031rnw.1:exon6:c.T530G:p.F177C,ALK:uc002rmy.3:exon24:c.T3734G:p.F1245C;ALK:uc010ymo.3:exon5:c.T530G:p.F177C,ALK:uc031rnw.1:exon6:c.T530G:p.F177C,ALK:uc002rmy.3:exon24:c.T3734G:p.F1245C;ALK:uc010ymo.3:exon5:c.T530G:p.F177C,ALK:uc031rnw.1:exon6:c.T530G:p.F177C,ALK:uc002rmy.3:exon24:c.T3734G:p.F1245C	.	.	.	.	.	.	.	.	.	.	rs863225283	0.0	D	1.0	D	1.0	D	0.000	D	1	D	1.8	L	-2.51	D	-7.88	D	0.972	6.652	32	0.994	0.991	D	0.604	D	0.777	D	0.616	0	5.63	1.062	1.199	1.000	1.000	15.838	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic	Neuroblastoma_3	RCV000201887.1	MedGen:OMIM	C2751681:613014	ID=COSM28500;OCCURENCE=3(autonomic_ganglia)	.	.	NSCLC
2	29443600	29443600	G	T	exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV	ALK:NM_004304:exon23:c.C3617A:p.S1206Y;ALK:NM_004304:exon23:c.C3617A:p.S1206Y	exonic;exonic	ENSG00000171094	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094:ENST00000389048:exon23:c.C3617A:p.S1206Y;ENSG00000171094:ENST00000389048:exon23:c.C3617A:p.S1206Y	exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV	ALK:uc010ymo.3:exon4:c.C413A:p.S138Y,ALK:uc031rnw.1:exon5:c.C413A:p.S138Y,ALK:uc002rmy.3:exon23:c.C3617A:p.S1206Y;ALK:uc010ymo.3:exon4:c.C413A:p.S138Y,ALK:uc031rnw.1:exon5:c.C413A:p.S138Y,ALK:uc002rmy.3:exon23:c.C3617A:p.S1206Y	.	.	.	.	.	.	.	.	.	.	.	0.002	D	0.994	D	0.967	D	0.000	U	1	D	1.685	L	-2.57	D	-5.62	D	0.825	5.998	27.8	0.996	0.990	D	0.530	D	0.780	D	0.487	0	5.59	0.913	1.034	1.000	1.000	19.990	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM144251;OCCURENCE=1(lung)	.	.	CANCER
2	29443600	29443600	G	T	exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV	ALK:NM_004304:exon23:c.C3617A:p.S1206Y;ALK:NM_004304:exon23:c.C3617A:p.S1206Y	exonic;exonic	ENSG00000171094	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094:ENST00000389048:exon23:c.C3617A:p.S1206Y;ENSG00000171094:ENST00000389048:exon23:c.C3617A:p.S1206Y	exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV	ALK:uc010ymo.3:exon4:c.C413A:p.S138Y,ALK:uc031rnw.1:exon5:c.C413A:p.S138Y,ALK:uc002rmy.3:exon23:c.C3617A:p.S1206Y;ALK:uc010ymo.3:exon4:c.C413A:p.S138Y,ALK:uc031rnw.1:exon5:c.C413A:p.S138Y,ALK:uc002rmy.3:exon23:c.C3617A:p.S1206Y	.	.	.	.	.	.	.	.	.	.	.	0.002	D	0.994	D	0.967	D	0.000	U	1	D	1.685	L	-2.57	D	-5.62	D	0.825	5.998	27.8	0.996	0.990	D	0.530	D	0.780	D	0.487	0	5.59	0.913	1.034	1.000	1.000	19.990	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM144251;OCCURENCE=1(lung)	.	.	NSCLC
2	29443613	29443613	C	T	exonic;exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ALK:NM_004304:exon23:c.G3604A:p.G1202R;ALK:NM_004304:exon23:c.G3604A:p.G1202R;ALK:NM_004304:exon23:c.G3604A:p.G1202R	exonic;exonic;exonic	ENSG00000171094	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094:ENST00000389048:exon23:c.G3604A:p.G1202R;ENSG00000171094:ENST00000389048:exon23:c.G3604A:p.G1202R;ENSG00000171094:ENST00000389048:exon23:c.G3604A:p.G1202R	exonic;exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ALK:uc010ymo.3:exon4:c.G400A:p.G134R,ALK:uc031rnw.1:exon5:c.G400A:p.G134R,ALK:uc002rmy.3:exon23:c.G3604A:p.G1202R;ALK:uc010ymo.3:exon4:c.G400A:p.G134R,ALK:uc031rnw.1:exon5:c.G400A:p.G134R,ALK:uc002rmy.3:exon23:c.G3604A:p.G1202R;ALK:uc010ymo.3:exon4:c.G400A:p.G134R,ALK:uc031rnw.1:exon5:c.G400A:p.G134R,ALK:uc002rmy.3:exon23:c.G3604A:p.G1202R	.	.	.	.	.	.	.	.	.	.	.	0.0	D	1.0	D	0.998	D	0.000	D	1	D	3.36	M	-2.59	D	-7.9	D	0.976	6.777	32	0.999	0.983	D	0.926	D	0.873	D	0.554	0	5.61	0.871	0.925	0.965	0.503	20.005	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM144250;OCCURENCE=2(lung)	.	.	CANCER
2	29443613	29443613	C	T	exonic;exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ALK:NM_004304:exon23:c.G3604A:p.G1202R;ALK:NM_004304:exon23:c.G3604A:p.G1202R;ALK:NM_004304:exon23:c.G3604A:p.G1202R	exonic;exonic;exonic	ENSG00000171094	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094:ENST00000389048:exon23:c.G3604A:p.G1202R;ENSG00000171094:ENST00000389048:exon23:c.G3604A:p.G1202R;ENSG00000171094:ENST00000389048:exon23:c.G3604A:p.G1202R	exonic;exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ALK:uc010ymo.3:exon4:c.G400A:p.G134R,ALK:uc031rnw.1:exon5:c.G400A:p.G134R,ALK:uc002rmy.3:exon23:c.G3604A:p.G1202R;ALK:uc010ymo.3:exon4:c.G400A:p.G134R,ALK:uc031rnw.1:exon5:c.G400A:p.G134R,ALK:uc002rmy.3:exon23:c.G3604A:p.G1202R;ALK:uc010ymo.3:exon4:c.G400A:p.G134R,ALK:uc031rnw.1:exon5:c.G400A:p.G134R,ALK:uc002rmy.3:exon23:c.G3604A:p.G1202R	.	.	.	.	.	.	.	.	.	.	.	0.0	D	1.0	D	0.998	D	0.000	D	1	D	3.36	M	-2.59	D	-7.9	D	0.976	6.777	32	0.999	0.983	D	0.926	D	0.873	D	0.554	0	5.61	0.871	0.925	0.965	0.503	20.005	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM144250;OCCURENCE=2(lung)	.	.	LUAD
2	29443613	29443613	C	T	exonic;exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ALK:NM_004304:exon23:c.G3604A:p.G1202R;ALK:NM_004304:exon23:c.G3604A:p.G1202R;ALK:NM_004304:exon23:c.G3604A:p.G1202R	exonic;exonic;exonic	ENSG00000171094	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094:ENST00000389048:exon23:c.G3604A:p.G1202R;ENSG00000171094:ENST00000389048:exon23:c.G3604A:p.G1202R;ENSG00000171094:ENST00000389048:exon23:c.G3604A:p.G1202R	exonic;exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ALK:uc010ymo.3:exon4:c.G400A:p.G134R,ALK:uc031rnw.1:exon5:c.G400A:p.G134R,ALK:uc002rmy.3:exon23:c.G3604A:p.G1202R;ALK:uc010ymo.3:exon4:c.G400A:p.G134R,ALK:uc031rnw.1:exon5:c.G400A:p.G134R,ALK:uc002rmy.3:exon23:c.G3604A:p.G1202R;ALK:uc010ymo.3:exon4:c.G400A:p.G134R,ALK:uc031rnw.1:exon5:c.G400A:p.G134R,ALK:uc002rmy.3:exon23:c.G3604A:p.G1202R	.	.	.	.	.	.	.	.	.	.	.	0.0	D	1.0	D	0.998	D	0.000	D	1	D	3.36	M	-2.59	D	-7.9	D	0.976	6.777	32	0.999	0.983	D	0.926	D	0.873	D	0.554	0	5.61	0.871	0.925	0.965	0.503	20.005	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM144250;OCCURENCE=2(lung)	.	.	NSCLC
2	29443631	29443631	G	T	exonic	ALK	.	nonsynonymous SNV	ALK:NM_004304:exon23:c.C3586A:p.L1196M	exonic	ENSG00000171094	.	nonsynonymous SNV	ENSG00000171094:ENST00000389048:exon23:c.C3586A:p.L1196M	exonic	ALK	.	nonsynonymous SNV	ALK:uc010ymo.3:exon4:c.C382A:p.L128M,ALK:uc031rnw.1:exon5:c.C382A:p.L128M,ALK:uc002rmy.3:exon23:c.C3586A:p.L1196M	.	.	.	.	.	.	.	.	.	.	.	0.003	D	1.0	D	1.0	D	0.002	N	1	D	0	N	-2.35	D	-1.97	N	0.628	4.383	24.1	0.996	0.979	D	0.181	D	0.623	D	0.554	0	5.61	0.917	1.036	0.993	0.995	15.201	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM99137;OCCURENCE=5(lung)	.	.	NSCLC
2	29443679	29443679	C	G	exonic	ALK	.	nonsynonymous SNV	ALK:NM_004304:exon23:c.G3538C:p.V1180L	exonic	ENSG00000171094	.	nonsynonymous SNV	ENSG00000171094:ENST00000389048:exon23:c.G3538C:p.V1180L	exonic	ALK	.	nonsynonymous SNV	ALK:uc010ymo.3:exon4:c.G334C:p.V112L,ALK:uc031rnw.1:exon5:c.G334C:p.V112L,ALK:uc002rmy.3:exon23:c.G3538C:p.V1180L	.	.	.	.	.	.	.	.	.	.	.	0.003	D	0.991	D	0.937	D	0.001	D	1	D	1.18	L	-3.02	D	-2.96	D	0.884	6.105	28.3	0.997	0.988	D	0.584	D	0.799	D	0.554	0	5.61	0.871	0.925	0.983	0.968	20.005	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	.	.	.	NSCLC
2	29443695	29443695	G	T	exonic;exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ALK:NM_004304:exon23:c.C3522A:p.F1174L;ALK:NM_004304:exon23:c.C3522A:p.F1174L;ALK:NM_004304:exon23:c.C3522A:p.F1174L	exonic;exonic;exonic	ENSG00000171094	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094:ENST00000389048:exon23:c.C3522A:p.F1174L;ENSG00000171094:ENST00000389048:exon23:c.C3522A:p.F1174L;ENSG00000171094:ENST00000389048:exon23:c.C3522A:p.F1174L	exonic;exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ALK:uc010ymo.3:exon4:c.C318A:p.F106L,ALK:uc031rnw.1:exon5:c.C318A:p.F106L,ALK:uc002rmy.3:exon23:c.C3522A:p.F1174L;ALK:uc010ymo.3:exon4:c.C318A:p.F106L,ALK:uc031rnw.1:exon5:c.C318A:p.F106L,ALK:uc002rmy.3:exon23:c.C3522A:p.F1174L;ALK:uc010ymo.3:exon4:c.C318A:p.F106L,ALK:uc031rnw.1:exon5:c.C318A:p.F106L,ALK:uc002rmy.3:exon23:c.C3522A:p.F1174L	.	.	.	.	.	.	.	.	.	.	rs863225281	0.022	D	0.933	P	0.699	P	0.000	D	1	D	-0.225	N	-1.98	D	-5.89	D	0.848	5.091	25.3	0.998	0.983	D	-0.182	T	0.452	T	0.554	0	5.61	0.917	1.036	1.000	1.000	20.005	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic,Pathogenic	Neuroblastoma_3,Neuroblastoma_3	RCV000201904.1,RCV000201882.1	MedGen:OMIM,MedGen:OMIM	C2751681:613014,C2751681:613014	ID=COSM28055;OCCURENCE=54(autonomic_ganglia)	MU3872721	NBL-US|5|108|0.04630	IM
2	29443695	29443695	G	T	exonic;exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ALK:NM_004304:exon23:c.C3522A:p.F1174L;ALK:NM_004304:exon23:c.C3522A:p.F1174L;ALK:NM_004304:exon23:c.C3522A:p.F1174L	exonic;exonic;exonic	ENSG00000171094	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094:ENST00000389048:exon23:c.C3522A:p.F1174L;ENSG00000171094:ENST00000389048:exon23:c.C3522A:p.F1174L;ENSG00000171094:ENST00000389048:exon23:c.C3522A:p.F1174L	exonic;exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ALK:uc010ymo.3:exon4:c.C318A:p.F106L,ALK:uc031rnw.1:exon5:c.C318A:p.F106L,ALK:uc002rmy.3:exon23:c.C3522A:p.F1174L;ALK:uc010ymo.3:exon4:c.C318A:p.F106L,ALK:uc031rnw.1:exon5:c.C318A:p.F106L,ALK:uc002rmy.3:exon23:c.C3522A:p.F1174L;ALK:uc010ymo.3:exon4:c.C318A:p.F106L,ALK:uc031rnw.1:exon5:c.C318A:p.F106L,ALK:uc002rmy.3:exon23:c.C3522A:p.F1174L	.	.	.	.	.	.	.	.	.	.	rs863225281	0.022	D	0.933	P	0.699	P	0.000	D	1	D	-0.225	N	-1.98	D	-5.89	D	0.848	5.091	25.3	0.998	0.983	D	-0.182	T	0.452	T	0.554	0	5.61	0.917	1.036	1.000	1.000	20.005	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic,Pathogenic	Neuroblastoma_3,Neuroblastoma_3	RCV000201904.1,RCV000201882.1	MedGen:OMIM,MedGen:OMIM	C2751681:613014,C2751681:613014	ID=COSM28055;OCCURENCE=54(autonomic_ganglia)	MU3872721	NBL-US|5|108|0.04630	NB
2	29443695	29443695	G	T	exonic;exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ALK:NM_004304:exon23:c.C3522A:p.F1174L;ALK:NM_004304:exon23:c.C3522A:p.F1174L;ALK:NM_004304:exon23:c.C3522A:p.F1174L	exonic;exonic;exonic	ENSG00000171094	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000171094:ENST00000389048:exon23:c.C3522A:p.F1174L;ENSG00000171094:ENST00000389048:exon23:c.C3522A:p.F1174L;ENSG00000171094:ENST00000389048:exon23:c.C3522A:p.F1174L	exonic;exonic;exonic	ALK	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ALK:uc010ymo.3:exon4:c.C318A:p.F106L,ALK:uc031rnw.1:exon5:c.C318A:p.F106L,ALK:uc002rmy.3:exon23:c.C3522A:p.F1174L;ALK:uc010ymo.3:exon4:c.C318A:p.F106L,ALK:uc031rnw.1:exon5:c.C318A:p.F106L,ALK:uc002rmy.3:exon23:c.C3522A:p.F1174L;ALK:uc010ymo.3:exon4:c.C318A:p.F106L,ALK:uc031rnw.1:exon5:c.C318A:p.F106L,ALK:uc002rmy.3:exon23:c.C3522A:p.F1174L	.	.	.	.	.	.	.	.	.	.	rs863225281	0.022	D	0.933	P	0.699	P	0.000	D	1	D	-0.225	N	-1.98	D	-5.89	D	0.848	5.091	25.3	0.998	0.983	D	-0.182	T	0.452	T	0.554	0	5.61	0.917	1.036	1.000	1.000	20.005	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic,Pathogenic	Neuroblastoma_3,Neuroblastoma_3	RCV000201904.1,RCV000201882.1	MedGen:OMIM,MedGen:OMIM	C2751681:613014,C2751681:613014	ID=COSM28055;OCCURENCE=54(autonomic_ganglia)	MU3872721	NBL-US|5|108|0.04630	NSCLC
2	29445213	29445213	A	C	exonic	ALK	.	nonsynonymous SNV	ALK:NM_004304:exon22:c.T3512G:p.I1171S	exonic	ENSG00000171094	.	nonsynonymous SNV	ENSG00000171094:ENST00000453137:exon3:c.T206G:p.I69S,ENSG00000171094:ENST00000389048:exon22:c.T3512G:p.I1171S	exonic	ALK	.	nonsynonymous SNV	ALK:uc010ymo.3:exon3:c.T308G:p.I103S,ALK:uc031rnw.1:exon4:c.T308G:p.I103S,ALK:uc002rmy.3:exon22:c.T3512G:p.I1171S	.	.	.	.	.	.	.	.	.	.	.	0.001	D	0.999	D	0.987	D	0.000	D	1	D	0.615	N	-1.71	D	-4.99	D	0.97	6.550	31	0.994	0.993	D	0.017	D	0.541	D	0.554	0	5.39	1.062	1.184	1.000	1.000	15.430	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	.	.	.	NSCLC
2	29445213	29445213	A	G	exonic	ALK	.	nonsynonymous SNV	ALK:NM_004304:exon22:c.T3512C:p.I1171T	exonic	ENSG00000171094	.	nonsynonymous SNV	ENSG00000171094:ENST00000453137:exon3:c.T206C:p.I69T,ENSG00000171094:ENST00000389048:exon22:c.T3512C:p.I1171T	exonic	ALK	.	nonsynonymous SNV	ALK:uc010ymo.3:exon3:c.T308C:p.I103T,ALK:uc031rnw.1:exon4:c.T308C:p.I103T,ALK:uc002rmy.3:exon22:c.T3512C:p.I1171T	.	.	.	.	.	.	.	.	.	.	.	0.002	D	0.998	D	0.982	D	0.000	D	1	D	0.735	N	-1.7	D	-4.32	D	0.967	6.057	28.1	0.998	0.993	D	0.044	D	0.559	D	0.554	0	5.39	1.062	1.184	1.000	1.000	15.430	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	.	.	.	NSCLC
2	29445213	29445213	A	T	exonic	ALK	.	nonsynonymous SNV	ALK:NM_004304:exon22:c.T3512A:p.I1171N	exonic	ENSG00000171094	.	nonsynonymous SNV	ENSG00000171094:ENST00000453137:exon3:c.T206A:p.I69N,ENSG00000171094:ENST00000389048:exon22:c.T3512A:p.I1171N	exonic	ALK	.	nonsynonymous SNV	ALK:uc010ymo.3:exon3:c.T308A:p.I103N,ALK:uc031rnw.1:exon4:c.T308A:p.I103N,ALK:uc002rmy.3:exon22:c.T3512A:p.I1171N	.	.	.	.	.	.	.	.	.	.	.	0.001	D	1.0	D	0.996	D	0.000	D	1	D	1.59	L	-1.73	D	-6.06	D	0.837	6.581	31	0.994	0.993	D	0.252	D	0.641	D	0.554	0	5.39	1.062	1.184	1.000	1.000	15.430	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM28498;OCCURENCE=4(autonomic_ganglia)	MU3872783	NBL-US|1|108|0.00926	NSCLC
2	29445258	29445258	C	T	exonic	ALK	.	nonsynonymous SNV	ALK:NM_004304:exon22:c.G3467A:p.C1156Y	exonic	ENSG00000171094	.	nonsynonymous SNV	ENSG00000171094:ENST00000453137:exon3:c.G161A:p.C54Y,ENSG00000171094:ENST00000389048:exon22:c.G3467A:p.C1156Y	exonic	ALK	.	nonsynonymous SNV	ALK:uc010ymo.3:exon3:c.G263A:p.C88Y,ALK:uc031rnw.1:exon4:c.G263A:p.C88Y,ALK:uc002rmy.3:exon22:c.G3467A:p.C1156Y	.	.	.	.	.	.	.	.	.	.	.	0.02	D	0.999	D	0.995	D	0.000	D	1	D	1.085	L	-1.57	D	-10.38	D	0.87	6.503	31	0.997	0.989	D	0.133	D	0.616	D	0.554	0	5.39	0.871	0.925	0.997	0.985	19.174	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM99136;OCCURENCE=2(lung)	.	.	NSCLC
2	29445270	29445270	A	C	exonic	ALK	.	nonsynonymous SNV	ALK:NM_004304:exon22:c.T3455G:p.L1152R	exonic	ENSG00000171094	.	nonsynonymous SNV	ENSG00000171094:ENST00000453137:exon3:c.T149G:p.L50R,ENSG00000171094:ENST00000389048:exon22:c.T3455G:p.L1152R	exonic	ALK	.	nonsynonymous SNV	ALK:uc010ymo.3:exon3:c.T251G:p.L84R,ALK:uc031rnw.1:exon4:c.T251G:p.L84R,ALK:uc002rmy.3:exon22:c.T3455G:p.L1152R	.	.	.	.	.	.	.	.	.	.	.	0.009	D	1.0	D	0.999	D	0.002	N	1	D	3.305	M	-2.82	D	-5.93	D	0.974	6.066	28.1	0.998	0.998	D	0.994	D	0.880	D	0.487	0	5.15	1.062	1.199	0.993	0.995	15.002	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM97185;OCCURENCE=1(lung)	.	.	NSCLC
2	47630413	47630414	-	G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Lynch Syndrome
2	47656951	47656951	C	T	exonic	MSH2	.	stopgain	MSH2:NM_000251:exon7:c.C1147T:p.R383X,MSH2:NM_001258281:exon8:c.C949T:p.R317X	exonic	ENSG00000095002	.	stopgain	ENSG00000095002:ENST00000233146:exon7:c.C1147T:p.R383X,ENSG00000095002:ENST00000406134:exon7:c.C1147T:p.R383X,ENSG00000095002:ENST00000543555:exon8:c.C949T:p.R317X	exonic	MSH2	.	stopgain	MSH2:uc010fbg.3:exon4:c.C577T:p.R193X,MSH2:uc002rvy.2:exon7:c.C1147T:p.R383X,MSH2:uc002rvz.4:exon7:c.C1147T:p.R383X,MSH2:uc010yoh.2:exon8:c.C949T:p.R317X	.	.	.	.	.	.	.	.	.	.	rs63749849	.	.	.	.	.	.	0.000	D	1	A	.	.	.	.	.	.	.	12.911	40	0.998	0.971	D	.	.	.	.	0.722	0	3.81	0.868	0.024	0.998	0.994	14.642	.	.	DNA mismatch repair protein MutS, core	Pathogenic|Pathogenic|Pathogenic	Lynch_syndrome|not_provided|Hereditary_cancer-predisposing_syndrome	RCV000076049.2|RCV000202261.1|RCV000221364.1	MedGen:Orphanet:SNOMED_CT|MedGen|MedGen:SNOMED_CT	C1333990:ORPHA144:315058005|CN221809|C0027672:699346009	ID=COSM330652;OCCURENCE=1(large_intestine)	.	.	Lynch Syndrome
2	47690231	47690231	A	G	exonic	MSH2	.	nonsynonymous SNV	MSH2:NM_000251:exon9:c.A1448G:p.E483G,MSH2:NM_001258281:exon10:c.A1250G:p.E417G	exonic	ENSG00000095002	.	nonsynonymous SNV	ENSG00000095002:ENST00000233146:exon9:c.A1448G:p.E483G,ENSG00000095002:ENST00000406134:exon9:c.A1448G:p.E483G,ENSG00000095002:ENST00000543555:exon10:c.A1250G:p.E417G	exonic	MSH2	.	nonsynonymous SNV	MSH2:uc010fbg.3:exon6:c.A878G:p.E293G,MSH2:uc002rvy.2:exon9:c.A1448G:p.E483G,MSH2:uc002rvz.4:exon9:c.A1448G:p.E483G,MSH2:uc010yoh.2:exon10:c.A1250G:p.E417G	.	.	.	.	.	.	.	.	.	.	.	0.115	T	0.034	B	0.037	B	0.000	D	1.000	D	1.935	M	-2.6	D	-3.59	D	0.8	3.056	22.4	0.997	0.971	D	0.065	D	0.627	D	0.732	0	5.4	1.062	1.140	0.934	1.000	15.419	.	.	DNA mismatch repair protein MutS, clamp;DNA mismatch repair protein MutS, core	.	.	.	.	.	.	.	.	Lynch Syndrome
2	48018217	48018217	C	A	exonic	MSH6	.	nonsynonymous SNV	MSH6:NM_000179:exon2:c.C412A:p.P138T	exonic	ENSG00000116062	.	nonsynonymous SNV	ENSG00000116062:ENST00000234420:exon2:c.C412A:p.P138T,ENSG00000116062:ENST00000411819:exon2:c.C115A:p.P39T,ENSG00000116062:ENST00000420813:exon2:c.C115A:p.P39T,ENSG00000116062:ENST00000445503:exon2:c.C412A:p.P138T,ENSG00000116062:ENST00000455383:exon2:c.C115A:p.P39T,ENSG00000116062:ENST00000606499:exon4:c.C115A:p.P39T	exonic	MSH6	.	nonsynonymous SNV	MSH6:uc002rwc.2:exon2:c.C412A:p.P138T,MSH6:uc002rwd.4:exon2:c.C412A:p.P138T	.	.	.	.	.	.	.	.	.	.	.	0.0	D	0.998	D	0.989	D	0.000	D	1	D	1.435	L	-0.47	T	-3.67	D	0.793	6.136	28.4	0.998	0.965	D	-0.049	T	0.481	T	0.672	0	5.63	0.871	0.935	0.993	1.000	19.682	.	.	PWWP domain	.	.	.	.	.	.	.	.	Lynch Syndrome
2	48026176	48026176	G	A	exonic	MSH6	.	nonsynonymous SNV	MSH6:NM_001281492:exon2:c.G664A:p.V222I,MSH6:NM_001281493:exon3:c.G148A:p.V50I,MSH6:NM_000179:exon4:c.G1054A:p.V352I,MSH6:NM_001281494:exon4:c.G148A:p.V50I	exonic	ENSG00000116062	.	nonsynonymous SNV	ENSG00000116062:ENST00000540021:exon2:c.G664A:p.V222I,ENSG00000116062:ENST00000234420:exon4:c.G1054A:p.V352I,ENSG00000116062:ENST00000538136:exon4:c.G148A:p.V50I	exonic	MSH6	.	nonsynonymous SNV	MSH6:uc010fbj.3:exon3:c.G148A:p.V50I,MSH6:uc002rwc.2:exon4:c.G1054A:p.V352I,MSH6:uc002rwd.4:exon4:c.G1054A:p.V352I,MSH6:uc010yoj.2:exon4:c.G148A:p.V50I	.	.	8.247e-05	0	0	0	0	7.501e-05	0	0.0003	rs730881787	0.837	T	0.003	B	0.002	B	0.544	N	1	N	0.92	L	-1.89	D	-0.2	N	0.1	-1.201	0.007	0.659	0.326	N	-0.752	T	0.414	T	0.672	0	-2.05	-0.011	-0.768	0.806	0.044	10.723	.	.	.	Likely benign|Uncertain significance|Uncertain significance|Uncertain significance	Hereditary_cancer-predisposing_syndrome|not_provided|Lynch_syndrome|not_specified	RCV000160662.5|RCV000178054.1|RCV000229366.1|RCV000235183.1	MedGen:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT|MedGen	C0027672:699346009|CN221809|C1333990:ORPHA144:315058005|CN169374	.	.	.	Lynch Syndrome
2	48033420	48033420	C	T	exonic	MSH6	.	nonsynonymous SNV	MSH6:NM_001281492:exon6:c.C3334T:p.R1112C,MSH6:NM_001281493:exon7:c.C2818T:p.R940C,MSH6:NM_000179:exon8:c.C3724T:p.R1242C,MSH6:NM_001281494:exon8:c.C2818T:p.R940C	exonic	ENSG00000116062	.	nonsynonymous SNV	ENSG00000116062:ENST00000540021:exon6:c.C3334T:p.R1112C,ENSG00000116062:ENST00000234420:exon8:c.C3724T:p.R1242C,ENSG00000116062:ENST00000538136:exon8:c.C2818T:p.R940C	exonic	MSH6	.	nonsynonymous SNV	MSH6:uc010fbj.3:exon7:c.C2818T:p.R940C,MSH6:uc002rwd.4:exon8:c.C3724T:p.R1242C,MSH6:uc010yoj.2:exon8:c.C2818T:p.R940C	.	.	.	.	.	.	.	.	.	.	.	0.0	D	1.0	D	1.0	D	0.000	D	1	D	3.47	M	-2.01	D	-7.4	D	0.961	7.006	33	0.999	0.950	D	0.811	D	0.813	D	0.672	0	4.59	0.871	0.935	1.000	0.999	16.599	.	.	DNA mismatch repair protein MutS, C-terminal;DNA mismatch repair protein MutS, clamp;DNA mismatch repair protein MutS, core;P-loop containing nucleoside triphosphate hydrolase	.	.	.	.	.	.	.	.	Lynch Syndrome
2	48033421	48033421	G	A	exonic	MSH6	.	nonsynonymous SNV	MSH6:NM_001281492:exon6:c.G3335A:p.R1112H,MSH6:NM_001281493:exon7:c.G2819A:p.R940H,MSH6:NM_000179:exon8:c.G3725A:p.R1242H,MSH6:NM_001281494:exon8:c.G2819A:p.R940H	exonic	ENSG00000116062	.	nonsynonymous SNV	ENSG00000116062:ENST00000540021:exon6:c.G3335A:p.R1112H,ENSG00000116062:ENST00000234420:exon8:c.G3725A:p.R1242H,ENSG00000116062:ENST00000538136:exon8:c.G2819A:p.R940H	exonic	MSH6	.	nonsynonymous SNV	MSH6:uc010fbj.3:exon7:c.G2819A:p.R940H,MSH6:uc002rwd.4:exon8:c.G3725A:p.R1242H,MSH6:uc010yoj.2:exon8:c.G2819A:p.R940H	.	.	8.25e-06	0	0	0.0001	0	0	0	0	rs63750119	0.0	D	1.0	D	1.0	D	0.000	D	1	D	2.845	M	-2.01	D	-4.68	D	0.967	6.639	32	0.999	0.979	D	0.720	D	0.797	D	0.672	0	5.5	0.917	1.048	0.999	0.998	19.592	.	.	DNA mismatch repair protein MutS, C-terminal;DNA mismatch repair protein MutS, clamp;DNA mismatch repair protein MutS, core;P-loop containing nucleoside triphosphate hydrolase	Likely pathogenic|Likely pathogenic,Uncertain significance|Uncertain significance	Hereditary_cancer-predisposing_syndrome|Lynch_syndrome,Lynch_syndrome|Hereditary_cancer-predisposing_syndrome	RCV000129081.3|RCV000230170.1,RCV000074919.2|RCV000130075.2	MedGen:SNOMED_CT|MedGen:Orphanet:SNOMED_CT,MedGen:Orphanet:SNOMED_CT|MedGen:SNOMED_CT	C0027672:699346009|C1333990:ORPHA144:315058005,C1333990:ORPHA144:315058005|C0027672:699346009	.	.	.	Lynch Syndrome
3	10183694	10183694	G	-	exonic	VHL	.	frameshift deletion	VHL:NM_000551:exon1:c.163delG:p.E55fs,VHL:NM_198156:exon1:c.163delG:p.E55fs	exonic	ENSG00000134086	.	frameshift deletion	ENSG00000134086:ENST00000256474:exon1:c.163delG:p.E55fs,ENSG00000134086:ENST00000345392:exon1:c.163delG:p.E55fs	exonic	VHL	.	frameshift deletion	VHL:uc003bvc.3:exon1:c.163delG:p.E55fs,VHL:uc003bvd.3:exon1:c.163delG:p.E55fs	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	ID=COSM17867,COSM1169474;OCCURENCE=1(adrenal_gland),1(kidney),1(soft_tissue)	.	.	Von Hippel-Lindau Disease
3	10183695	10183696	-	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Von Hippel-Lindau Disease
3	10183695	10183696	-	G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Von Hippel-Lindau Disease
3	10183696	10183696	G	A	exonic	VHL	.	synonymous SNV	VHL:NM_000551:exon1:c.G165A:p.E55E,VHL:NM_198156:exon1:c.G165A:p.E55E	exonic	ENSG00000134086	.	synonymous SNV	ENSG00000134086:ENST00000256474:exon1:c.G165A:p.E55E,ENSG00000134086:ENST00000345392:exon1:c.G165A:p.E55E	exonic	VHL	.	synonymous SNV	VHL:uc003bvc.3:exon1:c.G165A:p.E55E,VHL:uc003bvd.3:exon1:c.G165A:p.E55E	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Von Hippel-Lindau Disease
3	10188302	10188302	G	T	exonic	VHL	.	nonsynonymous SNV	VHL:NM_000551:exon2:c.G445T:p.A149S	exonic	ENSG00000134086	.	nonsynonymous SNV	ENSG00000134086:ENST00000256474:exon2:c.G445T:p.A149S	exonic	VHL	.	nonsynonymous SNV	VHL:uc003bvc.3:exon2:c.G445T:p.A149S	.	.	.	.	.	.	.	.	.	.	rs587780077	.	.	0.993	D	0.955	D	0.000	D	1	D	1.67	L	-6.77	D	-1.95	N	0.887	5.524	26.3	0.996	0.975	D	1.019	D	0.985	D	0.732	0	4.89	0.917	0.953	1.000	1.000	15.916	.	.	von Hippel-Lindau disease tumour suppressor,  beta domain;von Hippel-Lindau disease tumour suppressor, beta/alpha domain	Pathogenic,Uncertain significance,Pathogenic|Pathogenic	Von_Hippel-Lindau_syndrome,Von_Hippel-Lindau_syndrome,not_provided|Von_Hippel-Lindau_syndrome	RCV000208822.1,RCV000208855.1,RCV000115746.3|RCV000208783.1	MedGen:OMIM:Orphanet:SNOMED_CT,MedGen:OMIM:Orphanet:SNOMED_CT,MedGen|MedGen:OMIM:Orphanet:SNOMED_CT	C0019562:193300:ORPHA892:46659004,C0019562:193300:ORPHA892:46659004,CN221809|C0019562:193300:ORPHA892:46659004	ID=COSM1417320;OCCURENCE=1(large_intestine)	.	.	Von Hippel-Lindau Disease
3	10191605	10191605	C	T	exonic	VHL	.	nonsynonymous SNV	VHL:NM_198156:exon2:c.C475T:p.R159W,VHL:NM_000551:exon3:c.C598T:p.R200W	exonic	ENSG00000134086	.	nonsynonymous SNV	ENSG00000134086:ENST00000345392:exon2:c.C475T:p.R159W,ENSG00000134086:ENST00000256474:exon3:c.C598T:p.R200W	exonic	VHL	.	nonsynonymous SNV	VHL:uc003bvd.3:exon2:c.C475T:p.R159W,VHL:uc003bvc.3:exon3:c.C598T:p.R200W	0.0002	.	0.0002	9.787e-05	0	0	0	0.0003	0	0.0006	rs28940298	0.0	D	1.0	D	0.998	D	0.000	D	0.999	A	1.79	L	-7.05	D	-4.73	D	0.924	8.095	35	0.999	0.916	D	0.958	D	0.987	D	0.722	0	4.03	-0.058	0.935	0.115	0.711	12.602	.	.	von Hippel-Lindau disease tumour suppressor, alpha domain;von Hippel-Lindau disease tumour suppressor, beta/alpha domain	Pathogenic|Uncertain significance|Likely benign|Pathogenic	Erythrocytosis,_familial,_2|not_specified|Von_Hippel-Lindau_syndrome|not_provided	RCV000002320.5|RCV000122262.2|RCV000148922.4|RCV000161094.3	Gene:MedGen:OMIM:Orphanet|MedGen|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen	8056:C1837915:263400:ORPHA238557|CN169374|C0019562:193300:ORPHA892:46659004|CN221809	ID=COSM18024;OCCURENCE=2(kidney)	.	.	Chuvash Polycythemia
3	105439026	105439026	G	A	exonic	CBLB	.	synonymous SNV	CBLB:NM_170662:exon10:c.C1272T:p.D424D	exonic	ENSG00000114423	.	synonymous SNV	ENSG00000114423:ENST00000264122:exon10:c.C1272T:p.D424D,ENSG00000114423:ENST00000394027:exon10:c.C1338T:p.D446D,ENSG00000114423:ENST00000403724:exon10:c.C1272T:p.D424D,ENSG00000114423:ENST00000405772:exon10:c.C1272T:p.D424D	exonic	CBLB	.	synonymous SNV	CBLB:uc003dwc.3:exon10:c.C1272T:p.D424D,CBLB:uc003dwd.2:exon10:c.C1272T:p.D424D,CBLB:uc003dwe.2:exon10:c.C1272T:p.D424D,CBLB:uc011bhi.2:exon10:c.C1338T:p.D446D	0.2043	0.210064	0.2204	0.1883	0.3289	0.2354	0.2639	0.2176	0.2249	0.1506	rs2305035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MU73441	COAD-US|1|216|0.00463	NSCLC
3	138665163	138665163	G	C	exonic	FOXL2	.	nonsynonymous SNV	FOXL2:NM_023067:exon1:c.C402G:p.C134W	exonic	ENSG00000183770	.	nonsynonymous SNV	ENSG00000183770:ENST00000330315:exon1:c.C402G:p.C134W	exonic	FOXL2	.	nonsynonymous SNV	FOXL2:uc003esw.3:exon1:c.C402G:p.C134W	.	.	.	.	.	.	.	.	.	.	.	0.001	D	0.998	D	0.975	D	0.000	U	1	D	2.55	M	-3.69	D	-6.1	D	0.842	6.510	31	0.993	0.954	D	1.051	D	0.916	D	0.598	0	3.76	0.897	0.789	1.000	1.000	15.921	.	.	Transcription factor, fork head;Winged helix-turn-helix DNA-binding domain	.	.	.	.	.	ID=COSM33661;OCCURENCE=1(testis),413(ovary)	.	.	OVG
3	142274740	142274740	A	-	exonic	ATR	.	frameshift deletion	ATR:NM_001184:exon10:c.2320delA:p.I774fs	exonic	ENSG00000175054	.	frameshift deletion	ENSG00000175054:ENST00000383101:exon9:c.2128delA:p.I710fs,ENSG00000175054:ENST00000350721:exon10:c.2320delA:p.I774fs	exonic	ATR	.	frameshift deletion	ATR:uc003eux.4:exon10:c.2320delA:p.I774fs	.	.	0.0053	0.0030	0.0011	0.0039	0.0002	0.0075	0.0084	0.0030	rs757500301	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	ID=COSM214499;OCCURENCE=1(breast),22(large_intestine),1(pancreas)	MU4350843	BTCA-JP|1|239|0.00418,LICA-FR|1|240|0.00417,SKCM-US|1|335|0.00299	EDA
3	178928226	178928226	C	T	exonic	PIK3CA	.	nonsynonymous SNV	PIK3CA:NM_006218:exon9:c.C1412T:p.P471L	exonic	ENSG00000121879	.	nonsynonymous SNV	ENSG00000121879:ENST00000263967:exon9:c.C1412T:p.P471L	exonic	PIK3CA	.	nonsynonymous SNV	PIK3CA:uc003fjk.3:exon9:c.C1412T:p.P471L	.	.	.	.	.	.	.	.	.	.	.	0.031	D	0.978	D	0.824	P	0.000	D	1	D	2.255	M	-0.97	T	-2.02	N	0.932	5.609	26.5	0.999	0.996	D	-0.098	T	0.533	D	0.707	0	5.64	0.871	0.935	1.000	0.999	19.697	.	.	C2 domain;Phosphatidylinositol 3-kinase, C2 domain	.	.	.	.	.	ID=COSM136387,COSM136386;OCCURENCE=1(endometrium),1(skin),2(large_intestine)	MU1822387	LIHC-US|1|188|0.00532,UCEC-US|1|246|0.00407	MERC
3	178936082	178936082	G	A	exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K	exonic;exonic;exonic;exonic	ENSG00000121879	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K	exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K	.	.	.	.	.	.	.	.	.	.	rs121913273	0.016	D	0.995	D	0.912	D	0.000	D	1	D	1.27	L	0.05	T	-2.09	N	0.921	5.844	27.3	0.999	0.973	D	-0.729	T	0.309	T	0.732	0	5.78	0.917	0.998	0.999	0.997	20.002	.	.	Armadillo-type fold;Phosphoinositide 3-kinase, accessory (PIK) domain	Pathogenic|Pathogenic|Pathogenic	Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Neoplasm_of_ovary|Non-small_cell_lung_cancer	RCV000024622.6|RCV000151649.1|RCV000154513.1	MedGen:OMIM:Orphanet|Gene:MedGen:OMIM:SNOMED_CT|MeSH:MedGen:SNOMED_CT	C2752042:612918:ORPHA140944|6765:C0919267:167000:123843001|D002289:C0007131:254637007	ID=COSM760,COSM125369;OCCURENCE=5(gastrointestinal_tract_(site_indeterminate)),2(haematopoietic_and_lymphoid_tissue),7(cervix),18(lung),4(penis),15(thyroid),9(oesophagus),27(upper_aerodigestive_tract),8(central_nervous_system),16(stomach),1(biliary_tract),236(large_intestine),1(prostate),1(pancreas),3(kidney),9(liver),55(urinary_tract),1(small_intestine),21(skin),230(breast),54(endometrium),3(salivary_gland),21(ovary),2(soft_tissue),1(pituitary)	MU5136	KIRP-US|1|159|0.00629,BRCA-UK|3|117|0.02564,BTCA-JP|4|239|0.01674,LUSC-US|3|178|0.01685,LGG-US|2|283|0.00707,STAD-US|5|289|0.01730,BLCA-CN|4|103|0.03883,CESC-US|12|194|0.06186,BRCA-US|39|955|0.04084,UCEC-US|9|246|0.03659,LIRI-JP|1|260|0.00385,COCA-CN|2|187|0.01070,ESAD-UK|2|119|0.01681,ESCA-CN|3|228|0.01316,LIHC-US|1|188|0.00532,GACA-CN|1|9|0.11111,LINC-JP|1|244|0.00410,GBM-US|1|268|0.00373,PRAD-US|1|256|0.00391,BRCA-EU|21|560|0.03750,PACA-AU|1|391|0.00256,ORCA-IN|1|106|0.00943,KIRC-US|1|404|0.00248,COAD-US|8|216|0.03704	BRACA
3	178936082	178936082	G	A	exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K	exonic;exonic;exonic;exonic	ENSG00000121879	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K	exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K	.	.	.	.	.	.	.	.	.	.	rs121913273	0.016	D	0.995	D	0.912	D	0.000	D	1	D	1.27	L	0.05	T	-2.09	N	0.921	5.844	27.3	0.999	0.973	D	-0.729	T	0.309	T	0.732	0	5.78	0.917	0.998	0.999	0.997	20.002	.	.	Armadillo-type fold;Phosphoinositide 3-kinase, accessory (PIK) domain	Pathogenic|Pathogenic|Pathogenic	Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Neoplasm_of_ovary|Non-small_cell_lung_cancer	RCV000024622.6|RCV000151649.1|RCV000154513.1	MedGen:OMIM:Orphanet|Gene:MedGen:OMIM:SNOMED_CT|MeSH:MedGen:SNOMED_CT	C2752042:612918:ORPHA140944|6765:C0919267:167000:123843001|D002289:C0007131:254637007	ID=COSM760,COSM125369;OCCURENCE=5(gastrointestinal_tract_(site_indeterminate)),2(haematopoietic_and_lymphoid_tissue),7(cervix),18(lung),4(penis),15(thyroid),9(oesophagus),27(upper_aerodigestive_tract),8(central_nervous_system),16(stomach),1(biliary_tract),236(large_intestine),1(prostate),1(pancreas),3(kidney),9(liver),55(urinary_tract),1(small_intestine),21(skin),230(breast),54(endometrium),3(salivary_gland),21(ovary),2(soft_tissue),1(pituitary)	MU5136	KIRP-US|1|159|0.00629,BRCA-UK|3|117|0.02564,BTCA-JP|4|239|0.01674,LUSC-US|3|178|0.01685,LGG-US|2|283|0.00707,STAD-US|5|289|0.01730,BLCA-CN|4|103|0.03883,CESC-US|12|194|0.06186,BRCA-US|39|955|0.04084,UCEC-US|9|246|0.03659,LIRI-JP|1|260|0.00385,COCA-CN|2|187|0.01070,ESAD-UK|2|119|0.01681,ESCA-CN|3|228|0.01316,LIHC-US|1|188|0.00532,GACA-CN|1|9|0.11111,LINC-JP|1|244|0.00410,GBM-US|1|268|0.00373,PRAD-US|1|256|0.00391,BRCA-EU|21|560|0.03750,PACA-AU|1|391|0.00256,ORCA-IN|1|106|0.00943,KIRC-US|1|404|0.00248,COAD-US|8|216|0.03704	COREAD
3	178936082	178936082	G	A	exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K	exonic;exonic;exonic;exonic	ENSG00000121879	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K	exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K	.	.	.	.	.	.	.	.	.	.	rs121913273	0.016	D	0.995	D	0.912	D	0.000	D	1	D	1.27	L	0.05	T	-2.09	N	0.921	5.844	27.3	0.999	0.973	D	-0.729	T	0.309	T	0.732	0	5.78	0.917	0.998	0.999	0.997	20.002	.	.	Armadillo-type fold;Phosphoinositide 3-kinase, accessory (PIK) domain	Pathogenic|Pathogenic|Pathogenic	Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Neoplasm_of_ovary|Non-small_cell_lung_cancer	RCV000024622.6|RCV000151649.1|RCV000154513.1	MedGen:OMIM:Orphanet|Gene:MedGen:OMIM:SNOMED_CT|MeSH:MedGen:SNOMED_CT	C2752042:612918:ORPHA140944|6765:C0919267:167000:123843001|D002289:C0007131:254637007	ID=COSM760,COSM125369;OCCURENCE=5(gastrointestinal_tract_(site_indeterminate)),2(haematopoietic_and_lymphoid_tissue),7(cervix),18(lung),4(penis),15(thyroid),9(oesophagus),27(upper_aerodigestive_tract),8(central_nervous_system),16(stomach),1(biliary_tract),236(large_intestine),1(prostate),1(pancreas),3(kidney),9(liver),55(urinary_tract),1(small_intestine),21(skin),230(breast),54(endometrium),3(salivary_gland),21(ovary),2(soft_tissue),1(pituitary)	MU5136	KIRP-US|1|159|0.00629,BRCA-UK|3|117|0.02564,BTCA-JP|4|239|0.01674,LUSC-US|3|178|0.01685,LGG-US|2|283|0.00707,STAD-US|5|289|0.01730,BLCA-CN|4|103|0.03883,CESC-US|12|194|0.06186,BRCA-US|39|955|0.04084,UCEC-US|9|246|0.03659,LIRI-JP|1|260|0.00385,COCA-CN|2|187|0.01070,ESAD-UK|2|119|0.01681,ESCA-CN|3|228|0.01316,LIHC-US|1|188|0.00532,GACA-CN|1|9|0.11111,LINC-JP|1|244|0.00410,GBM-US|1|268|0.00373,PRAD-US|1|256|0.00391,BRCA-EU|21|560|0.03750,PACA-AU|1|391|0.00256,ORCA-IN|1|106|0.00943,KIRC-US|1|404|0.00248,COAD-US|8|216|0.03704	HNSC
3	178936082	178936082	G	A	exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K;PIK3CA:NM_006218:exon10:c.G1624A:p.E542K	exonic;exonic;exonic;exonic	ENSG00000121879	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K;ENSG00000121879:ENST00000263967:exon10:c.G1624A:p.E542K	exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K;PIK3CA:uc003fjk.3:exon10:c.G1624A:p.E542K	.	.	.	.	.	.	.	.	.	.	rs121913273	0.016	D	0.995	D	0.912	D	0.000	D	1	D	1.27	L	0.05	T	-2.09	N	0.921	5.844	27.3	0.999	0.973	D	-0.729	T	0.309	T	0.732	0	5.78	0.917	0.998	0.999	0.997	20.002	.	.	Armadillo-type fold;Phosphoinositide 3-kinase, accessory (PIK) domain	Pathogenic|Pathogenic|Pathogenic	Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Neoplasm_of_ovary|Non-small_cell_lung_cancer	RCV000024622.6|RCV000151649.1|RCV000154513.1	MedGen:OMIM:Orphanet|Gene:MedGen:OMIM:SNOMED_CT|MeSH:MedGen:SNOMED_CT	C2752042:612918:ORPHA140944|6765:C0919267:167000:123843001|D002289:C0007131:254637007	ID=COSM760,COSM125369;OCCURENCE=5(gastrointestinal_tract_(site_indeterminate)),2(haematopoietic_and_lymphoid_tissue),7(cervix),18(lung),4(penis),15(thyroid),9(oesophagus),27(upper_aerodigestive_tract),8(central_nervous_system),16(stomach),1(biliary_tract),236(large_intestine),1(prostate),1(pancreas),3(kidney),9(liver),55(urinary_tract),1(small_intestine),21(skin),230(breast),54(endometrium),3(salivary_gland),21(ovary),2(soft_tissue),1(pituitary)	MU5136	KIRP-US|1|159|0.00629,BRCA-UK|3|117|0.02564,BTCA-JP|4|239|0.01674,LUSC-US|3|178|0.01685,LGG-US|2|283|0.00707,STAD-US|5|289|0.01730,BLCA-CN|4|103|0.03883,CESC-US|12|194|0.06186,BRCA-US|39|955|0.04084,UCEC-US|9|246|0.03659,LIRI-JP|1|260|0.00385,COCA-CN|2|187|0.01070,ESAD-UK|2|119|0.01681,ESCA-CN|3|228|0.01316,LIHC-US|1|188|0.00532,GACA-CN|1|9|0.11111,LINC-JP|1|244|0.00410,GBM-US|1|268|0.00373,PRAD-US|1|256|0.00391,BRCA-EU|21|560|0.03750,PACA-AU|1|391|0.00256,ORCA-IN|1|106|0.00943,KIRC-US|1|404|0.00248,COAD-US|8|216|0.03704	TH
3	178936091	178936091	G	A	exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K	exonic;exonic;exonic;exonic;exonic	ENSG00000121879	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K	exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K	.	.	8.34e-06	0	0	0	0	1.508e-05	0	0	rs104886003	0.002	D	0.991	D	0.909	D	0.000	D	1	D	1.62	L	-0.03	T	-3.28	D	0.961	6.953	33	0.999	0.973	D	-0.529	T	0.364	T	0.732	0	5.78	0.917	0.998	1.000	0.999	20.002	.	.	Armadillo-type fold;Phosphoinositide 3-kinase, accessory (PIK) domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|not provided	Breast_adenocarcinoma|Ovarian_epithelial_cancer|Carcinoma_of_colon|Neoplasm_of_stomach|Keratosis,_seborrheic|Non-small_cell_lung_cancer|Megalencephaly_cutis_marmorata_telangiectatica_congenita|Sarcoma	RCV000014631.4|RCV000014632.4|RCV000014633.4|RCV000014634.4|RCV000014636.4|RCV000038671.7|RCV000055930.5|RCV000119356.1	MedGen|MedGen|MedGen:OMIM:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM|MeSH:MedGen:SNOMED_CT|MedGen:OMIM|MedGen	C0858252|C0677886|C0699790:114500:269533000|D013274:C0038356:613659:126824007|C0022603:182000|D002289:C0007131:254637007|C1865285:602501|C1261473	ID=COSM763,COSM125370;OCCURENCE=4(salivary_gland),38(endometrium),4(soft_tissue),28(ovary),1(pituitary),4(kidney),3(pancreas),3(liver),126(urinary_tract),1(biliary_tract),373(large_intestine),1(prostate),365(breast),16(skin),1(small_intestine),41(upper_aerodigestive_tract),8(oesophagus),18(stomach),17(central_nervous_system),21(cervix),7(gastrointestinal_tract_(site_indeterminate)),4(penis),44(lung),7(thyroid)	MU5219	BRCA-UK|4|117|0.03419,KIRP-US|1|159|0.00629,BTCA-JP|3|239|0.01255,LUSC-US|10|178|0.05618,OV-US|1|88|0.01136,READ-US|1|80|0.01250,LICA-FR|1|240|0.00417,BRCA-US|61|955|0.06387,LUSC-KR|2|66|0.03030,COCA-CN|4|187|0.02139,LIHC-US|1|188|0.00532,GBM-US|4|268|0.01493,LINC-JP|2|244|0.00820,PRAD-US|1|256|0.00391,PACA-AU|1|391|0.00256,COAD-US|19|216|0.08796,LGG-US|1|283|0.00353,STAD-US|11|289|0.03806,CESC-US|25|194|0.12887,BLCA-CN|9|103|0.08738,UCEC-US|10|246|0.04065,ESAD-UK|4|119|0.03361,ESCA-CN|4|228|0.01754,BRCA-EU|30|560|0.05357,ORCA-IN|1|106|0.00943,KIRC-US|1|404|0.00248,SKCM-US|2|335|0.00597	BRACA
3	178936091	178936091	G	A	exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K	exonic;exonic;exonic;exonic;exonic	ENSG00000121879	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K	exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K	.	.	8.34e-06	0	0	0	0	1.508e-05	0	0	rs104886003	0.002	D	0.991	D	0.909	D	0.000	D	1	D	1.62	L	-0.03	T	-3.28	D	0.961	6.953	33	0.999	0.973	D	-0.529	T	0.364	T	0.732	0	5.78	0.917	0.998	1.000	0.999	20.002	.	.	Armadillo-type fold;Phosphoinositide 3-kinase, accessory (PIK) domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|not provided	Breast_adenocarcinoma|Ovarian_epithelial_cancer|Carcinoma_of_colon|Neoplasm_of_stomach|Keratosis,_seborrheic|Non-small_cell_lung_cancer|Megalencephaly_cutis_marmorata_telangiectatica_congenita|Sarcoma	RCV000014631.4|RCV000014632.4|RCV000014633.4|RCV000014634.4|RCV000014636.4|RCV000038671.7|RCV000055930.5|RCV000119356.1	MedGen|MedGen|MedGen:OMIM:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM|MeSH:MedGen:SNOMED_CT|MedGen:OMIM|MedGen	C0858252|C0677886|C0699790:114500:269533000|D013274:C0038356:613659:126824007|C0022603:182000|D002289:C0007131:254637007|C1865285:602501|C1261473	ID=COSM763,COSM125370;OCCURENCE=4(salivary_gland),38(endometrium),4(soft_tissue),28(ovary),1(pituitary),4(kidney),3(pancreas),3(liver),126(urinary_tract),1(biliary_tract),373(large_intestine),1(prostate),365(breast),16(skin),1(small_intestine),41(upper_aerodigestive_tract),8(oesophagus),18(stomach),17(central_nervous_system),21(cervix),7(gastrointestinal_tract_(site_indeterminate)),4(penis),44(lung),7(thyroid)	MU5219	BRCA-UK|4|117|0.03419,KIRP-US|1|159|0.00629,BTCA-JP|3|239|0.01255,LUSC-US|10|178|0.05618,OV-US|1|88|0.01136,READ-US|1|80|0.01250,LICA-FR|1|240|0.00417,BRCA-US|61|955|0.06387,LUSC-KR|2|66|0.03030,COCA-CN|4|187|0.02139,LIHC-US|1|188|0.00532,GBM-US|4|268|0.01493,LINC-JP|2|244|0.00820,PRAD-US|1|256|0.00391,PACA-AU|1|391|0.00256,COAD-US|19|216|0.08796,LGG-US|1|283|0.00353,STAD-US|11|289|0.03806,CESC-US|25|194|0.12887,BLCA-CN|9|103|0.08738,UCEC-US|10|246|0.04065,ESAD-UK|4|119|0.03361,ESCA-CN|4|228|0.01754,BRCA-EU|30|560|0.05357,ORCA-IN|1|106|0.00943,KIRC-US|1|404|0.00248,SKCM-US|2|335|0.00597	CANCER
3	178936091	178936091	G	A	exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K	exonic;exonic;exonic;exonic;exonic	ENSG00000121879	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K	exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K	.	.	8.34e-06	0	0	0	0	1.508e-05	0	0	rs104886003	0.002	D	0.991	D	0.909	D	0.000	D	1	D	1.62	L	-0.03	T	-3.28	D	0.961	6.953	33	0.999	0.973	D	-0.529	T	0.364	T	0.732	0	5.78	0.917	0.998	1.000	0.999	20.002	.	.	Armadillo-type fold;Phosphoinositide 3-kinase, accessory (PIK) domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|not provided	Breast_adenocarcinoma|Ovarian_epithelial_cancer|Carcinoma_of_colon|Neoplasm_of_stomach|Keratosis,_seborrheic|Non-small_cell_lung_cancer|Megalencephaly_cutis_marmorata_telangiectatica_congenita|Sarcoma	RCV000014631.4|RCV000014632.4|RCV000014633.4|RCV000014634.4|RCV000014636.4|RCV000038671.7|RCV000055930.5|RCV000119356.1	MedGen|MedGen|MedGen:OMIM:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM|MeSH:MedGen:SNOMED_CT|MedGen:OMIM|MedGen	C0858252|C0677886|C0699790:114500:269533000|D013274:C0038356:613659:126824007|C0022603:182000|D002289:C0007131:254637007|C1865285:602501|C1261473	ID=COSM763,COSM125370;OCCURENCE=4(salivary_gland),38(endometrium),4(soft_tissue),28(ovary),1(pituitary),4(kidney),3(pancreas),3(liver),126(urinary_tract),1(biliary_tract),373(large_intestine),1(prostate),365(breast),16(skin),1(small_intestine),41(upper_aerodigestive_tract),8(oesophagus),18(stomach),17(central_nervous_system),21(cervix),7(gastrointestinal_tract_(site_indeterminate)),4(penis),44(lung),7(thyroid)	MU5219	BRCA-UK|4|117|0.03419,KIRP-US|1|159|0.00629,BTCA-JP|3|239|0.01255,LUSC-US|10|178|0.05618,OV-US|1|88|0.01136,READ-US|1|80|0.01250,LICA-FR|1|240|0.00417,BRCA-US|61|955|0.06387,LUSC-KR|2|66|0.03030,COCA-CN|4|187|0.02139,LIHC-US|1|188|0.00532,GBM-US|4|268|0.01493,LINC-JP|2|244|0.00820,PRAD-US|1|256|0.00391,PACA-AU|1|391|0.00256,COAD-US|19|216|0.08796,LGG-US|1|283|0.00353,STAD-US|11|289|0.03806,CESC-US|25|194|0.12887,BLCA-CN|9|103|0.08738,UCEC-US|10|246|0.04065,ESAD-UK|4|119|0.03361,ESCA-CN|4|228|0.01754,BRCA-EU|30|560|0.05357,ORCA-IN|1|106|0.00943,KIRC-US|1|404|0.00248,SKCM-US|2|335|0.00597	COREAD
3	178936091	178936091	G	A	exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K	exonic;exonic;exonic;exonic;exonic	ENSG00000121879	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K	exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K	.	.	8.34e-06	0	0	0	0	1.508e-05	0	0	rs104886003	0.002	D	0.991	D	0.909	D	0.000	D	1	D	1.62	L	-0.03	T	-3.28	D	0.961	6.953	33	0.999	0.973	D	-0.529	T	0.364	T	0.732	0	5.78	0.917	0.998	1.000	0.999	20.002	.	.	Armadillo-type fold;Phosphoinositide 3-kinase, accessory (PIK) domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|not provided	Breast_adenocarcinoma|Ovarian_epithelial_cancer|Carcinoma_of_colon|Neoplasm_of_stomach|Keratosis,_seborrheic|Non-small_cell_lung_cancer|Megalencephaly_cutis_marmorata_telangiectatica_congenita|Sarcoma	RCV000014631.4|RCV000014632.4|RCV000014633.4|RCV000014634.4|RCV000014636.4|RCV000038671.7|RCV000055930.5|RCV000119356.1	MedGen|MedGen|MedGen:OMIM:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM|MeSH:MedGen:SNOMED_CT|MedGen:OMIM|MedGen	C0858252|C0677886|C0699790:114500:269533000|D013274:C0038356:613659:126824007|C0022603:182000|D002289:C0007131:254637007|C1865285:602501|C1261473	ID=COSM763,COSM125370;OCCURENCE=4(salivary_gland),38(endometrium),4(soft_tissue),28(ovary),1(pituitary),4(kidney),3(pancreas),3(liver),126(urinary_tract),1(biliary_tract),373(large_intestine),1(prostate),365(breast),16(skin),1(small_intestine),41(upper_aerodigestive_tract),8(oesophagus),18(stomach),17(central_nervous_system),21(cervix),7(gastrointestinal_tract_(site_indeterminate)),4(penis),44(lung),7(thyroid)	MU5219	BRCA-UK|4|117|0.03419,KIRP-US|1|159|0.00629,BTCA-JP|3|239|0.01255,LUSC-US|10|178|0.05618,OV-US|1|88|0.01136,READ-US|1|80|0.01250,LICA-FR|1|240|0.00417,BRCA-US|61|955|0.06387,LUSC-KR|2|66|0.03030,COCA-CN|4|187|0.02139,LIHC-US|1|188|0.00532,GBM-US|4|268|0.01493,LINC-JP|2|244|0.00820,PRAD-US|1|256|0.00391,PACA-AU|1|391|0.00256,COAD-US|19|216|0.08796,LGG-US|1|283|0.00353,STAD-US|11|289|0.03806,CESC-US|25|194|0.12887,BLCA-CN|9|103|0.08738,UCEC-US|10|246|0.04065,ESAD-UK|4|119|0.03361,ESCA-CN|4|228|0.01754,BRCA-EU|30|560|0.05357,ORCA-IN|1|106|0.00943,KIRC-US|1|404|0.00248,SKCM-US|2|335|0.00597	Her2-receptor Positive Breast Cancer
3	178936091	178936091	G	A	exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K;PIK3CA:NM_006218:exon10:c.G1633A:p.E545K	exonic;exonic;exonic;exonic;exonic	ENSG00000121879	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K;ENSG00000121879:ENST00000263967:exon10:c.G1633A:p.E545K	exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K;PIK3CA:uc003fjk.3:exon10:c.G1633A:p.E545K	.	.	8.34e-06	0	0	0	0	1.508e-05	0	0	rs104886003	0.002	D	0.991	D	0.909	D	0.000	D	1	D	1.62	L	-0.03	T	-3.28	D	0.961	6.953	33	0.999	0.973	D	-0.529	T	0.364	T	0.732	0	5.78	0.917	0.998	1.000	0.999	20.002	.	.	Armadillo-type fold;Phosphoinositide 3-kinase, accessory (PIK) domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|not provided	Breast_adenocarcinoma|Ovarian_epithelial_cancer|Carcinoma_of_colon|Neoplasm_of_stomach|Keratosis,_seborrheic|Non-small_cell_lung_cancer|Megalencephaly_cutis_marmorata_telangiectatica_congenita|Sarcoma	RCV000014631.4|RCV000014632.4|RCV000014633.4|RCV000014634.4|RCV000014636.4|RCV000038671.7|RCV000055930.5|RCV000119356.1	MedGen|MedGen|MedGen:OMIM:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM|MeSH:MedGen:SNOMED_CT|MedGen:OMIM|MedGen	C0858252|C0677886|C0699790:114500:269533000|D013274:C0038356:613659:126824007|C0022603:182000|D002289:C0007131:254637007|C1865285:602501|C1261473	ID=COSM763,COSM125370;OCCURENCE=4(salivary_gland),38(endometrium),4(soft_tissue),28(ovary),1(pituitary),4(kidney),3(pancreas),3(liver),126(urinary_tract),1(biliary_tract),373(large_intestine),1(prostate),365(breast),16(skin),1(small_intestine),41(upper_aerodigestive_tract),8(oesophagus),18(stomach),17(central_nervous_system),21(cervix),7(gastrointestinal_tract_(site_indeterminate)),4(penis),44(lung),7(thyroid)	MU5219	BRCA-UK|4|117|0.03419,KIRP-US|1|159|0.00629,BTCA-JP|3|239|0.01255,LUSC-US|10|178|0.05618,OV-US|1|88|0.01136,READ-US|1|80|0.01250,LICA-FR|1|240|0.00417,BRCA-US|61|955|0.06387,LUSC-KR|2|66|0.03030,COCA-CN|4|187|0.02139,LIHC-US|1|188|0.00532,GBM-US|4|268|0.01493,LINC-JP|2|244|0.00820,PRAD-US|1|256|0.00391,PACA-AU|1|391|0.00256,COAD-US|19|216|0.08796,LGG-US|1|283|0.00353,STAD-US|11|289|0.03806,CESC-US|25|194|0.12887,BLCA-CN|9|103|0.08738,UCEC-US|10|246|0.04065,ESAD-UK|4|119|0.03361,ESCA-CN|4|228|0.01754,BRCA-EU|30|560|0.05357,ORCA-IN|1|106|0.00943,KIRC-US|1|404|0.00248,SKCM-US|2|335|0.00597	LUAD
3	178952085	178952085	A	G	exonic;exonic;exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R	exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000121879	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R	exonic;exonic;exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R	.	.	8.317e-06	0	0	0	0	1.505e-05	0	0	rs121913279	0.019	D	0.639	P	0.085	B	0.000	D	1	D	0	N	-1.35	T	-1.38	N	0.882	2.589	20.1	0.990	0.961	D	-0.565	T	0.243	T	0.707	0	6.08	1.062	1.140	1.000	1.000	16.651	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Protein kinase-like domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic	Breast_adenocarcinoma|Ovarian_epithelial_cancer|Carcinoma_of_colon|Neoplasm_of_stomach|Hepatocellular_carcinoma|Non-small_cell_lung_cancer|Keratosis,_seborrheic|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Neoplasm_of_ovary|PIK3CA_related_overgrowth_spectrum,Breast_adenocarcinoma|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|PIK3CA_related_overgrowth_spectrum	RCV000014622.5|RCV000014623.5|RCV000014624.4|RCV000014625.4|RCV000014626.5|RCV000014627.6|RCV000014628.5|RCV000024621.7|RCV000154516.1|RCV000201231.1,RCV000014629.4|RCV000032905.6|RCV000201235.1	MedGen|MedGen|MedGen:OMIM:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT:SNOMED_CT|MeSH:MedGen:SNOMED_CT|MedGen:OMIM|MedGen:OMIM:Orphanet|Gene:MedGen:OMIM:SNOMED_CT|MedGen,MedGen|MedGen:OMIM:Orphanet|MedGen	C0858252|C0677886|C0699790:114500:269533000|D013274:C0038356:613659:126824007|C2239176:114550:ORPHA88673:187769009:25370001|D002289:C0007131:254637007|C0022603:182000|C2752042:612918:ORPHA140944|6765:C0919267:167000:123843001|CN233161,C0858252|C2752042:612918:ORPHA140944|CN233161	ID=COSM94986,COSM775;OCCURENCE=249(large_intestine),2(prostate),2(kidney),9(liver),5(pancreas),30(urinary_tract),1(small_intestine),6(skin),1005(breast),125(endometrium),3(salivary_gland),83(ovary),7(soft_tissue),2(pituitary),8(gastrointestinal_tract_(site_indeterminate)),3(haematopoietic_and_lymphoid_tissue),3(cervix),2(meninges),15(lung),8(thyroid),4(oesophagus),8(NS),30(upper_aerodigestive_tract),19(central_nervous_system),22(stomach)	MU4468	BRCA-UK|15|117|0.12821,BTCA-JP|2|239|0.00837,LUSC-US|2|178|0.01124,OV-US|1|88|0.01136,READ-US|1|80|0.01250,LICA-FR|2|240|0.00833,BRCA-US|124|955|0.12984,COCA-CN|3|187|0.01604,LIHC-US|2|188|0.01064,LINC-JP|2|244|0.00820,GBM-US|2|268|0.00746,PRAD-US|1|256|0.00391,PRAD-CA|1|124|0.00806,PACA-AU|2|391|0.00512,COAD-US|6|216|0.02778,LGG-US|1|283|0.00353,STAD-US|12|289|0.04152,CESC-US|1|194|0.00515,BLCA-CN|1|103|0.00971,UCEC-US|12|246|0.04878,LIRI-JP|2|260|0.00769,ESCA-CN|1|228|0.00439,BRCA-EU|51|560|0.09107,ORCA-IN|3|106|0.02830,PBCA-DE|1|246|0.00407	BRACA
3	178952085	178952085	A	G	exonic;exonic;exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R	exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000121879	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R	exonic;exonic;exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R	.	.	8.317e-06	0	0	0	0	1.505e-05	0	0	rs121913279	0.019	D	0.639	P	0.085	B	0.000	D	1	D	0	N	-1.35	T	-1.38	N	0.882	2.589	20.1	0.990	0.961	D	-0.565	T	0.243	T	0.707	0	6.08	1.062	1.140	1.000	1.000	16.651	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Protein kinase-like domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic	Breast_adenocarcinoma|Ovarian_epithelial_cancer|Carcinoma_of_colon|Neoplasm_of_stomach|Hepatocellular_carcinoma|Non-small_cell_lung_cancer|Keratosis,_seborrheic|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Neoplasm_of_ovary|PIK3CA_related_overgrowth_spectrum,Breast_adenocarcinoma|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|PIK3CA_related_overgrowth_spectrum	RCV000014622.5|RCV000014623.5|RCV000014624.4|RCV000014625.4|RCV000014626.5|RCV000014627.6|RCV000014628.5|RCV000024621.7|RCV000154516.1|RCV000201231.1,RCV000014629.4|RCV000032905.6|RCV000201235.1	MedGen|MedGen|MedGen:OMIM:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT:SNOMED_CT|MeSH:MedGen:SNOMED_CT|MedGen:OMIM|MedGen:OMIM:Orphanet|Gene:MedGen:OMIM:SNOMED_CT|MedGen,MedGen|MedGen:OMIM:Orphanet|MedGen	C0858252|C0677886|C0699790:114500:269533000|D013274:C0038356:613659:126824007|C2239176:114550:ORPHA88673:187769009:25370001|D002289:C0007131:254637007|C0022603:182000|C2752042:612918:ORPHA140944|6765:C0919267:167000:123843001|CN233161,C0858252|C2752042:612918:ORPHA140944|CN233161	ID=COSM94986,COSM775;OCCURENCE=249(large_intestine),2(prostate),2(kidney),9(liver),5(pancreas),30(urinary_tract),1(small_intestine),6(skin),1005(breast),125(endometrium),3(salivary_gland),83(ovary),7(soft_tissue),2(pituitary),8(gastrointestinal_tract_(site_indeterminate)),3(haematopoietic_and_lymphoid_tissue),3(cervix),2(meninges),15(lung),8(thyroid),4(oesophagus),8(NS),30(upper_aerodigestive_tract),19(central_nervous_system),22(stomach)	MU4468	BRCA-UK|15|117|0.12821,BTCA-JP|2|239|0.00837,LUSC-US|2|178|0.01124,OV-US|1|88|0.01136,READ-US|1|80|0.01250,LICA-FR|2|240|0.00833,BRCA-US|124|955|0.12984,COCA-CN|3|187|0.01604,LIHC-US|2|188|0.01064,LINC-JP|2|244|0.00820,GBM-US|2|268|0.00746,PRAD-US|1|256|0.00391,PRAD-CA|1|124|0.00806,PACA-AU|2|391|0.00512,COAD-US|6|216|0.02778,LGG-US|1|283|0.00353,STAD-US|12|289|0.04152,CESC-US|1|194|0.00515,BLCA-CN|1|103|0.00971,UCEC-US|12|246|0.04878,LIRI-JP|2|260|0.00769,ESCA-CN|1|228|0.00439,BRCA-EU|51|560|0.09107,ORCA-IN|3|106|0.02830,PBCA-DE|1|246|0.00407	COREAD
3	178952085	178952085	A	G	exonic;exonic;exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R	exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000121879	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R	exonic;exonic;exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R	.	.	8.317e-06	0	0	0	0	1.505e-05	0	0	rs121913279	0.019	D	0.639	P	0.085	B	0.000	D	1	D	0	N	-1.35	T	-1.38	N	0.882	2.589	20.1	0.990	0.961	D	-0.565	T	0.243	T	0.707	0	6.08	1.062	1.140	1.000	1.000	16.651	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Protein kinase-like domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic	Breast_adenocarcinoma|Ovarian_epithelial_cancer|Carcinoma_of_colon|Neoplasm_of_stomach|Hepatocellular_carcinoma|Non-small_cell_lung_cancer|Keratosis,_seborrheic|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Neoplasm_of_ovary|PIK3CA_related_overgrowth_spectrum,Breast_adenocarcinoma|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|PIK3CA_related_overgrowth_spectrum	RCV000014622.5|RCV000014623.5|RCV000014624.4|RCV000014625.4|RCV000014626.5|RCV000014627.6|RCV000014628.5|RCV000024621.7|RCV000154516.1|RCV000201231.1,RCV000014629.4|RCV000032905.6|RCV000201235.1	MedGen|MedGen|MedGen:OMIM:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT:SNOMED_CT|MeSH:MedGen:SNOMED_CT|MedGen:OMIM|MedGen:OMIM:Orphanet|Gene:MedGen:OMIM:SNOMED_CT|MedGen,MedGen|MedGen:OMIM:Orphanet|MedGen	C0858252|C0677886|C0699790:114500:269533000|D013274:C0038356:613659:126824007|C2239176:114550:ORPHA88673:187769009:25370001|D002289:C0007131:254637007|C0022603:182000|C2752042:612918:ORPHA140944|6765:C0919267:167000:123843001|CN233161,C0858252|C2752042:612918:ORPHA140944|CN233161	ID=COSM94986,COSM775;OCCURENCE=249(large_intestine),2(prostate),2(kidney),9(liver),5(pancreas),30(urinary_tract),1(small_intestine),6(skin),1005(breast),125(endometrium),3(salivary_gland),83(ovary),7(soft_tissue),2(pituitary),8(gastrointestinal_tract_(site_indeterminate)),3(haematopoietic_and_lymphoid_tissue),3(cervix),2(meninges),15(lung),8(thyroid),4(oesophagus),8(NS),30(upper_aerodigestive_tract),19(central_nervous_system),22(stomach)	MU4468	BRCA-UK|15|117|0.12821,BTCA-JP|2|239|0.00837,LUSC-US|2|178|0.01124,OV-US|1|88|0.01136,READ-US|1|80|0.01250,LICA-FR|2|240|0.00833,BRCA-US|124|955|0.12984,COCA-CN|3|187|0.01604,LIHC-US|2|188|0.01064,LINC-JP|2|244|0.00820,GBM-US|2|268|0.00746,PRAD-US|1|256|0.00391,PRAD-CA|1|124|0.00806,PACA-AU|2|391|0.00512,COAD-US|6|216|0.02778,LGG-US|1|283|0.00353,STAD-US|12|289|0.04152,CESC-US|1|194|0.00515,BLCA-CN|1|103|0.00971,UCEC-US|12|246|0.04878,LIRI-JP|2|260|0.00769,ESCA-CN|1|228|0.00439,BRCA-EU|51|560|0.09107,ORCA-IN|3|106|0.02830,PBCA-DE|1|246|0.00407	HNC
3	178952085	178952085	A	G	exonic;exonic;exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R	exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000121879	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R	exonic;exonic;exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R	.	.	8.317e-06	0	0	0	0	1.505e-05	0	0	rs121913279	0.019	D	0.639	P	0.085	B	0.000	D	1	D	0	N	-1.35	T	-1.38	N	0.882	2.589	20.1	0.990	0.961	D	-0.565	T	0.243	T	0.707	0	6.08	1.062	1.140	1.000	1.000	16.651	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Protein kinase-like domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic	Breast_adenocarcinoma|Ovarian_epithelial_cancer|Carcinoma_of_colon|Neoplasm_of_stomach|Hepatocellular_carcinoma|Non-small_cell_lung_cancer|Keratosis,_seborrheic|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Neoplasm_of_ovary|PIK3CA_related_overgrowth_spectrum,Breast_adenocarcinoma|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|PIK3CA_related_overgrowth_spectrum	RCV000014622.5|RCV000014623.5|RCV000014624.4|RCV000014625.4|RCV000014626.5|RCV000014627.6|RCV000014628.5|RCV000024621.7|RCV000154516.1|RCV000201231.1,RCV000014629.4|RCV000032905.6|RCV000201235.1	MedGen|MedGen|MedGen:OMIM:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT:SNOMED_CT|MeSH:MedGen:SNOMED_CT|MedGen:OMIM|MedGen:OMIM:Orphanet|Gene:MedGen:OMIM:SNOMED_CT|MedGen,MedGen|MedGen:OMIM:Orphanet|MedGen	C0858252|C0677886|C0699790:114500:269533000|D013274:C0038356:613659:126824007|C2239176:114550:ORPHA88673:187769009:25370001|D002289:C0007131:254637007|C0022603:182000|C2752042:612918:ORPHA140944|6765:C0919267:167000:123843001|CN233161,C0858252|C2752042:612918:ORPHA140944|CN233161	ID=COSM94986,COSM775;OCCURENCE=249(large_intestine),2(prostate),2(kidney),9(liver),5(pancreas),30(urinary_tract),1(small_intestine),6(skin),1005(breast),125(endometrium),3(salivary_gland),83(ovary),7(soft_tissue),2(pituitary),8(gastrointestinal_tract_(site_indeterminate)),3(haematopoietic_and_lymphoid_tissue),3(cervix),2(meninges),15(lung),8(thyroid),4(oesophagus),8(NS),30(upper_aerodigestive_tract),19(central_nervous_system),22(stomach)	MU4468	BRCA-UK|15|117|0.12821,BTCA-JP|2|239|0.00837,LUSC-US|2|178|0.01124,OV-US|1|88|0.01136,READ-US|1|80|0.01250,LICA-FR|2|240|0.00833,BRCA-US|124|955|0.12984,COCA-CN|3|187|0.01604,LIHC-US|2|188|0.01064,LINC-JP|2|244|0.00820,GBM-US|2|268|0.00746,PRAD-US|1|256|0.00391,PRAD-CA|1|124|0.00806,PACA-AU|2|391|0.00512,COAD-US|6|216|0.02778,LGG-US|1|283|0.00353,STAD-US|12|289|0.04152,CESC-US|1|194|0.00515,BLCA-CN|1|103|0.00971,UCEC-US|12|246|0.04878,LIRI-JP|2|260|0.00769,ESCA-CN|1|228|0.00439,BRCA-EU|51|560|0.09107,ORCA-IN|3|106|0.02830,PBCA-DE|1|246|0.00407	HNSC
3	178952085	178952085	A	G	exonic;exonic;exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R	exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000121879	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R	exonic;exonic;exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R	.	.	8.317e-06	0	0	0	0	1.505e-05	0	0	rs121913279	0.019	D	0.639	P	0.085	B	0.000	D	1	D	0	N	-1.35	T	-1.38	N	0.882	2.589	20.1	0.990	0.961	D	-0.565	T	0.243	T	0.707	0	6.08	1.062	1.140	1.000	1.000	16.651	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Protein kinase-like domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic	Breast_adenocarcinoma|Ovarian_epithelial_cancer|Carcinoma_of_colon|Neoplasm_of_stomach|Hepatocellular_carcinoma|Non-small_cell_lung_cancer|Keratosis,_seborrheic|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Neoplasm_of_ovary|PIK3CA_related_overgrowth_spectrum,Breast_adenocarcinoma|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|PIK3CA_related_overgrowth_spectrum	RCV000014622.5|RCV000014623.5|RCV000014624.4|RCV000014625.4|RCV000014626.5|RCV000014627.6|RCV000014628.5|RCV000024621.7|RCV000154516.1|RCV000201231.1,RCV000014629.4|RCV000032905.6|RCV000201235.1	MedGen|MedGen|MedGen:OMIM:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT:SNOMED_CT|MeSH:MedGen:SNOMED_CT|MedGen:OMIM|MedGen:OMIM:Orphanet|Gene:MedGen:OMIM:SNOMED_CT|MedGen,MedGen|MedGen:OMIM:Orphanet|MedGen	C0858252|C0677886|C0699790:114500:269533000|D013274:C0038356:613659:126824007|C2239176:114550:ORPHA88673:187769009:25370001|D002289:C0007131:254637007|C0022603:182000|C2752042:612918:ORPHA140944|6765:C0919267:167000:123843001|CN233161,C0858252|C2752042:612918:ORPHA140944|CN233161	ID=COSM94986,COSM775;OCCURENCE=249(large_intestine),2(prostate),2(kidney),9(liver),5(pancreas),30(urinary_tract),1(small_intestine),6(skin),1005(breast),125(endometrium),3(salivary_gland),83(ovary),7(soft_tissue),2(pituitary),8(gastrointestinal_tract_(site_indeterminate)),3(haematopoietic_and_lymphoid_tissue),3(cervix),2(meninges),15(lung),8(thyroid),4(oesophagus),8(NS),30(upper_aerodigestive_tract),19(central_nervous_system),22(stomach)	MU4468	BRCA-UK|15|117|0.12821,BTCA-JP|2|239|0.00837,LUSC-US|2|178|0.01124,OV-US|1|88|0.01136,READ-US|1|80|0.01250,LICA-FR|2|240|0.00833,BRCA-US|124|955|0.12984,COCA-CN|3|187|0.01604,LIHC-US|2|188|0.01064,LINC-JP|2|244|0.00820,GBM-US|2|268|0.00746,PRAD-US|1|256|0.00391,PRAD-CA|1|124|0.00806,PACA-AU|2|391|0.00512,COAD-US|6|216|0.02778,LGG-US|1|283|0.00353,STAD-US|12|289|0.04152,CESC-US|1|194|0.00515,BLCA-CN|1|103|0.00971,UCEC-US|12|246|0.04878,LIRI-JP|2|260|0.00769,ESCA-CN|1|228|0.00439,BRCA-EU|51|560|0.09107,ORCA-IN|3|106|0.02830,PBCA-DE|1|246|0.00407	Her2-receptor Positive Breast Cancer
3	178952085	178952085	A	G	exonic;exonic;exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R	exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000121879	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R	exonic;exonic;exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R	.	.	8.317e-06	0	0	0	0	1.505e-05	0	0	rs121913279	0.019	D	0.639	P	0.085	B	0.000	D	1	D	0	N	-1.35	T	-1.38	N	0.882	2.589	20.1	0.990	0.961	D	-0.565	T	0.243	T	0.707	0	6.08	1.062	1.140	1.000	1.000	16.651	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Protein kinase-like domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic	Breast_adenocarcinoma|Ovarian_epithelial_cancer|Carcinoma_of_colon|Neoplasm_of_stomach|Hepatocellular_carcinoma|Non-small_cell_lung_cancer|Keratosis,_seborrheic|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Neoplasm_of_ovary|PIK3CA_related_overgrowth_spectrum,Breast_adenocarcinoma|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|PIK3CA_related_overgrowth_spectrum	RCV000014622.5|RCV000014623.5|RCV000014624.4|RCV000014625.4|RCV000014626.5|RCV000014627.6|RCV000014628.5|RCV000024621.7|RCV000154516.1|RCV000201231.1,RCV000014629.4|RCV000032905.6|RCV000201235.1	MedGen|MedGen|MedGen:OMIM:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT:SNOMED_CT|MeSH:MedGen:SNOMED_CT|MedGen:OMIM|MedGen:OMIM:Orphanet|Gene:MedGen:OMIM:SNOMED_CT|MedGen,MedGen|MedGen:OMIM:Orphanet|MedGen	C0858252|C0677886|C0699790:114500:269533000|D013274:C0038356:613659:126824007|C2239176:114550:ORPHA88673:187769009:25370001|D002289:C0007131:254637007|C0022603:182000|C2752042:612918:ORPHA140944|6765:C0919267:167000:123843001|CN233161,C0858252|C2752042:612918:ORPHA140944|CN233161	ID=COSM94986,COSM775;OCCURENCE=249(large_intestine),2(prostate),2(kidney),9(liver),5(pancreas),30(urinary_tract),1(small_intestine),6(skin),1005(breast),125(endometrium),3(salivary_gland),83(ovary),7(soft_tissue),2(pituitary),8(gastrointestinal_tract_(site_indeterminate)),3(haematopoietic_and_lymphoid_tissue),3(cervix),2(meninges),15(lung),8(thyroid),4(oesophagus),8(NS),30(upper_aerodigestive_tract),19(central_nervous_system),22(stomach)	MU4468	BRCA-UK|15|117|0.12821,BTCA-JP|2|239|0.00837,LUSC-US|2|178|0.01124,OV-US|1|88|0.01136,READ-US|1|80|0.01250,LICA-FR|2|240|0.00833,BRCA-US|124|955|0.12984,COCA-CN|3|187|0.01604,LIHC-US|2|188|0.01064,LINC-JP|2|244|0.00820,GBM-US|2|268|0.00746,PRAD-US|1|256|0.00391,PRAD-CA|1|124|0.00806,PACA-AU|2|391|0.00512,COAD-US|6|216|0.02778,LGG-US|1|283|0.00353,STAD-US|12|289|0.04152,CESC-US|1|194|0.00515,BLCA-CN|1|103|0.00971,UCEC-US|12|246|0.04878,LIRI-JP|2|260|0.00769,ESCA-CN|1|228|0.00439,BRCA-EU|51|560|0.09107,ORCA-IN|3|106|0.02830,PBCA-DE|1|246|0.00407	LUAD
3	178952085	178952085	A	G	exonic;exonic;exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R;PIK3CA:NM_006218:exon21:c.A3140G:p.H1047R	exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000121879	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R;ENSG00000121879:ENST00000263967:exon21:c.A3140G:p.H1047R	exonic;exonic;exonic;exonic;exonic;exonic;exonic	PIK3CA	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R;PIK3CA:uc003fjk.3:exon21:c.A3140G:p.H1047R	.	.	8.317e-06	0	0	0	0	1.505e-05	0	0	rs121913279	0.019	D	0.639	P	0.085	B	0.000	D	1	D	0	N	-1.35	T	-1.38	N	0.882	2.589	20.1	0.990	0.961	D	-0.565	T	0.243	T	0.707	0	6.08	1.062	1.140	1.000	1.000	16.651	.	.	Phosphatidylinositol 3-/4-kinase, catalytic domain;Protein kinase-like domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic	Breast_adenocarcinoma|Ovarian_epithelial_cancer|Carcinoma_of_colon|Neoplasm_of_stomach|Hepatocellular_carcinoma|Non-small_cell_lung_cancer|Keratosis,_seborrheic|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Neoplasm_of_ovary|PIK3CA_related_overgrowth_spectrum,Breast_adenocarcinoma|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|PIK3CA_related_overgrowth_spectrum	RCV000014622.5|RCV000014623.5|RCV000014624.4|RCV000014625.4|RCV000014626.5|RCV000014627.6|RCV000014628.5|RCV000024621.7|RCV000154516.1|RCV000201231.1,RCV000014629.4|RCV000032905.6|RCV000201235.1	MedGen|MedGen|MedGen:OMIM:SNOMED_CT|MeSH:MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT:SNOMED_CT|MeSH:MedGen:SNOMED_CT|MedGen:OMIM|MedGen:OMIM:Orphanet|Gene:MedGen:OMIM:SNOMED_CT|MedGen,MedGen|MedGen:OMIM:Orphanet|MedGen	C0858252|C0677886|C0699790:114500:269533000|D013274:C0038356:613659:126824007|C2239176:114550:ORPHA88673:187769009:25370001|D002289:C0007131:254637007|C0022603:182000|C2752042:612918:ORPHA140944|6765:C0919267:167000:123843001|CN233161,C0858252|C2752042:612918:ORPHA140944|CN233161	ID=COSM94986,COSM775;OCCURENCE=249(large_intestine),2(prostate),2(kidney),9(liver),5(pancreas),30(urinary_tract),1(small_intestine),6(skin),1005(breast),125(endometrium),3(salivary_gland),83(ovary),7(soft_tissue),2(pituitary),8(gastrointestinal_tract_(site_indeterminate)),3(haematopoietic_and_lymphoid_tissue),3(cervix),2(meninges),15(lung),8(thyroid),4(oesophagus),8(NS),30(upper_aerodigestive_tract),19(central_nervous_system),22(stomach)	MU4468	BRCA-UK|15|117|0.12821,BTCA-JP|2|239|0.00837,LUSC-US|2|178|0.01124,OV-US|1|88|0.01136,READ-US|1|80|0.01250,LICA-FR|2|240|0.00833,BRCA-US|124|955|0.12984,COCA-CN|3|187|0.01604,LIHC-US|2|188|0.01064,LINC-JP|2|244|0.00820,GBM-US|2|268|0.00746,PRAD-US|1|256|0.00391,PRAD-CA|1|124|0.00806,PACA-AU|2|391|0.00512,COAD-US|6|216|0.02778,LGG-US|1|283|0.00353,STAD-US|12|289|0.04152,CESC-US|1|194|0.00515,BLCA-CN|1|103|0.00971,UCEC-US|12|246|0.04878,LIRI-JP|2|260|0.00769,ESCA-CN|1|228|0.00439,BRCA-EU|51|560|0.09107,ORCA-IN|3|106|0.02830,PBCA-DE|1|246|0.00407	TH
3	38182641	38182641	T	C	exonic;exonic	MYD88	.	stoploss;stoploss	MYD88:NM_001172566:exon3:c.T478C:p.X160R,MYD88:NM_001172569:exon4:c.T613C:p.X205R;MYD88:NM_001172566:exon3:c.T478C:p.X160R,MYD88:NM_001172569:exon4:c.T613C:p.X205R	exonic;exonic	ENSG00000172936	.	stoploss;stoploss	ENSG00000172936:ENST00000495303:exon3:c.T478C:p.X160R,ENSG00000172936:ENST00000443433:exon4:c.T613C:p.X205R;ENSG00000172936:ENST00000495303:exon3:c.T478C:p.X160R,ENSG00000172936:ENST00000443433:exon4:c.T613C:p.X205R	exonic;exonic	MYD88	.	stoploss;stoploss	MYD88:uc011ayk.2:exon3:c.T478C:p.X160R,MYD88:uc011ayj.2:exon4:c.T613C:p.X205R;MYD88:uc011ayk.2:exon3:c.T478C:p.X160R,MYD88:uc011ayj.2:exon4:c.T613C:p.X205R	.	0.000199681	9.885e-05	0	0	0.0001	0.0002	0.0001	0	0	rs387907272	0.0	D	1.0	D	0.999	D	0.000	D	1	D	.	.	2.42	T	-5.24	D	0.996	6.636	32	0.865	0.963	D	-0.482	T	0.337	T	0.732	0	5.74	0.991	1.061	0.999	0.999	15.535	.	.	Toll/interleukin-1 receptor homology (TIR) domain	Pathogenic	Macroglobulinemia,_waldenstrom,_somatic	RCV000030709.6	MedGen	CN143715	ID=COSM85940;OCCURENCE=1079(haematopoietic_and_lymphoid_tissue),3(NS)	MU50057	CLLE-ES|3|218|0.01376	CLL
3	38182641	38182641	T	C	exonic;exonic	MYD88	.	stoploss;stoploss	MYD88:NM_001172566:exon3:c.T478C:p.X160R,MYD88:NM_001172569:exon4:c.T613C:p.X205R;MYD88:NM_001172566:exon3:c.T478C:p.X160R,MYD88:NM_001172569:exon4:c.T613C:p.X205R	exonic;exonic	ENSG00000172936	.	stoploss;stoploss	ENSG00000172936:ENST00000495303:exon3:c.T478C:p.X160R,ENSG00000172936:ENST00000443433:exon4:c.T613C:p.X205R;ENSG00000172936:ENST00000495303:exon3:c.T478C:p.X160R,ENSG00000172936:ENST00000443433:exon4:c.T613C:p.X205R	exonic;exonic	MYD88	.	stoploss;stoploss	MYD88:uc011ayk.2:exon3:c.T478C:p.X160R,MYD88:uc011ayj.2:exon4:c.T613C:p.X205R;MYD88:uc011ayk.2:exon3:c.T478C:p.X160R,MYD88:uc011ayj.2:exon4:c.T613C:p.X205R	.	0.000199681	9.885e-05	0	0	0.0001	0.0002	0.0001	0	0	rs387907272	0.0	D	1.0	D	0.999	D	0.000	D	1	D	.	.	2.42	T	-5.24	D	0.996	6.636	32	0.865	0.963	D	-0.482	T	0.337	T	0.732	0	5.74	0.991	1.061	0.999	0.999	15.535	.	.	Toll/interleukin-1 receptor homology (TIR) domain	Pathogenic	Macroglobulinemia,_waldenstrom,_somatic	RCV000030709.6	MedGen	CN143715	ID=COSM85940;OCCURENCE=1079(haematopoietic_and_lymphoid_tissue),3(NS)	MU50057	CLLE-ES|3|218|0.01376	Waldenstr.ms Macroglobulinemia
4	1803568	1803568	C	G	exonic	FGFR3	.	nonsynonymous SNV	FGFR3:NM_000142:exon7:c.C746G:p.S249C,FGFR3:NM_001163213:exon7:c.C746G:p.S249C,FGFR3:NM_022965:exon7:c.C746G:p.S249C	exonic	ENSG00000068078	.	nonsynonymous SNV	ENSG00000068078:ENST00000507588:exon3:c.C206G:p.S69C,ENSG00000068078:ENST00000260795:exon6:c.C746G:p.S249C,ENSG00000068078:ENST00000352904:exon6:c.C746G:p.S249C,ENSG00000068078:ENST00000340107:exon7:c.C746G:p.S249C,ENSG00000068078:ENST00000412135:exon7:c.C746G:p.S249C,ENSG00000068078:ENST00000440486:exon7:c.C746G:p.S249C,ENSG00000068078:ENST00000481110:exon7:c.C746G:p.S249C	exonic	FGFR3	.	nonsynonymous SNV	FGFR3:uc003gdt.1:exon3:c.C272G:p.S91C,FGFR3:uc010icb.1:exon3:c.C272G:p.S91C,FGFR3:uc003gdq.3:exon7:c.C746G:p.S249C,FGFR3:uc003gdr.3:exon7:c.C746G:p.S249C,FGFR3:uc003gds.3:exon7:c.C746G:p.S249C,FGFR3:uc003gdu.2:exon7:c.C746G:p.S249C	.	.	9.654e-06	0	0	0	0	1.777e-05	0	0	rs121913483	0.045	D	1.0	D	0.994	D	0.000	D	1	A	3.305	M	-1.32	T	-4.17	D	0.877	3.567	23.1	0.988	0.962	D	0.799	D	0.771	D	0.696	0	3.94	0.871	0.721	0.991	0.928	16.288	.	.	.	Pathogenic|Pathogenic|Pathogenic|Pathogenic	Thanatophoric_dysplasia_type_1|Carcinoma_of_cervix|Malignant_tumor_of_urinary_bladder|Keratosis,_seborrheic	RCV000017742.28|RCV000017743.5|RCV000017744.5|RCV000017745.5	MedGen:OMIM|MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen:OMIM	C1868678:187600|C0302592:603956:285432005|C0005684:109800:ORPHA157980:399326009|C0022603:182000	ID=COSM1149892,COSM715;OCCURENCE=5(cervix),2(lung),2(upper_aerodigestive_tract),1203(urinary_tract),27(skin)	MU1305116	LUSC-US|2|178|0.01124,BLCA-CN|3|103|0.02913,BLCA-US|2|130|0.01538	UTH
4	1806099	1806099	A	G	exonic	FGFR3	.	nonsynonymous SNV	FGFR3:NM_000142:exon9:c.A1118G:p.Y373C,FGFR3:NM_001163213:exon9:c.A1124G:p.Y375C	exonic	ENSG00000068078	.	nonsynonymous SNV	ENSG00000068078:ENST00000260795:exon8:c.A1118G:p.Y373C,ENSG00000068078:ENST00000340107:exon9:c.A1124G:p.Y375C,ENSG00000068078:ENST00000440486:exon9:c.A1118G:p.Y373C,ENSG00000068078:ENST00000481110:exon9:c.A1118G:p.Y373C	exonic	FGFR3	.	nonsynonymous SNV	FGFR3:uc003gdq.3:exon9:c.A1118G:p.Y373C,FGFR3:uc003gdr.3:exon9:c.A1118G:p.Y373C,FGFR3:uc003gdu.2:exon9:c.A1124G:p.Y375C	.	.	.	.	.	.	.	.	.	.	rs121913485	0.003	D	0.999	D	0.978	D	0.008	N	1	A	2.595	M	-2.35	D	-6.0	D	0.916	3.448	23.0	0.993	0.979	D	0.732	D	0.782	D	0.696	0	1.93	0.042	1.194	0.944	0.948	8.987	.	.	.	Pathogenic|Pathogenic	Thanatophoric_dysplasia_type_1|not_provided	RCV000017751.24|RCV000255235.1	MedGen:OMIM|MedGen	C1868678:187600|CN221809	ID=COSM718,COSM1666838;OCCURENCE=8(haematopoietic_and_lymphoid_tissue),394(urinary_tract),16(skin)	MU4618837	KIRP-US|1|159|0.00629,BLCA-CN|6|103|0.05825	BLCA
4	55141036	55141036	T	C	exonic	PDGFRA	.	nonsynonymous SNV	PDGFRA:NM_006206:exon12:c.T1682C:p.V561A	exonic	ENSG00000134853	.	nonsynonymous SNV	ENSG00000134853:ENST00000257290:exon12:c.T1682C:p.V561A,ENSG00000134853:ENST00000509490:exon12:c.T1682C:p.V561A	exonic	PDGFRA	.	nonsynonymous SNV	PDGFRA:uc010igq.1:exon11:c.T1364C:p.V455A,PDGFRA:uc003han.4:exon12:c.T1682C:p.V561A	.	.	.	.	.	.	.	.	.	.	.	0.005	D	1.0	D	1.0	D	0.012	U	1	D	3.055	M	-3.63	D	-3.38	D	0.903	5.603	26.5	0.999	0.983	D	0.938	D	0.912	D	0.598	0	4.67	0.991	0.114	0.999	0.996	13.137	.	.	.	.	.	.	.	.	ID=COSM1430077;OCCURENCE=1(large_intestine)	.	.	GIST
4	55144547	55144547	C	T	exonic;exonic	PDGFRA	.	nonsynonymous SNV;nonsynonymous SNV	PDGFRA:NM_006206:exon15:c.C2021T:p.T674I;PDGFRA:NM_006206:exon15:c.C2021T:p.T674I	exonic;exonic	ENSG00000134853,ENSG00000145216	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000134853:ENST00000257290:exon15:c.C2021T:p.T674I,ENSG00000134853:ENST00000509490:exon15:c.C2021T:p.T674I,ENSG00000145216:ENST00000507166:exon16:c.C1301T:p.T434I;ENSG00000134853:ENST00000257290:exon15:c.C2021T:p.T674I,ENSG00000134853:ENST00000509490:exon15:c.C2021T:p.T674I,ENSG00000145216:ENST00000507166:exon16:c.C1301T:p.T434I	exonic;exonic	PDGFRA	.	nonsynonymous SNV;nonsynonymous SNV	PDGFRA:uc003hao.1:exon3:c.C158T:p.T53I,PDGFRA:uc010igq.1:exon14:c.C1703T:p.T568I,PDGFRA:uc003han.4:exon15:c.C2021T:p.T674I,PDGFRA:uc003haa.3:exon16:c.C1301T:p.T434I;PDGFRA:uc003hao.1:exon3:c.C158T:p.T53I,PDGFRA:uc010igq.1:exon14:c.C1703T:p.T568I,PDGFRA:uc003han.4:exon15:c.C2021T:p.T674I,PDGFRA:uc003haa.3:exon16:c.C1301T:p.T434I	.	.	.	.	.	.	.	.	.	.	rs121908587	0.007	D	1.0	D	0.999	D	0.005	U	1	A	0.55	N	-2.53	D	-5.48	D	0.983	6.999	33	0.998	0.988	D	0.554	D	0.721	D	0.560	0	6.06	0.871	0.935	0.997	0.767	20.621	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic	Hypereosinophilic_syndrome,_idiopathic,_resistant_to_imatinib	RCV000014509.25	MedGen	C4016331	ID=COSM743;OCCURENCE=1(large_intestine),4(haematopoietic_and_lymphoid_tissue)	.	.	Chronic Eosinophilic Leukemia
4	55144547	55144547	C	T	exonic;exonic	PDGFRA	.	nonsynonymous SNV;nonsynonymous SNV	PDGFRA:NM_006206:exon15:c.C2021T:p.T674I;PDGFRA:NM_006206:exon15:c.C2021T:p.T674I	exonic;exonic	ENSG00000134853,ENSG00000145216	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000134853:ENST00000257290:exon15:c.C2021T:p.T674I,ENSG00000134853:ENST00000509490:exon15:c.C2021T:p.T674I,ENSG00000145216:ENST00000507166:exon16:c.C1301T:p.T434I;ENSG00000134853:ENST00000257290:exon15:c.C2021T:p.T674I,ENSG00000134853:ENST00000509490:exon15:c.C2021T:p.T674I,ENSG00000145216:ENST00000507166:exon16:c.C1301T:p.T434I	exonic;exonic	PDGFRA	.	nonsynonymous SNV;nonsynonymous SNV	PDGFRA:uc003hao.1:exon3:c.C158T:p.T53I,PDGFRA:uc010igq.1:exon14:c.C1703T:p.T568I,PDGFRA:uc003han.4:exon15:c.C2021T:p.T674I,PDGFRA:uc003haa.3:exon16:c.C1301T:p.T434I;PDGFRA:uc003hao.1:exon3:c.C158T:p.T53I,PDGFRA:uc010igq.1:exon14:c.C1703T:p.T568I,PDGFRA:uc003han.4:exon15:c.C2021T:p.T674I,PDGFRA:uc003haa.3:exon16:c.C1301T:p.T434I	.	.	.	.	.	.	.	.	.	.	rs121908587	0.007	D	1.0	D	0.999	D	0.005	U	1	A	0.55	N	-2.53	D	-5.48	D	0.983	6.999	33	0.998	0.988	D	0.554	D	0.721	D	0.560	0	6.06	0.871	0.935	0.997	0.767	20.621	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic	Hypereosinophilic_syndrome,_idiopathic,_resistant_to_imatinib	RCV000014509.25	MedGen	C4016331	ID=COSM743;OCCURENCE=1(large_intestine),4(haematopoietic_and_lymphoid_tissue)	.	.	Hypereosinophilic Syndrome, Myeloproliferative Subtype
4	55152092	55152092	G	T	exonic	PDGFRA	.	nonsynonymous SNV	PDGFRA:NM_006206:exon18:c.G2524T:p.D842Y	exonic	ENSG00000134853,ENSG00000145216	.	nonsynonymous SNV	ENSG00000134853:ENST00000257290:exon18:c.G2524T:p.D842Y,ENSG00000145216:ENST00000507166:exon19:c.G1804T:p.D602Y	exonic	PDGFRA	.	nonsynonymous SNV	PDGFRA:uc003han.4:exon18:c.G2524T:p.D842Y,PDGFRA:uc003haa.3:exon19:c.G1804T:p.D602Y	.	.	.	.	.	.	.	.	.	.	rs121913265	0.011	D	1.0	D	1.0	D	0.005	U	1	D	0.95	L	-1.76	D	-6.69	D	0.967	7.212	34	0.996	0.994	D	0.289	D	0.625	D	0.598	0	6.04	0.917	1.048	1.000	1.000	20.579	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM12396;OCCURENCE=3(soft_tissue)	.	.	GIST
4	55152093	55152093	A	T	exonic	PDGFRA	.	nonsynonymous SNV	PDGFRA:NM_006206:exon18:c.A2525T:p.D842V	exonic	ENSG00000134853,ENSG00000145216	.	nonsynonymous SNV	ENSG00000134853:ENST00000257290:exon18:c.A2525T:p.D842V,ENSG00000145216:ENST00000507166:exon19:c.A1805T:p.D602V	exonic	PDGFRA	.	nonsynonymous SNV	PDGFRA:uc003han.4:exon18:c.A2525T:p.D842V,PDGFRA:uc003haa.3:exon19:c.A1805T:p.D602V	.	.	.	.	.	.	.	.	.	.	rs121908585	0.001	D	1.0	D	1.0	D	0.005	U	1	D	0.6	N	-1.74	D	-6.75	D	0.982	6.552	31	0.995	0.993	D	0.265	D	0.568	D	0.598	0	5.85	1.062	1.088	1.000	1.000	16.248	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic	Gastrointestinal_stromal_tumor	RCV000014501.5	MedGen:OMIM:Orphanet	C0238198:606764:ORPHA44890	ID=COSM736;OCCURENCE=1(large_intestine),4(small_intestine),157(soft_tissue),1(haematopoietic_and_lymphoid_tissue),10(stomach)	.	.	GIST
4	55593464	55593464	A	C	exonic;exonic	KIT	.	nonsynonymous SNV;nonsynonymous SNV	KIT:NM_000222:exon10:c.A1621C:p.M541L,KIT:NM_001093772:exon10:c.A1609C:p.M537L;KIT:NM_000222:exon10:c.A1621C:p.M541L,KIT:NM_001093772:exon10:c.A1609C:p.M537L	exonic;exonic	ENSG00000157404	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000157404:ENST00000288135:exon10:c.A1621C:p.M541L,ENSG00000157404:ENST00000412167:exon10:c.A1609C:p.M537L;ENSG00000157404:ENST00000288135:exon10:c.A1621C:p.M541L,ENSG00000157404:ENST00000412167:exon10:c.A1609C:p.M537L	exonic;exonic	KIT	.	nonsynonymous SNV;nonsynonymous SNV	KIT:uc010igr.3:exon10:c.A1621C:p.M541L,KIT:uc010igs.3:exon10:c.A1609C:p.M537L;KIT:uc010igr.3:exon10:c.A1621C:p.M541L,KIT:uc010igs.3:exon10:c.A1609C:p.M537L	0.0955	0.0644968	0.0789	0.0601	0.0423	0.0446	0.0392	0.0970	0.0771	0.0771	rs3822214	0.804	T	0.012	B	0.015	B	0.001	N	0.947	N	-0.09	N	-0.74	T	0.22	N	0.726	0.183	4.498	0.491	0.744	D	-1.131	T	0.004	T	0.706	0	1.82	1.062	0.202	0.977	0.055	5.741	.	.	.	Benign|Benign	not_provided|not_specified	RCV000034504.1|RCV000121313.2	MedGen|MedGen	CN221809|CN169374	ID=COSM28026;OCCURENCE=1(stomach)	.	.	Chronic Leukemia
4	55593464	55593464	A	C	exonic;exonic	KIT	.	nonsynonymous SNV;nonsynonymous SNV	KIT:NM_000222:exon10:c.A1621C:p.M541L,KIT:NM_001093772:exon10:c.A1609C:p.M537L;KIT:NM_000222:exon10:c.A1621C:p.M541L,KIT:NM_001093772:exon10:c.A1609C:p.M537L	exonic;exonic	ENSG00000157404	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000157404:ENST00000288135:exon10:c.A1621C:p.M541L,ENSG00000157404:ENST00000412167:exon10:c.A1609C:p.M537L;ENSG00000157404:ENST00000288135:exon10:c.A1621C:p.M541L,ENSG00000157404:ENST00000412167:exon10:c.A1609C:p.M537L	exonic;exonic	KIT	.	nonsynonymous SNV;nonsynonymous SNV	KIT:uc010igr.3:exon10:c.A1621C:p.M541L,KIT:uc010igs.3:exon10:c.A1609C:p.M537L;KIT:uc010igr.3:exon10:c.A1621C:p.M541L,KIT:uc010igs.3:exon10:c.A1609C:p.M537L	0.0955	0.0644968	0.0789	0.0601	0.0423	0.0446	0.0392	0.0970	0.0771	0.0771	rs3822214	0.804	T	0.012	B	0.015	B	0.001	N	0.947	N	-0.09	N	-0.74	T	0.22	N	0.726	0.183	4.498	0.491	0.744	D	-1.131	T	0.004	T	0.706	0	1.82	1.062	0.202	0.977	0.055	5.741	.	.	.	Benign|Benign	not_provided|not_specified	RCV000034504.1|RCV000121313.2	MedGen|MedGen	CN221809|CN169374	ID=COSM28026;OCCURENCE=1(stomach)	.	.	CML
4	55593661	55593661	T	C	exonic;exonic	KIT	.	nonsynonymous SNV;nonsynonymous SNV	KIT:NM_000222:exon11:c.T1727C:p.L576P,KIT:NM_001093772:exon11:c.T1715C:p.L572P;KIT:NM_000222:exon11:c.T1727C:p.L576P,KIT:NM_001093772:exon11:c.T1715C:p.L572P	exonic;exonic	ENSG00000157404	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000157404:ENST00000288135:exon11:c.T1727C:p.L576P,ENSG00000157404:ENST00000412167:exon11:c.T1715C:p.L572P;ENSG00000157404:ENST00000288135:exon11:c.T1727C:p.L576P,ENSG00000157404:ENST00000412167:exon11:c.T1715C:p.L572P	exonic;exonic	KIT	.	nonsynonymous SNV;nonsynonymous SNV	KIT:uc010igt.2:exon1:c.T74C:p.L25P,KIT:uc010igr.3:exon11:c.T1727C:p.L576P,KIT:uc010igs.3:exon11:c.T1715C:p.L572P;KIT:uc010igt.2:exon1:c.T74C:p.L25P,KIT:uc010igr.3:exon11:c.T1727C:p.L576P,KIT:uc010igs.3:exon11:c.T1715C:p.L572P	.	.	.	.	.	.	.	.	.	.	rs121913513	0.0	D	0.968	D	0.431	B	0.000	D	1	D	2.895	M	-4.43	D	-6.34	D	0.955	4.652	24.5	0.998	0.966	D	1.019	D	0.909	D	0.706	0	6.06	0.991	1.061	0.999	0.999	16.600	.	.	Protein kinase-like domain	.	.	.	.	.	ID=COSM1290;OCCURENCE=1(haematopoietic_and_lymphoid_tissue),2(testis),2(NS),2(thymus),2(large_intestine),1(genital_tract),53(skin),2(breast),19(soft_tissue)	MU4342957	SKCM-US|1|335|0.00299,MELA-AU|1|183|0.00546	M
4	55593661	55593661	T	C	exonic;exonic	KIT	.	nonsynonymous SNV;nonsynonymous SNV	KIT:NM_000222:exon11:c.T1727C:p.L576P,KIT:NM_001093772:exon11:c.T1715C:p.L572P;KIT:NM_000222:exon11:c.T1727C:p.L576P,KIT:NM_001093772:exon11:c.T1715C:p.L572P	exonic;exonic	ENSG00000157404	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000157404:ENST00000288135:exon11:c.T1727C:p.L576P,ENSG00000157404:ENST00000412167:exon11:c.T1715C:p.L572P;ENSG00000157404:ENST00000288135:exon11:c.T1727C:p.L576P,ENSG00000157404:ENST00000412167:exon11:c.T1715C:p.L572P	exonic;exonic	KIT	.	nonsynonymous SNV;nonsynonymous SNV	KIT:uc010igt.2:exon1:c.T74C:p.L25P,KIT:uc010igr.3:exon11:c.T1727C:p.L576P,KIT:uc010igs.3:exon11:c.T1715C:p.L572P;KIT:uc010igt.2:exon1:c.T74C:p.L25P,KIT:uc010igr.3:exon11:c.T1727C:p.L576P,KIT:uc010igs.3:exon11:c.T1715C:p.L572P	.	.	.	.	.	.	.	.	.	.	rs121913513	0.0	D	0.968	D	0.431	B	0.000	D	1	D	2.895	M	-4.43	D	-6.34	D	0.955	4.652	24.5	0.998	0.966	D	1.019	D	0.909	D	0.706	0	6.06	0.991	1.061	0.999	0.999	16.600	.	.	Protein kinase-like domain	.	.	.	.	.	ID=COSM1290;OCCURENCE=1(haematopoietic_and_lymphoid_tissue),2(testis),2(NS),2(thymus),2(large_intestine),1(genital_tract),53(skin),2(breast),19(soft_tissue)	MU4342957	SKCM-US|1|335|0.00299,MELA-AU|1|183|0.00546	NSCLC
4	55594258	55594258	T	C	exonic	KIT	.	nonsynonymous SNV	KIT:NM_000222:exon13:c.T1961C:p.V654A,KIT:NM_001093772:exon13:c.T1949C:p.V650A	exonic	ENSG00000157404	.	nonsynonymous SNV	ENSG00000157404:ENST00000288135:exon13:c.T1961C:p.V654A,ENSG00000157404:ENST00000412167:exon13:c.T1949C:p.V650A	exonic	KIT	.	nonsynonymous SNV	KIT:uc010igt.2:exon3:c.T308C:p.V103A,KIT:uc010igr.3:exon13:c.T1961C:p.V654A,KIT:uc010igs.3:exon13:c.T1949C:p.V650A	.	.	.	.	.	.	.	.	.	.	rs121913523	0.021	D	0.789	P	0.741	P	0.000	D	1	D	2.285	M	-3.11	D	-3.68	D	0.858	5.700	26.8	0.999	0.953	D	0.818	D	0.836	D	0.706	0	6.06	0.991	1.061	0.997	0.995	16.609	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain;Tyrosine-protein kinase, receptor class III, conserved site	.	.	.	.	.	ID=COSM12706;OCCURENCE=1(haematopoietic_and_lymphoid_tissue),2(large_intestine),20(soft_tissue)	MU55852071	MELA-AU|1|183|0.00546	GIST
4	55599321	55599321	A	T	exonic;exonic	KIT	.	nonsynonymous SNV;nonsynonymous SNV	KIT:NM_000222:exon17:c.A2447T:p.D816V,KIT:NM_001093772:exon17:c.A2435T:p.D812V;KIT:NM_000222:exon17:c.A2447T:p.D816V,KIT:NM_001093772:exon17:c.A2435T:p.D812V	exonic;exonic	ENSG00000157404	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000157404:ENST00000288135:exon17:c.A2447T:p.D816V,ENSG00000157404:ENST00000412167:exon17:c.A2435T:p.D812V;ENSG00000157404:ENST00000288135:exon17:c.A2447T:p.D816V,ENSG00000157404:ENST00000412167:exon17:c.A2435T:p.D812V	exonic;exonic	KIT	.	nonsynonymous SNV;nonsynonymous SNV	KIT:uc010igr.3:exon17:c.A2447T:p.D816V,KIT:uc010igs.3:exon17:c.A2435T:p.D812V;KIT:uc010igr.3:exon17:c.A2447T:p.D816V,KIT:uc010igs.3:exon17:c.A2435T:p.D812V	.	.	.	.	.	.	.	.	.	.	rs121913507	0.0	D	0.998	D	0.961	D	0.000	D	1	A	0.63	N	-1.74	D	-7.53	D	0.99	6.511	31	0.994	0.991	D	0.303	D	0.562	D	0.707	0	5.62	1.062	1.140	1.000	1.000	15.813	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic|Pathogenic|Pathogenic	Mast_cell_leukemia|Mastocytosis_with_associated_hematologic_disorder|Mastocytosis,_adult_sporadic	RCV000014864.21|RCV000014865.25|RCV000014866.21	MedGen:Orphanet|MedGen|MedGen	C0023461:ORPHA98851|C1833856|C1833857	ID=COSM1314;OCCURENCE=712(haematopoietic_and_lymphoid_tissue),15(testis),5(ovary),2(skin),2(genital_tract)	MU820931	AML-US|3|161|0.01863,LAML-KR|1|107|0.00935,SKCA-BR|1|66|0.01515	AML
4	55599321	55599321	A	T	exonic;exonic	KIT	.	nonsynonymous SNV;nonsynonymous SNV	KIT:NM_000222:exon17:c.A2447T:p.D816V,KIT:NM_001093772:exon17:c.A2435T:p.D812V;KIT:NM_000222:exon17:c.A2447T:p.D816V,KIT:NM_001093772:exon17:c.A2435T:p.D812V	exonic;exonic	ENSG00000157404	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000157404:ENST00000288135:exon17:c.A2447T:p.D816V,ENSG00000157404:ENST00000412167:exon17:c.A2435T:p.D812V;ENSG00000157404:ENST00000288135:exon17:c.A2447T:p.D816V,ENSG00000157404:ENST00000412167:exon17:c.A2435T:p.D812V	exonic;exonic	KIT	.	nonsynonymous SNV;nonsynonymous SNV	KIT:uc010igr.3:exon17:c.A2447T:p.D816V,KIT:uc010igs.3:exon17:c.A2435T:p.D812V;KIT:uc010igr.3:exon17:c.A2447T:p.D816V,KIT:uc010igs.3:exon17:c.A2435T:p.D812V	.	.	.	.	.	.	.	.	.	.	rs121913507	0.0	D	0.998	D	0.961	D	0.000	D	1	A	0.63	N	-1.74	D	-7.53	D	0.99	6.511	31	0.994	0.991	D	0.303	D	0.562	D	0.707	0	5.62	1.062	1.140	1.000	1.000	15.813	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic|Pathogenic|Pathogenic	Mast_cell_leukemia|Mastocytosis_with_associated_hematologic_disorder|Mastocytosis,_adult_sporadic	RCV000014864.21|RCV000014865.25|RCV000014866.21	MedGen:Orphanet|MedGen|MedGen	C0023461:ORPHA98851|C1833856|C1833857	ID=COSM1314;OCCURENCE=712(haematopoietic_and_lymphoid_tissue),15(testis),5(ovary),2(skin),2(genital_tract)	MU820931	AML-US|3|161|0.01863,LAML-KR|1|107|0.00935,SKCA-BR|1|66|0.01515	SM
4	55602765	55602765	G	C	exonic	KIT	.	synonymous SNV	KIT:NM_000222:exon18:c.G2586C:p.L862L,KIT:NM_001093772:exon18:c.G2574C:p.L858L	exonic	ENSG00000157404	.	synonymous SNV	ENSG00000157404:ENST00000288135:exon18:c.G2586C:p.L862L,ENSG00000157404:ENST00000412167:exon18:c.G2574C:p.L858L	exonic	KIT	.	synonymous SNV	KIT:uc010igr.3:exon18:c.G2586C:p.L862L,KIT:uc010igs.3:exon18:c.G2574C:p.L858L	0.1931	0.164137	0.1159	0.3357	0.0545	0.0495	0.0527	0.1095	0.0993	0.1068	rs3733542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Benign	not_specified	RCV000252976.1	MedGen	CN169374	ID=COSM1325;OCCURENCE=2(large_intestine),1(stomach),2(bone),3(haematopoietic_and_lymphoid_tissue)	.	.	AML
4	55955969	55955969	C	T	exonic	KDR	.	nonsynonymous SNV	KDR:NM_002253:exon24:c.G3193A:p.A1065T	exonic	ENSG00000128052	.	nonsynonymous SNV	ENSG00000128052:ENST00000263923:exon24:c.G3193A:p.A1065T	exonic	KDR	.	nonsynonymous SNV	KDR:uc003has.3:exon24:c.G3193A:p.A1065T,KDR:uc003hat.1:exon24:c.G3193A:p.A1065T	0.0004	.	0.0004	0	8.652e-05	0	0	0.0008	0.0011	0	rs56302315	0.144	T	0.992	D	0.954	D	0.000	D	1	D	0.11	N	-2.47	D	-3.16	D	0.765	7.336	34	0.999	0.984	D	0.437	D	0.663	D	0.722	0	5.81	0.871	0.935	0.878	0.910	20.067	0.9990	0.886	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	.	.	.	AS
4	55961059	55961059	G	A	exonic	KDR	.	nonsynonymous SNV	KDR:NM_002253:exon21:c.C2881T:p.R961W	exonic	ENSG00000128052	.	nonsynonymous SNV	ENSG00000128052:ENST00000263923:exon21:c.C2881T:p.R961W	exonic	KDR	.	nonsynonymous SNV	KDR:uc003has.3:exon21:c.C2881T:p.R961W,KDR:uc003hat.1:exon21:c.C2881T:p.R961W	.	0.000199681	6.593e-05	0	8.663e-05	0.0001	0	1.499e-05	0	0.0003	rs530419081	0.004	D	0.999	D	0.72	P	0.006	N	0.959	D	1.32	L	-1.11	T	-3.91	D	0.649	7.079	33	0.999	0.947	D	-0.226	T	0.407	T	0.722	0	4.08	-0.026	0.079	0.622	0.493	9.509	.	.	Protein kinase domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM213169;OCCURENCE=1(breast),1(central_nervous_system)	MU596250	BTCA-JP|1|239|0.00418,GBM-US|1|268|0.00373	COREAD
4	55968180	55968180	T	A	exonic	KDR	.	nonsynonymous SNV	KDR:NM_002253:exon15:c.A2150T:p.D717V	exonic	ENSG00000128052	.	nonsynonymous SNV	ENSG00000128052:ENST00000263923:exon15:c.A2150T:p.D717V	exonic	KDR	.	nonsynonymous SNV	KDR:uc003has.3:exon15:c.A2150T:p.D717V,KDR:uc003hat.1:exon15:c.A2150T:p.D717V	.	.	.	.	.	.	.	.	.	.	.	0.008	D	0.856	P	0.529	P	0.000	D	1	D	1.4	L	-0.13	T	-4.35	D	0.531	5.926	27.6	0.990	0.977	D	-0.648	T	0.235	T	0.707	0	4.76	0.991	1.058	0.988	0.939	13.492	.	.	Immunoglobulin I-set;Immunoglobulin subtype 2;Immunoglobulin-like domain;Immunoglobulin-like fold	.	.	.	.	.	.	.	.	AS
4	89052323	89052323	G	T	exonic	ABCG2	.	nonsynonymous SNV	ABCG2:NM_001257386:exon5:c.C421A:p.Q141K,ABCG2:NM_004827:exon5:c.C421A:p.Q141K	exonic	ENSG00000118777	.	nonsynonymous SNV	ENSG00000118777:ENST00000237612:exon5:c.C421A:p.Q141K,ENSG00000118777:ENST00000515655:exon5:c.C421A:p.Q141K	exonic	ABCG2	.	nonsynonymous SNV	ABCG2:uc003hrf.3:exon2:c.C31A:p.Q11K,ABCG2:uc003hrg.3:exon5:c.C421A:p.Q141K,ABCG2:uc003hrh.3:exon5:c.C421A:p.Q141K	0.0845	0.119409	0.1180	0.0274	0.2407	0.3007	0.0732	0.0991	0.0639	0.0908	rs2231142	0.42	T	0.442	B	0.219	B	0.000	D	0.029	P	0.165	N	1.14	T	-1.59	N	0.441	2.305	18.20	0.977	0.835	D	-0.942	T	0.000	T	0.615	0	5.37	0.897	1.048	1.000	1.000	19.087	.	.	AAA+ ATPase domain;ABC transporter-like;P-loop containing nucleoside triphosphate hydrolase	other|other|drug response	Uric_acid_concentration,_serum,_quantitative_trait_locus_1|Blood_group,_Junior_system|rosuvastatin_response_-_Efficacy	RCV000023341.2|RCV000023342.2|RCV000211355.1	MedGen:OMIM|MedGen:OMIM|MedGen	C1841837:138900|C3280986:614490|CN236578	.	MU157530	LAML-KR|1|107|0.00935,COAD-US|1|216|0.00463	OV-PR
5	1286516	1286516	C	A	intronic	TERT	.	.	.	intronic	ENSG00000164362	.	.	.	intronic	TERT	.	.	.	.	0.515375	.	.	.	.	.	.	.	.	rs2736100	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MU20100042	PRAD-CA|1|124|0.00806	Brain Glioma
5	1295228	1295228	G	A	upstream;upstream	TERT	.	.	.	upstream;upstream	ENSG00000164362	.	.	.	upstream;upstream	TERT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MU832963	LIHM-FR|2|4|0.50000,LINC-JP|72|244|0.29508,BOCA-FR|1|98|0.01020,LICA-FR|128|240|0.53333,SKCA-BR|3|66|0.04545,CLLE-ES|1|218|0.00459,PBCA-DE|1|246|0.00407,MELA-AU|14|183|0.07650	Papillary Thyroid Carcinoma
5	1295228	1295228	G	A	upstream;upstream	TERT	.	.	.	upstream;upstream	ENSG00000164362	.	.	.	upstream;upstream	TERT	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MU832963	LIHM-FR|2|4|0.50000,LINC-JP|72|244|0.29508,BOCA-FR|1|98|0.01020,LICA-FR|128|240|0.53333,SKCA-BR|3|66|0.04545,CLLE-ES|1|218|0.00459,PBCA-DE|1|246|0.00407,MELA-AU|14|183|0.07650	TH
6	117630062	117630062	A	G	exonic	ROS1	.	nonsynonymous SNV	ROS1:NM_002944:exon41:c.T6464C:p.L2155S	exonic	ENSG00000047936	.	nonsynonymous SNV	ENSG00000047936:ENST00000368508:exon41:c.T6464C:p.L2155S,ENSG00000047936:ENST00000368507:exon42:c.T6446C:p.L2149S	exonic	ROS1	.	nonsynonymous SNV	ROS1:uc003pxp.1:exon41:c.T6464C:p.L2155S	.	.	.	.	.	.	.	.	.	.	.	0.007	D	1.0	D	0.999	D	0.000	D	0.975	D	1.31	L	-1.75	D	-2.84	D	0.444	6.262	29.0	0.998	0.896	D	0.234	D	0.556	D	0.487	0	5.05	1.062	1.199	1.000	1.000	14.262	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	.	.	.	NSCLC
6	117631376	117631376	C	G	exonic	ROS1	.	nonsynonymous SNV	ROS1:NM_002944:exon40:c.G6302C:p.G2101A	exonic	ENSG00000047936	.	nonsynonymous SNV	ENSG00000047936:ENST00000368508:exon40:c.G6302C:p.G2101A,ENSG00000047936:ENST00000368507:exon41:c.G6284C:p.G2095A	exonic	ROS1	.	nonsynonymous SNV	ROS1:uc003pxp.1:exon40:c.G6302C:p.G2101A	.	.	.	.	.	.	.	.	.	.	.	0.0	D	1.0	D	1.0	D	0.000	D	0.998	D	-1.055	N	-1.49	T	-5.48	D	0.353	5.655	26.7	0.998	0.889	D	-0.090	T	0.282	T	0.487	0	4.66	0.033	0.935	0.528	0.993	14.425	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	.	.	.	NSCLC
6	117638347	117638347	C	T	exonic;exonic	ROS1	.	nonsynonymous SNV;nonsynonymous SNV	ROS1:NM_002944:exon38:c.G6094A:p.G2032R;ROS1:NM_002944:exon38:c.G6094A:p.G2032R	exonic;exonic	ENSG00000047936	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000047936:ENST00000368508:exon38:c.G6094A:p.G2032R,ENSG00000047936:ENST00000368507:exon39:c.G6076A:p.G2026R;ENSG00000047936:ENST00000368508:exon38:c.G6094A:p.G2032R,ENSG00000047936:ENST00000368507:exon39:c.G6076A:p.G2026R	exonic;exonic	ROS1	.	nonsynonymous SNV;nonsynonymous SNV	ROS1:uc003pxp.1:exon38:c.G6094A:p.G2032R;ROS1:uc003pxp.1:exon38:c.G6094A:p.G2032R	.	.	.	.	.	.	.	.	.	.	.	0.0	D	1.0	D	1.0	D	0.000	D	1.000	D	3.08	M	-2.59	D	-7.04	D	0.938	7.541	34	0.999	0.939	D	0.891	D	0.845	D	0.487	0	5.31	0.871	0.935	0.999	1.000	17.978	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	.	.	.	LUAD
6	117638347	117638347	C	T	exonic;exonic	ROS1	.	nonsynonymous SNV;nonsynonymous SNV	ROS1:NM_002944:exon38:c.G6094A:p.G2032R;ROS1:NM_002944:exon38:c.G6094A:p.G2032R	exonic;exonic	ENSG00000047936	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000047936:ENST00000368508:exon38:c.G6094A:p.G2032R,ENSG00000047936:ENST00000368507:exon39:c.G6076A:p.G2026R;ENSG00000047936:ENST00000368508:exon38:c.G6094A:p.G2032R,ENSG00000047936:ENST00000368507:exon39:c.G6076A:p.G2026R	exonic;exonic	ROS1	.	nonsynonymous SNV;nonsynonymous SNV	ROS1:uc003pxp.1:exon38:c.G6094A:p.G2032R;ROS1:uc003pxp.1:exon38:c.G6094A:p.G2032R	.	.	.	.	.	.	.	.	.	.	.	0.0	D	1.0	D	1.0	D	0.000	D	1.000	D	3.08	M	-2.59	D	-7.04	D	0.938	7.541	34	0.999	0.939	D	0.891	D	0.845	D	0.487	0	5.31	0.871	0.935	0.999	1.000	17.978	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	.	.	.	NSCLC
6	117638365	117638365	G	T	exonic	ROS1	.	nonsynonymous SNV	ROS1:NM_002944:exon38:c.C6076A:p.L2026M	exonic	ENSG00000047936	.	nonsynonymous SNV	ENSG00000047936:ENST00000368508:exon38:c.C6076A:p.L2026M,ENSG00000047936:ENST00000368507:exon39:c.C6058A:p.L2020M	exonic	ROS1	.	nonsynonymous SNV	ROS1:uc003pxp.1:exon38:c.C6076A:p.L2026M	.	.	.	.	.	.	.	.	.	.	.	0.169	T	1.0	D	0.999	D	0.000	D	0.867	D	0.08	N	-2.35	D	-0.43	N	0.474	4.177	23.8	0.995	0.803	D	-0.301	T	0.437	T	0.487	0	1.33	0.069	1.048	0.998	1.000	6.747	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	.	.	.	NSCLC
6	152415537	152415537	T	C	exonic	ESR1	.	nonsynonymous SNV	ESR1:NM_000125:exon7:c.T1387C:p.S463P,ESR1:NM_001122740:exon8:c.T1387C:p.S463P,ESR1:NM_001122741:exon8:c.T1387C:p.S463P,ESR1:NM_001291230:exon8:c.T1393C:p.S465P,ESR1:NM_001291241:exon8:c.T1384C:p.S462P,ESR1:NM_001122742:exon9:c.T1387C:p.S463P	exonic	ENSG00000091831	.	nonsynonymous SNV	ENSG00000091831:ENST00000406599:exon3:c.T604C:p.S202P,ENSG00000091831:ENST00000206249:exon7:c.T1387C:p.S463P,ENSG00000091831:ENST00000456483:exon7:c.T1051C:p.S351P,ENSG00000091831:ENST00000338799:exon8:c.T1387C:p.S463P,ENSG00000091831:ENST00000443427:exon8:c.T1387C:p.S463P,ENSG00000091831:ENST00000440973:exon9:c.T1387C:p.S463P	exonic	ESR1	.	nonsynonymous SNV	ESR1:uc011eev.2:exon2:c.T142C:p.S48P,ESR1:uc010kir.3:exon3:c.T604C:p.S202P,ESR1:uc010kiq.3:exon4:c.T181C:p.S61P,ESR1:uc010kis.3:exon5:c.T532C:p.S178P,ESR1:uc003qoo.4:exon7:c.T1387C:p.S463P,ESR1:uc003qon.4:exon8:c.T1387C:p.S463P,ESR1:uc010kin.3:exon8:c.T1387C:p.S463P,ESR1:uc010kio.3:exon8:c.T1393C:p.S465P,ESR1:uc010kip.3:exon8:c.T1384C:p.S462P,ESR1:uc003qom.4:exon9:c.T1387C:p.S463P	.	.	.	.	.	.	.	.	.	.	.	0.223	T	1.0	D	0.999	D	0.000	D	1	D	1.75	L	-0.49	T	-2.79	D	0.264	4.626	24.5	0.998	0.999	D	0.780	D	0.803	D	0.487	0	5.43	0.991	1.061	0.998	1.000	15.488	.	.	Nuclear hormone receptor, ligand-binding;Nuclear hormone receptor, ligand-binding, core	.	.	.	.	.	.	.	.	Estrogen-receptor Positive Breast Cancer
6	152419922	152419922	T	A	exonic	ESR1	.	nonsynonymous SNV	ESR1:NM_000125:exon8:c.T1609A:p.Y537N,ESR1:NM_001122740:exon9:c.T1609A:p.Y537N,ESR1:NM_001122741:exon9:c.T1609A:p.Y537N,ESR1:NM_001291230:exon9:c.T1615A:p.Y539N,ESR1:NM_001291241:exon9:c.T1606A:p.Y536N,ESR1:NM_001122742:exon10:c.T1609A:p.Y537N	exonic	ENSG00000091831	.	nonsynonymous SNV	ENSG00000091831:ENST00000406599:exon4:c.T826A:p.Y276N,ENSG00000091831:ENST00000206249:exon8:c.T1609A:p.Y537N,ENSG00000091831:ENST00000456483:exon8:c.T1273A:p.Y425N,ENSG00000091831:ENST00000338799:exon9:c.T1609A:p.Y537N,ENSG00000091831:ENST00000443427:exon9:c.T1609A:p.Y537N,ENSG00000091831:ENST00000440973:exon10:c.T1609A:p.Y537N	exonic	ESR1	.	nonsynonymous SNV	ESR1:uc011eev.2:exon3:c.T364A:p.Y122N,ESR1:uc021zha.1:exon3:c.T238A:p.Y80N,ESR1:uc010kir.3:exon4:c.T826A:p.Y276N,ESR1:uc011eex.2:exon4:c.T634A:p.Y212N,ESR1:uc010kiq.3:exon5:c.T403A:p.Y135N,ESR1:uc003qoo.4:exon8:c.T1609A:p.Y537N,ESR1:uc003qon.4:exon9:c.T1609A:p.Y537N,ESR1:uc010kin.3:exon9:c.T1609A:p.Y537N,ESR1:uc010kio.3:exon9:c.T1615A:p.Y539N,ESR1:uc010kip.3:exon9:c.T1606A:p.Y536N,ESR1:uc003qom.4:exon10:c.T1609A:p.Y537N	.	.	.	.	.	.	.	.	.	.	.	0.001	D	1.0	D	1.0	D	0.000	D	1	D	1.84	L	-0.4	T	-6.3	D	0.863	6.428	29.7	0.991	0.946	D	0.822	D	0.811	D	0.487	0	5.31	0.991	1.061	0.996	0.985	15.268	.	.	Nuclear hormone receptor, ligand-binding	.	.	.	.	.	ID=COSM1074635;OCCURENCE=1(endometrium)	MU1819139	UCEC-US|1|246|0.00407	BRACA
6	152419923	152419923	A	C	exonic	ESR1	.	nonsynonymous SNV	ESR1:NM_000125:exon8:c.A1610C:p.Y537S,ESR1:NM_001122740:exon9:c.A1610C:p.Y537S,ESR1:NM_001122741:exon9:c.A1610C:p.Y537S,ESR1:NM_001291230:exon9:c.A1616C:p.Y539S,ESR1:NM_001291241:exon9:c.A1607C:p.Y536S,ESR1:NM_001122742:exon10:c.A1610C:p.Y537S	exonic	ENSG00000091831	.	nonsynonymous SNV	ENSG00000091831:ENST00000406599:exon4:c.A827C:p.Y276S,ENSG00000091831:ENST00000206249:exon8:c.A1610C:p.Y537S,ENSG00000091831:ENST00000456483:exon8:c.A1274C:p.Y425S,ENSG00000091831:ENST00000338799:exon9:c.A1610C:p.Y537S,ENSG00000091831:ENST00000443427:exon9:c.A1610C:p.Y537S,ENSG00000091831:ENST00000440973:exon10:c.A1610C:p.Y537S	exonic	ESR1	.	nonsynonymous SNV	ESR1:uc011eev.2:exon3:c.A365C:p.Y122S,ESR1:uc021zha.1:exon3:c.A239C:p.Y80S,ESR1:uc010kir.3:exon4:c.A827C:p.Y276S,ESR1:uc011eex.2:exon4:c.A635C:p.Y212S,ESR1:uc010kiq.3:exon5:c.A404C:p.Y135S,ESR1:uc003qoo.4:exon8:c.A1610C:p.Y537S,ESR1:uc003qon.4:exon9:c.A1610C:p.Y537S,ESR1:uc010kin.3:exon9:c.A1610C:p.Y537S,ESR1:uc010kio.3:exon9:c.A1616C:p.Y539S,ESR1:uc010kip.3:exon9:c.A1607C:p.Y536S,ESR1:uc003qom.4:exon10:c.A1610C:p.Y537S	.	.	.	.	.	.	.	.	.	.	.	0.014	D	1.0	D	1.0	D	0.000	D	1	D	2.245	M	-0.39	T	-6.28	D	0.92	6.401	29.6	0.994	0.961	D	0.883	D	0.839	D	0.487	0	5.31	1.062	1.199	0.996	0.979	15.268	.	.	Nuclear hormone receptor, ligand-binding	.	.	.	.	.	ID=COSM1074639;OCCURENCE=1(endometrium)	MU1831340	UCEC-US|1|246|0.00407	BRACA
6	152419923	152419923	A	G	exonic	ESR1	.	nonsynonymous SNV	ESR1:NM_000125:exon8:c.A1610G:p.Y537C,ESR1:NM_001122740:exon9:c.A1610G:p.Y537C,ESR1:NM_001122741:exon9:c.A1610G:p.Y537C,ESR1:NM_001291230:exon9:c.A1616G:p.Y539C,ESR1:NM_001291241:exon9:c.A1607G:p.Y536C,ESR1:NM_001122742:exon10:c.A1610G:p.Y537C	exonic	ENSG00000091831	.	nonsynonymous SNV	ENSG00000091831:ENST00000406599:exon4:c.A827G:p.Y276C,ENSG00000091831:ENST00000206249:exon8:c.A1610G:p.Y537C,ENSG00000091831:ENST00000456483:exon8:c.A1274G:p.Y425C,ENSG00000091831:ENST00000338799:exon9:c.A1610G:p.Y537C,ENSG00000091831:ENST00000443427:exon9:c.A1610G:p.Y537C,ENSG00000091831:ENST00000440973:exon10:c.A1610G:p.Y537C	exonic	ESR1	.	nonsynonymous SNV	ESR1:uc011eev.2:exon3:c.A365G:p.Y122C,ESR1:uc021zha.1:exon3:c.A239G:p.Y80C,ESR1:uc010kir.3:exon4:c.A827G:p.Y276C,ESR1:uc011eex.2:exon4:c.A635G:p.Y212C,ESR1:uc010kiq.3:exon5:c.A404G:p.Y135C,ESR1:uc003qoo.4:exon8:c.A1610G:p.Y537C,ESR1:uc003qon.4:exon9:c.A1610G:p.Y537C,ESR1:uc010kin.3:exon9:c.A1610G:p.Y537C,ESR1:uc010kio.3:exon9:c.A1616G:p.Y539C,ESR1:uc010kip.3:exon9:c.A1607G:p.Y536C,ESR1:uc003qom.4:exon10:c.A1610G:p.Y537C	.	.	.	.	.	.	.	.	.	.	.	0.0	D	1.0	D	1.0	D	0.000	D	1	D	1.97	M	-0.46	T	-6.43	D	0.883	6.155	28.5	0.998	0.959	D	0.837	D	0.818	D	0.487	0	5.31	1.062	1.199	0.996	0.979	15.268	.	.	Nuclear hormone receptor, ligand-binding	.	.	.	.	.	ID=COSM1074637;OCCURENCE=1(endometrium)	MU1801291	BRCA-EU|1|560|0.00179,UCEC-US|1|246|0.00407	BRACA
6	152419926	152419926	A	G	exonic	ESR1	.	nonsynonymous SNV	ESR1:NM_000125:exon8:c.A1613G:p.D538G,ESR1:NM_001122740:exon9:c.A1613G:p.D538G,ESR1:NM_001122741:exon9:c.A1613G:p.D538G,ESR1:NM_001291230:exon9:c.A1619G:p.D540G,ESR1:NM_001291241:exon9:c.A1610G:p.D537G,ESR1:NM_001122742:exon10:c.A1613G:p.D538G	exonic	ENSG00000091831	.	nonsynonymous SNV	ENSG00000091831:ENST00000406599:exon4:c.A830G:p.D277G,ENSG00000091831:ENST00000206249:exon8:c.A1613G:p.D538G,ENSG00000091831:ENST00000456483:exon8:c.A1277G:p.D426G,ENSG00000091831:ENST00000338799:exon9:c.A1613G:p.D538G,ENSG00000091831:ENST00000443427:exon9:c.A1613G:p.D538G,ENSG00000091831:ENST00000440973:exon10:c.A1613G:p.D538G	exonic	ESR1	.	nonsynonymous SNV	ESR1:uc011eev.2:exon3:c.A368G:p.D123G,ESR1:uc021zha.1:exon3:c.A242G:p.D81G,ESR1:uc010kir.3:exon4:c.A830G:p.D277G,ESR1:uc011eex.2:exon4:c.A638G:p.D213G,ESR1:uc010kiq.3:exon5:c.A407G:p.D136G,ESR1:uc003qoo.4:exon8:c.A1613G:p.D538G,ESR1:uc003qon.4:exon9:c.A1613G:p.D538G,ESR1:uc010kin.3:exon9:c.A1613G:p.D538G,ESR1:uc010kio.3:exon9:c.A1619G:p.D540G,ESR1:uc010kip.3:exon9:c.A1610G:p.D537G,ESR1:uc003qom.4:exon10:c.A1613G:p.D538G	.	.	.	.	.	.	.	.	.	.	.	0.031	D	0.998	D	0.991	D	0.000	D	1	D	2.51	M	-0.54	T	-5.14	D	0.854	4.909	25.0	0.998	0.959	D	0.909	D	0.849	D	0.487	0	5.31	1.062	1.199	0.999	0.994	15.268	.	.	Nuclear hormone receptor, ligand-binding	.	.	.	.	.	ID=COSM94250;OCCURENCE=1(breast),1(endometrium)	MU1818835	BRCA-EU|2|560|0.00357,UCEC-US|1|246|0.00407	BRACA
7	116423407	116423407	G	A	exonic	MET	.	nonsynonymous SNV	MET:NM_000245:exon19:c.G3682A:p.D1228N,MET:NM_001127500:exon19:c.G3736A:p.D1246N	exonic	ENSG00000105976	.	nonsynonymous SNV	ENSG00000105976:ENST00000539704:exon5:c.G292A:p.D98N,ENSG00000105976:ENST00000318493:exon19:c.G3736A:p.D1246N,ENSG00000105976:ENST00000397752:exon19:c.G3682A:p.D1228N	exonic	MET	.	nonsynonymous SNV	MET:uc003vij.3:exon19:c.G3682A:p.D1228N,MET:uc010lkh.3:exon19:c.G3736A:p.D1246N,MET:uc011knj.2:exon19:c.G2392A:p.D798N	.	.	.	.	.	.	.	.	.	.	rs121913671	0.0	D	1.0	D	0.999	D	0.000	D	1	A	1.705	L	-1.72	D	-4.36	D	0.485	6.532	31	0.999	0.991	D	0.426	D	0.683	D	0.722	0	5.46	0.917	1.048	1.000	0.998	19.667	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic	Renal_cell_carcinoma,_papillary,_1	RCV000014898.25	MedGen:OMIM:Orphanet:SNOMED_CT	C0007134:605074:ORPHA217071:41607009	.	.	.	NSCLC
7	116423408	116423408	A	T	exonic	MET	.	nonsynonymous SNV	MET:NM_000245:exon19:c.A3683T:p.D1228V,MET:NM_001127500:exon19:c.A3737T:p.D1246V	exonic	ENSG00000105976	.	nonsynonymous SNV	ENSG00000105976:ENST00000539704:exon5:c.A293T:p.D98V,ENSG00000105976:ENST00000318493:exon19:c.A3737T:p.D1246V,ENSG00000105976:ENST00000397752:exon19:c.A3683T:p.D1228V	exonic	MET	.	nonsynonymous SNV	MET:uc003vij.3:exon19:c.A3683T:p.D1228V,MET:uc010lkh.3:exon19:c.A3737T:p.D1246V,MET:uc011knj.2:exon19:c.A2393T:p.D798V	.	.	.	.	.	.	.	.	.	.	.	0.0	D	1.0	D	1.0	D	0.000	D	1	D	1.69	L	-1.74	D	-7.95	D	0.97	5.663	26.7	0.994	0.989	D	0.425	D	0.662	D	0.722	0	5.46	1.062	1.199	1.000	0.994	15.824	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	.	.	.	NSCLC
7	128849189	128849189	G	C	exonic;exonic	SMO	.	nonsynonymous SNV;nonsynonymous SNV	SMO:NM_005631:exon8:c.G1417C:p.D473H;SMO:NM_005631:exon8:c.G1417C:p.D473H	exonic;exonic	ENSG00000128602	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000128602:ENST00000249373:exon8:c.G1417C:p.D473H;ENSG00000128602:ENST00000249373:exon8:c.G1417C:p.D473H	exonic;exonic	SMO	.	nonsynonymous SNV;nonsynonymous SNV	SMO:uc003vos.3:exon4:c.G442C:p.D148H,SMO:uc003vor.3:exon8:c.G1417C:p.D473H;SMO:uc003vos.3:exon4:c.G442C:p.D148H,SMO:uc003vor.3:exon8:c.G1417C:p.D473H	.	.	.	.	.	.	.	.	.	.	rs17710891	0.004	D	1.0	D	1.0	D	0.000	D	1	D	1.95	M	-1.71	D	-3.53	D	0.948	6.823	32	0.996	0.992	D	0.478	D	0.693	D	0.706	0	5.4	0.917	1.048	1.000	0.997	18.168	.	.	GPCR, family 2-like	not provided	not_specified	RCV000122084.1	MedGen	CN169374	ID=COSM34198;OCCURENCE=1(central_nervous_system)	.	.	BCC
7	128849189	128849189	G	C	exonic;exonic	SMO	.	nonsynonymous SNV;nonsynonymous SNV	SMO:NM_005631:exon8:c.G1417C:p.D473H;SMO:NM_005631:exon8:c.G1417C:p.D473H	exonic;exonic	ENSG00000128602	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000128602:ENST00000249373:exon8:c.G1417C:p.D473H;ENSG00000128602:ENST00000249373:exon8:c.G1417C:p.D473H	exonic;exonic	SMO	.	nonsynonymous SNV;nonsynonymous SNV	SMO:uc003vos.3:exon4:c.G442C:p.D148H,SMO:uc003vor.3:exon8:c.G1417C:p.D473H;SMO:uc003vos.3:exon4:c.G442C:p.D148H,SMO:uc003vor.3:exon8:c.G1417C:p.D473H	.	.	.	.	.	.	.	.	.	.	rs17710891	0.004	D	1.0	D	1.0	D	0.000	D	1	D	1.95	M	-1.71	D	-3.53	D	0.948	6.823	32	0.996	0.992	D	0.478	D	0.693	D	0.706	0	5.4	0.917	1.048	1.000	0.997	18.168	.	.	GPCR, family 2-like	not provided	not_specified	RCV000122084.1	MedGen	CN169374	ID=COSM34198;OCCURENCE=1(central_nervous_system)	.	.	Brain Medulloblastoma
7	140453134	140453134	T	C	exonic	BRAF	.	nonsynonymous SNV	BRAF:NM_004333:exon15:c.A1801G:p.K601E	exonic	ENSG00000157764	.	nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.A85G:p.K29E,ENSG00000157764:ENST00000288602:exon15:c.A1801G:p.K601E	exonic	BRAF	.	nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.A1801G:p.K601E	.	.	.	.	.	.	.	.	.	.	rs121913364	0.0	D	0.784	P	0.626	P	0.000	D	1	D	0.74	N	-1.64	D	-3.71	D	0.947	4.670	24.5	0.999	0.977	D	-0.875	T	0.186	T	0.651	0	5.65	0.991	1.057	1.000	1.000	15.933	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	Pathogenic|Pathogenic|Pathogenic,Pathogenic|Pathogenic	Carcinoma_of_colon|Thyroid_cancer,_follicular|Non-small_cell_lung_cancer,not_provided|Rasopathy	RCV000014999.7|RCV000015000.7|RCV000037938.2,RCV000034332.5|RCV000150201.2	MedGen:OMIM:SNOMED_CT|MedGen:OMIM|MeSH:MedGen:SNOMED_CT,MedGen|MedGen:Orphanet	C0699790:114500:269533000|C0206682:188470|D002289:C0007131:254637007,CN221809|CN166718:ORPHA98733	ID=COSM478;OCCURENCE=20(skin),1(biliary_tract),6(large_intestine),1(ovary),1(endometrium),26(thyroid),3(lung),1(upper_aerodigestive_tract),5(NS)	MU1846052	PRAD-CA|1|124|0.00806,STAD-US|1|289|0.00346,SKCM-US|5|335|0.01493,UCEC-US|1|246|0.00407,MELA-AU|2|183|0.01093,THCA-US|1|400|0.00250	Skin Melanoma
7	140453136	140453136	A	T	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000157764	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	.	.	1.65e-05	0	8.715e-05	0	0	0	0	6.06e-05	rs113488022	0.001	D	0.971	D	0.943	D	0.000	D	1	D	1.32	L	-1.53	D	-4.78	D	0.967	6.642	32	0.985	0.985	D	-0.768	T	0.236	T	0.651	0	5.65	1.062	1.193	1.000	1.000	15.933	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Rasopathy|Cardio-facio-cutaneous_syndrome,Carcinoma_of_colon|Papillary_thyroid_carcinoma|Astrocytoma,_low-grade,_somatic|Germ_cell_tumor,_nonseminomatous|Non-small_cell_lung_cancer|Malignant_melanoma|not_provided|Cardio-facio-cutaneous_syndrome	RCV000033335.2|RCV000208774.1,RCV000014992.14|RCV000014993.14|RCV000014994.14|RCV000022677.14|RCV000037936.2|RCV000067669.13|RCV000080903.4|RCV000208763.1	MedGen:Orphanet|MedGen:Orphanet:SNOMED_CT,MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen|MeSH:MedGen:SNOMED_CT|MedGen:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	CN166718:ORPHA98733|C1275081:ORPHA1340:403770008,C0699790:114500:269533000|C0238463:188550:ORPHA146:255029007|C2674727|C1266158|D002289:C0007131:254637007|C0025202:2092003|CN221809|C1275081:ORPHA1340:403770008	ID=COSM476;OCCURENCE=3(adrenal_gland),3(urinary_tract),4(genital_tract),7(pancreas),16(liver),68(eye),2(prostate),4161(large_intestine),21(biliary_tract),11(breast),4377(skin),9(small_intestine),1(autonomic_ganglia),20(pituitary),242(ovary),32(soft_tissue),7(testis),459(haematopoietic_and_lymphoid_tissue),9534(thyroid),78(lung),1(meninges),12(upper_aerodigestive_tract),717(NS),15(bone),2(oesophagus),4(stomach),228(central_nervous_system)	MU62030	COCA-CN|6|187|0.03209,GBM-US|5|268|0.01866,READ-US|1|80|0.01250,LGG-US|1|283|0.00353,LICA-FR|1|240|0.00417,SKCA-BR|19|66|0.28788,SKCM-US|127|335|0.37910,PBCA-DE|4|246|0.01626,MELA-AU|47|183|0.25683,COAD-US|25|216|0.11574,THCA-SA|7|15|0.46667,THCA-US|234|400|0.58500	CANCER
7	140453136	140453136	A	T	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000157764	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	.	.	1.65e-05	0	8.715e-05	0	0	0	0	6.06e-05	rs113488022	0.001	D	0.971	D	0.943	D	0.000	D	1	D	1.32	L	-1.53	D	-4.78	D	0.967	6.642	32	0.985	0.985	D	-0.768	T	0.236	T	0.651	0	5.65	1.062	1.193	1.000	1.000	15.933	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Rasopathy|Cardio-facio-cutaneous_syndrome,Carcinoma_of_colon|Papillary_thyroid_carcinoma|Astrocytoma,_low-grade,_somatic|Germ_cell_tumor,_nonseminomatous|Non-small_cell_lung_cancer|Malignant_melanoma|not_provided|Cardio-facio-cutaneous_syndrome	RCV000033335.2|RCV000208774.1,RCV000014992.14|RCV000014993.14|RCV000014994.14|RCV000022677.14|RCV000037936.2|RCV000067669.13|RCV000080903.4|RCV000208763.1	MedGen:Orphanet|MedGen:Orphanet:SNOMED_CT,MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen|MeSH:MedGen:SNOMED_CT|MedGen:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	CN166718:ORPHA98733|C1275081:ORPHA1340:403770008,C0699790:114500:269533000|C0238463:188550:ORPHA146:255029007|C2674727|C1266158|D002289:C0007131:254637007|C0025202:2092003|CN221809|C1275081:ORPHA1340:403770008	ID=COSM476;OCCURENCE=3(adrenal_gland),3(urinary_tract),4(genital_tract),7(pancreas),16(liver),68(eye),2(prostate),4161(large_intestine),21(biliary_tract),11(breast),4377(skin),9(small_intestine),1(autonomic_ganglia),20(pituitary),242(ovary),32(soft_tissue),7(testis),459(haematopoietic_and_lymphoid_tissue),9534(thyroid),78(lung),1(meninges),12(upper_aerodigestive_tract),717(NS),15(bone),2(oesophagus),4(stomach),228(central_nervous_system)	MU62030	COCA-CN|6|187|0.03209,GBM-US|5|268|0.01866,READ-US|1|80|0.01250,LGG-US|1|283|0.00353,LICA-FR|1|240|0.00417,SKCA-BR|19|66|0.28788,SKCM-US|127|335|0.37910,PBCA-DE|4|246|0.01626,MELA-AU|47|183|0.25683,COAD-US|25|216|0.11574,THCA-SA|7|15|0.46667,THCA-US|234|400|0.58500	COREAD
7	140453136	140453136	A	T	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000157764	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	.	.	1.65e-05	0	8.715e-05	0	0	0	0	6.06e-05	rs113488022	0.001	D	0.971	D	0.943	D	0.000	D	1	D	1.32	L	-1.53	D	-4.78	D	0.967	6.642	32	0.985	0.985	D	-0.768	T	0.236	T	0.651	0	5.65	1.062	1.193	1.000	1.000	15.933	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Rasopathy|Cardio-facio-cutaneous_syndrome,Carcinoma_of_colon|Papillary_thyroid_carcinoma|Astrocytoma,_low-grade,_somatic|Germ_cell_tumor,_nonseminomatous|Non-small_cell_lung_cancer|Malignant_melanoma|not_provided|Cardio-facio-cutaneous_syndrome	RCV000033335.2|RCV000208774.1,RCV000014992.14|RCV000014993.14|RCV000014994.14|RCV000022677.14|RCV000037936.2|RCV000067669.13|RCV000080903.4|RCV000208763.1	MedGen:Orphanet|MedGen:Orphanet:SNOMED_CT,MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen|MeSH:MedGen:SNOMED_CT|MedGen:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	CN166718:ORPHA98733|C1275081:ORPHA1340:403770008,C0699790:114500:269533000|C0238463:188550:ORPHA146:255029007|C2674727|C1266158|D002289:C0007131:254637007|C0025202:2092003|CN221809|C1275081:ORPHA1340:403770008	ID=COSM476;OCCURENCE=3(adrenal_gland),3(urinary_tract),4(genital_tract),7(pancreas),16(liver),68(eye),2(prostate),4161(large_intestine),21(biliary_tract),11(breast),4377(skin),9(small_intestine),1(autonomic_ganglia),20(pituitary),242(ovary),32(soft_tissue),7(testis),459(haematopoietic_and_lymphoid_tissue),9534(thyroid),78(lung),1(meninges),12(upper_aerodigestive_tract),717(NS),15(bone),2(oesophagus),4(stomach),228(central_nervous_system)	MU62030	COCA-CN|6|187|0.03209,GBM-US|5|268|0.01866,READ-US|1|80|0.01250,LGG-US|1|283|0.00353,LICA-FR|1|240|0.00417,SKCA-BR|19|66|0.28788,SKCM-US|127|335|0.37910,PBCA-DE|4|246|0.01626,MELA-AU|47|183|0.25683,COAD-US|25|216|0.11574,THCA-SA|7|15|0.46667,THCA-US|234|400|0.58500	Gastrointestinal Neuroendocrine Tumor
7	140453136	140453136	A	T	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000157764	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	.	.	1.65e-05	0	8.715e-05	0	0	0	0	6.06e-05	rs113488022	0.001	D	0.971	D	0.943	D	0.000	D	1	D	1.32	L	-1.53	D	-4.78	D	0.967	6.642	32	0.985	0.985	D	-0.768	T	0.236	T	0.651	0	5.65	1.062	1.193	1.000	1.000	15.933	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Rasopathy|Cardio-facio-cutaneous_syndrome,Carcinoma_of_colon|Papillary_thyroid_carcinoma|Astrocytoma,_low-grade,_somatic|Germ_cell_tumor,_nonseminomatous|Non-small_cell_lung_cancer|Malignant_melanoma|not_provided|Cardio-facio-cutaneous_syndrome	RCV000033335.2|RCV000208774.1,RCV000014992.14|RCV000014993.14|RCV000014994.14|RCV000022677.14|RCV000037936.2|RCV000067669.13|RCV000080903.4|RCV000208763.1	MedGen:Orphanet|MedGen:Orphanet:SNOMED_CT,MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen|MeSH:MedGen:SNOMED_CT|MedGen:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	CN166718:ORPHA98733|C1275081:ORPHA1340:403770008,C0699790:114500:269533000|C0238463:188550:ORPHA146:255029007|C2674727|C1266158|D002289:C0007131:254637007|C0025202:2092003|CN221809|C1275081:ORPHA1340:403770008	ID=COSM476;OCCURENCE=3(adrenal_gland),3(urinary_tract),4(genital_tract),7(pancreas),16(liver),68(eye),2(prostate),4161(large_intestine),21(biliary_tract),11(breast),4377(skin),9(small_intestine),1(autonomic_ganglia),20(pituitary),242(ovary),32(soft_tissue),7(testis),459(haematopoietic_and_lymphoid_tissue),9534(thyroid),78(lung),1(meninges),12(upper_aerodigestive_tract),717(NS),15(bone),2(oesophagus),4(stomach),228(central_nervous_system)	MU62030	COCA-CN|6|187|0.03209,GBM-US|5|268|0.01866,READ-US|1|80|0.01250,LGG-US|1|283|0.00353,LICA-FR|1|240|0.00417,SKCA-BR|19|66|0.28788,SKCM-US|127|335|0.37910,PBCA-DE|4|246|0.01626,MELA-AU|47|183|0.25683,COAD-US|25|216|0.11574,THCA-SA|7|15|0.46667,THCA-US|234|400|0.58500	HCL
7	140453136	140453136	A	T	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000157764	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	.	.	1.65e-05	0	8.715e-05	0	0	0	0	6.06e-05	rs113488022	0.001	D	0.971	D	0.943	D	0.000	D	1	D	1.32	L	-1.53	D	-4.78	D	0.967	6.642	32	0.985	0.985	D	-0.768	T	0.236	T	0.651	0	5.65	1.062	1.193	1.000	1.000	15.933	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Rasopathy|Cardio-facio-cutaneous_syndrome,Carcinoma_of_colon|Papillary_thyroid_carcinoma|Astrocytoma,_low-grade,_somatic|Germ_cell_tumor,_nonseminomatous|Non-small_cell_lung_cancer|Malignant_melanoma|not_provided|Cardio-facio-cutaneous_syndrome	RCV000033335.2|RCV000208774.1,RCV000014992.14|RCV000014993.14|RCV000014994.14|RCV000022677.14|RCV000037936.2|RCV000067669.13|RCV000080903.4|RCV000208763.1	MedGen:Orphanet|MedGen:Orphanet:SNOMED_CT,MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen|MeSH:MedGen:SNOMED_CT|MedGen:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	CN166718:ORPHA98733|C1275081:ORPHA1340:403770008,C0699790:114500:269533000|C0238463:188550:ORPHA146:255029007|C2674727|C1266158|D002289:C0007131:254637007|C0025202:2092003|CN221809|C1275081:ORPHA1340:403770008	ID=COSM476;OCCURENCE=3(adrenal_gland),3(urinary_tract),4(genital_tract),7(pancreas),16(liver),68(eye),2(prostate),4161(large_intestine),21(biliary_tract),11(breast),4377(skin),9(small_intestine),1(autonomic_ganglia),20(pituitary),242(ovary),32(soft_tissue),7(testis),459(haematopoietic_and_lymphoid_tissue),9534(thyroid),78(lung),1(meninges),12(upper_aerodigestive_tract),717(NS),15(bone),2(oesophagus),4(stomach),228(central_nervous_system)	MU62030	COCA-CN|6|187|0.03209,GBM-US|5|268|0.01866,READ-US|1|80|0.01250,LGG-US|1|283|0.00353,LICA-FR|1|240|0.00417,SKCA-BR|19|66|0.28788,SKCM-US|127|335|0.37910,PBCA-DE|4|246|0.01626,MELA-AU|47|183|0.25683,COAD-US|25|216|0.11574,THCA-SA|7|15|0.46667,THCA-US|234|400|0.58500	M
7	140453136	140453136	A	T	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000157764	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	.	.	1.65e-05	0	8.715e-05	0	0	0	0	6.06e-05	rs113488022	0.001	D	0.971	D	0.943	D	0.000	D	1	D	1.32	L	-1.53	D	-4.78	D	0.967	6.642	32	0.985	0.985	D	-0.768	T	0.236	T	0.651	0	5.65	1.062	1.193	1.000	1.000	15.933	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Rasopathy|Cardio-facio-cutaneous_syndrome,Carcinoma_of_colon|Papillary_thyroid_carcinoma|Astrocytoma,_low-grade,_somatic|Germ_cell_tumor,_nonseminomatous|Non-small_cell_lung_cancer|Malignant_melanoma|not_provided|Cardio-facio-cutaneous_syndrome	RCV000033335.2|RCV000208774.1,RCV000014992.14|RCV000014993.14|RCV000014994.14|RCV000022677.14|RCV000037936.2|RCV000067669.13|RCV000080903.4|RCV000208763.1	MedGen:Orphanet|MedGen:Orphanet:SNOMED_CT,MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen|MeSH:MedGen:SNOMED_CT|MedGen:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	CN166718:ORPHA98733|C1275081:ORPHA1340:403770008,C0699790:114500:269533000|C0238463:188550:ORPHA146:255029007|C2674727|C1266158|D002289:C0007131:254637007|C0025202:2092003|CN221809|C1275081:ORPHA1340:403770008	ID=COSM476;OCCURENCE=3(adrenal_gland),3(urinary_tract),4(genital_tract),7(pancreas),16(liver),68(eye),2(prostate),4161(large_intestine),21(biliary_tract),11(breast),4377(skin),9(small_intestine),1(autonomic_ganglia),20(pituitary),242(ovary),32(soft_tissue),7(testis),459(haematopoietic_and_lymphoid_tissue),9534(thyroid),78(lung),1(meninges),12(upper_aerodigestive_tract),717(NS),15(bone),2(oesophagus),4(stomach),228(central_nervous_system)	MU62030	COCA-CN|6|187|0.03209,GBM-US|5|268|0.01866,READ-US|1|80|0.01250,LGG-US|1|283|0.00353,LICA-FR|1|240|0.00417,SKCA-BR|19|66|0.28788,SKCM-US|127|335|0.37910,PBCA-DE|4|246|0.01626,MELA-AU|47|183|0.25683,COAD-US|25|216|0.11574,THCA-SA|7|15|0.46667,THCA-US|234|400|0.58500	MM
7	140453136	140453136	A	T	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000157764	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	.	.	1.65e-05	0	8.715e-05	0	0	0	0	6.06e-05	rs113488022	0.001	D	0.971	D	0.943	D	0.000	D	1	D	1.32	L	-1.53	D	-4.78	D	0.967	6.642	32	0.985	0.985	D	-0.768	T	0.236	T	0.651	0	5.65	1.062	1.193	1.000	1.000	15.933	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Rasopathy|Cardio-facio-cutaneous_syndrome,Carcinoma_of_colon|Papillary_thyroid_carcinoma|Astrocytoma,_low-grade,_somatic|Germ_cell_tumor,_nonseminomatous|Non-small_cell_lung_cancer|Malignant_melanoma|not_provided|Cardio-facio-cutaneous_syndrome	RCV000033335.2|RCV000208774.1,RCV000014992.14|RCV000014993.14|RCV000014994.14|RCV000022677.14|RCV000037936.2|RCV000067669.13|RCV000080903.4|RCV000208763.1	MedGen:Orphanet|MedGen:Orphanet:SNOMED_CT,MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen|MeSH:MedGen:SNOMED_CT|MedGen:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	CN166718:ORPHA98733|C1275081:ORPHA1340:403770008,C0699790:114500:269533000|C0238463:188550:ORPHA146:255029007|C2674727|C1266158|D002289:C0007131:254637007|C0025202:2092003|CN221809|C1275081:ORPHA1340:403770008	ID=COSM476;OCCURENCE=3(adrenal_gland),3(urinary_tract),4(genital_tract),7(pancreas),16(liver),68(eye),2(prostate),4161(large_intestine),21(biliary_tract),11(breast),4377(skin),9(small_intestine),1(autonomic_ganglia),20(pituitary),242(ovary),32(soft_tissue),7(testis),459(haematopoietic_and_lymphoid_tissue),9534(thyroid),78(lung),1(meninges),12(upper_aerodigestive_tract),717(NS),15(bone),2(oesophagus),4(stomach),228(central_nervous_system)	MU62030	COCA-CN|6|187|0.03209,GBM-US|5|268|0.01866,READ-US|1|80|0.01250,LGG-US|1|283|0.00353,LICA-FR|1|240|0.00417,SKCA-BR|19|66|0.28788,SKCM-US|127|335|0.37910,PBCA-DE|4|246|0.01626,MELA-AU|47|183|0.25683,COAD-US|25|216|0.11574,THCA-SA|7|15|0.46667,THCA-US|234|400|0.58500	MYMA
7	140453136	140453136	A	T	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000157764	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	.	.	1.65e-05	0	8.715e-05	0	0	0	0	6.06e-05	rs113488022	0.001	D	0.971	D	0.943	D	0.000	D	1	D	1.32	L	-1.53	D	-4.78	D	0.967	6.642	32	0.985	0.985	D	-0.768	T	0.236	T	0.651	0	5.65	1.062	1.193	1.000	1.000	15.933	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Rasopathy|Cardio-facio-cutaneous_syndrome,Carcinoma_of_colon|Papillary_thyroid_carcinoma|Astrocytoma,_low-grade,_somatic|Germ_cell_tumor,_nonseminomatous|Non-small_cell_lung_cancer|Malignant_melanoma|not_provided|Cardio-facio-cutaneous_syndrome	RCV000033335.2|RCV000208774.1,RCV000014992.14|RCV000014993.14|RCV000014994.14|RCV000022677.14|RCV000037936.2|RCV000067669.13|RCV000080903.4|RCV000208763.1	MedGen:Orphanet|MedGen:Orphanet:SNOMED_CT,MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen|MeSH:MedGen:SNOMED_CT|MedGen:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	CN166718:ORPHA98733|C1275081:ORPHA1340:403770008,C0699790:114500:269533000|C0238463:188550:ORPHA146:255029007|C2674727|C1266158|D002289:C0007131:254637007|C0025202:2092003|CN221809|C1275081:ORPHA1340:403770008	ID=COSM476;OCCURENCE=3(adrenal_gland),3(urinary_tract),4(genital_tract),7(pancreas),16(liver),68(eye),2(prostate),4161(large_intestine),21(biliary_tract),11(breast),4377(skin),9(small_intestine),1(autonomic_ganglia),20(pituitary),242(ovary),32(soft_tissue),7(testis),459(haematopoietic_and_lymphoid_tissue),9534(thyroid),78(lung),1(meninges),12(upper_aerodigestive_tract),717(NS),15(bone),2(oesophagus),4(stomach),228(central_nervous_system)	MU62030	COCA-CN|6|187|0.03209,GBM-US|5|268|0.01866,READ-US|1|80|0.01250,LGG-US|1|283|0.00353,LICA-FR|1|240|0.00417,SKCA-BR|19|66|0.28788,SKCM-US|127|335|0.37910,PBCA-DE|4|246|0.01626,MELA-AU|47|183|0.25683,COAD-US|25|216|0.11574,THCA-SA|7|15|0.46667,THCA-US|234|400|0.58500	NSCLC
7	140453136	140453136	A	T	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000157764	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	.	.	1.65e-05	0	8.715e-05	0	0	0	0	6.06e-05	rs113488022	0.001	D	0.971	D	0.943	D	0.000	D	1	D	1.32	L	-1.53	D	-4.78	D	0.967	6.642	32	0.985	0.985	D	-0.768	T	0.236	T	0.651	0	5.65	1.062	1.193	1.000	1.000	15.933	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Rasopathy|Cardio-facio-cutaneous_syndrome,Carcinoma_of_colon|Papillary_thyroid_carcinoma|Astrocytoma,_low-grade,_somatic|Germ_cell_tumor,_nonseminomatous|Non-small_cell_lung_cancer|Malignant_melanoma|not_provided|Cardio-facio-cutaneous_syndrome	RCV000033335.2|RCV000208774.1,RCV000014992.14|RCV000014993.14|RCV000014994.14|RCV000022677.14|RCV000037936.2|RCV000067669.13|RCV000080903.4|RCV000208763.1	MedGen:Orphanet|MedGen:Orphanet:SNOMED_CT,MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen|MeSH:MedGen:SNOMED_CT|MedGen:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	CN166718:ORPHA98733|C1275081:ORPHA1340:403770008,C0699790:114500:269533000|C0238463:188550:ORPHA146:255029007|C2674727|C1266158|D002289:C0007131:254637007|C0025202:2092003|CN221809|C1275081:ORPHA1340:403770008	ID=COSM476;OCCURENCE=3(adrenal_gland),3(urinary_tract),4(genital_tract),7(pancreas),16(liver),68(eye),2(prostate),4161(large_intestine),21(biliary_tract),11(breast),4377(skin),9(small_intestine),1(autonomic_ganglia),20(pituitary),242(ovary),32(soft_tissue),7(testis),459(haematopoietic_and_lymphoid_tissue),9534(thyroid),78(lung),1(meninges),12(upper_aerodigestive_tract),717(NS),15(bone),2(oesophagus),4(stomach),228(central_nervous_system)	MU62030	COCA-CN|6|187|0.03209,GBM-US|5|268|0.01866,READ-US|1|80|0.01250,LGG-US|1|283|0.00353,LICA-FR|1|240|0.00417,SKCA-BR|19|66|0.28788,SKCM-US|127|335|0.37910,PBCA-DE|4|246|0.01626,MELA-AU|47|183|0.25683,COAD-US|25|216|0.11574,THCA-SA|7|15|0.46667,THCA-US|234|400|0.58500	Papillary Thyroid Carcinoma
7	140453136	140453136	A	T	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000157764	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	.	.	1.65e-05	0	8.715e-05	0	0	0	0	6.06e-05	rs113488022	0.001	D	0.971	D	0.943	D	0.000	D	1	D	1.32	L	-1.53	D	-4.78	D	0.967	6.642	32	0.985	0.985	D	-0.768	T	0.236	T	0.651	0	5.65	1.062	1.193	1.000	1.000	15.933	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Rasopathy|Cardio-facio-cutaneous_syndrome,Carcinoma_of_colon|Papillary_thyroid_carcinoma|Astrocytoma,_low-grade,_somatic|Germ_cell_tumor,_nonseminomatous|Non-small_cell_lung_cancer|Malignant_melanoma|not_provided|Cardio-facio-cutaneous_syndrome	RCV000033335.2|RCV000208774.1,RCV000014992.14|RCV000014993.14|RCV000014994.14|RCV000022677.14|RCV000037936.2|RCV000067669.13|RCV000080903.4|RCV000208763.1	MedGen:Orphanet|MedGen:Orphanet:SNOMED_CT,MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen|MeSH:MedGen:SNOMED_CT|MedGen:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	CN166718:ORPHA98733|C1275081:ORPHA1340:403770008,C0699790:114500:269533000|C0238463:188550:ORPHA146:255029007|C2674727|C1266158|D002289:C0007131:254637007|C0025202:2092003|CN221809|C1275081:ORPHA1340:403770008	ID=COSM476;OCCURENCE=3(adrenal_gland),3(urinary_tract),4(genital_tract),7(pancreas),16(liver),68(eye),2(prostate),4161(large_intestine),21(biliary_tract),11(breast),4377(skin),9(small_intestine),1(autonomic_ganglia),20(pituitary),242(ovary),32(soft_tissue),7(testis),459(haematopoietic_and_lymphoid_tissue),9534(thyroid),78(lung),1(meninges),12(upper_aerodigestive_tract),717(NS),15(bone),2(oesophagus),4(stomach),228(central_nervous_system)	MU62030	COCA-CN|6|187|0.03209,GBM-US|5|268|0.01866,READ-US|1|80|0.01250,LGG-US|1|283|0.00353,LICA-FR|1|240|0.00417,SKCA-BR|19|66|0.28788,SKCM-US|127|335|0.37910,PBCA-DE|4|246|0.01626,MELA-AU|47|183|0.25683,COAD-US|25|216|0.11574,THCA-SA|7|15|0.46667,THCA-US|234|400|0.58500	Skin Melanoma
7	140453136	140453136	A	T	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E;BRAF:NM_004333:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	ENSG00000157764	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E;ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E;BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	.	.	1.65e-05	0	8.715e-05	0	0	0	0	6.06e-05	rs113488022	0.001	D	0.971	D	0.943	D	0.000	D	1	D	1.32	L	-1.53	D	-4.78	D	0.967	6.642	32	0.985	0.985	D	-0.768	T	0.236	T	0.651	0	5.65	1.062	1.193	1.000	1.000	15.933	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic	Rasopathy|Cardio-facio-cutaneous_syndrome,Carcinoma_of_colon|Papillary_thyroid_carcinoma|Astrocytoma,_low-grade,_somatic|Germ_cell_tumor,_nonseminomatous|Non-small_cell_lung_cancer|Malignant_melanoma|not_provided|Cardio-facio-cutaneous_syndrome	RCV000033335.2|RCV000208774.1,RCV000014992.14|RCV000014993.14|RCV000014994.14|RCV000022677.14|RCV000037936.2|RCV000067669.13|RCV000080903.4|RCV000208763.1	MedGen:Orphanet|MedGen:Orphanet:SNOMED_CT,MedGen:OMIM:SNOMED_CT|MedGen:OMIM:Orphanet:SNOMED_CT|MedGen|MedGen|MeSH:MedGen:SNOMED_CT|MedGen:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	CN166718:ORPHA98733|C1275081:ORPHA1340:403770008,C0699790:114500:269533000|C0238463:188550:ORPHA146:255029007|C2674727|C1266158|D002289:C0007131:254637007|C0025202:2092003|CN221809|C1275081:ORPHA1340:403770008	ID=COSM476;OCCURENCE=3(adrenal_gland),3(urinary_tract),4(genital_tract),7(pancreas),16(liver),68(eye),2(prostate),4161(large_intestine),21(biliary_tract),11(breast),4377(skin),9(small_intestine),1(autonomic_ganglia),20(pituitary),242(ovary),32(soft_tissue),7(testis),459(haematopoietic_and_lymphoid_tissue),9534(thyroid),78(lung),1(meninges),12(upper_aerodigestive_tract),717(NS),15(bone),2(oesophagus),4(stomach),228(central_nervous_system)	MU62030	COCA-CN|6|187|0.03209,GBM-US|5|268|0.01866,READ-US|1|80|0.01250,LGG-US|1|283|0.00353,LICA-FR|1|240|0.00417,SKCA-BR|19|66|0.28788,SKCM-US|127|335|0.37910,PBCA-DE|4|246|0.01626,MELA-AU|47|183|0.25683,COAD-US|25|216|0.11574,THCA-SA|7|15|0.46667,THCA-US|234|400|0.58500	TH
7	140453145	140453145	A	C	exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV	BRAF:NM_004333:exon15:c.T1790G:p.L597R;BRAF:NM_004333:exon15:c.T1790G:p.L597R	exonic;exonic	ENSG00000157764	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.T74G:p.L25R,ENSG00000157764:ENST00000288602:exon15:c.T1790G:p.L597R;ENSG00000157764:ENST00000479537:exon2:c.T74G:p.L25R,ENSG00000157764:ENST00000288602:exon15:c.T1790G:p.L597R	exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.T1790G:p.L597R;BRAF:uc003vwc.4:exon15:c.T1790G:p.L597R	.	.	.	.	.	.	.	.	.	.	rs121913366	0.0	D	1.0	D	1.0	D	0.000	D	1	D	4.06	H	-2.83	D	-5.53	D	0.996	4.592	24.4	0.998	0.987	D	0.599	D	0.642	D	0.651	0	5.65	1.062	1.193	0.998	1.000	15.933	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	Pathogenic	Adenocarcinoma_of_lung	RCV000015002.5	MedGen	C0152013	ID=COSM471;OCCURENCE=1(NS),3(lung),3(ovary),3(large_intestine),1(prostate),7(skin)	.	.	M
7	140453145	140453145	A	C	exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV	BRAF:NM_004333:exon15:c.T1790G:p.L597R;BRAF:NM_004333:exon15:c.T1790G:p.L597R	exonic;exonic	ENSG00000157764	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.T74G:p.L25R,ENSG00000157764:ENST00000288602:exon15:c.T1790G:p.L597R;ENSG00000157764:ENST00000479537:exon2:c.T74G:p.L25R,ENSG00000157764:ENST00000288602:exon15:c.T1790G:p.L597R	exonic;exonic	BRAF	.	nonsynonymous SNV;nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.T1790G:p.L597R;BRAF:uc003vwc.4:exon15:c.T1790G:p.L597R	.	.	.	.	.	.	.	.	.	.	rs121913366	0.0	D	1.0	D	1.0	D	0.000	D	1	D	4.06	H	-2.83	D	-5.53	D	0.996	4.592	24.4	0.998	0.987	D	0.599	D	0.642	D	0.651	0	5.65	1.062	1.193	0.998	1.000	15.933	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	Pathogenic	Adenocarcinoma_of_lung	RCV000015002.5	MedGen	C0152013	ID=COSM471;OCCURENCE=1(NS),3(lung),3(ovary),3(large_intestine),1(prostate),7(skin)	.	.	Skin Melanoma
7	140453145	140453145	A	T	exonic	BRAF	.	nonsynonymous SNV	BRAF:NM_004333:exon15:c.T1790A:p.L597Q	exonic	ENSG00000157764	.	nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.T74A:p.L25Q,ENSG00000157764:ENST00000288602:exon15:c.T1790A:p.L597Q	exonic	BRAF	.	nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.T1790A:p.L597Q	.	.	.	.	.	.	.	.	.	.	rs121913366	0.0	D	1.0	D	1.0	D	0.000	D	1	D	3.255	M	-2.82	D	-5.51	D	0.991	6.239	28.8	0.995	0.985	D	0.298	D	0.556	D	0.651	0	5.65	1.062	1.193	0.998	1.000	15.933	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	Pathogenic	Adenocarcinoma_of_lung	RCV000015002.5	MedGen	C0152013	ID=COSM1125;OCCURENCE=1(ovary),1(large_intestine),8(skin),1(NS),1(lung)	MU4410750	CLLE-ES|1|218|0.00459,SKCM-US|1|335|0.00299	Skin Melanoma
7	140453146	140453146	G	C	exonic	BRAF	.	nonsynonymous SNV	BRAF:NM_004333:exon15:c.C1789G:p.L597V	exonic	ENSG00000157764	.	nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.C73G:p.L25V,ENSG00000157764:ENST00000288602:exon15:c.C1789G:p.L597V	exonic	BRAF	.	nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.C1789G:p.L597V	.	.	.	.	.	.	.	.	.	.	rs121913369	0.001	D	0.934	P	0.955	D	0.000	D	1	D	1.805	L	-2.72	D	-2.68	D	0.965	4.979	25.1	0.997	0.967	D	0.564	D	0.780	D	0.651	0	2.86	-0.021	0.140	0.998	1.000	11.228	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	Pathogenic|Pathogenic|Pathogenic|Pathogenic	Non-small_cell_lung_cancer|Noonan_syndrome_7|Rasopathy|Noonan_syndrome_1	RCV000015003.7|RCV000030948.27|RCV000033333.3|RCV000208539.1	MeSH:MedGen:SNOMED_CT|MedGen:OMIM|MedGen:Orphanet|MedGen:OMIM	D002289:C0007131:254637007|C3150970:613706|CN166718:ORPHA98733|C0041409:163950	ID=COSM470;OCCURENCE=1(biliary_tract),2(skin),1(cervix),5(lung)	MU44221302	BTCA-JP|1|239|0.00418	Skin Melanoma
7	140453149	140453149	C	A	exonic	BRAF	.	nonsynonymous SNV	BRAF:NM_004333:exon15:c.G1786T:p.G596C	exonic	ENSG00000157764	.	nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.G70T:p.G24C,ENSG00000157764:ENST00000288602:exon15:c.G1786T:p.G596C	exonic	BRAF	.	nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.G1786T:p.G596C	.	.	.	.	.	.	.	.	.	.	rs121913361	0.0	D	1.0	D	1.0	D	0.000	D	1	D	4.1	H	-7.6	D	-8.19	D	0.963	7.486	34	0.997	0.983	D	0.707	D	0.713	D	0.651	0	5.65	0.871	0.931	1.000	1.000	19.792	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	Uncertain significance	not_specified	RCV000037933.4	MedGen	CN169374	.	.	.	NSCLC
7	140453154	140453154	T	A	exonic	BRAF	.	nonsynonymous SNV	BRAF:NM_004333:exon15:c.A1781T:p.D594V	exonic	ENSG00000157764	.	nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.A65T:p.D22V,ENSG00000157764:ENST00000288602:exon15:c.A1781T:p.D594V	exonic	BRAF	.	nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.A1781T:p.D594V	.	.	.	.	.	.	.	.	.	.	rs121913338	0.001	D	1.0	D	1.0	D	0.000	D	1	D	4.46	H	-7.22	D	-8.25	D	0.978	6.796	32	0.994	0.980	D	0.795	D	0.720	D	0.651	0	5.65	0.991	1.057	1.000	1.000	15.933	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	Pathogenic|Pathogenic	Malignant_lymphoma,_non-Hodgkin|Non-small_cell_lung_cancer	RCV000015006.9|RCV000037932.2	MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:SNOMED_CT	C0024305:605027:ORPHA547:1929004|D002289:C0007131:254637007	ID=COSM466;OCCURENCE=2(large_intestine),1(skin)	.	.	Skin Melanoma
7	140453154	140453154	T	C	exonic	BRAF	.	nonsynonymous SNV	BRAF:NM_004333:exon15:c.A1781G:p.D594G	exonic	ENSG00000157764	.	nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.A65G:p.D22G,ENSG00000157764:ENST00000288602:exon15:c.A1781G:p.D594G	exonic	BRAF	.	nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.A1781G:p.D594G	.	.	.	.	.	.	.	.	.	.	rs121913338	0.002	D	0.994	D	0.983	D	0.000	D	1	D	3.565	H	-7.18	D	-6.43	D	0.988	6.419	29.7	0.999	0.977	D	0.452	D	0.603	D	0.651	0	5.65	0.991	1.057	1.000	1.000	15.933	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	Pathogenic|Pathogenic	Malignant_lymphoma,_non-Hodgkin|Non-small_cell_lung_cancer	RCV000015006.9|RCV000037932.2	MedGen:OMIM:Orphanet:SNOMED_CT|MeSH:MedGen:SNOMED_CT	C0024305:605027:ORPHA547:1929004|D002289:C0007131:254637007	ID=COSM467;OCCURENCE=10(skin),1(breast),2(urinary_tract),2(pancreas),21(large_intestine),2(ovary),1(salivary_gland),2(endometrium),5(lung),6(haematopoietic_and_lymphoid_tissue),2(stomach),1(upper_aerodigestive_tract)	MU50763	COCA-CN|2|187|0.01070,LGG-US|1|283|0.00353,PACA-CA|1|227|0.00441,CLLE-ES|1|218|0.00459,BLCA-CN|1|103|0.00971,PAEN-AU|1|52|0.01923,PRAD-UK|1|108|0.00926	COREAD
7	140453154	140453154	T	G	exonic	BRAF	.	nonsynonymous SNV	BRAF:NM_004333:exon15:c.A1781C:p.D594A	exonic	ENSG00000157764	.	nonsynonymous SNV	ENSG00000157764:ENST00000479537:exon2:c.A65C:p.D22A,ENSG00000157764:ENST00000288602:exon15:c.A1781C:p.D594A	exonic	BRAF	.	nonsynonymous SNV	BRAF:uc003vwc.4:exon15:c.A1781C:p.D594A	.	.	.	.	.	.	.	.	.	.	.	0.028	D	1.0	D	0.998	D	0.000	D	1	D	4.46	H	-7.21	D	-7.33	D	0.95	6.325	29.2	0.996	0.981	D	0.795	D	0.720	D	0.651	0	5.65	0.991	1.057	1.000	1.000	15.933	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	.	.	.	.	.	ID=COSM1583010;OCCURENCE=1(NS)	MU30632423	COCA-CN|1|187|0.00535,LIRI-JP|1|260|0.00385	Skin Melanoma
7	140477794	140477794	A	T	exonic	BRAF	.	nonsynonymous SNV	BRAF:NM_004333:exon12:c.T1514A:p.L505H	exonic	ENSG00000157764	.	nonsynonymous SNV	ENSG00000157764:ENST00000288602:exon12:c.T1514A:p.L505H	exonic	BRAF	.	nonsynonymous SNV	BRAF:uc003vwc.4:exon12:c.T1514A:p.L505H	.	.	.	.	.	.	.	.	.	.	.	0.0	D	0.997	D	0.941	D	0.000	D	1	D	2.37	M	-2.13	D	-6.46	D	0.982	6.461	29.9	0.981	0.997	D	-0.302	T	0.375	T	0.732	0	4.96	1.062	1.136	0.999	1.000	14.344	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	.	.	.	.	.	ID=COSM243226;OCCURENCE=1(prostate)	.	.	M
7	55227884	55227884	C	T	exonic	EGFR	.	nonsynonymous SNV	EGFR:NM_005228:exon12:c.C1351T:p.R451C,EGFR:NM_201282:exon12:c.C1351T:p.R451C,EGFR:NM_201284:exon12:c.C1351T:p.R451C	exonic	ENSG00000146648	.	nonsynonymous SNV	ENSG00000146648:ENST00000455089:exon11:c.C1216T:p.R406C,ENSG00000146648:ENST00000275493:exon12:c.C1351T:p.R451C,ENSG00000146648:ENST00000342916:exon12:c.C1351T:p.R451C,ENSG00000146648:ENST00000344576:exon12:c.C1351T:p.R451C,ENSG00000146648:ENST00000442591:exon12:c.C1351T:p.R451C,ENSG00000146648:ENST00000454757:exon12:c.C1192T:p.R398C	exonic	EGFR	.	nonsynonymous SNV	EGFR:uc010kzg.2:exon11:c.C1216T:p.R406C,EGFR:uc022adn.1:exon11:c.C1216T:p.R406C,EGFR:uc003tqi.3:exon12:c.C1351T:p.R451C,EGFR:uc003tqj.3:exon12:c.C1351T:p.R451C,EGFR:uc003tqk.3:exon12:c.C1351T:p.R451C,EGFR:uc011kco.2:exon12:c.C1192T:p.R398C,EGFR:uc022adm.1:exon12:c.C1351T:p.R451C	7.7e-05	.	.	.	.	.	.	.	.	.	rs377567759	0.0	D	1.0	D	1.0	D	0.000	D	1	D	3.24	M	-1.4	T	-5.61	D	0.956	7.668	35	0.999	0.975	D	0.669	D	0.732	D	0.653	0	4.93	0.871	0.935	0.995	0.617	14.962	.	.	Receptor L-domain	.	.	.	.	.	.	.	.	COREAD
7	55227926	55227926	G	A	exonic	EGFR	.	nonsynonymous SNV	EGFR:NM_005228:exon12:c.G1393A:p.G465R,EGFR:NM_201282:exon12:c.G1393A:p.G465R,EGFR:NM_201284:exon12:c.G1393A:p.G465R	exonic	ENSG00000146648	.	nonsynonymous SNV	ENSG00000146648:ENST00000455089:exon11:c.G1258A:p.G420R,ENSG00000146648:ENST00000275493:exon12:c.G1393A:p.G465R,ENSG00000146648:ENST00000342916:exon12:c.G1393A:p.G465R,ENSG00000146648:ENST00000344576:exon12:c.G1393A:p.G465R,ENSG00000146648:ENST00000442591:exon12:c.G1393A:p.G465R,ENSG00000146648:ENST00000454757:exon12:c.G1234A:p.G412R	exonic	EGFR	.	nonsynonymous SNV	EGFR:uc010kzg.2:exon11:c.G1258A:p.G420R,EGFR:uc022adn.1:exon11:c.G1258A:p.G420R,EGFR:uc003tqi.3:exon12:c.G1393A:p.G465R,EGFR:uc003tqj.3:exon12:c.G1393A:p.G465R,EGFR:uc003tqk.3:exon12:c.G1393A:p.G465R,EGFR:uc011kco.2:exon12:c.G1234A:p.G412R,EGFR:uc022adm.1:exon12:c.G1393A:p.G465R	.	.	.	.	.	.	.	.	.	.	.	0.789	T	0.02	B	0.024	B	0.004	N	0.964	N	0	N	0.97	T	0.27	N	0.707	2.555	19.82	0.873	0.198	N	-1.028	T	0.043	T	0.653	0	4.84	0.069	1.048	0.875	0.992	4.678	.	.	Receptor L-domain	.	.	.	.	.	ID=COSM601582,COSM601581;OCCURENCE=1(lung)	.	.	COREAD
7	55227933	55227933	A	C	exonic	EGFR	.	nonsynonymous SNV	EGFR:NM_005228:exon12:c.A1400C:p.K467T,EGFR:NM_201282:exon12:c.A1400C:p.K467T,EGFR:NM_201284:exon12:c.A1400C:p.K467T	exonic	ENSG00000146648	.	nonsynonymous SNV	ENSG00000146648:ENST00000455089:exon11:c.A1265C:p.K422T,ENSG00000146648:ENST00000275493:exon12:c.A1400C:p.K467T,ENSG00000146648:ENST00000342916:exon12:c.A1400C:p.K467T,ENSG00000146648:ENST00000344576:exon12:c.A1400C:p.K467T,ENSG00000146648:ENST00000442591:exon12:c.A1400C:p.K467T,ENSG00000146648:ENST00000454757:exon12:c.A1241C:p.K414T	exonic	EGFR	.	nonsynonymous SNV	EGFR:uc010kzg.2:exon11:c.A1265C:p.K422T,EGFR:uc022adn.1:exon11:c.A1265C:p.K422T,EGFR:uc003tqi.3:exon12:c.A1400C:p.K467T,EGFR:uc003tqj.3:exon12:c.A1400C:p.K467T,EGFR:uc003tqk.3:exon12:c.A1400C:p.K467T,EGFR:uc011kco.2:exon12:c.A1241C:p.K414T,EGFR:uc022adm.1:exon12:c.A1400C:p.K467T	.	.	.	.	.	.	.	.	.	.	.	0.584	T	0.03	B	0.024	B	0.050	N	1.000	N	1.31	L	0.95	T	-0.54	N	0.246	0.429	6.861	0.955	0.104	N	-0.994	T	0.065	T	0.653	0	-3.64	-0.056	-0.448	0.917	0.940	9.942	.	.	Receptor L-domain	.	.	.	.	.	.	.	.	COREAD
7	55228009	55228009	C	A	exonic	EGFR	.	nonsynonymous SNV	EGFR:NM_005228:exon12:c.C1476A:p.S492R,EGFR:NM_201282:exon12:c.C1476A:p.S492R,EGFR:NM_201284:exon12:c.C1476A:p.S492R	exonic	ENSG00000146648	.	nonsynonymous SNV	ENSG00000146648:ENST00000455089:exon11:c.C1341A:p.S447R,ENSG00000146648:ENST00000275493:exon12:c.C1476A:p.S492R,ENSG00000146648:ENST00000342916:exon12:c.C1476A:p.S492R,ENSG00000146648:ENST00000344576:exon12:c.C1476A:p.S492R,ENSG00000146648:ENST00000442591:exon12:c.C1476A:p.S492R,ENSG00000146648:ENST00000454757:exon12:c.C1317A:p.S439R	exonic	EGFR	.	nonsynonymous SNV	EGFR:uc010kzg.2:exon11:c.C1341A:p.S447R,EGFR:uc022adn.1:exon11:c.C1341A:p.S447R,EGFR:uc003tqi.3:exon12:c.C1476A:p.S492R,EGFR:uc003tqj.3:exon12:c.C1476A:p.S492R,EGFR:uc003tqk.3:exon12:c.C1476A:p.S492R,EGFR:uc011kco.2:exon12:c.C1317A:p.S439R,EGFR:uc022adm.1:exon12:c.C1476A:p.S492R	.	.	.	.	.	.	.	.	.	.	.	0.634	T	0.249	B	0.065	B	0.013	N	0.993	N	0	N	-0.78	T	-0.82	N	0.255	2.980	22.2	0.971	0.358	N	-0.898	T	0.240	T	0.653	0	5.66	0.871	0.935	0.991	0.992	14.810	.	.	Receptor L-domain	.	.	.	.	.	ID=COSM236670;OCCURENCE=4(large_intestine)	.	.	COREAD
7	55241707	55241707	G	A	exonic;exonic	EGFR	.	nonsynonymous SNV;nonsynonymous SNV	EGFR:NM_005228:exon18:c.G2155A:p.G719S;EGFR:NM_005228:exon18:c.G2155A:p.G719S	exonic;exonic	ENSG00000146648	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000146648:ENST00000455089:exon17:c.G2020A:p.G674S,ENSG00000146648:ENST00000275493:exon18:c.G2155A:p.G719S,ENSG00000146648:ENST00000454757:exon18:c.G1996A:p.G666S;ENSG00000146648:ENST00000455089:exon17:c.G2020A:p.G674S,ENSG00000146648:ENST00000275493:exon18:c.G2155A:p.G719S,ENSG00000146648:ENST00000454757:exon18:c.G1996A:p.G666S	exonic;exonic	EGFR	.	nonsynonymous SNV;nonsynonymous SNV	EGFR:uc010kzg.2:exon17:c.G2020A:p.G674S,EGFR:uc022adn.1:exon17:c.G2020A:p.G674S,EGFR:uc003tqk.3:exon18:c.G2155A:p.G719S,EGFR:uc011kco.2:exon18:c.G1996A:p.G666S,EGFR:uc022adm.1:exon18:c.G2155A:p.G719S;EGFR:uc010kzg.2:exon17:c.G2020A:p.G674S,EGFR:uc022adn.1:exon17:c.G2020A:p.G674S,EGFR:uc003tqk.3:exon18:c.G2155A:p.G719S,EGFR:uc011kco.2:exon18:c.G1996A:p.G666S,EGFR:uc022adm.1:exon18:c.G2155A:p.G719S	.	.	.	.	.	.	.	.	.	.	rs28929495	0.003	D	1.0	D	0.999	D	0.000	D	1	D	3.88	H	-1.16	T	-5.06	D	0.922	5.520	26.3	0.998	0.974	D	0.769	D	0.764	D	0.563	0	5.83	0.917	1.048	0.986	0.661	18.672	.	.	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	drug response|drug response,Likely pathogenic|drug response,drug response|Pathogenic	Nonsmall_cell_lung_cancer,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Tyrosine_kinase_inhibitor_response,Non-small_cell_lung_cancer|Squamous_cell_carcinoma_of_the_head_and_neck,Nonsmall_cell_lung_cancer,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Non-small_cell_lung_cancer	RCV000018087.84|RCV000154198.1,RCV000038379.2|RCV000114405.1,RCV000018086.84|RCV000038380.2	MedGen|MedGen,MeSH:MedGen:SNOMED_CT|MedGen:OMIM:Orphanet,MedGen|MeSH:MedGen:SNOMED_CT	C4016032|CN225347,D002289:C0007131:254637007|C1168401:275355:ORPHA67037,C4016032|D002289:C0007131:254637007	ID=COSM6252;OCCURENCE=1(large_intestine),2(biliary_tract),32(lung)	.	.	COREAD
7	55241707	55241707	G	A	exonic;exonic	EGFR	.	nonsynonymous SNV;nonsynonymous SNV	EGFR:NM_005228:exon18:c.G2155A:p.G719S;EGFR:NM_005228:exon18:c.G2155A:p.G719S	exonic;exonic	ENSG00000146648	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000146648:ENST00000455089:exon17:c.G2020A:p.G674S,ENSG00000146648:ENST00000275493:exon18:c.G2155A:p.G719S,ENSG00000146648:ENST00000454757:exon18:c.G1996A:p.G666S;ENSG00000146648:ENST00000455089:exon17:c.G2020A:p.G674S,ENSG00000146648:ENST00000275493:exon18:c.G2155A:p.G719S,ENSG00000146648:ENST00000454757:exon18:c.G1996A:p.G666S	exonic;exonic	EGFR	.	nonsynonymous SNV;nonsynonymous SNV	EGFR:uc010kzg.2:exon17:c.G2020A:p.G674S,EGFR:uc022adn.1:exon17:c.G2020A:p.G674S,EGFR:uc003tqk.3:exon18:c.G2155A:p.G719S,EGFR:uc011kco.2:exon18:c.G1996A:p.G666S,EGFR:uc022adm.1:exon18:c.G2155A:p.G719S;EGFR:uc010kzg.2:exon17:c.G2020A:p.G674S,EGFR:uc022adn.1:exon17:c.G2020A:p.G674S,EGFR:uc003tqk.3:exon18:c.G2155A:p.G719S,EGFR:uc011kco.2:exon18:c.G1996A:p.G666S,EGFR:uc022adm.1:exon18:c.G2155A:p.G719S	.	.	.	.	.	.	.	.	.	.	rs28929495	0.003	D	1.0	D	0.999	D	0.000	D	1	D	3.88	H	-1.16	T	-5.06	D	0.922	5.520	26.3	0.998	0.974	D	0.769	D	0.764	D	0.563	0	5.83	0.917	1.048	0.986	0.661	18.672	.	.	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	drug response|drug response,Likely pathogenic|drug response,drug response|Pathogenic	Nonsmall_cell_lung_cancer,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Tyrosine_kinase_inhibitor_response,Non-small_cell_lung_cancer|Squamous_cell_carcinoma_of_the_head_and_neck,Nonsmall_cell_lung_cancer,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Non-small_cell_lung_cancer	RCV000018087.84|RCV000154198.1,RCV000038379.2|RCV000114405.1,RCV000018086.84|RCV000038380.2	MedGen|MedGen,MeSH:MedGen:SNOMED_CT|MedGen:OMIM:Orphanet,MedGen|MeSH:MedGen:SNOMED_CT	C4016032|CN225347,D002289:C0007131:254637007|C1168401:275355:ORPHA67037,C4016032|D002289:C0007131:254637007	ID=COSM6252;OCCURENCE=1(large_intestine),2(biliary_tract),32(lung)	.	.	NSCLC
7	55241722	55241722	G	A	exonic	EGFR	.	nonsynonymous SNV	EGFR:NM_005228:exon18:c.G2170A:p.G724S	exonic	ENSG00000146648	.	nonsynonymous SNV	ENSG00000146648:ENST00000455089:exon17:c.G2035A:p.G679S,ENSG00000146648:ENST00000275493:exon18:c.G2170A:p.G724S,ENSG00000146648:ENST00000454757:exon18:c.G2011A:p.G671S	exonic	EGFR	.	nonsynonymous SNV	EGFR:uc010kzg.2:exon17:c.G2035A:p.G679S,EGFR:uc022adn.1:exon17:c.G2035A:p.G679S,EGFR:uc003tqk.3:exon18:c.G2170A:p.G724S,EGFR:uc011kco.2:exon18:c.G2011A:p.G671S,EGFR:uc022adm.1:exon18:c.G2170A:p.G724S	.	.	.	.	.	.	.	.	.	.	.	0.001	D	1.0	D	1.0	D	0.000	D	1	D	2.7	M	-1.16	T	-5.06	D	0.905	6.169	28.5	0.999	0.983	D	0.478	D	0.674	D	0.563	0	5.5	0.917	0.953	0.978	0.503	17.948	.	.	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM13979;OCCURENCE=2(lung),4(large_intestine)	MU4807805	LGG-US|1|283|0.00353,BRCA-EU|1|560|0.00179	COREAD
7	55242487	55242487	C	T	exonic	EGFR	.	nonsynonymous SNV	EGFR:NM_005228:exon19:c.C2257T:p.P753S	exonic	ENSG00000146648	.	nonsynonymous SNV	ENSG00000146648:ENST00000455089:exon18:c.C2122T:p.P708S,ENSG00000146648:ENST00000275493:exon19:c.C2257T:p.P753S,ENSG00000146648:ENST00000454757:exon19:c.C2098T:p.P700S	exonic	EGFR	.	nonsynonymous SNV	EGFR:uc010kzg.2:exon18:c.C2122T:p.P708S,EGFR:uc022adn.1:exon18:c.C2122T:p.P708S,EGFR:uc003tqk.3:exon19:c.C2257T:p.P753S,EGFR:uc011kco.2:exon19:c.C2098T:p.P700S,EGFR:uc022adm.1:exon19:c.C2257T:p.P753S	.	.	8.243e-06	0	0	0.0001	0	0	0	0	rs121913231	0.013	D	0.949	P	0.748	P	0.000	D	1	D	0.08	N	-1.5	D	-6.57	D	0.668	5.180	25.5	0.998	0.985	D	-0.053	T	0.412	T	0.653	0	5.45	0.871	0.935	0.991	0.479	17.840	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM6268;OCCURENCE=1(large_intestine),1(skin),1(haematopoietic_and_lymphoid_tissue)	MU31643573	SKCM-US|1|335|0.00299	Skin Squamous Cell Carcinoma
7	55242511	55242511	G	T	exonic	EGFR	.	nonsynonymous SNV	EGFR:NM_005228:exon19:c.G2281T:p.D761Y	exonic	ENSG00000146648	.	nonsynonymous SNV	ENSG00000146648:ENST00000455089:exon18:c.G2146T:p.D716Y,ENSG00000146648:ENST00000275493:exon19:c.G2281T:p.D761Y,ENSG00000146648:ENST00000454757:exon19:c.G2122T:p.D708Y	exonic	EGFR	.	nonsynonymous SNV	EGFR:uc010kzg.2:exon18:c.G2146T:p.D716Y,EGFR:uc022adn.1:exon18:c.G2146T:p.D716Y,EGFR:uc003tqk.3:exon19:c.G2281T:p.D761Y,EGFR:uc011kco.2:exon19:c.G2122T:p.D708Y,EGFR:uc022adm.1:exon19:c.G2281T:p.D761Y	.	.	.	.	.	.	.	.	.	.	rs121913418	0.0	D	1.0	D	0.999	D	0.000	D	1	D	0.88	L	-1.66	D	-7.88	D	0.882	7.250	34	0.995	0.996	D	0.305	D	0.605	D	0.653	0	5.45	0.917	1.048	0.998	0.796	17.840	0.9703	0.782	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Uncertain significance	not_specified	RCV000038400.2	MedGen	CN169374	ID=COSM21984;OCCURENCE=4(lung)	.	.	NSCLC
7	55249005	55249005	G	T	exonic	EGFR	.	nonsynonymous SNV	EGFR:NM_005228:exon20:c.G2303T:p.S768I	exonic	ENSG00000146648	.	nonsynonymous SNV	ENSG00000146648:ENST00000455089:exon19:c.G2168T:p.S723I,ENSG00000146648:ENST00000275493:exon20:c.G2303T:p.S768I,ENSG00000146648:ENST00000454757:exon20:c.G2144T:p.S715I	exonic	EGFR	.	nonsynonymous SNV	EGFR:uc022ado.1:exon1:c.G8T:p.S3I,EGFR:uc010kzg.2:exon19:c.G2168T:p.S723I,EGFR:uc022adn.1:exon19:c.G2168T:p.S723I,EGFR:uc003tqk.3:exon20:c.G2303T:p.S768I,EGFR:uc011kco.2:exon20:c.G2144T:p.S715I,EGFR:uc022adm.1:exon20:c.G2303T:p.S768I	.	.	.	.	.	.	.	.	.	.	rs121913465	0.002	D	1.0	D	0.999	D	0.000	D	1	D	1.995	M	-1.7	D	-4.84	D	0.845	6.143	28.4	0.996	0.987	D	0.454	D	0.698	D	0.653	0	5.85	0.917	1.048	0.999	0.992	18.727	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic	Non-small_cell_lung_cancer	RCV000038407.2	MeSH:MedGen:SNOMED_CT	D002289:C0007131:254637007	ID=COSM6241;OCCURENCE=30(lung),1(oesophagus),1(central_nervous_system),1(prostate)	.	.	LUAD
7	55249071	55249071	C	T	exonic;exonic;exonic	EGFR	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	EGFR:NM_005228:exon20:c.C2369T:p.T790M;EGFR:NM_005228:exon20:c.C2369T:p.T790M;EGFR:NM_005228:exon20:c.C2369T:p.T790M	exonic;exonic;exonic	ENSG00000146648	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000146648:ENST00000455089:exon19:c.C2234T:p.T745M,ENSG00000146648:ENST00000275493:exon20:c.C2369T:p.T790M,ENSG00000146648:ENST00000454757:exon20:c.C2210T:p.T737M;ENSG00000146648:ENST00000455089:exon19:c.C2234T:p.T745M,ENSG00000146648:ENST00000275493:exon20:c.C2369T:p.T790M,ENSG00000146648:ENST00000454757:exon20:c.C2210T:p.T737M;ENSG00000146648:ENST00000455089:exon19:c.C2234T:p.T745M,ENSG00000146648:ENST00000275493:exon20:c.C2369T:p.T790M,ENSG00000146648:ENST00000454757:exon20:c.C2210T:p.T737M	exonic;exonic;exonic	EGFR	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	EGFR:uc022ado.1:exon1:c.C74T:p.T25M,EGFR:uc010kzg.2:exon19:c.C2234T:p.T745M,EGFR:uc022adn.1:exon19:c.C2234T:p.T745M,EGFR:uc003tqk.3:exon20:c.C2369T:p.T790M,EGFR:uc011kco.2:exon20:c.C2210T:p.T737M,EGFR:uc022adm.1:exon20:c.C2369T:p.T790M;EGFR:uc022ado.1:exon1:c.C74T:p.T25M,EGFR:uc010kzg.2:exon19:c.C2234T:p.T745M,EGFR:uc022adn.1:exon19:c.C2234T:p.T745M,EGFR:uc003tqk.3:exon20:c.C2369T:p.T790M,EGFR:uc011kco.2:exon20:c.C2210T:p.T737M,EGFR:uc022adm.1:exon20:c.C2369T:p.T790M;EGFR:uc022ado.1:exon1:c.C74T:p.T25M,EGFR:uc010kzg.2:exon19:c.C2234T:p.T745M,EGFR:uc022adn.1:exon19:c.C2234T:p.T745M,EGFR:uc003tqk.3:exon20:c.C2369T:p.T790M,EGFR:uc011kco.2:exon20:c.C2210T:p.T737M,EGFR:uc022adm.1:exon20:c.C2369T:p.T790M	.	.	4.122e-05	9.63e-05	0	0	0	6e-05	0	0	rs121434569	0.003	D	1.0	D	1.0	D	0.000	D	1	A	1.17	L	0.24	T	-5.22	D	0.923	7.364	34	0.999	0.941	D	-0.467	T	0.317	T	0.653	0	5.92	0.871	0.935	0.982	0.986	18.872	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	other|drug response|Likely pathogenic|drug response|drug response	Nonsmall_cell_lung_cancer,_resistance_to_tyrosine_kinase_inhibitor_in|Tyrosine_kinase_inhibitor_response|Non-small_cell_lung_cancer|gefitinib_response_-_Efficacy|erlotinib_response_-_Efficacy	RCV000018088.28|RCV000154232.1|RCV000154233.1|RCV000211140.1|RCV000211319.1	MedGen|MedGen|MeSH:MedGen:SNOMED_CT|MedGen|MedGen	C4016033|CN225347|D002289:C0007131:254637007|CN236558|CN236552	ID=COSM6240;OCCURENCE=1(biliary_tract),1(large_intestine),1(soft_tissue),341(lung),2(upper_aerodigestive_tract),1(central_nervous_system)	.	.	LUAD
7	55249071	55249071	C	T	exonic;exonic;exonic	EGFR	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	EGFR:NM_005228:exon20:c.C2369T:p.T790M;EGFR:NM_005228:exon20:c.C2369T:p.T790M;EGFR:NM_005228:exon20:c.C2369T:p.T790M	exonic;exonic;exonic	ENSG00000146648	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000146648:ENST00000455089:exon19:c.C2234T:p.T745M,ENSG00000146648:ENST00000275493:exon20:c.C2369T:p.T790M,ENSG00000146648:ENST00000454757:exon20:c.C2210T:p.T737M;ENSG00000146648:ENST00000455089:exon19:c.C2234T:p.T745M,ENSG00000146648:ENST00000275493:exon20:c.C2369T:p.T790M,ENSG00000146648:ENST00000454757:exon20:c.C2210T:p.T737M;ENSG00000146648:ENST00000455089:exon19:c.C2234T:p.T745M,ENSG00000146648:ENST00000275493:exon20:c.C2369T:p.T790M,ENSG00000146648:ENST00000454757:exon20:c.C2210T:p.T737M	exonic;exonic;exonic	EGFR	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	EGFR:uc022ado.1:exon1:c.C74T:p.T25M,EGFR:uc010kzg.2:exon19:c.C2234T:p.T745M,EGFR:uc022adn.1:exon19:c.C2234T:p.T745M,EGFR:uc003tqk.3:exon20:c.C2369T:p.T790M,EGFR:uc011kco.2:exon20:c.C2210T:p.T737M,EGFR:uc022adm.1:exon20:c.C2369T:p.T790M;EGFR:uc022ado.1:exon1:c.C74T:p.T25M,EGFR:uc010kzg.2:exon19:c.C2234T:p.T745M,EGFR:uc022adn.1:exon19:c.C2234T:p.T745M,EGFR:uc003tqk.3:exon20:c.C2369T:p.T790M,EGFR:uc011kco.2:exon20:c.C2210T:p.T737M,EGFR:uc022adm.1:exon20:c.C2369T:p.T790M;EGFR:uc022ado.1:exon1:c.C74T:p.T25M,EGFR:uc010kzg.2:exon19:c.C2234T:p.T745M,EGFR:uc022adn.1:exon19:c.C2234T:p.T745M,EGFR:uc003tqk.3:exon20:c.C2369T:p.T790M,EGFR:uc011kco.2:exon20:c.C2210T:p.T737M,EGFR:uc022adm.1:exon20:c.C2369T:p.T790M	.	.	4.122e-05	9.63e-05	0	0	0	6e-05	0	0	rs121434569	0.003	D	1.0	D	1.0	D	0.000	D	1	A	1.17	L	0.24	T	-5.22	D	0.923	7.364	34	0.999	0.941	D	-0.467	T	0.317	T	0.653	0	5.92	0.871	0.935	0.982	0.986	18.872	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	other|drug response|Likely pathogenic|drug response|drug response	Nonsmall_cell_lung_cancer,_resistance_to_tyrosine_kinase_inhibitor_in|Tyrosine_kinase_inhibitor_response|Non-small_cell_lung_cancer|gefitinib_response_-_Efficacy|erlotinib_response_-_Efficacy	RCV000018088.28|RCV000154232.1|RCV000154233.1|RCV000211140.1|RCV000211319.1	MedGen|MedGen|MeSH:MedGen:SNOMED_CT|MedGen|MedGen	C4016033|CN225347|D002289:C0007131:254637007|CN236558|CN236552	ID=COSM6240;OCCURENCE=1(biliary_tract),1(large_intestine),1(soft_tissue),341(lung),2(upper_aerodigestive_tract),1(central_nervous_system)	.	.	L
7	55249071	55249071	C	T	exonic;exonic;exonic	EGFR	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	EGFR:NM_005228:exon20:c.C2369T:p.T790M;EGFR:NM_005228:exon20:c.C2369T:p.T790M;EGFR:NM_005228:exon20:c.C2369T:p.T790M	exonic;exonic;exonic	ENSG00000146648	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000146648:ENST00000455089:exon19:c.C2234T:p.T745M,ENSG00000146648:ENST00000275493:exon20:c.C2369T:p.T790M,ENSG00000146648:ENST00000454757:exon20:c.C2210T:p.T737M;ENSG00000146648:ENST00000455089:exon19:c.C2234T:p.T745M,ENSG00000146648:ENST00000275493:exon20:c.C2369T:p.T790M,ENSG00000146648:ENST00000454757:exon20:c.C2210T:p.T737M;ENSG00000146648:ENST00000455089:exon19:c.C2234T:p.T745M,ENSG00000146648:ENST00000275493:exon20:c.C2369T:p.T790M,ENSG00000146648:ENST00000454757:exon20:c.C2210T:p.T737M	exonic;exonic;exonic	EGFR	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	EGFR:uc022ado.1:exon1:c.C74T:p.T25M,EGFR:uc010kzg.2:exon19:c.C2234T:p.T745M,EGFR:uc022adn.1:exon19:c.C2234T:p.T745M,EGFR:uc003tqk.3:exon20:c.C2369T:p.T790M,EGFR:uc011kco.2:exon20:c.C2210T:p.T737M,EGFR:uc022adm.1:exon20:c.C2369T:p.T790M;EGFR:uc022ado.1:exon1:c.C74T:p.T25M,EGFR:uc010kzg.2:exon19:c.C2234T:p.T745M,EGFR:uc022adn.1:exon19:c.C2234T:p.T745M,EGFR:uc003tqk.3:exon20:c.C2369T:p.T790M,EGFR:uc011kco.2:exon20:c.C2210T:p.T737M,EGFR:uc022adm.1:exon20:c.C2369T:p.T790M;EGFR:uc022ado.1:exon1:c.C74T:p.T25M,EGFR:uc010kzg.2:exon19:c.C2234T:p.T745M,EGFR:uc022adn.1:exon19:c.C2234T:p.T745M,EGFR:uc003tqk.3:exon20:c.C2369T:p.T790M,EGFR:uc011kco.2:exon20:c.C2210T:p.T737M,EGFR:uc022adm.1:exon20:c.C2369T:p.T790M	.	.	4.122e-05	9.63e-05	0	0	0	6e-05	0	0	rs121434569	0.003	D	1.0	D	1.0	D	0.000	D	1	A	1.17	L	0.24	T	-5.22	D	0.923	7.364	34	0.999	0.941	D	-0.467	T	0.317	T	0.653	0	5.92	0.871	0.935	0.982	0.986	18.872	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	other|drug response|Likely pathogenic|drug response|drug response	Nonsmall_cell_lung_cancer,_resistance_to_tyrosine_kinase_inhibitor_in|Tyrosine_kinase_inhibitor_response|Non-small_cell_lung_cancer|gefitinib_response_-_Efficacy|erlotinib_response_-_Efficacy	RCV000018088.28|RCV000154232.1|RCV000154233.1|RCV000211140.1|RCV000211319.1	MedGen|MedGen|MeSH:MedGen:SNOMED_CT|MedGen|MedGen	C4016033|CN225347|D002289:C0007131:254637007|CN236558|CN236552	ID=COSM6240;OCCURENCE=1(biliary_tract),1(large_intestine),1(soft_tissue),341(lung),2(upper_aerodigestive_tract),1(central_nervous_system)	.	.	NSCLC
7	55249091	55249091	T	A	exonic;exonic	EGFR	.	nonsynonymous SNV;nonsynonymous SNV	EGFR:NM_005228:exon20:c.T2389A:p.C797S;EGFR:NM_005228:exon20:c.T2389A:p.C797S	exonic;exonic	ENSG00000146648	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000146648:ENST00000455089:exon19:c.T2254A:p.C752S,ENSG00000146648:ENST00000275493:exon20:c.T2389A:p.C797S,ENSG00000146648:ENST00000454757:exon20:c.T2230A:p.C744S;ENSG00000146648:ENST00000455089:exon19:c.T2254A:p.C752S,ENSG00000146648:ENST00000275493:exon20:c.T2389A:p.C797S,ENSG00000146648:ENST00000454757:exon20:c.T2230A:p.C744S	exonic;exonic	EGFR	.	nonsynonymous SNV;nonsynonymous SNV	EGFR:uc022ado.1:exon1:c.T94A:p.C32S,EGFR:uc010kzg.2:exon19:c.T2254A:p.C752S,EGFR:uc022adn.1:exon19:c.T2254A:p.C752S,EGFR:uc003tqk.3:exon20:c.T2389A:p.C797S,EGFR:uc011kco.2:exon20:c.T2230A:p.C744S,EGFR:uc022adm.1:exon20:c.T2389A:p.C797S;EGFR:uc022ado.1:exon1:c.T94A:p.C32S,EGFR:uc010kzg.2:exon19:c.T2254A:p.C752S,EGFR:uc022adn.1:exon19:c.T2254A:p.C752S,EGFR:uc003tqk.3:exon20:c.T2389A:p.C797S,EGFR:uc011kco.2:exon20:c.T2230A:p.C744S,EGFR:uc022adm.1:exon20:c.T2389A:p.C797S	.	.	.	.	.	.	.	.	.	.	.	0.397	T	0.989	D	0.83	P	0.000	D	1	D	-1.725	N	0.46	T	-7.93	D	0.942	4.789	24.7	0.959	0.956	D	-0.700	T	0.084	T	0.653	0	5.92	0.991	1.061	0.998	0.995	15.177	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	.	.	.	LUAD
7	55249091	55249091	T	A	exonic;exonic	EGFR	.	nonsynonymous SNV;nonsynonymous SNV	EGFR:NM_005228:exon20:c.T2389A:p.C797S;EGFR:NM_005228:exon20:c.T2389A:p.C797S	exonic;exonic	ENSG00000146648	.	nonsynonymous SNV;nonsynonymous SNV	ENSG00000146648:ENST00000455089:exon19:c.T2254A:p.C752S,ENSG00000146648:ENST00000275493:exon20:c.T2389A:p.C797S,ENSG00000146648:ENST00000454757:exon20:c.T2230A:p.C744S;ENSG00000146648:ENST00000455089:exon19:c.T2254A:p.C752S,ENSG00000146648:ENST00000275493:exon20:c.T2389A:p.C797S,ENSG00000146648:ENST00000454757:exon20:c.T2230A:p.C744S	exonic;exonic	EGFR	.	nonsynonymous SNV;nonsynonymous SNV	EGFR:uc022ado.1:exon1:c.T94A:p.C32S,EGFR:uc010kzg.2:exon19:c.T2254A:p.C752S,EGFR:uc022adn.1:exon19:c.T2254A:p.C752S,EGFR:uc003tqk.3:exon20:c.T2389A:p.C797S,EGFR:uc011kco.2:exon20:c.T2230A:p.C744S,EGFR:uc022adm.1:exon20:c.T2389A:p.C797S;EGFR:uc022ado.1:exon1:c.T94A:p.C32S,EGFR:uc010kzg.2:exon19:c.T2254A:p.C752S,EGFR:uc022adn.1:exon19:c.T2254A:p.C752S,EGFR:uc003tqk.3:exon20:c.T2389A:p.C797S,EGFR:uc011kco.2:exon20:c.T2230A:p.C744S,EGFR:uc022adm.1:exon20:c.T2389A:p.C797S	.	.	.	.	.	.	.	.	.	.	.	0.397	T	0.989	D	0.83	P	0.000	D	1	D	-1.725	N	0.46	T	-7.93	D	0.942	4.789	24.7	0.959	0.956	D	-0.700	T	0.084	T	0.653	0	5.92	0.991	1.061	0.998	0.995	15.177	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	.	.	.	NSCLC
7	6022512	6022512	T	-	exonic	PMS2	.	frameshift deletion	PMS2:NM_000535:exon12:c.2117delA:p.K706fs	exonic	ENSG00000122512	.	frameshift deletion	ENSG00000122512:ENST00000382321:exon8:c.914delA:p.K305fs,ENSG00000122512:ENST00000441476:exon9:c.1799delA:p.K600fs,ENSG00000122512:ENST00000265849:exon12:c.2117delA:p.K706fs	exonic	PMS2	.	frameshift deletion	PMS2:uc010kte.3:exon8:c.914delA:p.K305fs,PMS2:uc003spj.3:exon9:c.1799delA:p.K600fs,PMS2:uc011jwl.2:exon11:c.1712delA:p.K571fs,PMS2:uc003spk.3:exon12:c.1712delA:p.K571fs,PMS2:uc003spl.3:exon12:c.2117delA:p.K706fs,PMS2:uc010ktg.3:exon12:c.1184delA:p.K395fs	.	.	.	.	.	.	.	.	.	.	rs587782704	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic|Pathogenic|Pathogenic	Hereditary_cancer-predisposing_syndrome|not_provided|Lynch_syndrome	RCV000132155.2|RCV000221406.1|RCV000228992.1	MedGen:SNOMED_CT|MedGen|MedGen:Orphanet:SNOMED_CT	C0027672:699346009|CN221809|C1333990:ORPHA144:315058005	.	.	.	GBM
7	6426892	6426892	C	T	exonic	RAC1	.	nonsynonymous SNV	RAC1:NM_006908:exon2:c.C85T:p.P29S,RAC1:NM_018890:exon2:c.C85T:p.P29S	exonic	ENSG00000136238	.	nonsynonymous SNV	ENSG00000136238:ENST00000348035:exon2:c.C85T:p.P29S,ENSG00000136238:ENST00000356142:exon2:c.C85T:p.P29S	exonic	RAC1	.	nonsynonymous SNV	RAC1:uc003spw.3:exon2:c.C85T:p.P29S,RAC1:uc003spx.3:exon2:c.C85T:p.P29S	.	.	.	.	.	.	.	.	.	.	.	0.0	D	0.936	P	0.846	P	0.000	D	1	D	1.77	L	-1.0	T	-7.27	D	0.687	6.512	31	0.999	0.992	D	-0.013	T	0.517	D	0.554	0	6.05	0.871	0.925	0.999	0.979	20.212	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	.	.	.	.	.	ID=COSM1167878,COSM125734;OCCURENCE=3(NS),1(upper_aerodigestive_tract),1(breast),38(skin),1(endometrium)	MU1853156	SKCA-BR|2|66|0.03030,SKCM-US|10|335|0.02985,UCEC-US|1|246|0.00407,MELA-AU|4|183|0.02186	M
7	87138645	87138645	A	G	exonic;exonic	ABCB1	.	synonymous SNV;synonymous SNV	ABCB1:NM_000927:exon27:c.T3435C:p.I1145I;ABCB1:NM_000927:exon27:c.T3435C:p.I1145I	exonic;exonic	ENSG00000085563	.	synonymous SNV;synonymous SNV	ENSG00000085563:ENST00000543898:exon24:c.T3243C:p.I1081I,ENSG00000085563:ENST00000265724:exon27:c.T3435C:p.I1145I;ENSG00000085563:ENST00000543898:exon24:c.T3243C:p.I1081I,ENSG00000085563:ENST00000265724:exon27:c.T3435C:p.I1145I	exonic;exonic	ABCB1	.	synonymous SNV;synonymous SNV	ABCB1:uc011khc.2:exon24:c.T3243C:p.I1081I,ABCB1:uc003uiz.2:exon27:c.T3435C:p.I1145I;ABCB1:uc011khc.2:exon24:c.T3243C:p.I1081I,ABCB1:uc003uiz.2:exon27:c.T3435C:p.I1145I	0.5767	0.604832	0.5034	0.7980	0.5467	0.6245	0.3895	0.4719	0.4890	0.3981	rs1045642	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	drug response|drug response|drug response|drug response|drug response|drug response|drug response|drug response|drug response|drug response	ondansetron_response_-_Efficacy|oxycodone_response_-_Dosage|methadone_response_-_Dosage|methotrexate_response_-_Toxicity/ADR|nevirapine_response_-_Toxicity/ADR|tramadol_response_-_Dosage|morphine_response_-_Dosage|digoxin_response_-_Other|opioids_response_-_Dosage|fentanyl_response_-_Dosage	RCV000211142.1|RCV000211170.1|RCV000211173.1|RCV000211266.1|RCV000211276.1|RCV000211291.1|RCV000211300.1|RCV000211363.1|RCV000211388.1|RCV000211389.1	MedGen|MedGen|MedGen|MedGen|MedGen|MedGen|MedGen|MedGen|MedGen|MedGen	CN236569|CN236540|CN236536|CN236607|CN236609|CN236548|CN236537|CN236525|CN236539|CN236531	.	.	.	BRACA
7	87138645	87138645	A	G	exonic;exonic	ABCB1	.	synonymous SNV;synonymous SNV	ABCB1:NM_000927:exon27:c.T3435C:p.I1145I;ABCB1:NM_000927:exon27:c.T3435C:p.I1145I	exonic;exonic	ENSG00000085563	.	synonymous SNV;synonymous SNV	ENSG00000085563:ENST00000543898:exon24:c.T3243C:p.I1081I,ENSG00000085563:ENST00000265724:exon27:c.T3435C:p.I1145I;ENSG00000085563:ENST00000543898:exon24:c.T3243C:p.I1081I,ENSG00000085563:ENST00000265724:exon27:c.T3435C:p.I1145I	exonic;exonic	ABCB1	.	synonymous SNV;synonymous SNV	ABCB1:uc011khc.2:exon24:c.T3243C:p.I1081I,ABCB1:uc003uiz.2:exon27:c.T3435C:p.I1145I;ABCB1:uc011khc.2:exon24:c.T3243C:p.I1081I,ABCB1:uc003uiz.2:exon27:c.T3435C:p.I1145I	0.5767	0.604832	0.5034	0.7980	0.5467	0.6245	0.3895	0.4719	0.4890	0.3981	rs1045642	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	drug response|drug response|drug response|drug response|drug response|drug response|drug response|drug response|drug response|drug response	ondansetron_response_-_Efficacy|oxycodone_response_-_Dosage|methadone_response_-_Dosage|methotrexate_response_-_Toxicity/ADR|nevirapine_response_-_Toxicity/ADR|tramadol_response_-_Dosage|morphine_response_-_Dosage|digoxin_response_-_Other|opioids_response_-_Dosage|fentanyl_response_-_Dosage	RCV000211142.1|RCV000211170.1|RCV000211173.1|RCV000211266.1|RCV000211276.1|RCV000211291.1|RCV000211300.1|RCV000211363.1|RCV000211388.1|RCV000211389.1	MedGen|MedGen|MedGen|MedGen|MedGen|MedGen|MedGen|MedGen|MedGen|MedGen	CN236569|CN236540|CN236536|CN236607|CN236609|CN236548|CN236537|CN236525|CN236539|CN236531	.	.	.	NSCLC
7	87160618	87160618	A	C	exonic	ABCB1	.	nonsynonymous SNV	ABCB1:NM_000927:exon22:c.T2677G:p.S893A	exonic	ENSG00000085563	.	nonsynonymous SNV	ENSG00000085563:ENST00000543898:exon19:c.T2485G:p.S829A,ENSG00000085563:ENST00000265724:exon22:c.T2677G:p.S893A	exonic	ABCB1	.	nonsynonymous SNV	ABCB1:uc011khc.2:exon19:c.T2485G:p.S829A,ABCB1:uc003uiz.2:exon22:c.T2677G:p.S893A	0.6781	0.617013	0.5432	0.9101	0.5395	0.4653	0.4700	0.5523	0.5187	0.3496	rs2032582	1.0	T	0.0	B	0.005	B	0.000	N	0.999	P	-0.98	N	-2.24	D	1.7	N	0.057	0.796	9.437	0.332	0.315	N	-0.903	T	0.000	T	0.615	0	3.72	-1.295	-0.466	0.988	0.985	14.563	.	.	ABC transporter type 1, transmembrane domain	Benign|drug response|drug response,Benign	not_specified|ondansetron_response_-_Efficacy|simvastatin_response_-_Efficacy,not_specified	RCV000152717.3|RCV000211207.1|RCV000211425.1,RCV000152713.3	MedGen|MedGen|MedGen,MedGen	CN169374|CN236569|CN236582,CN169374	.	.	.	BRACA
7	87160618	87160618	A	T	exonic	ABCB1	.	nonsynonymous SNV	ABCB1:NM_000927:exon22:c.T2677A:p.S893T	exonic	ENSG00000085563	.	nonsynonymous SNV	ENSG00000085563:ENST00000543898:exon19:c.T2485A:p.S829T,ENSG00000085563:ENST00000265724:exon22:c.T2677A:p.S893T	exonic	ABCB1	.	nonsynonymous SNV	ABCB1:uc011khc.2:exon19:c.T2485A:p.S829T,ABCB1:uc003uiz.2:exon22:c.T2677A:p.S893T	.	0.048722	0.0371	0.0045	0.0571	0.1393	0.0344	0.0244	0.0297	0.0434	rs2032582	0.027	D	0.001	B	0.07	B	0.000	D	0.997	N	1.66	L	-2.58	D	-1.1	N	0.197	3.597	23.2	0.962	0.789	D	-0.264	T	0.614	D	0.615	0	3.72	-1.295	-0.466	0.988	0.985	14.563	.	.	ABC transporter type 1, transmembrane domain	Benign|drug response|drug response,Benign	not_specified|ondansetron_response_-_Efficacy|simvastatin_response_-_Efficacy,not_specified	RCV000152717.3|RCV000211207.1|RCV000211425.1,RCV000152713.3	MedGen|MedGen|MedGen,MedGen	CN169374|CN236569|CN236582,CN169374	.	.	.	OV-PR
8	38274849	38274849	G	T	exonic	FGFR1	.	nonsynonymous SNV	FGFR1:NM_001174066:exon11:c.C1371A:p.N457K,FGFR1:NM_023105:exon11:c.C1371A:p.N457K,FGFR1:NM_023106:exon11:c.C1365A:p.N455K,FGFR1:NM_001174063:exon12:c.C1632A:p.N544K,FGFR1:NM_001174065:exon12:c.C1632A:p.N544K,FGFR1:NM_015850:exon12:c.C1632A:p.N544K,FGFR1:NM_023110:exon12:c.C1638A:p.N546K,FGFR1:NM_001174064:exon13:c.C1608A:p.N536K,FGFR1:NM_001174067:exon13:c.C1731A:p.N577K	exonic	ENSG00000077782	.	nonsynonymous SNV	ENSG00000077782:ENST00000397103:exon10:c.C1371A:p.N457K,ENSG00000077782:ENST00000326324:exon11:c.C1365A:p.N455K,ENSG00000077782:ENST00000356207:exon11:c.C1371A:p.N457K,ENSG00000077782:ENST00000341462:exon12:c.C1638A:p.N546K,ENSG00000077782:ENST00000397091:exon12:c.C1632A:p.N544K,ENSG00000077782:ENST00000397113:exon12:c.C1632A:p.N544K,ENSG00000077782:ENST00000447712:exon12:c.C1638A:p.N546K,ENSG00000077782:ENST00000532791:exon12:c.C1632A:p.N544K,ENSG00000077782:ENST00000335922:exon13:c.C1608A:p.N536K,ENSG00000077782:ENST00000397108:exon13:c.C1632A:p.N544K,ENSG00000077782:ENST00000425967:exon13:c.C1731A:p.N577K	exonic	FGFR1	.	nonsynonymous SNV	FGFR1:uc011lbw.2:exon11:c.C1371A:p.N457K,FGFR1:uc022auc.1:exon11:c.C1371A:p.N457K,FGFR1:uc022aud.1:exon11:c.C1365A:p.N455K,FGFR1:uc003xlp.3:exon12:c.C1632A:p.N544K,FGFR1:uc011lbv.2:exon12:c.C1632A:p.N544K,FGFR1:uc022aua.1:exon12:c.C1638A:p.N546K,FGFR1:uc022aub.1:exon12:c.C1632A:p.N544K,FGFR1:uc010lwk.3:exon13:c.C1608A:p.N536K,FGFR1:uc011lbu.2:exon13:c.C1731A:p.N577K	.	.	.	.	.	.	.	.	.	.	.	0.0	D	1.0	D	1.0	D	0.000	D	1	D	-0.21	N	-2.7	D	-5.15	D	0.402	6.413	29.7	0.999	0.949	D	0.313	D	0.621	D	0.722	0	3.76	0.917	1.048	0.999	1.000	9.313	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM3670398,COSM1284966,COSM1284968,COSM1284967,COSM19176;OCCURENCE=5(central_nervous_system),1(autonomic_ganglia)	MU1698207	NBL-US|1|108|0.00926,PBCA-DE|3|246|0.01220	Bone Ewings Sarcoma
9	133738363	133738363	G	A	exonic	ABL1	.	nonsynonymous SNV	ABL1:NM_005157:exon4:c.G763A:p.E255K,ABL1:NM_007313:exon4:c.G820A:p.E274K	exonic	ENSG00000097007	.	nonsynonymous SNV	ENSG00000097007:ENST00000318560:exon4:c.G763A:p.E255K,ENSG00000097007:ENST00000372348:exon4:c.G820A:p.E274K	exonic	ABL1	.	nonsynonymous SNV	ABL1:uc004bzv.3:exon4:c.G820A:p.E274K,ABL1:uc004bzw.3:exon4:c.G763A:p.E255K	.	.	.	.	.	.	.	.	.	.	rs121913448	0.001	D	1.0	D	0.996	D	0.000	D	1	A	0.785	N	-1.61	D	-3.59	D	0.943	7.269	34	0.999	0.961	D	0.271	D	0.609	D	0.737	0	6.03	0.917	1.043	1.000	1.000	19.612	.	.	Protein kinase domain;Protein kinase, ATP binding site;Protein kinase-like domain;SH2 domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM12573;OCCURENCE=24(haematopoietic_and_lymphoid_tissue)	.	.	CML
9	133748283	133748283	C	T	exonic	ABL1	.	nonsynonymous SNV	ABL1:NM_005157:exon6:c.C944T:p.T315I,ABL1:NM_007313:exon6:c.C1001T:p.T334I	exonic	ENSG00000097007	.	nonsynonymous SNV	ENSG00000097007:ENST00000318560:exon6:c.C944T:p.T315I,ENSG00000097007:ENST00000372348:exon6:c.C1001T:p.T334I	exonic	ABL1	.	nonsynonymous SNV	ABL1:uc004bzv.3:exon6:c.C1001T:p.T334I,ABL1:uc004bzw.3:exon6:c.C944T:p.T315I	.	.	.	.	.	.	.	.	.	.	rs121913459	0.002	D	0.999	D	0.989	D	0.000	D	1	A	0.565	N	-0.02	T	-5.72	D	0.964	6.838	33	0.999	0.967	D	-0.417	T	0.314	T	0.707	0	6.04	0.871	0.935	0.992	0.992	19.583	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic	Leukemia,_Philadelphia_chromosome-positive,_resistant_to_imatinib	RCV000013459.24	MedGen	C4016396	ID=COSM12560;OCCURENCE=60(haematopoietic_and_lymphoid_tissue)	.	.	CML
9	133748288	133748288	T	C	exonic	ABL1	.	nonsynonymous SNV	ABL1:NM_005157:exon6:c.T949C:p.F317L,ABL1:NM_007313:exon6:c.T1006C:p.F336L	exonic	ENSG00000097007	.	nonsynonymous SNV	ENSG00000097007:ENST00000318560:exon6:c.T949C:p.F317L,ENSG00000097007:ENST00000372348:exon6:c.T1006C:p.F336L	exonic	ABL1	.	nonsynonymous SNV	ABL1:uc004bzv.3:exon6:c.T1006C:p.F336L,ABL1:uc004bzw.3:exon6:c.T949C:p.F317L	.	.	.	.	.	.	.	.	.	.	.	0.269	T	0.953	P	0.86	P	0.000	D	1	D	0.395	N	0.13	T	-5.34	D	0.93	5.220	25.6	0.998	0.964	D	-0.647	T	0.221	T	0.707	0	6.04	0.991	1.061	0.998	0.998	15.770	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	ID=COSM49074;OCCURENCE=1(haematopoietic_and_lymphoid_tissue)	.	.	CML
9	139390861	139390861	G	TGT	exonic	NOTCH1	.	frameshift substitution	NOTCH1:NM_017617:exon34:c.7330_7330delinsACA	exonic	ENSG00000148400	.	frameshift substitution	ENSG00000148400:ENST00000277541:exon34:c.7330_7330delinsACA	exonic	NOTCH1	.	frameshift substitution	NOTCH1:uc004chz.3:exon34:c.7330_7330delinsACA	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	NSCLC
9	139391212	139391212	G	A	exonic	NOTCH1	.	nonsynonymous SNV	NOTCH1:NM_017617:exon34:c.C6979T:p.R2327W	exonic	ENSG00000148400	.	nonsynonymous SNV	ENSG00000148400:ENST00000277541:exon34:c.C6979T:p.R2327W	exonic	NOTCH1	.	nonsynonymous SNV	NOTCH1:uc004chz.3:exon34:c.C6979T:p.R2327W	.	.	1.702e-05	0	8.673e-05	0	0	0	0	6.061e-05	rs751007903	0.185	T	0.999	D	0.794	P	0.000	D	1.000	D	0.55	N	-1.56	D	-2.1	N	0.725	5.012	25.1	0.999	0.911	D	-0.204	T	0.452	T	0.672	0	2.02	-0.788	1.048	0.031	0.022	14.245	.	.	.	.	.	.	.	.	ID=COSM43356,COSM120008;OCCURENCE=1(ovary),2(large_intestine),1(lung)	.	.	NSCLC
9	139391369	139391370	-	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	NSCLC
9	139399219	139399219	C	G	exonic	NOTCH1	.	nonsynonymous SNV	NOTCH1:NM_017617:exon26:c.G4924C:p.D1642H	exonic	ENSG00000148400	.	nonsynonymous SNV	ENSG00000148400:ENST00000277541:exon26:c.G4924C:p.D1642H	exonic	NOTCH1	.	nonsynonymous SNV	NOTCH1:uc004cia.1:exon13:c.G2614C:p.D872H,NOTCH1:uc004chz.3:exon26:c.G4924C:p.D1642H	.	.	.	.	.	.	.	.	.	.	.	0.086	T	0.0	B	0.001	B	0.273	U	1	N	0	N	-1.63	D	-0.56	N	0.127	-0.745	0.057	0.335	0.206	N	-0.883	T	0.239	T	0.672	0	0.901	0.666	-0.142	0.001	0.000	4.002	.	.	.	.	.	.	.	.	ID=COSM43355;OCCURENCE=1(lung)	.	.	NSCLC
9	21975017	21975017	C	T	UTR5	CDKN2A	NM_001195132:c.-191G>A,NM_000077:c.-191G>A	.	.	UTR5	ENSG00000147889	ENST00000304494:c.-191G>A,ENST00000446177:c.-191G>A	.	.	UTR5	CDKN2A	uc010miu.3:c.-191G>A,uc003zpk.3:c.-191G>A	.	.	.	0.487819	.	.	.	.	.	.	.	.	rs3814960	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	ESSC
9	5070053	5070054	-	G	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Skin Melanoma
9	5073770	5073770	G	T	exonic;exonic;exonic;exonic	JAK2	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F	exonic;exonic;exonic;exonic	ENSG00000096968	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F	exonic;exonic;exonic;exonic	JAK2	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F	0.0002	.	0.0007	0.0006	0.0003	0.0006	0.0005	0.0008	0	0.0005	rs77375493	0.002	D	0.996	D	0.934	D	0.000	D	1	D	2	M	-1.69	D	-3.86	D	0.94	6.874	33	0.995	0.945	D	0.442	D	0.681	D	0.653	0	5.51	0.917	0.980	1.000	1.000	19.407	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic,Pathogenic|Pathogenic|Pathogenic|other|Pathogenic|other	Thrombocythemia_3,Polycythemia_vera|Myelofibrosis|Acute_myeloid_leukemia|Budd-Chiari_syndrome,_susceptibility_to,_somatic|Thrombocythemia_3|Familial_erythrocytosis,_1	RCV000022629.25,RCV000015769.7|RCV000015770.7|RCV000015771.7|RCV000015772.68|RCV000022627.7|RCV000022628.8	MedGen:OMIM,MedGen:OMIM:Orphanet|MedGen:OMIM|MedGen:OMIM:Orphanet:SNOMED_CT|.|MedGen:OMIM|MedGen:OMIM	C3281125:614521,C0032463:263300:ORPHA729|C0001815:254450|C0023467:601626:ORPHA519:17788007|.|C3281125:614521|C1851490:133100	ID=COSM12600;OCCURENCE=1(central_nervous_system),3(lung),33324(haematopoietic_and_lymphoid_tissue)	MU599827	LAML-CN|1|63|0.01587,GBM-US|1|268|0.00373	Bone Marrow Cancer
9	5073770	5073770	G	T	exonic;exonic;exonic;exonic	JAK2	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F	exonic;exonic;exonic;exonic	ENSG00000096968	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F	exonic;exonic;exonic;exonic	JAK2	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F	0.0002	.	0.0007	0.0006	0.0003	0.0006	0.0005	0.0008	0	0.0005	rs77375493	0.002	D	0.996	D	0.934	D	0.000	D	1	D	2	M	-1.69	D	-3.86	D	0.94	6.874	33	0.995	0.945	D	0.442	D	0.681	D	0.653	0	5.51	0.917	0.980	1.000	1.000	19.407	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic,Pathogenic|Pathogenic|Pathogenic|other|Pathogenic|other	Thrombocythemia_3,Polycythemia_vera|Myelofibrosis|Acute_myeloid_leukemia|Budd-Chiari_syndrome,_susceptibility_to,_somatic|Thrombocythemia_3|Familial_erythrocytosis,_1	RCV000022629.25,RCV000015769.7|RCV000015770.7|RCV000015771.7|RCV000015772.68|RCV000022627.7|RCV000022628.8	MedGen:OMIM,MedGen:OMIM:Orphanet|MedGen:OMIM|MedGen:OMIM:Orphanet:SNOMED_CT|.|MedGen:OMIM|MedGen:OMIM	C3281125:614521,C0032463:263300:ORPHA729|C0001815:254450|C0023467:601626:ORPHA519:17788007|.|C3281125:614521|C1851490:133100	ID=COSM12600;OCCURENCE=1(central_nervous_system),3(lung),33324(haematopoietic_and_lymphoid_tissue)	MU599827	LAML-CN|1|63|0.01587,GBM-US|1|268|0.00373	CML
9	5073770	5073770	G	T	exonic;exonic;exonic;exonic	JAK2	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F	exonic;exonic;exonic;exonic	ENSG00000096968	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F	exonic;exonic;exonic;exonic	JAK2	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F	0.0002	.	0.0007	0.0006	0.0003	0.0006	0.0005	0.0008	0	0.0005	rs77375493	0.002	D	0.996	D	0.934	D	0.000	D	1	D	2	M	-1.69	D	-3.86	D	0.94	6.874	33	0.995	0.945	D	0.442	D	0.681	D	0.653	0	5.51	0.917	0.980	1.000	1.000	19.407	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic,Pathogenic|Pathogenic|Pathogenic|other|Pathogenic|other	Thrombocythemia_3,Polycythemia_vera|Myelofibrosis|Acute_myeloid_leukemia|Budd-Chiari_syndrome,_susceptibility_to,_somatic|Thrombocythemia_3|Familial_erythrocytosis,_1	RCV000022629.25,RCV000015769.7|RCV000015770.7|RCV000015771.7|RCV000015772.68|RCV000022627.7|RCV000022628.8	MedGen:OMIM,MedGen:OMIM:Orphanet|MedGen:OMIM|MedGen:OMIM:Orphanet:SNOMED_CT|.|MedGen:OMIM|MedGen:OMIM	C3281125:614521,C0032463:263300:ORPHA729|C0001815:254450|C0023467:601626:ORPHA519:17788007|.|C3281125:614521|C1851490:133100	ID=COSM12600;OCCURENCE=1(central_nervous_system),3(lung),33324(haematopoietic_and_lymphoid_tissue)	MU599827	LAML-CN|1|63|0.01587,GBM-US|1|268|0.00373	Lymphoid Leukemia
9	5073770	5073770	G	T	exonic;exonic;exonic;exonic	JAK2	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F;JAK2:NM_004972:exon14:c.G1849T:p.V617F	exonic;exonic;exonic;exonic	ENSG00000096968	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F;ENSG00000096968:ENST00000544510:exon11:c.G1402T:p.V468F,ENSG00000096968:ENST00000539801:exon13:c.G1849T:p.V617F,ENSG00000096968:ENST00000381652:exon14:c.G1849T:p.V617F	exonic;exonic;exonic;exonic	JAK2	.	nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV;nonsynonymous SNV	JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F;JAK2:uc010mhm.3:exon13:c.G1849T:p.V617F,JAK2:uc003ziw.3:exon14:c.G1849T:p.V617F	0.0002	.	0.0007	0.0006	0.0003	0.0006	0.0005	0.0008	0	0.0005	rs77375493	0.002	D	0.996	D	0.934	D	0.000	D	1	D	2	M	-1.69	D	-3.86	D	0.94	6.874	33	0.995	0.945	D	0.442	D	0.681	D	0.653	0	5.51	0.917	0.980	1.000	1.000	19.407	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	Pathogenic,Pathogenic|Pathogenic|Pathogenic|other|Pathogenic|other	Thrombocythemia_3,Polycythemia_vera|Myelofibrosis|Acute_myeloid_leukemia|Budd-Chiari_syndrome,_susceptibility_to,_somatic|Thrombocythemia_3|Familial_erythrocytosis,_1	RCV000022629.25,RCV000015769.7|RCV000015770.7|RCV000015771.7|RCV000015772.68|RCV000022627.7|RCV000022628.8	MedGen:OMIM,MedGen:OMIM:Orphanet|MedGen:OMIM|MedGen:OMIM:Orphanet:SNOMED_CT|.|MedGen:OMIM|MedGen:OMIM	C3281125:614521,C0032463:263300:ORPHA729|C0001815:254450|C0023467:601626:ORPHA519:17788007|.|C3281125:614521|C1851490:133100	ID=COSM12600;OCCURENCE=1(central_nervous_system),3(lung),33324(haematopoietic_and_lymphoid_tissue)	MU599827	LAML-CN|1|63|0.01587,GBM-US|1|268|0.00373	PV
9	80409488	80409488	T	G	exonic	GNAQ	.	nonsynonymous SNV	GNAQ:NM_002072:exon5:c.A626C:p.Q209P	exonic	ENSG00000156052	.	nonsynonymous SNV	ENSG00000156052:ENST00000397476:exon4:c.A20C:p.Q7P,ENSG00000156052:ENST00000286548:exon5:c.A626C:p.Q209P	exonic	GNAQ	.	nonsynonymous SNV	GNAQ:uc011lso.2:exon4:c.A20C:p.Q7P,GNAQ:uc004akw.3:exon5:c.A626C:p.Q209P	.	.	.	.	.	.	.	.	.	.	rs121913492	0.001	D	0.999	D	0.997	D	0.000	D	1	D	3.975	H	-2.81	D	-5.78	D	0.939	5.746	26.9	0.996	0.985	D	1.066	D	0.907	D	0.706	0	5.69	0.991	1.061	0.999	0.999	15.950	.	.	P-loop containing nucleoside triphosphate hydrolase	.	.	.	.	.	ID=COSM28758;OCCURENCE=1(central_nervous_system),1(NS),1(meninges),12(skin),81(eye)	MU4481344	SKCM-US|1|335|0.00299	Skin Melanoma
X	100611165	100611165	A	T	exonic	BTK	.	nonsynonymous SNV	BTK:NM_000061:exon15:c.T1441A:p.C481S,BTK:NM_001287344:exon15:c.T1543A:p.C515S	exonic	ENSG00000010671	.	nonsynonymous SNV	ENSG00000010671:ENST00000308731:exon15:c.T1441A:p.C481S	exonic	BTK	.	nonsynonymous SNV	BTK:uc010nnm.2:exon4:c.T151A:p.C51S,BTK:uc004ehg.2:exon15:c.T1441A:p.C481S,BTK:uc004ehi.3:exon15:c.T1441A:p.C481S,BTK:uc010nno.2:exon15:c.T1543A:p.C515S	.	.	.	.	.	.	.	.	.	.	.	0.307	T	0.981	D	0.897	P	0.000	D	1	D	-2.18	N	-2.08	D	-6.97	D	0.637	3.702	23.3	0.991	0.973	D	0.074	D	0.358	T	.	.	5.63	1.062	1.083	1.000	1.000	14.529	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	.	.	.	.	.	.	.	.	CLL
X	47426121	47426121	C	G	exonic	ARAF	.	nonsynonymous SNV	ARAF:NM_001256196:exon7:c.C650G:p.S217C,ARAF:NM_001654:exon7:c.C641G:p.S214C	exonic	ENSG00000078061	.	nonsynonymous SNV	ENSG00000078061:ENST00000377045:exon7:c.C641G:p.S214C	exonic	ARAF	.	nonsynonymous SNV	ARAF:uc004dic.2:exon7:c.C650G:p.S217C,ARAF:uc011mlo.3:exon7:c.C239G:p.S80C,ARAF:uc011mlp.3:exon7:c.C641G:p.S214C	.	.	.	.	.	.	.	.	.	.	.	0.0	D	0.997	D	0.926	D	0.000	D	1	D	2.415	M	-1.08	T	-3.81	D	0.723	5.211	25.6	0.993	0.974	D	0.336	D	0.610	D	.	.	5.37	0.871	0.881	0.998	0.994	15.417	.	.	.	.	.	.	.	.	.	.	.	NSCLC
X	66943549	66943549	T	C	exonic	AR	.	nonsynonymous SNV	AR:NM_000044:exon8:c.T2629C:p.F877L,AR:NM_001011645:exon8:c.T1033C:p.F345L	exonic	ENSG00000169083	.	nonsynonymous SNV	ENSG00000169083:ENST00000396044:exon5:c.T2195C:p.V732A,ENSG00000169083:ENST00000374690:exon8:c.T2629C:p.F877L,ENSG00000169083:ENST00000396043:exon8:c.T1033C:p.F345L	exonic	AR	.	nonsynonymous SNV	AR:uc022byk.1:exon5:c.T2195C:p.V732A,AR:uc004dwu.2:exon8:c.T2629C:p.F877L,AR:uc004dwv.2:exon8:c.T1033C:p.F345L	.	.	.	.	.	.	.	.	.	.	.	0.001	D	1.0	D	0.999	D	0.000	D	1	D	2.57	M	-4.04	D	-4.58	D	0.86	5.811	27.2	0.999	0.980	D	0.833	D	0.731	D	.	.	5.18	0.991	1.058	1.000	1.000	11.815	.	.	Nuclear hormone receptor, ligand-binding;Nuclear hormone receptor, ligand-binding, core	.	.	.	.	.	.	.	.	PRAD
